,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-40,"October 01, 2016 -  September 30, 2017",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",NULL,"Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Eran  Meshorer (Hebrew University)|Jefferey  Hayes (University of Rochester medical Center)",Joost J Oppenheim; MD (Cancer Inflammation Program),David  Landsman; PhD (NLM),"1. Murphy K, Cutter A, Fang H, Postnikov Y, Bustin M, Hayes J (2017) HMGN1 and 2 Remodel Core And Linker Histone Tail Domains Within Chromatin. Nucleic Acids Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98649
1,BC004504-45,"October 01, 2016 -  September 30, 2017",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Luowei  Li|Christophe  Cataisson|Wendy  Weinberg|Glenn  Merlino; PhD|Peter  Blumberg; PhD,NULL,Giorgio  Trinchieri (Cancer Inflammation Program),Maria Irene Morasso; PhD (NIAMS),"1. Kiss A, Koppel AC, Anders J, Cataisson C, Yuspa SH, Blumenberg M, Efimova T (2016). Keratinocyte p38δ loss inhibits Ras-induced tumor formation, while systemic p38δ loss enhances skin inflammation in the early phase of chemical carcinogenesis in mouse skin. Mol Carcinog  55, 563-74.   https://doi.org/10.1002/mc.22303|2. Palazzo E, Kellett M, Cataisson C, Gormley A, Bible PW, Pietroni V, Radoja N, Hwang J, Blumenberg M, Yuspa SH, Morasso MI (2016). The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth. Oncogene  35, 3114-24.   https://doi.org/10.1038/onc.2015.380",https://intramural.nih.gov/search/searchview.taf?ipid=98650
2,BC004517-41,"October 01, 2016 -  September 30, 2017",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",John  Digiovanna|Sikandar  Khan|Melissa Ann Levoska|Nathaniel Anup Patel,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|N G  Jaspers (Genetics, Erasmus Univ)|Show all 12","Ryusuke  Ono; MD (Dermatology Branch)|Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Michael  Bustin; PhD (Protein Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark  Raffeld; MD (Laboratory of Pathology)","Jennifer M Pugh (OD) |Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Melissa A Merideth (NHGRI) |Carmen Crowell Brewer; PhD (NIDCD)","1. Kraemer K, Sarasin A (2017) Xeroderma Pigmentosum, in WHO Classification of Skin Tumours (4th edition), in press.|2. Tamura D, Kraemer K, DiGiovanna J (2017) Xeroderma Pigmentosum, in Treatment of skin diseases (5th edition), in press.|3. Tamura D, Ono R, DiGiovanna J, Kraemer K (2017) Management of xeroderma pigmentosum, in DNA Repair Disorders, in press.|4. Kuschal C, Botta E, Orioli D, Digiovanna JJ, Seneca S, Keymolen K, Tamura D, Heller E, Khan SG, Caligiuri G, Lanzafame M, Nardo T, Ricotti R, Peverali FA, Stephens R, Zhao Y, Lehmann AR, Baranello L, Levens D, Kraemer KH, Stefanini M (2016). GTF2E2 Mutations Destabilize the General Transcription Factor Complex TFIIE in Individuals with DNA Repair-Proficient Trichothiodystrophy. Am J Hum Genet  98, 627-42.   https://doi.org/10.1016/j.ajhg.2016.02.008|5. Levoska M, Kraemer K, Maoli E, Cohen J, Lee C, Tamura D, DiGiovanna J (2017) Recurrent scarring papulovesicular lesions on sun exposed skin in a 22 year old man. Journal of the American Academy of Dermatology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98651
3,BC005093-39,"October 01, 2016 -  September 30, 2017",Growth-Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Nirmala D Sharma|Kangsun  Yun|Michael David Hall|Heather Marie Wojcik|Susan  Mackem; MD,Harold  Lovvorn (Vanderbilt University)|Mark  de Caestecker (Vanderbilt University),Mark B Lewandoski (Genetics of Vertebrate Development Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|James  Lautenberger; PhD (Office of the Director)|George  Nelson (Office of the Director),NULL,"1. Tanigawa S, Perantoni AO (2016). Modeling renal progenitors - defining the niche. Differentiation  91, 152-8.   https://doi.org/10.1016/j.diff.2016.01.007",https://intramural.nih.gov/search/searchview.taf?ipid=98652
4,BC005177-37,"October 01, 2016 -  September 30, 2017",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mehnaz  Ali,Daniel  Martineau (University of Montreal at St. Hyacinthe)|John  Wise,Qing  Lan (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Daniel C Edelman (Cancer Genetics Branch),Esther Jo Asaki (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98653
5,BC005268-30,"October 01, 2016 -  September 30, 2017",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Darpan Kaustuv Medhi|Hardeep  Kaur; PhD|Jasvinder  Singh; PhD|Martin  Xaver; PhD|Anura Gokul Shodhan; PhD|Catherine Scarlett Harvey,Alastair  Goldman (University of Sheffield)|Soni  Lacefield (Indiana University)|Akira  Shinohara (Osaka University),NULL,NULL,"1. Medhi D, Goldman AS, Lichten M (2016). Local chromosome context is a major determinant of crossover pathway biochemistry during budding yeast meiosis. Elife  5.   https://doi.org/10.7554/eLife.19669|2. Vaid R, Dev K, Lichten M, Sourirajan A (2016). Generation of an inducible system to express polo-like kinase, Cdc5 as TAP fusion protein during meiosis in Saccharomyces cerevisiae. 3 Biotech  6, 185.   https://doi.org/10.1007/s13205-016-0503-x|3. Xue X, Papusha A, Choi K, Bonner JN, Kumar S, Niu H, Kaur H, Zheng XF, Donnianni RA, Lu L, Lichten M, Zhao X, Ira G, Sung P (2016). Differential regulation of the anti-crossover and replication fork regression activities of Mph1 by Mte1. Genes Dev  30, 687-99.   https://doi.org/10.1101/gad.276139.115",https://intramural.nih.gov/search/searchview.taf?ipid=98654
6,BC005270-36,"October 01, 2016 -  September 30, 2017",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Noemi  Kedei|Larry V Pearce|Agnes  Czikora|Adelle  Abramovitz|Xiaoling  Zhou|Gary Alexander Mitchell|Show all 10,"Gary  Keck (Dept. of Chemistry, University of Utah)|Marie  Comin (National Institute of Industrial Technology)|Jeewoo  Lee (Seoul National Univeristy)|Derek C Braun|Sun J Choi|Joydip  Das (University of Houston)|Show all 13",Megan L Peach (Chemical Biology Laboratory)|Lisa Marie Jenkins (Pigment Cell Biology Section),Kenton J Swartz; PhD (NINDS) |Heather R Kalish; PhD (NIBIB),"1. Ann J, Ki Y, Yoon S, Kim MS, Lee JU, Kim C, Lee S, Jung A, Baek J, Hong S, Choi S, Pearce LV, Esch TE, Turcios NA, Lewin NE, Ogunjirin AE, Herold BK, McCall AK, Blumberg PM, Lee J (2016). 2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists. Bioorg Med Chem  24, 1231-40.   https://doi.org/10.1016/j.bmc.2016.01.051|2. Ann J, Sun W, Zhou X, Jung A, Baek J, Lee S, Kim C, Yoon S, Hong S, Choi S, Turcios NA, Herold BK, Esch TE, Lewin NE, Abramovitz A, Pearce LV, Blumberg PM, Lee J (2016). Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template. Bioorg Med Chem Lett  26, 3603-7.   https://doi.org/10.1016/j.bmcl.2016.06.010|3. Baumann DO, McGowan KM, Kedei N, Peach ML, Blumberg PM, Keck GE (2016). Synthesis and Biological Evaluation of Several Bryostatin Analogues Bearing a Diacylglycerol Lactone C-Ring. J Org Chem  81, 7862-83.   https://doi.org/10.1021/acs.joc.6b01516|4. Czikora A, Lundberg DJ, Abramovitz A, Lewin NE, Kedei N, Peach ML, Zhou X, Merritt RC, Craft EA, Braun DC, Blumberg PM (2016). Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity. J Biol Chem  291, 11133-47.   https://doi.org/10.1074/jbc.M116.725333|5. Feng Z, Pearce LV, Zhang Y, Xing C, Herold BK, Ma S, Hu Z, Turcios NA, Yang P, Tong Q, McCall AK, Blumberg PM, Xie XQ (2016). Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation. AAPS J  18, 898-913.   https://doi.org/10.1208/s12248-016-9888-z|6. Ketcham JM, Volchkov I, Chen TY, Blumberg PM, Kedei N, Lewin NE, Krische MJ (2016). Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology. J Am Chem Soc  138, 13415-13423.   https://doi.org/10.1021/jacs.6b08695|7. Petersen ME, Kedei N, Lewin NE, Blumberg PM, Keck GE (2016). Replacement of the Bryostatin A- and B-Pyran Rings With Phenyl Rings Leads to Loss of High Affinity Binding With PKC. Tetrahedron Lett  57, 4749-4753.   https://doi.org/10.1016/j.tetlet.2016.09.040|8. Zhang F, Hanson SM, Jara-Oseguera A, Krepkiy D, Bae C, Pearce LV, Blumberg PM, Newstead S, Swartz KJ (2016). Engineering vanilloid-sensitivity into the rat TRPV2 channel. Elife  5.   https://doi.org/10.7554/eLife.16409",https://intramural.nih.gov/search/searchview.taf?ipid=98655
7,BC005271-26,"October 01, 2016 -  September 30, 2017",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Desiree Christine Tillo|Aniekanabasi Ime Ufot|Sreejana  Ray|Nima Michael Assad,Tim  Hughes (University of Toronto)|Matthew T Weirauch (University of Toronto)|John  Stamatoyannopoulos (University of Washington)|Andrew  Smith (University of Southern California)|Jussi  Taipale (Karolinska Institute),Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Michael  Bustin; PhD (Protein Section)|Peter C Fitzgerald (Office of the Director),Ann  Dean; PhD (NIDDK) |Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98656
8,BC005445-33,"October 01, 2016 -  September 30, 2017",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Vanesa Cecilia Sanchez; PhD|Brandi Lynn Carofino; PhD|Heba Khair Al Khamici|Pui Yan  Ho|Alayna Brenna Craig-Lucas|Christophe  Cataisson|Show all 10,NULL,Christina M Annunziata (Womens Malignancies Branch)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,"1. Mascia F, Schloemann DT, Cataisson C, McKinnon KM, Krymskaya L, Wolcott KM, Yuspa SH (2016). Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas. Int J Cancer  139, 2593-7.   https://doi.org/10.1002/ijc.30376|2. Shukla A, Yang Y, Madanikia S, Ho Y, Li M, Sanchez V, Cataisson C, Huang J, Yuspa SH (2016). Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant. PLoS One  11, e0161410.   https://doi.org/10.1371/journal.pone.0161410",https://intramural.nih.gov/search/searchview.taf?ipid=98657
9,BC005450-34,"October 01, 2016 -  September 30, 2017",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Thomas A Johnson|Rodney Louis Schiltz; PhD|Diana  Stavreva|Songjoon  Baek|Miroslav  Dundr|Ido  Goldstein; PhD|Show all 11,Susanne  Mandrup (University of Southern Denmark)|Dan  Theodorescu (University of Colorado)|Lars  Grontved,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Sheueyann  Cheng; PhD (Gene Regulation Section)|Michael L Nickerson (Laboratory Translational Genomics)|Peter A Pinto; MD (Urologic Oncology Branch)|David  Levens; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),"Rafael Cristian Casellas; PhD (NIAMS) |Jay H Chung; MD, PhD (NHLBI) |David Johannes Clark; PhD (NICHD)","1. Baek S, Goldstein I, Hager GL (2017). Bivariate Genomic Footprinting Detects Changes in Transcription Factor Activity. Cell Rep  19, 1710-1722.   https://doi.org/10.1016/j.celrep.2017.05.003|2. Pooley JR, Flynn BP, Grøntved L, Baek S, Guertin MJ, Kershaw YM, Birnie MT, Pellatt A, Rivers CA, Schiltz RL, Hager GL, Lightman SL, Conway-Campbell BL (2017). Genome-Wide Identification of Basic Helix-Loop-Helix and NF-1 Motifs Underlying GR Binding Sites in Male Rat Hippocampus. Endocrinology  158, 1486-1501.   https://doi.org/10.1210/en.2016-1929|3. Sawyer IA, Hager GL, Dundr M (2017). Specific genomic cues regulate Cajal body assembly. RNA Biol  14, 791-803.   https://doi.org/10.1080/15476286.2016.1243648|4. Siersbæk M, Varticovski L, Yang S, Baek S, Nielsen R, Mandrup S, Hager GL, Chung JH, Grøntved L (2017). High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss. Sci Rep  7, 40220.   https://doi.org/10.1038/srep40220|5. Swinstead E, Presman D, Paakinaho V, Hager G (2016) The dynamics of chromatin programming. Bioessays, in press.|6. Swinstead EE, Paakinaho V, Presman DM, Hager GL (2016). Pioneer factors and ATP-dependent chromatin remodeling factors interact dynamically: A new perspective: Multiple transcription factors can effect chromatin pioneer functions through dynamic interactions with ATP-dependent chromatin remodeling factors. Bioessays  38, 1150-1157.   https://doi.org/10.1002/bies.201600137",https://intramural.nih.gov/search/searchview.taf?ipid=98658
10,BC005522-30,"October 01, 2016 -  September 30, 2017",Stem-Progenitor Cells and Carcinogenesis of Thyroid,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yo-Taro  Shirai|Henrique Bregolin Dias|Shigetoshi  Yokoyama,NULL,Michael  Bustin; PhD (Protein Section),"Jerrold M Ward; DVM, PhD (NIAID) |Jun  Zhu; PhD (NHLBI)","1. Zou M, Baitei EY, Al-Rijjal RA, Parhar RS, Al-Mohanna FA, Kimura S, Pritchard C, Binessa HA, Alzahrani AS, Al-Khalaf HH, Hawwari A, Akhtar M, Assiri AM, Meyer BF, Shi Y (2016). TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. Oncogene  35, 1909-18.   https://doi.org/10.1038/onc.2015.253",https://intramural.nih.gov/search/searchview.taf?ipid=98659
11,BC005562-30,"October 01, 2016 -  September 30, 2017",Xenobiotic receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Kristopher W Krausz,Jeffrey  Peters (NCI)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah|Changtao  Jiang|Moshe  Levi (University of Colorado School of Medicine)|Show all 9,Shogo  Takahashi (Nucleic Acids Section)|Tingting  Yan (Nucleic Acids Section)|Cen  Xie (Nucleic Acids Section)|Linda G Byrd (Nucleic Acids Section),Oksana  Gavrilova; PhD (NIDDK),"1. Balandaram G, Kramer LR, Kang BH, Murray IA, Perdew GH, Gonzalez FJ, Peters JM (2016). Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice. Toxicology  363-364, 1-9.   https://doi.org/10.1016/j.tox.2016.07.010|2. Cai J, Zhang J, Tian Y, Zhang L, Hatzakis E, Krausz KW, Smith PB, Gonzalez FJ, Patterson AD (2017). Orthogonal Comparison of GC-MS and 1H NMR Spectroscopy for Short Chain Fatty Acid Quantitation. Anal Chem  89, 7900-7906.   https://doi.org/10.1021/acs.analchem.7b00848|3. Cai J, Zhang L, Jones RA, Correll JB, Hatzakis E, Smith PB, Gonzalez FJ, Patterson AD (2016). Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota. J Proteome Res  15, 563-71.   https://doi.org/10.1021/acs.jproteome.5b00957|4. Cao YF, Du Z, Zhu ZT, Sun HZ, Fu ZW, Yang K, Liu YZ, Hu CM, Dong PP, Gonzalez FJ, Fang ZZ (2017). Inhibitory effects of fifteen phthalate esters in human cDNA-expressed UDP-glucuronosyltransferase supersomes. Chemosphere  185, 983-990.   https://doi.org/10.1016/j.chemosphere.2017.07.105|5. Climaco-Arvizu S, Domínguez-Acosta O, Cabañas-Cortés MA, Rodríguez-Sosa M, Gonzalez FJ, Vega L, Elizondo G (2016). Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization. Life Sci  155, 76-84.   https://doi.org/10.1016/j.lfs.2016.05.001|6. Gao X, Xie C, Wang Y, Luo Y, Yagai T, Sun D, Qin X, Krausz KW, Gonzalez FJ (2016). The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4. Biochem Pharmacol  119, 93-104.   https://doi.org/10.1016/j.bcp.2016.08.021|7. Gonzalez FJ, Jiang C, Patterson AD (2016). An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology  151, 845-859.   https://doi.org/10.1053/j.gastro.2016.08.057|8. Harada Y, Tanaka N, Ichikawa M, Kamijo Y, Sugiyama E, Gonzalez FJ, Aoyama T (2016). PPARα-dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4-dichlorophenoxyacetic acid-induced testicular toxicity in mice. Arch Toxicol  90, 3061-3071.   https://doi.org/10.1007/s00204-016-1669-z|9. Hashiguchi T, Arakawa S, Takahashi S, Gonzalez FJ, Sueyoshi T, Negishi M (2016). Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation. Mol Endocrinol  30, 1070-1080.   https://doi.org/10.1210/me.2016-1105|10. Kim JH, Wahyudi LD, Kim KK, Gonzalez FJ (2016). PPARα activation drives demethylation of the CpG islands of the Gadd45b promoter in the mouse liver. Biochem Biophys Res Commun  476, 293-298.   https://doi.org/10.1016/j.bbrc.2016.05.115|11. Li F, Zhu W, Gonzalez FJ (2017). Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther  178, 18-30.   https://doi.org/10.1016/j.pharmthera.2017.03.007|12. Patel CN, Georrge JJ, Modi KM, Narechania MB, Patel DP, Gonzalez FJ, Pandya HA (2018). Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease. J Biomol Struct Dyn  36, 3938-3957.   https://doi.org/10.1080/07391102.2017.1404931|13. Patel DP, Krausz KW, Xie C, Beyoğlu D, Gonzalez FJ, Idle JR (2017). Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice. PLoS One  12, e0177953.   https://doi.org/10.1371/journal.pone.0177953|14. Ramakrishnan SK, Zhang H, Takahashi S, Centofanti B, Periyasamy S, Weisz K, Chen Z, Uhler MD, Rui L, Gonzalez FJ, Shah YM (2016). HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling. Cell Metab  23, 505-16.   https://doi.org/10.1016/j.cmet.2016.01.004|15. Roy A, Kundu M, Jana M, Mishra RK, Yung Y, Luan CH, Gonzalez FJ, Pahan K (2016). Identification and characterization of PPARα ligands in the hippocampus. Nat Chem Biol  12, 1075-1083.   https://doi.org/10.1038/nchembio.2204|16. Takahashi S, Fukami T, Masuo Y, Brocker CN, Xie C, Krausz KW, Wolf CR, Henderson CJ, Gonzalez FJ (2016). Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. J Lipid Res  57, 2130-2137.   https://doi.org/10.1194/jlr.M071183|17. Tan Z, Luo M, Yang J, Cheng Y, Huang J, Lu C, Song D, Ye M, Dai M, Gonzalez FJ, Liu A, Guo B (2016). Chlorogenic acid inhibits cholestatic liver injury induced by α-naphthylisothiocyanate: involvement of STAT3 and NFκB signalling regulation. J Pharm Pharmacol  68, 1203-13.   https://doi.org/10.1111/jphp.12592|18. Tian Y, Yang Y, Zhang X, Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Lu Y, Moriya K, Koike K, Gonzalez FJ, Aoyama T (2016). Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene. Glycoconj J  33, 927-936.   https://doi.org/10.1007/s10719-016-9703-1|19. Wang H, Fang ZZ, Meng R, Cao YF, Tanaka N, Krausz KW, Gonzalez FJ (2017). Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption. Toxicology  386, 133-142.   https://doi.org/10.1016/j.tox.2017.05.012|20. Xu Y, Li F, Zalzala M, Xu J, Gonzalez FJ, Adorini L, Lee YK, Yin L, Zhang Y (2016). Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology  64, 1072-85.   https://doi.org/10.1002/hep.28712|21. Yao ZH, Qin ZF, He LL, Wang XL, Dai Y, Qin L, Gonzalez FJ, Ye WC, Yao XS (2017). Identification, bioactivity evaluation and pharmacokinetics of multiple components in rat serum after oral administration of Xian-Ling-Gu-Bao capsule by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  1041-1042, 104-112.   https://doi.org/10.1016/j.jchromb.2016.12.026|22. Zeng H, Jiang Y, Chen P, Fan X, Li D, Liu A, Ma X, Xie W, Liu P, Gonzalez FJ, Huang M, Bi H (2017). Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br J Pharmacol  174, 672-688.   https://doi.org/10.1111/bph.13729|23. Zhang L, Xie C, Nichols RG, Chan SH, Jiang C, Hao R, Smith PB, Cai J, Simons MN, Hatzakis E, Maranas CD, Gonzalez FJ, Patterson AD (2016). Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism. mSystems  1.   https://doi.org/10.1128/mSystems.00070-16|24. Zhao J, Sun T, Wu JJ, Cao YF, Fang ZZ, Sun HZ, Zhu ZT, Yang K, Liu YZ, Gonzalez FJ, Yin J (2017). Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis. Fitoterapia  119, 26-31.   https://doi.org/10.1016/j.fitote.2017.03.010",https://intramural.nih.gov/search/searchview.taf?ipid=98660
12,BC005597-28,"October 01, 2016 -  September 30, 2017",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",NULL,"Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Anuradha  Janakiraman (The City College of CUNY)|Alfred  Goldberg (Department Cell Biology, Harvard University Medical School)",NULL,Grzegorz  Piszczek; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98661
13,BC005598-28,"October 01, 2016 -  September 30, 2017",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lyn Ann J Mickley|Robert W Robey|Pedro Jorge De Oliveira Rodrigues Batista; PhD|Sriram  Subramaniam; PhD|Kandice Danielle Tanner; PhD,"JeanPierre  Gillet (University of Namur)|Antonio  Fojo; MD, PhD (NCI)|Bates  Susan (Columbia University)","Wilfred D Vieira (Multidrug Resistence Section)|Carol O Cardarelli (Multidrug Resistence Section)|Andrea Nicole Robinson (Multidrug Resistence Section)|Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Matthew David Hall (NCATS) |Christopher Simon Hourigan (NHLBI) |Raman  Sood; PhD (NHGRI),"1. Bakhsheshian J, Wei BR, Hall MD, Simpson RM, Gottesman MM (2016). In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier. Methods Mol Biol  1461, 227-39.   https://doi.org/10.1007/978-1-4939-3813-1_19|2. Fung KL, Kapoor K, Pixley JN, Talbert DJ, Kwit AD, Ambudkar SV, Gottesman MM (2016). Using the BacMam Baculovirus System to Study Expression and Function of Recombinant Efflux Drug Transporters in Polarized Epithelial Cell Monolayers. Drug Metab Dispos  44, 180-8.   https://doi.org/10.1124/dmd.115.066506|3. Kannan P, Schain M, Kretzschmar WW, Weidner L, Mitsios N, Gulyás B, Blom H, Gottesman MM, Innis RB, Hall MD, Mulder J (2017). An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter. J Cereb Blood Flow Metab  37, 2062-2075.   https://doi.org/10.1177/0271678X16660984|4. Kumar JS, Wei BR, Madigan JP, Simpson RM, Hall MD, Gottesman MM (2016). Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier. Sci Rep  6, 20418.   https://doi.org/10.1038/srep20418|5. Liow JS, Zoghbi SS, Hu S, Hall MD, Hines CS, Shetty HU, Araneta MD, Page EM, Pike VW, Kreisl WC, Herscovitch P, Gottesman MM, Theodore WH, Innis RB (2016). (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier. Neuroimage  138, 134-140.   https://doi.org/10.1016/j.neuroimage.2016.05.045|6. Weidner LD, Fung KL, Kannan P, Moen JK, Kumar JS, Mulder J, Innis RB, Gottesman MM, Hall MD (2016). Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein. Drug Metab Dispos  44, 275-82.   https://doi.org/10.1124/dmd.115.067785",https://intramural.nih.gov/search/searchview.taf?ipid=98662
14,BC005599-27,"October 01, 2016 -  September 30, 2017","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD|Subrata  Debnath; PhD|Aamir  Akbarali|Daniel James Schilling,NULL,Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Robert Taylor Ripley; MD (Thoracic & Oncologic Surgery Branch),NULL,"1. Mazur SJ, Gallagher ES, Debnath S, Durell SR, Anderson KW, Miller Jenkins LM, Appella E, Hudgens JW (2017). Conformational Changes in Active and Inactive States of Human PP2Cα Characterized by Hydrogen/Deuterium Exchange-Mass Spectrometry. Biochemistry  56, 2676-2689.   https://doi.org/10.1021/acs.biochem.6b01220|2. Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ, Lam N, Souza BK, Giannini G, Hager GL, Arrowsmith CH, Khan J, Appella E, Thiele CJ (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell  31, 50-63.   https://doi.org/10.1016/j.ccell.2016.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=98663
15,BC005645-28,"October 01, 2016 -  September 30, 2017",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Robyn M Washington Parks|Corrado  Gurgo|Maria  Omsland|Dai  Fujikawa|Beverly Sue Packard; PhD|Veronica  Galli,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)",NULL,Steven J Jacobson; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98664
16,BC005708-26,"October 01, 2016 -  September 30, 2017","Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Cashman  John (Human Biomolecular Research Institute)|Huichang  Bi (Sun Yat-sen University)|Show all 7",Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Electron  Kebebew; MD (Endocrine Oncology Branch)|Shioko  Kimura; PhD (Endocrinology Section)|James B Mitchell; PhD (Radiation Biology Branch),Oksana  Gavrilova; PhD (NIDDK) |Carole A Bewley; PhD (NIDDK),"1. Chen Y, Singh S, Matsumoto A, Manna SK, Abdelmegeed MA, Golla S, Murphy RC, Dong H, Song BJ, Gonzalez FJ, Thompson DC, Vasiliou V (2016). Chronic Glutathione Depletion Confers Protection against Alcohol-induced Steatosis: Implication for Redox Activation of AMP-activated Protein Kinase Pathway. Sci Rep  6, 29743.   https://doi.org/10.1038/srep29743|2. Fang ZZ, Zhang D, Cao YF, Xie C, Lu D, Sun DX, Tanaka N, Jiang C, Chen Q, Chen Y, Wang H, Gonzalez FJ (2016). Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression. Toxicol Appl Pharmacol  291, 21-7.   https://doi.org/10.1016/j.taap.2015.12.003|3. Harada M, Kamijo Y, Nakajima T, Hashimoto K, Yamada Y, Shimojo H, Gonzalez FJ, Aoyama T (2016). Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan. Clin Sci (Lond)  130, 1969-1981.   https://doi.org/10.1042/CS20160343|4. Liu X, Cao YF, Ran RX, Dong PP, Gonzalez FJ, Wu X, Huang T, Chen JX, Fu ZW, Li RS, Liu YZ, Sun HZ, Fang ZZ (2016). New insights into the risk of phthalates: Inhibition of UDP-glucuronosyltransferases. Chemosphere  144, 1966-72.   https://doi.org/10.1016/j.chemosphere.2015.10.076|5. Madeen EP, Löhr CV, You H, Siddens LK, Krueger SK, Dashwood RH, Gonzalez FJ, Baird WM, Ho E, Bramer L, Waters KM, Williams DE (2017). Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice. Mol Carcinog  56, 163-171.   https://doi.org/10.1002/mc.22480|6. Patel D, Thompson MD, Manna SK, Krausz KW, Zhang L, Nilubol N, Gonzalez FJ, Kebebew E (2017). Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms. Clin Cancer Res  23, 5302-5310.   https://doi.org/10.1158/1078-0432.CCR-16-3156|7. Shi J, Xie C, Liu H, Krausz KW, Bewley CA, Zhang S, Tang L, Zhou Z, Gonzalez FJ (2016). Metabolism and Bioactivation of Fluorochloridone, a Novel Selective Herbicide, in Vivo and in Vitro. Environ Sci Technol  50, 9652-60.   https://doi.org/10.1021/acs.est.6b02113|8. Song CY, Ghafoor K, Ghafoor HU, Khan NS, Thirunavukkarasu S, Jennings BL, Estes AM, Zaidi S, Bridges D, Tso P, Gonzalez FJ, Malik KU (2016). Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice. Hypertension  67, 206-13.   https://doi.org/10.1161/HYPERTENSIONAHA.115.06427|9. Thirunavukkarasu S, Khan NS, Song CY, Ghafoor HU, Brand DD, Gonzalez FJ, Malik KU (2016). Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice. Am J Pathol  186, 2204-2219.   https://doi.org/10.1016/j.ajpath.2016.04.005|10. Wang R, Gu X, Dai W, Ye J, Lu F, Chai Y, Fan G, Gonzalez FJ, Duan G, Qi Y (2016). A lipidomics investigation into the intervention of celastrol in experimental colitis. Mol Biosyst  12, 1436-44.   https://doi.org/10.1039/c5mb00864f|11. Yan T, Wang H, Zhao M, Yagai T, Chai Y, Krausz KW, Xie C, Cheng X, Zhang J, Che Y, Li F, Wu Y, Brocker CN, Gonzalez FJ, Wang G, Hao H (2016). Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis. Drug Metab Dispos  44, 720-31.   https://doi.org/10.1124/dmd.116.069419|12. Yu T, Wang Y, Zhang H, Johnson CH, Jiang Y, Li X, Wu Z, Liu T, Krausz KW, Yu A, Gonzalez FJ, Huang M, Bi H (2016). Metabolomics reveals mycoplasma contamination interferes with the metabolism of PANC-1 cells. Anal Bioanal Chem  408, 4267-73.   https://doi.org/10.1007/s00216-016-9525-9",https://intramural.nih.gov/search/searchview.taf?ipid=98665
17,BC005785-23,"October 01, 2016 -  September 30, 2017",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Binwu  Tang|Nellie  Moshkovich; BS|Yuval  Raviv|George  Baker,John  Condeelis (Albert Einstein College of Medicine)|Maja  Oktay (Albert Einstein College of Medicine),Dominic  Esposito; PhD (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98667
18,BC005793-23,"October 01, 2016 -  September 30, 2017",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu,NULL,Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,"1. Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, TIGER-LC Consortium, et al. [12 more authors] (2017). Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell  32, 57-70.e3.   https://doi.org/10.1016/j.ccell.2017.05.009",https://intramural.nih.gov/search/searchview.taf?ipid=98668
19,BC006150-36,"October 01, 2016 -  September 30, 2017","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Hongliang  Zhang|Keli  Agama|Shar-Yin Naomi Huang|Margot  Sunshine|Sudhir  Varma|Vinodh  Rajapakse|Show all 18,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yuk  Sham (University of Minnesota)|Show all 16","Robert  Shoemaker (Chemopreventive Agent Development Research Group)|David S Waugh; PhD (Protein Engineering Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|George T Lountos (Protein Engineering Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)","Christopher P Austin; AB, MD (NCATS) |Weidong  Wang; PhD (NIA)","1. Croglio MP, Haake JM, Ryan CP, Wang VS, Lapier J, Schlarbaum JP, Dayani Y, Artuso E, Prandi C, Koltai H, Agama K, Pommier Y, Chen Y, Tricoli L, LaRocque JR, Albanese C, Yarden RI (2016). Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair. Oncotarget  7, 13984-4001.   https://doi.org/10.18632/oncotarget.7414|2. Gmeiner WH, Gearhart PJ, Pommier Y, Nakamura J (2016). F10 cytotoxicity via topoisomerase I cleavage complex repair consistent with a unique mechanism for thymineless death. Future Oncol  12, 2183-8.   https://doi.org/10.2217/fon-2016-0127|3. Gurard-Levin ZA, Wilson LO, Pancaldi V, Postel-Vinay S, Sousa FG, Reyes C, Marangoni E, Gentien D, Valencia A, Pommier Y, Cottu P, Almouzni G (2016). Chromatin Regulators as a Guide for Cancer Treatment Choice. Mol Cancer Ther  15, 1768-77.   https://doi.org/10.1158/1535-7163.MCT-15-1008|4. Kossmann BR, Abdelmalak M, Lopez S, Tender G, Yan C, Pommier Y, Marchand C, Ivanov I (2016). Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft. Bioorg Med Chem Lett  26, 3232-3236.   https://doi.org/10.1016/j.bmcl.2016.05.065|5. Lee HS, Lee NC, Kouprina N, Kim JH, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V (2016). Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies. Cancer Res  76, 902-11.   https://doi.org/10.1158/0008-5472.CAN-15-1617|6. Shamanna RA, Lu H, Croteau DL, Arora A, Agarwal D, Ball G, Aleskandarany MA, Ellis IO, Pommier Y, Madhusudan S, Bohr VA (2016). Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Oncotarget  7, 13269-84.   https://doi.org/10.18632/oncotarget.7906",https://intramural.nih.gov/search/searchview.taf?ipid=98669
20,BC006161-34,"October 01, 2016 -  September 30, 2017",DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Hongliang  Zhang|Keli  Agama|Shar-Yin Naomi Huang|Ann  Orr|Andrea Simone Baechler|Laetitia  Marzi|Show all 14,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch),"Keir Cajal Neuman; BA, PhD (NHLBI)","1. Ahmad M, Xue Y, Lee SK, Martindale JL, Shen W, Li W, Zou S, Ciaramella M, Debat H, Nadal M, Leng F, Zhang H, Wang Q, Siaw GE, Niu H, Pommier Y, Gorospe M, Hsieh TS, Tse-Dinh YC, Xu D, Wang W (2016). RNA topoisomerase is prevalent in all domains of life and associates with polyribosomes in animals. Nucleic Acids Res  44, 6335-49.   https://doi.org/10.1093/nar/gkw508|2. Beck DE, Lv W, Abdelmalak M, Plescia CB, Agama K, Marchand C, Pommier Y, Cushman M (2016). Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons. Bioorg Med Chem  24, 1469-79.   https://doi.org/10.1016/j.bmc.2016.02.015|3. Beck DE, Reddy PV, Lv W, Abdelmalak M, Tender GS, Lopez S, Agama K, Marchand C, Pommier Y, Cushman M (2016). Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons. J Med Chem  59, 3840-53.   https://doi.org/10.1021/acs.jmedchem.6b00003|4. Cho JE, Huang SY, Burgers PM, Shuman S, Pommier Y, Jinks-Robertson S (2016). Parallel analysis of ribonucleotide-dependent deletions produced by yeast Top1 in vitro and in vivo. Nucleic Acids Res  44, 7714-21.   https://doi.org/10.1093/nar/gkw495|5. Dahmane N, Gadelle D, Delmas S, Criscuolo A, Eberhard S, Desnoues N, Collin S, Zhang H, Pommier Y, Forterre P, Sezonov G (2016). topIb, a phylogenetic hallmark gene of Thaumarchaeota encodes a functional eukaryote-like topoisomerase IB. Nucleic Acids Res  44, 2795-805.   https://doi.org/10.1093/nar/gkw097|6. Jandu H, Aluzaite K, Fogh L, Thrane SW, Noer JB, Proszek J, Do KN, Hansen SN, Damsgaard B, Nielsen SL, Stougaard M, Knudsen BR, Moreira J, Hamerlik P, Gajjar M, Smid M, Martens J, Foekens J, Pommier Y, Brünner N, Schrohl AS, Stenvang J (2016). Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines. BMC Cancer  16, 34.   https://doi.org/10.1186/s12885-016-2071-1|7. Lv PC, Elsayed MS, Agama K, Marchand C, Pommier Y, Cushman M (2016). Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400). J Med Chem  59, 4890-9.   https://doi.org/10.1021/acs.jmedchem.6b00220",https://intramural.nih.gov/search/searchview.taf?ipid=98670
21,BC006198-28,"October 01, 2016 -  September 30, 2017",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Xue Zhi  Zhao|Trung Xuan Nguyen|Kohei  Tsuji|James A Kelley; PhD,Michael  Yaffe (Massachusetts Institute of Technology)|Christoph  Rader; PhD,David S Waugh; PhD (Protein Engineering Section)|Kyung  Lee; PhD (Chemistry Section),NULL,"1. Park J, Hymel D, Burke T, Lee K (2017) Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents F1000 6:1024|2. Zhao XZ, Hymel D, Burke TR (2016). Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain. Bioorg Med Chem Lett  26, 5009-5012.   https://doi.org/10.1016/j.bmcl.2016.08.098",https://intramural.nih.gov/search/searchview.taf?ipid=98671
22,BC007333-26,"October 01, 2016 -  September 30, 2017",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Evgeny Anatolyevich Kiselev; PhD|Azhar A Ravji,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Xue Zhi  Zhao (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98672
23,BC007363-23,"October 01, 2016 -  September 30, 2017",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Xue Zhi  Zhao,Peter  Cherepanov (Imperial College London)|Arnold  Edward (Rutgers University),Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,"1. Zhao X, Smith S, Maskell D, Metifiot M, Pye V, Fesen K, Marchand C, Pommier Y, Cherepanov P, Hughes S, Burke T (2017) Structure-guided optimization of HIV integrase strand transfer inhibitors. Journal of Medicinal Chemistry, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98673
24,BC007365-23,"October 01, 2016 -  September 30, 2017",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Ruibai  Luo|Xiaoying  Jian; PhD|Neeladri Sekhar Roy; PhD|Sofia Alexandra Girald Berlingeri|Anjelika  Gasilina|Roberto  Weigert; MSc Chemistry, PhD",Richard  Kahn (Emory University)|Elizabeth  Sztul (University of Alabama)|Thomas  Abrams (University of Maryland School of Medicine)|Robert  Kalb,"Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Marielle Elizabeth Yohe (Pediatric Oncology Branch)|Di S Xia; PhD, MS, BS (Crystallography Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|John Frederick Shern (Pediatric Oncology Branch)",James  Gruschus; PhD (NHLBI) |James Robert Sellers; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98674
25,BC008382-34,"October 01, 2016 -  September 30, 2017",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Kazimierz Wojcieck Kasprzak|Eckart  Bindewald|Tae Jin  Kim|Manav  Mathur,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Hanan  Samet (University of Maryland)|Jonathan  Dinman (University of Maryland)",Stuart F J Le Grice; PhD (Basic Research Laboratory)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98675
26,BC008710-40,"October 01, 2016 -  September 30, 2017",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Joel R Hoskins|Andrea Nicole Kravats|Anuradha  Balasubramanian|Srilakshmi A Garikapati|Audrey Lynne Heffner,NULL,Shannon M Doyle (Laboratory of Molecular Biology)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Susan  Gottesman; PhD (Biochemical Genetics Section),Daniel C Masison; PhD (NIDDK),"1. Hoskins J, McKenney S, Doyle S (2017) Bacterial Hsp90 ATPase assays, in Methods in Molecular Biology, Molecular Chaperones, in press.|2. McKenney S, Camberg J, Doyle S (2017) Molecular Chaperones, in Brenner's Encyclopedia of Genetics, 2nd Edition, update, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98645
27,BC008714-40,"October 01, 2016 -  September 30, 2017",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nadim  Majdalani|Song  Tong|Jiandong  Chen|Francois  De Mets|Erin Ashley Wall|Kumari  Kavita|Show all 8,"Maude  Guillier|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Evgeny  Nudler (New York University School of Medicine, HHMI)",NULL,"Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC) |Yasmine  Belkaid; PhD (NIAID)","1. Brosse A, Korobeinikova A, Gottesman S, Guillier M (2016). Unexpected properties of sRNA promoters allow feedback control via regulation of a two-component system. Nucleic Acids Res  44, 9650-9666.   https://doi.org/10.1093/nar/gkw642|2. Chen J, Gottesman S (2017) Hfq links translation repression to stress-induced mutagenesis in E. coli. Genes Development, in press.|3. Chen J, Gottesman S (2017). Spot 42 sRNA regulates arabinose-inducible araBAD promoter activity by repressing synthesis of the high-affinity low-capacity arabinose transporter. J Bacteriol  199, e00691-16.   https://doi.org/10.1128/JB.00691-16|4. Gottesman S (2017) Stress Reduction, Bacterial Style. Journal of Bacteriology, in press.|5. Lee HJ, Gottesman S (2016). sRNA roles in regulating transcriptional regulators: Lrp and SoxS regulation by sRNAs. Nucleic Acids Res  44, 6907-23.   https://doi.org/10.1093/nar/gkw358|6. Parker A, Gottesman S (2016). Small RNA Regulation of TolC, the Outer Membrane Component of Bacterial Multidrug Transporters. J Bacteriol  198, 1101-13.   https://doi.org/10.1128/JB.00971-15|7. Santiago-Frangos A, Kavita K, Schu DJ, Gottesman S, Woodson SA (2016). C-terminal domain of the RNA chaperone Hfq drives sRNA competition and release of target RNA. Proc Natl Acad Sci U S A  113, E6089-E6096.   https://doi.org/10.1073/pnas.1613053113|8. Sedlyarova N, Shamovsky I, Bharati BK, Epshtein V, Chen J, Gottesman S, Schroeder R, Nudler E (2016). sRNA-Mediated Control of Transcription Termination in E. coli. Cell  167, 111-121.e13.   https://doi.org/10.1016/j.cell.2016.09.004",https://intramural.nih.gov/search/searchview.taf?ipid=98676
28,BC008751-37,"October 01, 2016 -  September 30, 2017",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,Szabolcs  Semsey|Michal  Hammel (Lawrence Berkeley National Laboratory),Victor  Zhurkin; PhD (Laboratory of Cell Biology)|David  Levens; PhD (Laboratory of Pathology),NULL,"1. Hammel M, Amlanjyoti D, Reyes FE, Chen JH, Parpana R, Tang HY, Larabell CA, Tainer JA, Adhya S (2016). HU multimerization shift controls nucleoid compaction. Sci Adv  2, e1600650.   https://doi.org/10.1126/sciadv.1600650|2. Lal A, Dhar A, Trostel A, Kouzine F, Seshasayee AS, Adhya S (2016). Genome scale patterns of supercoiling in a bacterial chromosome. Nat Commun  7, 11055.   https://doi.org/10.1038/ncomms11055|3. Qian Z, Trostel A, Lewis DE, Lee SJ, He X, Stringer AM, Wade JT, Schneider TD, Durfee T, Adhya S (2016). Genome-Wide Transcriptional Regulation and Chromosome Structural Arrangement by GalR in E. coli. Front Mol Biosci  3, 74.   https://doi.org/10.3389/fmolb.2016.00074|4. Tolstorukov MY, Virnik K, Zhurkin VB, Adhya S (2016). Organization of DNA in a bacterial nucleoid. BMC Microbiol  16, 22.   https://doi.org/10.1186/s12866-016-0637-3",https://intramural.nih.gov/search/searchview.taf?ipid=98677
29,BC008752-37,"October 01, 2016 -  September 30, 2017",Thyroid Hormone Nuclear Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Li  Zhao|Xuguang  Zhu|Sunmi  Park|Cho Rong  Han,"G.R.  Williams (Imperial College London, Imperial College London)|James  Lechleiter (University of Texas Health Science Center at San Antonio)|V K K  Chatterjee (Institute of Metabolic Science)|Paul M Yen; MD (NIDDK)|Gregory  Brent (VA Greater Los Angeles Healthcare System)","Erik Kristian Holmsen (Biochemical Genetics Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Yun-Bo  Shi; PhD (NICHD),"1. Milanesi A, Lee JW, Kim NH, Liu YY, Yang A, Sedrakyan S, Kahng A, Cervantes V, Tripuraneni N, Cheng SY, Perin L, Brent GA (2016). Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury. Endocrinology  157, 4-15.   https://doi.org/10.1210/en.2015-1443|2. Sayre NL, Sifuentes M, Holstein D, Cheng SY, Zhu X, Lechleiter JD (2017). Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage. J Cereb Blood Flow Metab  37, 514-527.   https://doi.org/10.1177/0271678X16629153",https://intramural.nih.gov/search/searchview.taf?ipid=98678
30,BC008753-35,"October 01, 2016 -  September 30, 2017",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Richard A Beers|Tapan K Bera|Masanori  Onda|Ronit  Jolles Mazor; MSc|Jasmin  Leshem|Fred  Lee|Show all 17,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Satoshi  Nagata (Sanford Research/USD)|Ulrich  Brinkmann (NCI)|Taiji  Matsusaka (Tokyo Medical & Dental University)|Itai  Benhar (Tel Aviv University)|Show all 11",Xiu Fen Liu (Laboratory of Molecular Biology)|Chin-Hsien  Tai (Laboratory of Molecular Biology)|Dawn A Walker (Laboratory of Molecular Biology)|Steve  Giardina (Clinical Immunotherapy Section)|Adam Charles Cerise; MD (Thoracic & Oncologic Surgery Branch)|David J Fitzgerald; PhD (Biotherapy Section),NULL,"1. Awuah P, Bera TK, Folivi M, Chertov O, Pastan I (2016). Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins. Mol Cancer Ther  15, 1648-55.   https://doi.org/10.1158/1535-7163.MCT-15-0863|2. Bao X, Chandramohan V, Reynolds RP, Norton JN, Wetsel WC, Rodriguiz RM, Aryal DK, McLendon RE, Levin ED, Petry NA, Zalutsky MR, Burnett BK, Kuan CT, Pastan IH, Bigner DD (2016). Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats. Invest New Drugs  34, 149-58.   https://doi.org/10.1007/s10637-015-0318-3|3. Bauss F, Lechmann M, Krippendorff BF, Staack R, Herting F, Festag M, Imhof-Jung S, Hesse F, Pompiati M, Kollmorgen G, da Silva Mateus Seidl R, Bossenmaier B, Lau W, Schantz C, Stracke JO, Brinkmann U, Onda M, Pastan I, Bosslet K, Niederfellner G (2016). Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy. Mol Oncol  10, 1317-29.   https://doi.org/10.1016/j.molonc.2016.07.003|4. Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ (2016). Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy. Appl Immunohistochem Mol Morphol  24, 246-52.   https://doi.org/10.1097/PAI.0000000000000292|5. Kaplan G, Lee F, Onda M, Kolyvas E, Bhardwaj G, Baker D, Pastan I (2016). Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A. Toxins (Basel)  8.   https://doi.org/10.3390/toxins8080217|6. Liu X, Müller F, Wayne AS, Pastan I (2016). Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A-Based Immunotoxins. Mol Cancer Ther  15, 1053-62.   https://doi.org/10.1158/1535-7163.MCT-15-0828|7. Liu XF, Xiang L, Zhou Q, Carralot JP, Prunotto M, Niederfellner G, Pastan I (2016). Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proc Natl Acad Sci U S A  113, 10666-71.   https://doi.org/10.1073/pnas.1611481113|8. Müller F, Cunningham T, Liu XF, Wayne AS, Pastan I (2016). Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design. Clin Cancer Res  22, 4913-4922.   https://doi.org/10.1158/1078-0432.CCR-15-2500|9. Mazor R, Onda M, Park D, Addissie S, Xiang L, Zhang J, Hassan R, Pastan I (2016). Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity. Oncotarget  7, 29916-26.   https://doi.org/10.18632/oncotarget.9171|10. Mazor R, Onda M, Pastan I (2016). Immunogenicity of therapeutic recombinant immunotoxins. Immunol Rev  270, 152-64.   https://doi.org/10.1111/imr.12390",https://intramural.nih.gov/search/searchview.taf?ipid=98679
31,BC008756-30,"October 01, 2016 -  September 30, 2017",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Helen Thompson Michael|Yifei  Qin|Tunde Marcus Smith|Antonella  Sassano|Helen  Zhang|Kerrie Leanne Marie|Show all 8,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Scott  Lowe (Cold Spring Harbor Laboratory)|Norman  Sharpless (University of North Carolina)|Show all 12","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|Margaret Anne Tucker (Human Genetics Program)|Howard A Young; PhD (Cancer Inflammation Program)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Curtis  Henrich (Molecular Targets Laboratory)",Heinz  Arnheiter; MD (NINDS) |J Silvio  Gutkind; PhD (NIDCR) |William James Pavan; PhD (NHGRI),"1. Cataisson C, Michalowski AM, Shibuya K, Ryscavage A, Klosterman M, Wright L, Dubois W, Liu F, Zhuang A, Rodrigues KB, Hoover S, Dwyer J, Simpson MR, Merlino G, Yuspa SH (2016). MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. Sci Signal  9, ra62.   https://doi.org/10.1126/scisignal.aaf5106|2. Mishra PJ, Mishra PJ, Merlino G (2016). Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy. PLoS One  11, e0165102.   https://doi.org/10.1371/journal.pone.0165102|3. Pérez-Guijarro E, Merlino G (2017). Lymphangiogenesis: From passive disseminator to dynamic metastatic enabler. Pigment Cell Melanoma Res  30, 509-510.   https://doi.org/10.1111/pcmr.12621",https://intramural.nih.gov/search/searchview.taf?ipid=98680
32,BC008757-30,"October 01, 2016 -  September 30, 2017",Bio-Therapies for the Treatment of Cancer,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI",Eric Chun Hei  Ho,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Christine Campo Alewine (Laboratory of Molecular Biology)",Craig Joseph Thomas (NCATS) |Massimo Giulio Gadina; PhD (NIAMS) |Michael J Iadarola; PhD (CC),"1. Ali-Rahmani F, FitzGerald DJ, Martin S, Patel P, Prunotto M, Ormanoglu P, Thomas C, Pastan I (2016). Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1. Cancer Res  76, 1560-8.   https://doi.org/10.1158/0008-5472.CAN-15-2401|2. Antignani A, Mathews Griner L, Guha R, Simon N, Pasetto M, Keller J, Huang M, Angelus E, Pastan I, Ferrer M, FitzGerald DJ, Thomas CJ (2016). Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins. PLoS One  11, e0161415.   https://doi.org/10.1371/journal.pone.0161415",https://intramural.nih.gov/search/searchview.taf?ipid=98681
33,BC008905-36,"October 01, 2016 -  September 30, 2017",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",NULL,Steven J Carr|Igor  Barsukov (University of Liverpool),NULL,NULL,"1. Collins FS, Anderson JM, Austin CP, Battey JF, Birnbaum LS, Briggs JP, Clayton JA, Cuthbert B, Eisinger RW, Fauci AS, Gallin JI, Gibbons GH, Glass RI, Gottesman MM, Gray PA, Green ED, Greider FB, Hodes R, Hudson KL, Humphreys B, Katz SI, Koob GF, Koroshetz WJ, Lauer MS, Lorsch JR, et al. [15 more authors] (2016). Basic science: Bedrock of progress. Science  351, 1405.   https://doi.org/10.1126/science.351.6280.1405-a|2. Lowy DR, Singer DS (2017). Implementing the Cancer Moonshot and beyond. Lancet Oncol  18, e622-e623.   https://doi.org/10.1016/S1470-2045(17)30797-0|3. Zacharchenko T, Qian X, Goult B, Jethwa D, Almeida T, Ballestrem C, Critchley D, Lowy D, Barsukov I (2016) LD Motif Recognition in Talin: Structure of the Talin-DLC1 Complex Structure 24:1130-41",https://intramural.nih.gov/search/searchview.taf?ipid=98682
34,BC009052-28,"October 01, 2016 -  September 30, 2017",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Patricia  Day; PhD|Cynthia D Thompson|Nicolas  Cuburu; PhD|Yuk Ying S Pang|Carla Vanessa Correia Cerqueira|Rhonda C Kines|Show all 7,Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Elisabet  de los Pinos (Aura Biosciences Inc.)|Ali  Salanti (University of Copenhagen)|Gert  Scheper (Crucell/Johnson&Johnson),Tara Ariela Berman; MD (Office Of The Clinical Director)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Aimee Rebecca Kreimer (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Barney S Graham; MD, PhD (NIAID) |Jeffrey  Cohen; MD (NIAID) |Alan T Remaley; MD, PhD (NHLBI)","1. Çuburu N, Schiller JT (2016). Moving forward with human papillomavirus immunotherapies. Hum Vaccin Immunother  12, 2875-2880.   https://doi.org/10.1080/21645515.2016.1199302|2. Hojeij R, Domingos-Pereira S, Nkosi M, Gharbi D, Derré L, Schiller JT, Jichlinski P, Nardelli-Haefliger D (2016). Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer. Int J Mol Sci  17.   https://doi.org/10.3390/ijms17071125|3. Schiller JT (2016). The Potential Benefits of HPV Vaccination in Previously Infected Women. EBioMedicine  10, 5-6.   https://doi.org/10.1016/j.ebiom.2016.08.005|4. Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM (2016). Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A  113, 10750-8.   https://doi.org/10.1073/pnas.1608077113|5. Thrane S, Janitzek CM, Matondo S, Resende M, Gustavsson T, de Jongh WA, Clemmensen S, Roeffen W, van de Vegte-Bolmer M, van Gemert GJ, Sauerwein R, Schiller JT, Nielsen MA, Theander TG, Salanti A, Sander AF (2016). Bacterial superglue enables easy development of efficient virus-like particle based vaccines. J Nanobiotechnology  14, 30.   https://doi.org/10.1186/s12951-016-0181-1",https://intramural.nih.gov/search/searchview.taf?ipid=98684
35,BC009265-35,"October 01, 2016 -  September 30, 2017",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,Gail  Bishop (University of Iowa)|Yousuke  Takahama (Tokushima),Joseph Byung Hoon An (Immune Regulation Section)|Farrah Ali Alkhaleel (Immune Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98685
36,BC009273-30,"October 01, 2016 -  September 30, 2017",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dinah  Singer; PhD|Jung-Hyun  Park,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)|Ed  Palmer (University of Basel)|Show all 7","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD)","1. Madi A, Poran A, Shifrut E, Reich-Zeliger S, Greenstein E, Zaretsky I, Arnon T, Laethem FV, Singer A, Lu J, Sun PD, Cohen IR, Friedman N (2017). T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences. Elife  6.   https://doi.org/10.7554/eLife.22057",https://intramural.nih.gov/search/searchview.taf?ipid=98686
37,BC009279-32,"October 01, 2016 -  September 30, 2017",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Susan  Sharrow,NULL,Jocelyn D Weissman (Molecular Regulation Section)|Jie  Mu (Molecular Regulation Section)|Oliver James Hendy (Immune Regulation Section)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98687
38,BC009281-31,"October 01, 2016 -  September 30, 2017",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,"Ronald N Germain; MD, PhD (NIAID) |Keji  Zhao; PhD (NHLBI)","1. Chiang Y, Hodes R (2016) T- cell development  is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages European Journal of Immunology 46:4601-4608|2. Watanabe M, Fujihara C, Radtke A, Chiang J, Bhatia S, Germain R, Hodes R (2017) Costimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells. Journal of Experimental Medicine, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98688
39,BC009283-33,"October 01, 2016 -  September 30, 2017",Consequences of chronic Interferon-gamma expression on the host,Howard A Young; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Michael E Sanford|Julio C Valencia; MD|John Maxwell Fenimore|Nkolika Chisom Egbukichi|Rebecca Ann Erwin-Cohen|Kevin Hong Chen|Show all 11,STEFANIE  VOGEL (UNIV. OF MARYLAND SCHOOL OF MEDICINE)|Ram  Savan|Monika  Wolkers (Sanquin)|M  Gershwin (University of Califernia at Davis)|Zia  Rahman (Penn State Univ. College of Medicine),Jonathan  Keller; PhD (Mouse Cancer Genetics Program)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Bae HR, Leung PS, Tsuneyama K, Valencia JC, Hodge DL, Kim S, Back T, Karwan M, Merchant AS, Baba N, Feng D, Park O, Gao B, Yang GX, Gershwin ME, Young HA (2016). Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology  64, 1189-201.   https://doi.org/10.1002/hep.28641|2. Lee-Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, Young HA, Croft M, Ferrucci L, Biragyn A (2016). Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol  196, 3385-97.   https://doi.org/10.4049/jimmunol.1502034|3. Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, Barber DL (2016). CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease. PLoS Pathog  12, e1005667.   https://doi.org/10.1371/journal.ppat.1005667",https://intramural.nih.gov/search/searchview.taf?ipid=98689
40,BC009285-31,"October 01, 2016 -  September 30, 2017",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Susan  Sharrow,NULL,Oliver James Hendy (Immune Regulation Section)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98690
41,BC009287-33,"October 01, 2016 -  September 30, 2017",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Wenqing  Li|Julie  Hixon|Emilee Rose Senkevitch|Caroline Elizabeth Salter|Courtney Elizabeth Daymude,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),Peter D Aplan; MD (Cancer Genetics Branch)|Terry J Fry (Pediatric Oncology Branch)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE (2016). Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases. PLoS One  11, e0155262.   https://doi.org/10.1371/journal.pone.0155262|2. Cramer SD, Aplan PD, Durum SK (2016). Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment. Blood  128, 473-8.   https://doi.org/10.1182/blood-2016-03-679209|3. McLean MH, Andrews C, Hanson ML, Baseler WA, Anver MR, Senkevitch E, Staniszewska AK, Smith C, Davies LC, Hixon J, Li W, Shen W, Steidler L, Durum SK (2017). Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses. Inflamm Bowel Dis  23, 1983-1995.   https://doi.org/10.1097/MIB.0000000000001274",https://intramural.nih.gov/search/searchview.taf?ipid=98691
42,BC009369-27,"October 01, 2016 -  September 30, 2017",Studies of Receptor Interactions and Effects of Alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",De  Yang|Anna Lee  Trivett|Zhen  Han; PhD|Md Masud Alam|Helia  Hadavi|Poonam  Tewary|Show all 7,Feng  Wei|Oystein  Rekdal (Lytix Biopharma)|W  Wu (University of Maryland)|Richard  Jewell (University of Maryland),Amogh  Narendra (Radiation Research Program)|Michael  Bustin; PhD (Protein Section)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory)|Joseph John Barchi (Chemical Biology Laboratory),NULL,"1. Yoon J, Leyva-Castillo JM, Wang G, Galand C, Oyoshi MK, Kumar L, Hoff S, He R, Chervonsky A, Oppenheim JJ, Kuchroo VK, van den Brink MR, Malefyt Rde W, Tessier PA, Fuhlbrigge R, Rosenstiel P, Terhorst C, Murphy G, Geha RS (2016). IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med  213, 2147-66.   https://doi.org/10.1084/jem.20150376",https://intramural.nih.gov/search/searchview.taf?ipid=98692
43,BC009392-25,"October 01, 2016 -  September 30, 2017",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Yien-Che  Tsai|Mei  Yang; MD|Meredith Boyle Metzger; PhD|Christopher Edward Smith|Martha Iveth Garcia; PhD|Federico  Bernal,Joseph  Roitelman|Jeffrey  Brodsky (University of Pittsburgh)|Mickael  Cohen (IBPC),Stefan  Ambs (Laboratory of Human Carcinogenesis)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Chung WJ, Goeckeler-Fried JL, Havasi V, Chiang A, Rowe SM, Plyler ZE, Hong JS, Mazur M, Piazza GA, Keeton AB, White EL, Rasmussen L, Weissman AM, Denny RA, Brodsky JL, Sorscher EJ (2016). Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PLoS One  11, e0163615.   https://doi.org/10.1371/journal.pone.0163615",https://intramural.nih.gov/search/searchview.taf?ipid=98639
44,BC009404-23,"October 01, 2016 -  September 30, 2017",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul|Kyung Jin  Cho|Lei  Lei|Even  Walseng|Hei Jung  Kim|Show all 7,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)|J  Blander (Icahn School of Medicine at Mount Sinai)|Show all 7",NULL,NULL,"1. Cresswell P, Roche PA (2017). Editorial Overview: Antigen Processing and Presentation; many fingers in many pies. Curr Opin Immunol  46, v-vii.   https://doi.org/10.1016/j.coi.2017.07.002",https://intramural.nih.gov/search/searchview.taf?ipid=98693
45,BC009405-23,"October 01, 2016 -  September 30, 2017",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Joseph Byung Hoon An (Immune Regulation Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98694
46,BC010001-22,"October 01, 2016 -  September 30, 2017",Molecular-Cellular Regulation of Hematopoietic Stem Cells,Jonathan  Keller; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Kimberly D Klarmann|Lei  Sun|Shweta  Singh; PhD|Kathrin  Muegge; MD,NULL,"Laura  Schmidt (Urologic Oncology Branch)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",NULL,"1. Baba M, Toyama H, Sun L, Takubo K, Suh HC, Hasumi H, Nakamura-Ishizu A, Hasumi Y, Klarmann KD, Nakagata N, Schmidt LS, Linehan WM, Suda T, Keller JR (2016). Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure. Stem Cells  34, 1068-82.   https://doi.org/10.1002/stem.2293|2. Puverel S, Kiris E, Singh S, Klarmann KD, Coppola V, Keller JR, Tessarollo L (2016). RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells. Oncotarget  7, 85109-85123.   https://doi.org/10.18632/oncotarget.13198|3. Sharma BK, Kolhe R, Black SM, Keller JR, Mivechi NF, Satyanarayana A (2016). Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. FASEB J  30, 262-75.   https://doi.org/10.1096/fj.15-277749",https://intramural.nih.gov/search/searchview.taf?ipid=98695
47,BC010006-22,"October 01, 2016 -  September 30, 2017",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jaeho  Yoon; PhD|Moonsup  Lee|Jian  Sun; PhD,Sally  Moody (George Washington University Medical Center)|Hee Jun  Cho; PhD,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98696
48,BC010008-22,"October 01, 2016 -  September 30, 2017",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD|Ke  Zhang|John K Simmons|Patricia Ann Wiley|Daniel George Connors|Snehal Mahendra Gaikwad|Show all 8",NULL,NULL,NULL,"1. Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, Zingone A, Landgren O, Ordentlich P, Huang J, Mock BA (2017). Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. Mol Cancer Ther  16, 2008-2021.   https://doi.org/10.1158/1535-7163.MCT-17-0171",https://intramural.nih.gov/search/searchview.taf?ipid=98697
49,BC010012-22,"October 01, 2016 -  September 30, 2017",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",NULL,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98698
50,BC010013-22,"October 01, 2016 -  September 30, 2017",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Cancer Inflammation Program, NCI","Paul  Wright|Hong-Chuan  Li|Donnell Dee White|Daniel  McVicar; PhD|Mary  Carrington; MS, PhD",Jeffrey  Miller (University of Minnesota Cancer Center)|Taku  Kambayashi (University of Pennsylvania),NULL,NULL,"1. Freund J, May RM, Yang E, Li H, McCullen M, Zhang B, Lenvik T, Cichocki F, Anderson SK, Kambayashi T (2016). Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells. PLoS Biol  14, e1002526.   https://doi.org/10.1371/journal.pbio.1002526|2. Li H, Wright PW, McCullen M, Anderson SK (2016). Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes. Genes Immun  17, 66-74.   https://doi.org/10.1038/gene.2015.56",https://intramural.nih.gov/search/searchview.taf?ipid=98699
51,BC010014-22,"October 01, 2016 -  September 30, 2017",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Mouse Cancer Genetics Program, NCI",Xiaoping  Xu|Yafeng  He|Kai  Ni; PhD|Andrew James Schwader,NULL,Robert M Leighty (Office Of The Director)|Carl E Mcintosh (Office of the Director),NULL,"1. Han Y, Ren J, Lee E, Xu X, Yu W, Muegge K (2017). Lsh/HELLS regulates self-renewal/proliferation of neural stem/progenitor cells. Sci Rep  7, 1136.   https://doi.org/10.1038/s41598-017-00804-6|2. Ren J, Hathaway NA, Crabtree GR, Muegge K (2018). Tethering of Lsh at the Oct4 locus promotes gene repression associated with epigenetic changes. Epigenetics  13, 173-181.   https://doi.org/10.1080/15592294.2017.1338234",https://intramural.nih.gov/search/searchview.taf?ipid=98700
52,BC010015-22,"October 01, 2016 -  September 30, 2017",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,NULL,"1. Chen K, Bao Z, Gong W, Yoshimura T, Wang J (2017) Regulation of inflammation by members of the FPR family. Journal of Autoimmunity, in press.|2. Guo ZJ, Yang L, Qian F, Wang YX, Yu X, Ji CD, Cui W, Xiang DF, Zhang X, Zhang P, Wang JM, Cui YH, Bian XW (2016). Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer. Oncotarget  7, 20999-1012.   https://doi.org/10.18632/oncotarget.8236|3. Hou XL, Ji CD, Tang J, Wang YX, Xiang DF, Li HQ, Liu WW, Wang JX, Yan HZ, Wang Y, Zhang P, Cui YH, Wang JM, Bian XW, Liu W (2017). FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients. Sci Rep  7, 3153.   https://doi.org/10.1038/s41598-017-03368-7|4. Liu Q, Cui X, Yu X, Bian BS, Qian F, Hu XG, Ji CD, Yang L, Ren Y, Cui W, Zhang X, Zhang P, Wang JM, Cui YH, Bian XW (2017). Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Mol Cancer  16, 81.   https://doi.org/10.1186/s12943-017-0650-7|5. Yoshimura T, Imamichi T, Weiss JM, Sato M, Li L, Matsukawa A, Wang JM (2016). Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells. Front Immunol  7, 2.   https://doi.org/10.3389/fimmu.2016.00002|6. Zhang L, Wang H, Yang T, Su Z, Fang D, Wang Y, Fang J, Hou X, Le Y, Chen K, Wang JM, Su SB, Lin Q, Zhou Q (2016). Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells. Oncoimmunology  5, e1078055.   https://doi.org/10.1080/2162402X.2015.1078055",https://intramural.nih.gov/search/searchview.taf?ipid=98701
53,BC010017-22,"October 01, 2016 -  September 30, 2017","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98702
54,BC010020-22,"October 01, 2016 -  September 30, 2017",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",NULL,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Alan S Wayne; MD","Barbara  Debrah (Clinical Immunotherapy Section)|Sonya C Duke (Clinical Immunotherapy Section)|Christine Campo Alewine (Laboratory of Molecular Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,"1. Bao X, Pastan I, Bigner DD, Chandramohan V (2016). EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery. Receptors Clin Investig  3.   https://doi.org/10.14800/rci.1430|2. Berzofsky JA, Terabe M, Trepel JB, Pastan I, Stroncek DF, Morris JC, Wood LV (2018). Cancer vaccine strategies: translation from mice to human clinical trials. Cancer Immunol Immunother  67, 1863-1869.   https://doi.org/10.1007/s00262-017-2084-x|3. Hassan R, Alewine C, Pastan I (2016). New Life for Immunotoxin Cancer Therapy. Clin Cancer Res  22, 1055-8.   https://doi.org/10.1158/1078-0432.CCR-15-1623|4. Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I (2016). Mesothelin Immunotherapy for Cancer: Ready for Prime Time? J Clin Oncol  34, 4171-4179.   https://doi.org/10.1200/JCO.2016.68.3672",https://intramural.nih.gov/search/searchview.taf?ipid=98703
55,BC010021-22,"October 01, 2016 -  September 30, 2017",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Corinne A Boulanger-Espeut|Jabril Rahim Johnson|Lauren Elizabeth Ragle,"Cathrin  Brisken (ISREC/EPFL)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)|Nelson  Horseman (Univ. Cinn.)|Robert D Bruno|Pepper  Schedin (University of Colorado)|Brian  Booth",NULL,NULL,"1. Bruno RD, Fleming JM, George AL, Boulanger CA, Schedin P, Smith GH (2017). Mammary extracellular matrix directs differentiation of testicular and embryonic stem cells to form functional mammary glands in vivo. Sci Rep  7, 40196.   https://doi.org/10.1038/srep40196|2. George A, BoulangerEspeut C, Smith G (2016) ""Telomerase and estrogen-sensing activities are essential for continued mammary growth in vivo but dispensable for ""reprogramming"" neural stem cells"" Aging In Press:In Press|3. George AL, Boulanger CA, Anderson LH, Cagnet S, Brisken C, Smith GH (2017). In vivo reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. J Cell Sci  130, 2018-2025.   https://doi.org/10.1242/jcs.200030|4. George AL, Boulanger CA, Smith GH (2016). Telomerase and estrogen-sensing activities are essential for continued mammary growth in vivo but dispensable for ""reprogramming"" neural stem cells. Aging (Albany NY)  8, 1353-63.   https://doi.org/10.18632/aging.100985|5. George AL, Smith GH (2016). Mammary Epithelial Cell Lineage Analysis via the Lyon's Hypothesis. Int J Stem Cell Res Ther  3.   https://doi.org/10.23937/2469-570x/1410018|6. Smith GH (2016). Binuclear Cells in the Lactating Mammary Gland: New Insights on an Old Concept? J Mammary Gland Biol Neoplasia  21, 21-3.   https://doi.org/10.1007/s10911-016-9356-5|7. Smith GH, Boulanger CA (2017). Techniques for the Reprogramming of Exogenous Stem/Progenitor Cell Populations Towards a Mammary Epithelial Cell Fate. Methods Mol Biol  1501, 277-289.   https://doi.org/10.1007/978-1-4939-6475-8_14",https://intramural.nih.gov/search/searchview.taf?ipid=98704
56,BC010022-22,"October 01, 2016 -  September 30, 2017",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Elizabeth  Binns-Roemer|Sophie Mh Limou|Victor A David|Brean Elysse Derrett,Gregory D Kirk|Etienne  Pays (Universite Libre de Bruxelles)|Mohammed  Atta (Johns Hopkins University)|Rajendra  Bhimma (University of KwaZulu-Natal)|Michael  Lipkowitz (Georgetown University)|Rakhi  Naik (Johns Hopkins University)|Show all 9,Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Jonathan Nicholas Hofmann (Occupational and Environmental Epidemiology Branch)|George  Nelson (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Randall C Johnson (Office Of The Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Bodonyi-Kovacs G, Ma JZ, Chang J, Lipkowitz MS, Kopp JB, Winkler CA, Le TH (2016). Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial. J Am Soc Nephrol  27, 3140-3152.   https://doi.org/10.1681/ASN.2015050487|2. Finkel TH, Li J, Wei Z, Wang W, Zhang H, Behrens EM, Reuschel EL, Limou S, Wise C, Punaro M, Becker ML, Munro JE, Flatø B, Førre Ø, Thompson SD, Langefeld CD, Glass DN, Glessner JT, Kim CE, Frackelton E, Shivers DK, Thomas KA, Chiavacci RM, Hou C, Xu K, et al. [8 more authors] (2016). Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility. BMC Med Genet  17, 24.   https://doi.org/10.1186/s12881-016-0285-3|3. Heymann J, Winkler CA, Hoek M, Susztak K, Kopp JB (2017). Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte. Nephrol Dial Transplant  32, i65-i70.   https://doi.org/10.1093/ndt/gfw402|4. Hughson MD, Hoy WE, Mott SA, Puelles VG, Bertram JF, Winkler CL, Kopp JB (2016). APOL1 Risk Alleles are Associated with More Severe Arteriosclerosis in Renal Resistance Vessels with Aging and Hypertension. Kidney Int Rep  1, 10-23.   https://doi.org/10.1016/j.ekir.2016.03.002|5. Limou S, Taverner AM, Winkler CA (2016). Ferret: a user-friendly Java tool to extract data from the 1000 Genomes Project. Bioinformatics  32, 2224-6.   https://doi.org/10.1093/bioinformatics/btw147|6. Madlala P, Singh R, An P, Werner L, Mlisana K, Abdool Karim SS, Winkler CA, Ndungʼu T (2016). Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression. J Acquir Immune Defic Syndr  72, 465-73.   https://doi.org/10.1097/QAI.0000000000001028|7. Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG (2017). APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts. Nephrol Dial Transplant  32, 983-990.   https://doi.org/10.1093/ndt/gfw061|8. Su H, Zhu G, Djaja P, Lin Y, Gong Y, Liu X, Li J, Liu Z, Qin X, Li L, Liu T, Lu Z, Wei M, Yan L, Winkler CA, O'Brien SJ, Li J, Xiao K, Peng T (2017) Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse. Oncotarget 8:54402-15|9. Williams RC, Elston RC, Kumar P, Knowler WC, Abboud HE, Adler S, Bowden DW, Divers J, Freedman BI, Igo RP, Ipp E, Iyengar SK, Kimmel PL, Klag MJ, Kohn O, Langefeld CD, Leehey DJ, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Rotter JI, Schelling JR, Sedor JR, Shah VO, FIND Research Group, et al. [8 more authors] (2016). Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND). BMC Genomics  17, 325.   https://doi.org/10.1186/s12864-016-2654-x|10. Woroniecki RP, Ng DK, Limou S, Winkler CA, Reidy KJ, Mitsnefes M, Sampson MG, Wong CS, Warady BA, Furth SL, Kopp JB, Kaskel FJ (2016). Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis. Front Pediatr  4, 122.   https://doi.org/10.3389/fped.2016.00122|11. Yu H, Artomov M, Brähler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS (2016). A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest  126, 1067-78.   https://doi.org/10.1172/JCI82592|12. Yu H, Artomov M, Brähler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS (2016). A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest  126, 1603.   https://doi.org/10.1172/JCI87342",https://intramural.nih.gov/search/searchview.taf?ipid=98705
57,BC010027-23,"October 01, 2016 -  September 30, 2017",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Thomas A Johnson|Rodney Louis Schiltz; PhD|Diana  Stavreva|Songjoon  Baek|Lyuba  Varticovski,NULL,NULL,NULL,"1. Presman DM, Ball DA, Paakinaho V, Grimm JB, Lavis LD, Karpova TS, Hager GL (2017). Quantifying transcription factor binding dynamics at the single-molecule level in live cells. Methods  123, 76-88.   https://doi.org/10.1016/j.ymeth.2017.03.014",https://intramural.nih.gov/search/searchview.taf?ipid=98706
58,BC010030-22,"October 01, 2016 -  September 30, 2017",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",NULL,"Rajendra  Prasad (Jawaharlal Nehru University)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Tanaji  Tallele (St. Johns University)|Michael  Mayer (University of Michigan)|John E Golin|Chung-Pu  Wu (Chang Gung University)","Di S Xia; PhD, MS, BS (Crystallography Section)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Stewart  Durell (Laboratory of Cell Biology)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)","Kenneth A Jacobson; BA, MS, PhD (NIDDK)","1. Chufan EE, Kapoor K, Ambudkar SV (2016). Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Biochem Pharmacol  101, 40-53.   https://doi.org/10.1016/j.bcp.2015.12.007|2. Mohana S, Ganesan M, Agilan B, Karthikeyan R, Srithar G, Beaulah Mary R, Ananthakrishnan D, Velmurugan D, Rajendra Prasad N, Ambudkar SV (2016). Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mol Biosyst  12, 2458-70.   https://doi.org/10.1039/c6mb00187d|3. Prasad NR, Muthusamy G, Shanmugam M, Ambudkar SV (2016). South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and Radiotherapy. Cancers (Basel)  8.   https://doi.org/10.3390/cancers8030032",https://intramural.nih.gov/search/searchview.taf?ipid=98707
59,BC010277-20,"October 01, 2016 -  September 30, 2017",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Revathy  Ramachandran; PhD|Peter Nicholas Ciaccia|Yawen  Bai; PhD,NULL,Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Aravind L Iyer; PhD (NLM) |Rodolfo  Ghirlando; PhD (NIDDK),"1. Jha J, Li M, Ghirlando R, Miller Jenkins L, Wlodawer A, Chattoraj D (2017) The DnaK chaperone uses different mechanisms to promote and inhibit replication of Vibrio cholerae chromosome 2 mBio 8:e00427-17|2. Jha JK, Chattoraj DK (2016). Inactivation of Individual SeqA Binding Sites of the E. coli Origin Reveals Robustness of Replication Initiation Synchrony. PLoS One  11, e0166722.   https://doi.org/10.1371/journal.pone.0166722|3. Jha JK, Ramachandran R, Chattoraj DK (2016). Opening the Strands of Replication Origins-Still an Open Question. Front Mol Biosci  3, 62.   https://doi.org/10.3389/fmolb.2016.00062|4. Ramachandran R, Jha J, Paulsson J, Chattoraj D (2017) Random versus cell cycle regulated replication initiation in bacteria: Insights from studying Vibrio cholerae chromosome 2 Microbiology and Molecular Biology Reviews 81:e00033-16",https://intramural.nih.gov/search/searchview.taf?ipid=98708
60,BC010278-20,"October 01, 2016 -  September 30, 2017",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lisa M. Hartnell|Andrei Radu Florescu|Lesley Ann Earl; PhD|Brian James Caffrey,Chris  Szakal (NIST)|Primal  de Lanerolle (University of Illinois at Chicago),Jeffrey D Lifson; MD (Office Of The Director)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Donald F Bliss (NLM) |Robert S Balaban; PhD (NHLBI) |Luigi  Ferrucci; MD (NIA),"1. Guo TW, Bartesaghi A, Yang H, Falconieri V, Rao P, Merk A, Eng ET, Raczkowski AM, Fox T, Earl LA, Patel DJ, Subramaniam S (2017). Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex. Cell  171, 414-426.e12.   https://doi.org/10.1016/j.cell.2017.09.006",https://intramural.nih.gov/search/searchview.taf?ipid=98709
61,BC010283-20,"October 01, 2016 -  September 30, 2017",DNA repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Hua Tang  Chen|Nancy  Wong|Maria Elsa  Callen Moreu|Andres  Canela Rodriguez|Dali  Zong|Andre  Stanlie|Show all 13,"Barry P. Sleckman; MD, PhD (Department of Pathology and Immunology, Washington University School of Medicine)|Eraz Lieberman  Aiden (Baylor College of Medicine)|Samuel  Bunting|Oscar  Fernandez-Capetillo (Spanish National Cancer Research Centre, CNIO)|Lee  Zou (Harvard University)","Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Kai  Ge; PhD (NIDDK) |Clare M Waterman (NHLBI),"1. Canela A, Maman Y, Jung S, Wong N, Callen E, Day A, Kieffer-Kwon KR, Pekowska A, Zhang H, Rao SSP, Huang SC, Mckinnon PJ, Aplan PD, Pommier Y, Aiden EL, Casellas R, Nussenzweig A (2017). Genome Organization Drives Chromosome Fragility. Cell  170, 507-521.e18.   https://doi.org/10.1016/j.cell.2017.06.034|2. Greer YE, Gao B, Yang Y, Nussenzweig A, Rubin JS (2017). Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1. PLoS One  12, e0170903.   https://doi.org/10.1371/journal.pone.0170903|3. Li M, Cole F, Patel DS, Misenko SM, Her J, Malhowski A, Alhamza A, Zheng H, Baer R, Ludwig T, Jasin M, Nussenzweig A, Serrano L, Bunting SF (2016). 53BP1 ablation rescues genomic instability in mice expressing 'RING-less' BRCA1. EMBO Rep  17, 1532-1541.   https://doi.org/10.15252/embr.201642497|4. Nieto-Soler M, Morgado-Palacin I, Lafarga V, Lecona E, Murga M, Callen E, Azorin D, Alonso J, Lopez-Contreras AJ, Nussenzweig A, Fernandez-Capetillo O (2016). Efficacy of ATR inhibitors as single agents in Ewing sarcoma. Oncotarget  7, 58759-58767.   https://doi.org/10.18632/oncotarget.11643|5. Skau CT, Fischer RS, Gurel P, Thiam HR, Tubbs A, Baird MA, Davidson MW, Piel M, Alushin GM, Nussenzweig A, Steeg PS, Waterman CM (2016). FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis. Cell  167, 1571-1585.e18.   https://doi.org/10.1016/j.cell.2016.10.023|6. Tubbs A, Nussenzweig A (2017). Endogenous DNA Damage as a Source of Genomic Instability in Cancer. Cell  168, 644-656.   https://doi.org/10.1016/j.cell.2017.01.002|7. Yazinski SA, Comaills V, Buisson R, Genois MM, Nguyen HD, Ho CK, Todorova Kwan T, Morris R, Lauffer S, Nussenzweig A, Ramaswamy S, Benes CH, Haber DA, Maheswaran S, Birrer MJ, Zou L (2017). ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells. Genes Dev  31, 318-332.   https://doi.org/10.1101/gad.290957.116|8. Zong D, Chaudhuri AR, Nussenzweig A (2016). More end resection is not merrier. Nat Struct Mol Biol  23, 699-701.   https://doi.org/10.1038/nsmb.3274",https://intramural.nih.gov/search/searchview.taf?ipid=98710
62,BC010292-20,"October 01, 2016 -  September 30, 2017",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Yien-Che  Tsai|Mei  Yang; MD|Jennifer B Mariano|Christopher Edward Smith|Sera  Choi|Martha Iveth Garcia; PhD|Show all 7,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)|Sina  Bavari (-, USAMRIID)|Danny  Huang (Beatson Institute)|George  Oyler (JHU)|Charles B Shoemaker; PhD (Veterinary Medicine, Tufts University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98640
63,BC010297-20,"October 01, 2016 -  September 30, 2017",Identification of Genetic Factors Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Sophie Mh Limou|Victor A David,Gregory D Kirk|William  Wester (Vanderbilt University School of Medicine)|Rajendra  Bhimma (University of KwaZulu-Natal)|Saraladevi  Naicker (University of the Witwatersrand)|Mohammed  Atta (Johns Hopkins University)|Frederick  Kaskel (Albert Einstein College of Medicine)|Show all 8,James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch)|Charles  Rabkin (Infection & Immunoepidemiology Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. An P, Penugonda S, Thorball CW, Bartha I, Goedert JJ, Donfield S, Buchbinder S, Binns-Roemer E, Kirk GD, Zhang W, Fellay J, Yu XF, Winkler CA (2016). Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia. PLoS Genet  12, e1005921.   https://doi.org/10.1371/journal.pgen.1005921|2. Atta MG, Estrella MM, Skorecki KL, Kopp JB, Winkler CA, Wasser WG, Shemer R, Racusen LC, Kuperman M, Foy MC, Lucas GM, Fine DM (2016). Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy. Clin J Am Soc Nephrol  11, 262-70.   https://doi.org/10.2215/CJN.07490715|3. Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, Ulasi I, Salako B, Plange-Rhule J, Mengistu Y, Mc'Ligeyo SO, Moturi G, Winkler CA, Moxey-Mims MM, Rasooly RS, Kimmel P, Adu D, Ojo A, Parekh RS, H3Africa Kidney Disease Research Network (2016). Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Kidney Int  90, 2-5.   https://doi.org/10.1016/j.kint.2015.12.059|4. Purswani MU, Patel K, Winkler CA, Spector SA, Hazra R, Seage GR, Mofenson L, Karalius B, Scott GB, Van Dyke RB, Kopp JB, Pediatric HIVAIDS Cohort Study (2016). Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection. J Acquir Immune Defic Syndr  73, 63-8.   https://doi.org/10.1097/QAI.0000000000001010|5. Yang X, Guo X, Chen Y, Chen G, Ma Y, Huang K, Zhang Y, Zhao Q, Winkler CA, An P, Lyu J (2016). Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget  7, 27838-47.   https://doi.org/10.18632/oncotarget.8539",https://intramural.nih.gov/search/searchview.taf?ipid=98711
64,BC010298-20,"October 01, 2016 -  September 30, 2017",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera,NULL,Christine Campo Alewine (Laboratory of Molecular Biology),NULL,"1. Liang X, Schnaper HW, Matsusaka T, Pastan I, Ledbetter S, Hayashida T (2016). Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS One  11, e0155534.   https://doi.org/10.1371/journal.pone.0155534",https://intramural.nih.gov/search/searchview.taf?ipid=98712
65,BC010300-20,"October 01, 2016 -  September 30, 2017",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Luke Cynlais Davies; BSC|Christopher Michael Rice; PhD|Jonathan  Weiss|Jeffrey J Subleski|Marieli  Gonzalez-Cotto|Erika Mariana Palmieri; PhD|Show all 8,"Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Selinda Jane Orr|Teresa  Fan (University of Louisville)|Show all 8",Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch),"Suk See De Ravin; MD, PhD (NIAID) |Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI) |Thomas Anthony Wynn; PhD (NIAID)","1. Burg AR, Quigley L, Jones AV, O'Connor GM, Boelte K, McVicar DW, Orr SJ (2016). Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity. Springerplus  5, 815.   https://doi.org/10.1186/s40064-016-2501-1|2. De Ravin SS, Wu X, Moir S, Anaya-O'Brien S, Kwatemaa N, Littel P, Theobald N, Choi U, Su L, Marquesen M, Hilligoss D, Lee J, Buckner CM, Zarember KA, O'Connor G, McVicar D, Kuhns D, Throm RE, Zhou S, Notarangelo LD, Hanson IC, Cowan MJ, Kang E, Hadigan C, Meagher M, et al. [4 more authors] (2016). Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med  8, 335ra57.   https://doi.org/10.1126/scitranslmed.aad8856",https://intramural.nih.gov/search/searchview.taf?ipid=98713
66,BC010301-20,"October 01, 2016 -  September 30, 2017",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Jack Gargani Tsintolas|Daniel  Gorelik,Arthur  Frankel (Texas A&M)|Francesco  Forconi (Policlinico le Scotte)|Tadeusz  Robak (University of Lodz)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Farhad  Ravandi (MD Anderson)|Michael  Grever (Ohio State Universithy)|Show all 9,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)",Nicholas  Patronas; MD (CC),"1. Mazor R, Kaplan G, Park D, Jang Y, Lee F, Kreitman R, Pastan I (2017). Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. Cell Immunol  313, 59-66.   https://doi.org/10.1016/j.cellimm.2017.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=98714
67,BC010304-19,"October 01, 2016 -  September 30, 2017",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Roberto  Weigert; MSc Chemistry, PhD",NULL,Ettore  Appella; MD (Chemical Immunology Section)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology),"Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD) |Jeffrey  Baron; MD (NICHD) |Keir Cajal Neuman; BA, PhD (NHLBI)","1. Guittard G, Gallardo DL, Li W, Melis N, Lui JC, Kortum RL, Shakarishvili NG, Huh S, Baron J, Weigert R, Kramer JA, Samelson LE, Sommers CL (2017). Unexpected Cartilage Phenotype in CD4-Cre-Conditional SOS-Deficient Mice. Front Immunol  8, 343.   https://doi.org/10.3389/fimmu.2017.00343|2. Yi JC, Samelson LE (2016). Microvilli set the stage for T-cell activation. Proc Natl Acad Sci U S A  113, 11061-11062.   https://doi.org/10.1073/pnas.1613832113",https://intramural.nih.gov/search/searchview.taf?ipid=98715
68,BC010307-18,"October 01, 2016 -  September 30, 2017",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Shikha  Sharan|Balamurugan  Kuppusamy|Namratha  Sheshadri|Dipak Kumar Poria,"Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Goran  Landberg (Paterson Institute for Cancer Research)|Naoto  Ueno (National Institute for Basic Biology)|Wendy  Woodward (The University of Texas MD Anderson Cancer Center)|Savitri  Krishnamurthy (The University of Texas MD Anderson Cancer Center)|Michael  Lewis (Lester and Sue Smith Breast Center, Baylor College of Medicine)",Glenn H Summers (Office Of The Director)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|Randall C Johnson (Office Of The Director)|Anand S Merchant (Office of the Director)|Ruth  Nussinov; PhD (Cancer Inflammation Program)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98647
69,BC010308-19,"October 01, 2016 -  September 30, 2017",In vivo Imaging Analysis of Steroid-Nuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rodney Louis Schiltz; PhD|Diana  Stavreva|Diego Martin Presman; PhD|Lyuba  Varticovski|Ville Juhani Paakinaho; PhD|David Alejandro Garcia Grisales,Luke  Iwanowicz (USGS-BRD)|Adali  Pecci (Ciudad Universitaria)|Michael  Collins (Center for Natural Capital)|Luke  Lavis; PhD (Howard Hughes Medical Institute/JFRC)|Patricia  Bright (U.S. Geological Survey)|Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter),"Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Lynch C, Sakamuru S, Huang R, Stavreva DA, Varticovski L, Hager GL, Judson RS, Houck KA, Kleinstreuer NC, Casey W, Paules RS, Simeonov A, Xia M (2017). Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform. Toxicology  385, 48-58.   https://doi.org/10.1016/j.tox.2017.05.001|2. Presman DM, Hager GL (2017). More than meets the dimer: What is the quaternary structure of the glucocorticoid receptor? Transcription  8, 32-39.   https://doi.org/10.1080/21541264.2016.1249045",https://intramural.nih.gov/search/searchview.taf?ipid=98718
70,BC010309-19,"October 01, 2016 -  September 30, 2017",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Gianluca  Pegoraro,Job  Dekker; PhD (University of Massachusetts)|Dan  Levy (University of Wyoming)|Rick  Young (Whitehead Institute),Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Finn EH, Misteli T, Shachar S (2016). Painting a Clearer Picture of Chromatin. Dev Cell  36, 356-7.   https://doi.org/10.1016/j.devcel.2016.02.002|2. Gordon LB, Kieran MW, Kleinman ME, Misteli T (2016). The decision-making process and criteria in selecting candidate drugs for progeria clinical trials. EMBO Mol Med  8, 685-7.   https://doi.org/10.15252/emmm.201606280|3. Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S, Weintraub AS, Hnisz D, Pegoraro G, Lee TI, Misteli T, Jaenisch R, Young RA (2016). 3D Chromosome Regulatory Landscape of Human Pluripotent Cells. Cell Stem Cell  18, 262-75.   https://doi.org/10.1016/j.stem.2015.11.007|4. Kubben N, Brimacombe KR, Donegan M, Li Z, Misteli T (2016). A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. Methods  96, 46-58.   https://doi.org/10.1016/j.ymeth.2015.08.024|5. Kubben N, Zhang W, Wang L, Voss TC, Yang J, Qu J, Liu GH, Misteli T (2016). Repression of the Antioxidant NRF2 Pathway in Premature Aging. Cell  165, 1361-1374.   https://doi.org/10.1016/j.cell.2016.05.017|6. Leshner M, Devine M, Roloff GW, True LD, Misteli T, Meaburn KJ (2016). Locus-specific gene repositioning in prostate cancer. Mol Biol Cell  27, 236-46.   https://doi.org/10.1091/mbc.E15-05-0280|7. Meaburn KJ, Agunloye O, Devine M, Leshner M, Roloff GW, True LD, Misteli T (2016). Tissue-of-origin-specific gene repositioning in breast and prostate cancer. Histochem Cell Biol  145, 433-46.   https://doi.org/10.1007/s00418-015-1401-8|8. Pegoraro G, Misteli T (2016). High-throughput Imaging as a versatile and unbiased discovery tool. Methods  96, 1-2.   https://doi.org/10.1016/j.ymeth.2016.01.003|9. Salton M, Misteli T (2016). Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy. Trends Mol Med  22, 28-37.   https://doi.org/10.1016/j.molmed.2015.11.005|10. Torres CM, Biran A, Burney MJ, Patel H, Henser-Brownhill T, Cohen AS, Li Y, Ben-Hamo R, Nye E, Spencer-Dene B, Chakravarty P, Efroni S, Matthews N, Misteli T, Meshorer E, Scaffidi P (2016). The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. Science  353.   https://doi.org/10.1126/science.aaf1644",https://intramural.nih.gov/search/searchview.taf?ipid=98719
71,BC010313-19,"October 01, 2016 -  September 30, 2017",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Hien Thi-Thu Dang|Valerie Fako Miller|Hongping  Zheng|Yotsawat  Pomyen; PhD|Haiyang  Wang|Show all 7,"Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Mathuros  Ruchirawat (Chulabhorn Research Institute)|Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Show all 16","Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)|Javed  Khan; MD (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,"1. Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, TIGER-LC Consortium, et al. [12 more authors] (2017). Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell  32, 57-70.e3.   https://doi.org/10.1016/j.ccell.2017.05.009|2. Ploeger C, Waldburger N, Fraas A, Goeppert B, Pusch S, Breuhahn K, Wang XW, Schirmacher P, Roessler S (2016). Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma. Hepatology  64, 828-42.   https://doi.org/10.1002/hep.28684|3. Zhao X, Parpart-Li S, Wang XW (2016). The importance of integrated genomics to uncover clinically relevant cancer driver genes. Mol Cell Oncol  3, e1019975.   https://doi.org/10.1080/23723556.2015.1019975",https://intramural.nih.gov/search/searchview.taf?ipid=98721
72,BC010319-19,"October 01, 2016 -  September 30, 2017",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Wai-Kwan  Tang|Fei  Zhou|Xiaoyun  Bai,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Laboratory of Cell Biology),NULL,"1. Esser L, Shukla S, Zhou F, Ambudkar SV, Xia D (2016). Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein. Acta Crystallogr F Struct Biol Commun  72, 636-41.   https://doi.org/10.1107/S2053230X16009778|2. Esser L, Zhou F, Pluchino KM, Shiloach J, Ma J, Tang WK, Gutierrez C, Zhang A, Shukla S, Madigan JP, Zhou T, Kwong PD, Ambudkar SV, Gottesman MM, Xia D (2017). Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity. J Biol Chem  292, 446-461.   https://doi.org/10.1074/jbc.M116.755884|3. Esser L, Zhou F, Zhou Y, Xiao Y, Tang WK, Yu CA, Qin Z, Xia D (2016). Hydrogen Bonding to the Substrate Is Not Required for Rieske Iron-Sulfur Protein Docking to the Quinol Oxidation Site of Complex III. J Biol Chem  291, 25019-25031.   https://doi.org/10.1074/jbc.M116.744391|4. Pluchino KM, Hall MD, Moen JK, Chufan EE, Fetsch PA, Shukla S, Gill DR, Hyde SC, Xia D, Ambudkar SV, Gottesman MM (2016). Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1). Biochemistry  55, 1010-23.   https://doi.org/10.1021/acs.biochem.5b01064|5. Zhou Z, Esser L, Xia D (2016) Recent Advances in Understanding the Structure and Function Relationship of Multidrug Resistance-linked ABC Transporter P-glycoprotein Journal of Cancer research Updates 5:88-98",https://intramural.nih.gov/search/searchview.taf?ipid=98722
73,BC010326-18,"October 01, 2016 -  September 30, 2017","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Gary X Shaw|Genbin  Shi|Vandana  Kumari; PhD|He  Song|Lan  Jin|Chao  Wang,Honggao  Yan|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University)|Shivendra  Singh (University of Pittsburgh),Ding Jun Jin (Rna Biology Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mikhail V Kashlev (Rna Biology Laboratory)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,"1. Ji X (2016). Structural insights into cell cycle control by essential GTPase Era. Postepy Biochem  62, 335-342.|2. Kumari V, Dyba MA, Holland RJ, Liang YH, Singh SV, Ji X (2016). Irreversible Inhibition of Glutathione S-Transferase by Phenethyl Isothiocyanate (PEITC), a Dietary Cancer Chemopreventive Phytochemical. PLoS One  11, e0163821.   https://doi.org/10.1371/journal.pone.0163821",https://intramural.nih.gov/search/searchview.taf?ipid=98723
74,BC010328-18,"October 01, 2016 -  September 30, 2017",Role of CEBP transcription factors in cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Nancy C Martin|Sandip  Basu|Jacqueline  Salotti; PhD|Srikanta  Basu; PhD|Linshan  Hu|Jonathan  Keller; PhD,Robert  Smart (North Carolina State University)|Warren  Tourtellotte (Northwestern University),Karen Lynn Saylor (Office Of The Director)|Maria  Miller (Protein Structure Section)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),Myriam  Gorospe; PhD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98724
75,BC010329-18,"October 01, 2016 -  September 30, 2017",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Daniel A Ritt|Suzanne I Specht|Elizabeth Mclean Terrell|David Ellis Durrant|John Fickes Brognard; MS,"Robert  Rottapel (University of Toronto)|Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)|Sharon  Campbell (University of North Carolina School of Medicine)|Adrienne  Cox (University of North Carolina School of Medicine)",Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Matthew T Holderfield (Office Of The Director)|Andrew G Stephen (Office Of The Director)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,"1. Holderfield M, Morrison DK (2016). RAS signaling: Divide and conquer. Nat Chem Biol  13, 7-8.   https://doi.org/10.1038/nchembio.2264|2. Ritt DA, Abreu-Blanco MT, Bindu L, Durrant DE, Zhou M, Specht SI, Stephen AG, Holderfield M, Morrison DK (2016). Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit. Mol Cell  64, 875-887.   https://doi.org/10.1016/j.molcel.2016.10.029",https://intramural.nih.gov/search/searchview.taf?ipid=98725
76,BC010331-18,"October 01, 2016 -  September 30, 2017",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Kunduri  Govind; PhD|Kenneth Min Kim,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)|Vivek  Jayaraman (HHMI Janelia Farms Research Campus)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98726
77,BC010334-18,"October 01, 2016 -  September 30, 2017",Immunotherapeutic Interventions of AIDS and Cancer,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Frances Talieh Dayton|Valerie  Letukas|Jenifer L Bear|Cristina  Bergamaschi|Santhi  Devasundaram|George N Pavlakis; MD, PhD|Show all 7","David A Zaharoff|Morten  Thaysen-Andersen (Macquarie University)|Galit  Alter; PhD (Division of Medical Sciences, Harvard Medical School)|Ira  Berkower|Kate  Broderick (Inovio Pharmaceuticals, Inc.)|Bernard  Fox (Oregon Cancer Center)|Show all 14",Bethany Anne Nagy (Office Of The Director)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Jacob D Estes (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section),Konstantinos  Petrovas (NIAID) |Mario  Roederer; PhD (NIAID),"1. Jayanthi S, Koppolu BP, Nguyen KG, Smith SG, Felber BK, Zaharoff DA (2017). Modulation of Interleukin-12 activity in the presence of heparin. Sci Rep  7, 5360.   https://doi.org/10.1038/s41598-017-05382-1|2. Ng SSM, Nagy BA, Jensen SM, Hu X, Alicea C, Fox BA, Felber BK, Bergamaschi C, Pavlakis GN (2017). Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion. Clin Cancer Res  23, 2817-2830.   https://doi.org/10.1158/1078-0432.CCR-16-1808",https://intramural.nih.gov/search/searchview.taf?ipid=98727
78,BC010336-18,"October 01, 2016 -  September 30, 2017",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Nina C Costantino|Xintian  Li|Gokhan  Tolun; PhD|Brenda K Shafer|Lynn C Thomason|Mikhail V Kashlev,"Max  Gottesman (Institute of Cancer Research, Columbia University)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Sankar  Adhya; PhD (Developmental Genetics Section)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Arbel-Goren R, Tal A, Parasar B, Dym A, Costantino N, Muñoz-García J, Court DL, Stavans J (2016). Transcript degradation and noise of small RNA-controlled genes in a switch activated network in Escherichia coli. Nucleic Acids Res  44, 6707-20.   https://doi.org/10.1093/nar/gkw273|2. Li XT, Jun Y, Erickstad MJ, Brown SD, Parks A, Court DL, Jun S (2016). tCRISPRi: tunable and reversible, one-step control of gene expression. Sci Rep  6, 39076.   https://doi.org/10.1038/srep39076|3. Singh N, Bubunenko M, Smith C, Abbott DM, Stringer AM, Shi R, Court DL, Wade JT (2016). SuhB Associates with Nus Factors To Facilitate 30S Ribosome Biogenesis in Escherichia coli. MBio  7, e00114.   https://doi.org/10.1128/mBio.00114-16|4. Thomason LC, Costantino N, Court DL (2016). Examining a DNA Replication Requirement for Bacteriophage λ Red- and Rac Prophage RecET-Promoted Recombination in Escherichia coli. MBio  7.   https://doi.org/10.1128/mBio.01443-16|5. Thomason LC, Court DL (2016). Evidence that bacteriophage λ lysogens may induce in response to the proton motive force uncoupler CCCP. FEMS Microbiol Lett  363.   https://doi.org/10.1093/femsle/fnv244",https://intramural.nih.gov/search/searchview.taf?ipid=98728
79,BC010338-18,"October 01, 2016 -  September 30, 2017",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Matthew J Anderson|Michael Graham Stanley Boylan|Sumi  Mondal|Mccauley Grace Brown,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)|Thomas  Schimmang (University of Valladolid)|David M Ornitz; MD (Department of Developmental Biology, Washington University, School of Medicine)",Thilinie Dilrukshi Kuruppu (Cancer and Developmental Biology Laboratory)|Salvia  Misaghian (Cancer and Developmental Biology Laboratory),NULL,"1. Anderson MJ, Schimmang T, Lewandoski M (2016). An FGF3-BMP Signaling Axis Regulates Caudal Neural Tube Closure, Neural Crest Specification and Anterior-Posterior Axis Extension. PLoS Genet  12, e1006018.   https://doi.org/10.1371/journal.pgen.1006018",https://intramural.nih.gov/search/searchview.taf?ipid=98729
80,BC010341-18,"October 01, 2016 -  September 30, 2017",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Danielle  Needle|Rajesh  Gumpena|Sreedevi  Nallamsetty|Anna Maria Mielech,NULL,NULL,NULL,"1. Raran-Kurussi S, Waugh DS (2016). A dual protease approach for expression and affinity purification of recombinant proteins. Anal Biochem  504, 30-7.   https://doi.org/10.1016/j.ab.2016.04.006|2. Waugh DS (2016). The remarkable solubility-enhancing power of Escherichia coli maltose-binding protein. Postepy Biochem  62, 377-382.",https://intramural.nih.gov/search/searchview.taf?ipid=98730
81,BC010345-18,"October 01, 2016 -  September 30, 2017",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Ravindra Babu  Chalamalasetty|Sara E Parkin|Akhil  Kapoor|Aysegul  Dogan; PhD|Matthew John Koury|Nikolaos Panagiotis Mandalos,NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section),NULL,"1. Kumar A, Chalamalasetty RB, Kennedy MW, Thomas S, Inala SN, Garriock RJ, Yamaguchi TP (2016). Zfp703 Is a Wnt/β-Catenin Feedback Suppressor Targeting the β-Catenin/Tcf1 Complex. Mol Cell Biol  36, 1793-802.   https://doi.org/10.1128/MCB.01010-15",https://intramural.nih.gov/search/searchview.taf?ipid=98731
82,BC010348-18,"October 01, 2016 -  September 30, 2017",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,Alla E Gustchina (Protein Structure Section)|Maria  Miller (Protein Structure Section)|Di  Zhang (Protein Structure Section)|Cem  Sonmez (Protein Structure Section)|Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Dauter Z, Wlodawer A (2016). Progress in protein crystallography. Protein Pept Lett  23, 201-10.   https://doi.org/10.2174/0929866523666160106153524|2. Leal AR, Cruz R, Bur D, Huesgen PF, Faro R, Manadas B, Wlodawer A, Faro C, Simões I (2016). Enzymatic properties, evidence for in vivo expression, and intracellular localization of shewasin D, the pepsin homolog from Shewanella denitrificans. Sci Rep  6, 23869.   https://doi.org/10.1038/srep23869|3. Li M, Kandror O, Akopian T, Dharkar P, Wlodawer A, Maurizi MR, Goldberg AL (2016). Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis. J Biol Chem  291, 7465-76.   https://doi.org/10.1074/jbc.M115.700344|4. Lubkowski J, Durbin SV, Silva MC, Farnsworth D, Gildersleeve JC, Oliva ML, Wlodawer A (2017). Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth. FEBS J  284, 429-450.   https://doi.org/10.1111/febs.13989|5. Minor W, Dauter Z, Helliwell JR, Jaskolski M, Wlodawer A (2016). Safeguarding Structural Data Repositories against Bad Apples. Structure  24, 216-20.   https://doi.org/10.1016/j.str.2015.12.010|6. Raczynska JE, Wlodawer A, Jaskolski M (2016). Prior knowledge or freedom of interpretation? A critical look at a recently published classification of ""novel"" Zn binding sites. Proteins  84, 770-6.   https://doi.org/10.1002/prot.25024|7. Rupp B, Wlodawer A, Minor W, Helliwell JR, Jaskolski M (2016). Correcting the record of structural publications requires joint effort of the community and journal editors. FEBS J  283, 4452-4457.   https://doi.org/10.1111/febs.13765|8. Wlodawer A (2016). Serendipity, politics, and crystal structures, or how I became a protein crystallographer. Postepy Biochem  62, 239-241.|9. Wlodawer A, Dauter Z (2017). `Atomic resolution': a badly abused term in structural biology. Acta Crystallogr D Struct Biol  73, 379-380.   https://doi.org/10.1107/S205979831700225X|10. Woodfolk JA, Glesner J, Wright PW, Kepley CL, Li M, Himly M, Muehling LM, Gustchina A, Wlodawer A, Chapman MD, Pomés A (2016). Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem  291, 2288-301.   https://doi.org/10.1074/jbc.M115.702324|11. Zhang D, Wlodawer A, Lubkowski J (2016). Crystal Structure of a Complex of the Intracellular Domain of Interferon λ Receptor 1 (IFNLR1) and the FERM/SH2 Domains of Human JAK1. J Mol Biol  428, 4651-4668.   https://doi.org/10.1016/j.jmb.2016.10.005",https://intramural.nih.gov/search/searchview.taf?ipid=98732
83,BC010350-18,"October 01, 2016 -  September 30, 2017",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Xintao  Hu|Frances Talieh Dayton|Zhongyan  Lu|Valerie  Letukas|Jenifer L Bear|George N Pavlakis; MD, PhD|Show all 9","Bart  Haynes (Duke Human Vaccine Institute)|Rama  Amara (Emory Vaccine Center)|Dan  Barouch (Harvard University)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Deborah  Fuller (University of Washington)|Show all 26",Bethany Anne Nagy (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section),Rajeev  Gautam (NIAID) |Richard A Koup; MD (NIAID) |Malcolm A Martin; MD (NIAID),"1. Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, Chowdhury B, Gautam R, Broderick KE, Sardesai NY, Martin MA, Mullins JI, Pavlakis GN, Felber BK (2016). DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol  197, 3999-4013.   https://doi.org/10.4049/jimmunol.1600697|2. Hu X, Valentin A, Rosati M, Manocheewa S, Alicea C, Chowdhury B, Bear J, Broderick KE, Sardesai NY, Gall SL, Mullins JI, Pavlakis GN, Felber BK (2017). HIV Env conserved element DNA vaccine alters immunodominance in macaques. Hum Vaccin Immunother  13, 2859-2871.   https://doi.org/10.1080/21645515.2017.1339852",https://intramural.nih.gov/search/searchview.taf?ipid=98733
84,BC010378-18,"October 01, 2016 -  September 30, 2017",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",NULL,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Dauter Z (2016). Objective evaluation of radiation damage in a nucleoprotein complex. Acta Crystallogr D Struct Biol  72, 601-2.   https://doi.org/10.1107/S2059798316006550|2. Dauter Z, Jaskólski M (2016). Crystal pathologies in macromolecular crystallography. Postepy Biochem  62, 401-407.|3. Kiliszek A, Banaszak K, Dauter Z, Rypniewski W (2016). The first crystal structures of RNA-PNA duplexes and a PNA-PNA duplex containing mismatches--toward anti-sense therapy against TREDs. Nucleic Acids Res  44, 1937-43.   https://doi.org/10.1093/nar/gkv1513|4. Malinska M, Dauter M, Dauter Z (2016). Geometry of guanidinium groups in arginines. Protein Sci  25, 1753-6.   https://doi.org/10.1002/pro.2970|5. Malinska M, Dauter Z (2016). Transferable aspherical atom model refinement of protein and DNA structures against ultrahigh-resolution X-ray data. Acta Crystallogr D Struct Biol  72, 770-9.   https://doi.org/10.1107/S2059798316006355|6. Minor W, Dauter Z, Jaskolski M (2016). The young person's guide to the PDB. Postepy Biochem  62, 242-249.|7. Pletneva NV, Pletnev S, Pakhomov AA, Chertkova RV, Martynov VI, Muslinkina L, Dauter Z, Pletnev VZ (2016). Crystal structure of the fluorescent protein from Dendronephthya sp. in both green and photoconverted red forms. Acta Crystallogr D Struct Biol  72, 922-32.   https://doi.org/10.1107/S205979831601038X|8. Ruszkowski M, Dauter Z (2016). On methylene-bridged cysteine and lysine residues in proteins. Protein Sci  25, 1734-6.   https://doi.org/10.1002/pro.2958|9. Ruszkowski M, Dauter Z (2016). Structural Studies of Medicago truncatula Histidinol Phosphate Phosphatase from Inositol Monophosphatase Superfamily Reveal Details of Penultimate Step of Histidine Biosynthesis in Plants. J Biol Chem  291, 9960-73.   https://doi.org/10.1074/jbc.M115.708727|10. Sekula B, Ruszkowski M, Malinska M, Dauter Z (2016). Structural Investigations of N-carbamoylputrescine Amidohydrolase from Medicago truncatula: Insights into the Ultimate Step of Putrescine Biosynthesis in Plants. Front Plant Sci  7, 350.   https://doi.org/10.3389/fpls.2016.00350|11. Sliwiak J, Dauter Z, Jaskolski M (2016). Crystal Structure of Hyp-1, a Hypericum perforatum PR-10 Protein, in Complex with Melatonin. Front Plant Sci  7, 668.   https://doi.org/10.3389/fpls.2016.00668",https://intramural.nih.gov/search/searchview.taf?ipid=98734
85,BC010379-18,"October 01, 2016 -  September 30, 2017",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,Henry  Chapman (CFEL/DESY/University of Hamburg)|John  Spence (Arizona State University),Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),Adrian Riu Ferre-D'Amare (NHLBI),"1. Liu Y, Sousa R, Wang YX (2016). Specific labeling: An effective tool to explore the RNA world. Bioessays  38, 192-200.   https://doi.org/10.1002/bies.201500119|2. Liu Y, Yu P, Dyba M, Sousa R, Stagno JR, Wang YX (2016). Applications of PLOR in labeling large RNAs at specific sites. Methods  103, 4-10.   https://doi.org/10.1016/j.ymeth.2016.03.014|3. Song H, Fang X, Jin L, Shaw GX, Wang YX, Ji X (2017). The Functional Cycle of Rnt1p: Five Consecutive Steps of Double-Stranded RNA Processing by a Eukaryotic RNase III. Structure  25, 353-363.   https://doi.org/10.1016/j.str.2016.12.013|4. Stagno JR, Liu Y, Bhandari YR, Conrad CE, Panja S, Swain M, Fan L, Nelson G, Li C, Wendel DR, White TA, Coe JD, Wiedorn MO, Knoska J, Oberthuer D, Tuckey RA, Yu P, Dyba M, Tarasov SG, Weierstall U, Grant TD, Schwieters CD, Zhang J, Ferré-D'Amaré AR, Fromme P, et al. [13 more authors] (2017). Structures of riboswitch RNA reaction states by mix-and-inject XFEL serial crystallography. Nature  541, 242-246.   https://doi.org/10.1038/nature20599",https://intramural.nih.gov/search/searchview.taf?ipid=98735
86,BC010387-18,"October 01, 2016 -  September 30, 2017",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Betty K Martin (Office Of The Director)|Arun Prakash Mishra (Mouse Cancer Genetics Program)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Kim S, Song JH, Kim S, Qu P, Martin BK, Sehareen WS, Haines DC, Lin PC, Sharan SK, Chang S (2016). Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration. Oncotarget  7, 11094-112.   https://doi.org/10.18632/oncotarget.7150",https://intramural.nih.gov/search/searchview.taf?ipid=98739
87,BC010390-18,"October 01, 2016 -  September 30, 2017",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Gianluca  Fulgenzi|Erkan  Kiris,"Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)",Mary Ellen  Palko (Neural Development Section)|Sudhirkumar U Yanpallewar (Neural Development Section)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Colleen A Barrick (Office Of The Director)|Zhenyi  Hong; PhD (Neural Development Section),NULL,"1. Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, Katz M, Baughn M, Platoshyn O, Marsala M, Watt A, Heyser CJ, Ard MC, De Muynck L, Daughrity LM, Swing DA, et al. [16 more authors] (2016). Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron  90, 535-50.   https://doi.org/10.1016/j.neuron.2016.04.006|2. Maynard KR, Hill JL, Calcaterra NE, Palko ME, Kardian A, Paredes D, Sukumar M, Adler BD, Jimenez DV, Schloesser RJ, Tessarollo L, Lu B, Martinowich K (2016). Functional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling. Neuropsychopharmacology  41, 1943-55.   https://doi.org/10.1038/npp.2015.349|3. Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, Tessarollo L, Oyler GA, Weissman AM (2017). Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication. Proc Natl Acad Sci U S A  114, E5158-E5166.   https://doi.org/10.1073/pnas.1621076114|4. Yanpallewar S, Wang T, Koh DC, Quarta E, Fulgenzi G, Tessarollo L (2016). Nedd4-2 haploinsufficiency causes hyperactivity and increased sensitivity to inflammatory stimuli. Sci Rep  6, 32957.   https://doi.org/10.1038/srep32957",https://intramural.nih.gov/search/searchview.taf?ipid=98740
88,BC010391-18,"October 01, 2016 -  September 30, 2017",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Gianluca  Fulgenzi|Jodi L Becker,NULL,Zhenyi  Hong; PhD (Neural Development Section)|Colleen A Barrick (Office Of The Director)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Mary Ellen  Palko (Neural Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98741
89,BC010411-18,"October 01, 2016 -  September 30, 2017",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Yves  Pommier; PhD|Vladimir L Larionov; PhD, DSc","Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Jean-Marc  Lemaitre (Institute of Functional Genomics)|lizhao  wu (Rutgers New Jersey Medical School Cancer Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)",Karen P Usdin; PhD (NIDDK),"1. Marks AB, Smith OK, Aladjem MI (2016). Replication origins: determinants or consequences of nuclear organization? Curr Opin Genet Dev  37, 67-75.   https://doi.org/10.1016/j.gde.2015.11.008|2. Smith OK, Kim R, Fu H, Martin MM, Lin CM, Utani K, Zhang Y, Marks AB, Lalande M, Chamberlain S, Libbrecht MW, Bouhassira EE, Ryan MC, Noble WS, Aladjem MI (2016). Distinct epigenetic features of differentiation-regulated replication origins. Epigenetics Chromatin  9, 18.   https://doi.org/10.1186/s13072-016-0067-3|3. Zhang Y, Huang L, Fu H, Smith OK, Lin CM, Utani K, Rao M, Reinhold WC, Redon CE, Ryan M, Kim R, You Y, Hanna H, Boisclair Y, Long Q, Aladjem MI (2016). A replicator-specific binding protein essential for site-specific initiation of DNA replication in mammalian cells. Nat Commun  7, 11748.   https://doi.org/10.1038/ncomms11748",https://intramural.nih.gov/search/searchview.taf?ipid=98742
90,BC010412-18,"October 01, 2016 -  September 30, 2017",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk|Sriram  Subramaniam; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98743
91,BC010413-17,"October 01, 2016 -  September 30, 2017",Human Artificial Chromosomes for Cancer Research and Functional Genomics,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Jung-Hyun  Kim|Hee-Sheung  Lee|Mikhail A Liskovykh|Nikolai S Petrov|Nikolay V Goncharov|Vladimir  Noskov; PhD,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)|Phil  Hieter (University of British Columbia)",NULL,NULL,"1. Booth DG, Beckett AJ, Molina O, Samejima I, Masumoto H, Kouprina N, Larionov V, Prior IA, Earnshaw WC (2016). 3D-CLEM Reveals that a Major Portion of Mitotic Chromosomes Is Not Chromatin. Mol Cell  64, 790-802.   https://doi.org/10.1016/j.molcel.2016.10.009|2. Duffy S, Fam HK, Wang YK, Styles EB, Kim JH, Ang JS, Singh T, Larionov V, Shah SP, Andrews B, Boerkoel CF, Hieter P (2016). Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer. Proc Natl Acad Sci U S A  113, 9967-76.   https://doi.org/10.1073/pnas.1611839113|3. Molina O, Vargiu G, Abad MA, Zhiteneva A, Jeyaprakash AA, Masumoto H, Kouprina N, Larionov V, Earnshaw WC (2016). Epigenetic engineering reveals a balance between histone modifications and transcription in kinetochore maintenance. Nat Commun  7, 13334.   https://doi.org/10.1038/ncomms13334",https://intramural.nih.gov/search/searchview.taf?ipid=98648
92,BC010418-18,"October 01, 2016 -  September 30, 2017",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Wolfgang  Losert; PhD|Weiye  Wang|Ritankar  Majumdar,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression)|Kedar  Narayan (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98744
93,BC010419-18,"October 01, 2016 -  September 30, 2017",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yi  Tang|Liuya  Tang|Veenu  Tripathi; PhD|Jee-Hye  Shin; PhD,NULL,Ming  Zhou (Nucleic Acids Section)|Jing  Huang (Laboratory of Cancer Biology and Genetics)|Lisa Marie Jenkins (Pigment Cell Biology Section)|James  Gao (Thoracic & Oncologic Surgery Branch),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Tripathi V, Sixt KM, Gao S, Xu X, Huang J, Weigert R, Zhou M, Zhang YE (2016). Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β. Mol Cell  64, 549-564.   https://doi.org/10.1016/j.molcel.2016.09.013",https://intramural.nih.gov/search/searchview.taf?ipid=98745
94,BC010425-18,"October 01, 2016 -  September 30, 2017",Strategies for Cancer Immunotherapy Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Morgan Lee Gargulak|Angela Mae Schwab|Martine  Policard|Caroline Mikaela Maria Jochems; PhD|Kwong Yok Tsang|Show all 7,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch),NULL,"1. Duggan MC, Jochems C, Donahue RN, Richards J, Karpa V, Foust E, Paul B, Brooks T, Tridandapani S, Olencki T, Pan X, Lesinski GB, Schlom J, Carson Iii WE (2016). A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas. Cancer Immunol Immunother  65, 1353-1364.   https://doi.org/10.1007/s00262-016-1893-7|2. Heery C, Palena C, McMahon S, Donahue N R, Lepone L, Grenga I, Dirmeier U, Cordes L, Mart J, Dahut W, Singh H, Madan R, Fernando R, Hamilton D, Schlom J, Gulley J (2017) Phase I study of a poxviral TRICOM-based vaccine directed against the transcription factor brachyury. Clin Cancer Res, in press.|3. Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL (2016). Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget  7, 69014-69023.   https://doi.org/10.18632/oncotarget.10883|4. Heery CR, O'Sullivan-Coyne G, Madan RA, Cordes L, Rajan A, Rauckhorst M, Lamping E, Oyelakin I, Marté JL, Lepone LM, Donahue RN, Grenga I, Cuillerot JM, Neuteboom B, Heydebreck AV, Chin K, Schlom J, Gulley JL (2017). Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial. Lancet Oncol  18, 587-598.   https://doi.org/10.1016/S1470-2045(17)30239-5",https://intramural.nih.gov/search/searchview.taf?ipid=98746
95,BC010440-16,"October 01, 2016 -  September 30, 2017","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Giorgio  Trinchieri|Nadya I Tarasova; PhD,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 13",NULL,NULL,"1. GuvenMaiorov E, Tsai C, Nussinov R (2016) Pathogen mimicry of host protein-protein interfaces modulates immunity. Semin Cell Dev Biol, in press.|2. Lu S, Jang H, Shuo G, Zhang J, Nussinov R (2016) Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev Epub ahead of print:Epub ahead of print",https://intramural.nih.gov/search/searchview.taf?ipid=98716
96,BC010441-16,"October 01, 2016 -  September 30, 2017",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Giorgio  Trinchieri|Nadya I Tarasova; PhD,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Peter  Csermely (Semmelweis University)|Jie  Zheng (University of Akron)|Show all 9",NULL,NULL,"1. Andrabi M, Hutchins AP, Miranda-Saavedra D, Kono H, Nussinov R, Mizuguchi K, Ahmad S (2017). Predicting conformational ensembles and genome-wide transcription factor binding sites from DNA sequences. Sci Rep  7, 4071.   https://doi.org/10.1038/s41598-017-03199-6|2. Banerjee A, Jang H, Nussinov R, Gaponenko V (2016). The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. Curr Opin Struct Biol  36, 10-7.   https://doi.org/10.1016/j.sbi.2015.11.010|3. Baram M, Atsmon-Raz Y, Ma B, Nussinov R, Miller Y (2016). Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease. Phys Chem Chem Phys  18, 2330-8.   https://doi.org/10.1039/c5cp03338a|4. Csermely P, Korcsmáros T, Nussinov R (2016). Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub. Semin Cell Dev Biol  58, 55-9.   https://doi.org/10.1016/j.semcdb.2016.07.005|5. Gan W, Schneidman D, Zhang N, Ma B, Nussinov R (2017). Probing Oligomerized Conformations of Defensin in the Membrane. Methods Mol Biol  1529, 353-362.   https://doi.org/10.1007/978-1-4939-6637-0_18|6. Gong Y, Zhu Y, Zou Y, Ma B, Nussinov R, Zhang Q (2017). Human Neuronal Calcium Sensor-1 Protein Avoids Histidine Residues To Decrease pH Sensitivity. J Phys Chem B  121, 508-517.   https://doi.org/10.1021/acs.jpcb.6b11094|7. GuvenMaiorov E, Tsai C, Nussinov R (2016) Pathogen mimicry of host protein-protein interfaces modulates immunity. Semin Cell Dev Biol, in press.|8. Jang H, Banerjee A, Chavan T, Gaponenko V, Nussinov R (2017). Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction. J Biol Chem  292, 12544-12559.   https://doi.org/10.1074/jbc.M117.785063|9. Jang H, Banerjee A, Chavan TS, Lu S, Zhang J, Gaponenko V, Nussinov R (2016). The higher level of complexity of K-Ras4B activation at the membrane. FASEB J  30, 1643-55.   https://doi.org/10.1096/fj.15-279091|10. Karchin R, Nussinov R (2016). Genome Landscapes of Disease: Strategies to Predict the Phenotypic Consequences of Human Germline and Somatic Variation. PLoS Comput Biol  12, e1005043.   https://doi.org/10.1371/journal.pcbi.1005043|11. Kuzu G, Keskin O, Nussinov R, Gursoy A (2016). PRISM-EM: template interface-based modelling of multi-protein complexes guided by cryo-electron microscopy density maps. Acta Crystallogr D Struct Biol  72, 1137-1148.   https://doi.org/10.1107/S2059798316013541|12. Lambrughi M, De Gioia L, Gervasio FL, Lindorff-Larsen K, Nussinov R, Urani C, Bruschi M, Papaleo E (2016). DNA-binding protects p53 from interactions with cofactors involved in transcription-independent functions. Nucleic Acids Res  44, 9096-9109.   https://doi.org/10.1093/nar/gkw770|13. Lee J, Kim YH, T Arce F, Gillman AL, Jang H, Kagan BL, Nussinov R, Yang J, Lal R (2017). Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts. ACS Chem Neurosci  8, 1348-1357.   https://doi.org/10.1021/acschemneuro.7b00006|14. Lei J, Qi R, Wei G, Nussinov R, Ma B (2016). Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant. Phys Chem Chem Phys  18, 8098-107.   https://doi.org/10.1039/c5cp06538k|15. Liao TJ, Jang H, Tsai CJ, Fushman D, Nussinov R (2017). The dynamic mechanism of RASSF5 and MST kinase activation by Ras. Phys Chem Chem Phys  19, 6470-6480.   https://doi.org/10.1039/c6cp08596b|16. Liao TJ, Tsai CJ, Jang H, Fushman D, Nussinov R (2016). RASSF5: An MST activator and tumor suppressor in vivo but opposite in vitro. Curr Opin Struct Biol  41, 217-224.   https://doi.org/10.1016/j.sbi.2016.09.001|17. Liu J, Nussinov R (2016). Allostery: An Overview of Its History, Concepts, Methods, and Applications. PLoS Comput Biol  12, e1004966.   https://doi.org/10.1371/journal.pcbi.1004966|18. Liu J, Nussinov R (2017). Energetic redistribution in allostery to execute protein function. Proc Natl Acad Sci U S A  114, 7480-7482.   https://doi.org/10.1073/pnas.1709071114|19. Lu S, Jang H, Gu S, Zhang J, Nussinov R (2016). Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev  45, 4929-52.   https://doi.org/10.1039/c5cs00911a|20. Lu S, Jang H, Nussinov R, Zhang J (2016). The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B. Sci Rep  6, 21949.   https://doi.org/10.1038/srep21949|21. Lu S, Jang H, Shuo G, Zhang J, Nussinov R (2016) Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev Epub ahead of print:Epub ahead of print|22. Ma B, Nussinov R (2016). Protein dynamics: Conformational footprints. Nat Chem Biol  12, 890-891.   https://doi.org/10.1038/nchembio.2212|23. Ma B, Zhao J, Nussinov R (2016). Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes. Biochim Biophys Acta  1860, 2672-81.   https://doi.org/10.1016/j.bbagen.2016.05.040|24. Maximova T, Moffatt R, Ma B, Nussinov R, Shehu A (2016). Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics. PLoS Comput Biol  12, e1004619.   https://doi.org/10.1371/journal.pcbi.1004619|25. Nussinov R, Jang H, Tsai CJ, Liao TJ, Li S, Fushman D, Zhang J (2017). Intrinsic protein disorder in oncogenic KRAS signaling. Cell Mol Life Sci  74, 3245-3261.   https://doi.org/10.1007/s00018-017-2564-3|26. Nussinov R, Papin JA (2016). Computing Biology. PLoS Comput Biol  12, e1005050.   https://doi.org/10.1371/journal.pcbi.1005050|27. Nussinov R, Papin JA, Vakser I (2017). Computing the Dynamic Supramolecular Structural Proteome. PLoS Comput Biol  13, e1005290.   https://doi.org/10.1371/journal.pcbi.1005290|28. Nussinov R, Tsai CJ, Jang H (2016). Independent and core pathways in oncogenic KRAS signaling. Expert Rev Proteomics  13, 711-6.   https://doi.org/10.1080/14789450.2016.1209417|29. Nussinov R, Tsai CJ, Jang H (2017). A New View of Pathway-Driven Drug Resistance in Tumor Proliferation. Trends Pharmacol Sci  38, 427-437.   https://doi.org/10.1016/j.tips.2017.02.001|30. Nussinov R, Wang G, Tsai CJ, Jang H, Lu S, Banerjee A, Zhang J, Gaponenko V (2017). Calmodulin and PI3K Signaling in KRAS Cancers. Trends Cancer  3, 214-224.   https://doi.org/10.1016/j.trecan.2017.01.007|31. Tsai CJ, Nussinov R (2017). Allostery modulates the beat rate of a cardiac pacemaker. J Biol Chem  292, 6429-6430.   https://doi.org/10.1074/jbc.H116.773697|32. Tuncbag N, Gursoy A, Keskin O, Nussinov R (2016). The potential impact of recent developments in three-dimensional quantitative interaction proteomics on structural biology. Expert Rev Proteomics  13, 447-9.   https://doi.org/10.1080/14789450.2016.1182023|33. Wei G, Xi W, Nussinov R, Ma B (2016). Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell. Chem Rev  116, 6516-51.   https://doi.org/10.1021/acs.chemrev.5b00562|34. Xu L, Nussinov R, Ma B (2016). Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal. Chem Commun (Camb)  52, 1733-6.   https://doi.org/10.1039/c5cc08107f|35. Xu L, Nussinov R, Ma B (2016). Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils. Eur J Med Chem  121, 841-850.   https://doi.org/10.1016/j.ejmech.2016.01.044|36. Zhan C, Qi R, Wei G, Guven-Maiorov E, Nussinov R, Ma B (2016). Conformational dynamics of cancer-associated MyD88-TIR domain mutant L252P (L265P) allosterically tilts the landscape toward homo-dimerization. Protein Eng Des Sel  29, 347-54.   https://doi.org/10.1093/protein/gzw033|37. Zhang M, Zheng J, Nussinov R, Ma B (2016). Oncogenic Mutations Differentially Affect Bax Monomer, Dimer, and Oligomeric Pore Formation in the Membrane. Sci Rep  6, 33340.   https://doi.org/10.1038/srep33340|38. Zhang M, Zheng J, Nussinov R, Ma B (2017). Release of Cytochrome C from Bax Pores at the Mitochondrial Membrane. Sci Rep  7, 2635.   https://doi.org/10.1038/s41598-017-02825-7|39. Zhao J, Nussinov R, Ma B (2017). Allosteric control of antibody-prion recognition through oxidation of a disulfide bond between the CH and CL chains. Protein Eng Des Sel  30, 67-76.   https://doi.org/10.1093/protein/gzw065|40. Zhu Y, Ma B, Qi R, Nussinov R, Zhang Q (2016). Temperature-Dependent Conformational Properties of Human Neuronal Calcium Sensor-1 Protein Revealed by All-Atom Simulations. J Phys Chem B  120, 3551-9.   https://doi.org/10.1021/acs.jpcb.5b12299",https://intramural.nih.gov/search/searchview.taf?ipid=98717
97,BC010442-16,"October 01, 2016 -  September 30, 2017",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",NULL,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Jie  Zheng (University of Akron)|Yoshitaka  Ishii|Show all 9",NULL,NULL,"1. GuvenMaiorov E, Tsai C, Nussinov R (2016) Pathogen mimicry of host protein-protein interfaces modulates immunity. Semin Cell Dev Biol, in press.|2. Lu S, Jang H, Shuo G, Zhang J, Nussinov R (2016) Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev Epub ahead of print:Epub ahead of print",https://intramural.nih.gov/search/searchview.taf?ipid=98720
98,BC010449-16,"October 01, 2016 -  September 30, 2017",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Shigetoshi  Yokoyama|Yongtao  Wang|Henrique Bregolin Dias,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),"Jerrold M Ward; DVM, PhD (NIAID)","1. Kurotani R, Kimura S (2017) Secretoglobin 3A2: potential for treatment of respiratory diseases The Allergy in Practice 37:48-53|2. Naizhen X, Linnoila RI, Kimura S (2016). Co-expression of Achaete-Scute Homologue-1 and Calcitonin Gene-Related Peptide during NNK-Induced Pulmonary Neuroendocrine Hyperplasia and Carcinogenesis in Hamsters. J Cancer  7, 2124-2131.   https://doi.org/10.7150/jca.16399|3. Yoneda M, Xu L, Kajiyama H, Kawabe S, Paiz J, Ward JM, Kimura S (2016). Secretoglobin Superfamily Protein SCGB3A2 Alleviates House Dust Mite-Induced Allergic Airway Inflammation in Mice. Int Arch Allergy Immunol  171, 36-44.   https://doi.org/10.1159/000450788",https://intramural.nih.gov/search/searchview.taf?ipid=98747
99,BC010451-16,"October 01, 2016 -  September 30, 2017",Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",M A Siddiqui|Kevin Roland Trabbic; PhD|Jeffrey  Gildersleeve,"David  Cheresh (University of California San Diego)|Philip  Deshong (University of Maryland, College Park)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98803
100,BC010453-16,"October 01, 2016 -  September 30, 2017",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Cindy Huong-Bich Chau|Douglas K Price|Edel Marie McCrea,"Ian Abban Thompson; MD|Robin  Leach (UT Health Science Center San Antonio)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Marian  Neuhouser (Fred Hutchinson Cancer Research Center)|Elizabeth  Platz; PhD (School of Public Health, Johns Hopkins University)|Show all 10",Emily Mae Harris (Office Of The Clinical Director)|Howard  Parnes (Prostate and Urologic Cancer Research Group),NULL,"1. Hauke RJ, Sissung TM, Figg WD (2017). Discussing the predictive, prognostic, and therapeutic value of germline DNA-repair gene mutations in metastatic prostate cancer patients. Cancer Biol Ther  18, 545-546.   https://doi.org/10.1080/15384047.2017.1345398|2. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|3. McCrea E, Sissung TM, Price DK, Chau CH, Figg WD (2016). Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacol Res  114, 152-162.   https://doi.org/10.1016/j.phrs.2016.10.001|4. Price DK, Chau CH, Till C, Goodman PJ, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Parnes HL, Schenk JM, Tangen CM, Thompson IM, Reichardt JK, Figg WD (2016). Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer  122, 2332-40.   https://doi.org/10.1002/cncr.30071|5. Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM (2016). Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes Control  27, 175-82.   https://doi.org/10.1007/s10552-015-0695-0|6. Sissung TM, Deeken J, Leibrand CR, Price DK, Ehrlich S, Steinberg SM, Liewehr DJ, Dahut W, Figg WD (2016). Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer. Pharmacogenomics  17, 1979-1986.   https://doi.org/10.2217/pgs-2016-0134|7. Sissung TM, Venzon DJ, Figg WD (2016). Erratum to: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-independent Prostate Cancer. Urology  95, 225.   https://doi.org/10.1016/j.urology.2016.05.047",https://intramural.nih.gov/search/searchview.taf?ipid=98748
101,BC010476-15,"October 01, 2016 -  September 30, 2017",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),"1. Subramanian S, Cherukuri M (2016) Electron Paramagnetic Resonance Imaging: Radiofrequency FT EPR Imaging. Resonance In Press",https://intramural.nih.gov/search/searchview.taf?ipid=98758
102,BC010477-15,"October 01, 2016 -  September 30, 2017",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98757
103,BC010481-15,"October 01, 2016 -  September 30, 2017",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Patrick K Clark|Linda L Dunn|Andrea L Ferris|Paul L Boyer|Steven J Smith,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Gary T Pauly (Chemical Biology Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98754
104,BC010484-15,"October 01, 2016 -  September 30, 2017",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Christopher S Szot,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Nancy J Emenaker (Nutritional Science Research Group)|Diana C Haines (Office Of The Director),NULL,"1. Andersen NJ, Boguslawski EA, Naidu AS, Szot C, Bromberg-White JL, Kits K, Kuk CY, Holton LE, St Croix B, Chambers CM, Duesbery NS (2016). Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia. PLoS One  11, e0146586.   https://doi.org/10.1371/journal.pone.0146586",https://intramural.nih.gov/search/searchview.taf?ipid=98764
105,BC010487-15,"October 01, 2016 -  September 30, 2017",The role of CPSF6 in HIV-1 infection,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Hope (Northwestern University)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|Richard  Sutton",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Xiaolin  Wu; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98755
106,BC010488-15,"October 01, 2016 -  September 30, 2017",HIV-1 passage through the nuclear pore complex,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Jeremy  Luban (Columbia University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98756
107,BC010493-15,"October 01, 2016 -  September 30, 2017",Nucleic Acid Footprinting and development of small molecule antagonists,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Marie-Louise  Hammarskjold (University of Virginia)|John  Tavis (Saint Louis University)|Theodore  Dayie (University of Maryland)|Peter  Stockley (University of Leeds)",John Stephen Schneekloth (Chemical Biology Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Denise  Whitby (Office Of The Director),NULL,"1. Abulwerdi F, Legrice S (2017) Recent Advances in Targeting the HIV-1 TatTAR complex. Current Pharmaceutical Research, in press.|2. Shapiro BA, Le Grice SF (2016). Advances in RNA structure determination. Methods  103, 1-3.   https://doi.org/10.1016/j.ymeth.2016.06.006|3. Sherpa C, Rausch J, Legrice S, Hammarskjold M, Rekosh D (2016) The HIV-1 Rev Response Element (RRE) exists in two alternative secondary structures which promote different replication activities. Nucleic Acids Res 43:4767-4686|4. SztubaSolinska J, Diaz L, Kumar M, Kolb G, Wiley M, Jozwik L, Kuhn J, Palacios G, Radoshitzky S, Legrice S, Johnson R (2016) A small stem-loop structure of the Ebola virus trailer is essential for replication and interacts with heat-shock protein A8. Nuc Acids Res 44:9831-9846",https://intramural.nih.gov/search/searchview.taf?ipid=98760
108,BC010494-15,"October 01, 2016 -  September 30, 2017",Small molecule targeting viral nucleotidyltransferases,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Graziella  Tocco (University of Cagliari)|John  Tavis (Saint Louis University)|Ryan  Murelli (Brooklyn College)|Blossom  Damania (University of North Carolina, Chapel Hill, NC)|Lynda  Morrison (St. Louis University)|Sandra  Weller (University of Connecticut)",John A Beutler (Molecular Targets Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Le Grice SF, Sztuba-Solinska J, Maccioni E, Purzycka KJ, Parolin C, Tramontano E (2017). Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS). Antiviral Res  139, 13-17.   https://doi.org/10.1016/j.antiviral.2016.12.004|2. Masaoka T, Zhao H, Hirsch DR, D'Erasmo MP, Meck C, Varnado B, Gupta A, Meyers MJ, Baines J, Beutler JA, Murelli RP, Tang L, Le Grice SF (2016). Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase Inhibitors. Biochemistry  55, 809-19.   https://doi.org/10.1021/acs.biochem.5b01254",https://intramural.nih.gov/search/searchview.taf?ipid=98759
109,BC010499-15,"October 01, 2016 -  September 30, 2017",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Rick  Kittles (University of Illinois at Chicago)|Nagireddy  Putluri (Baylor College of Medicine)|Carlos  Casiano (Loma Linda University School of Medicine)",Margaret Saira Pichardo (Molecular Genetics and Carcinogenesis Section)|Tsion Zewdu Minas (Molecular Genetics and Carcinogenesis Section)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Prueitt RL, Wallace TA, Glynn SA, Yi M, Tang W, Luo J, Dorsey TH, Stagliano KE, Gillespie JW, Hudson RS, Terunuma A, Shoe JL, Haines DC, Yfantis HG, Han M, Martin DN, Jordan SV, Borin JF, Naslund MJ, Alexander RB, Stephens RM, Loffredo CA, Lee DH, Putluri N, Sreekumar A, et al. [2 more authors] (2016). An Immune-Inflammation Gene Expression Signature in Prostate Tumors of Smokers. Cancer Res  76, 1055-1065.   https://doi.org/10.1158/0008-5472.CAN-14-3630|2. Smith CJ, Dorsey TH, Tang W, Jordan SV, Loffredo CA, Ambs S (2017). Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men. Cancer Epidemiol Biomarkers Prev  26, 845-853.   https://doi.org/10.1158/1055-9965.EPI-16-1027",https://intramural.nih.gov/search/searchview.taf?ipid=98749
110,BC010504-15,"October 01, 2016 -  September 30, 2017","Understanding Retroviral Reverse Transcription, Recombination, and Replication",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Yang  Liu; PhD|Steven Fernandes Dos Santos|Chijioke Nkemjika Umunnakwe|Jonathan Mark Olivares Rawson|Vinay K Pathak; PhD,NULL,Brandon Frank Keele (Office Of The Director),NULL,"1. Delviks-Frankenberry KA, Nikolaitchik OA, Burdick RC, Gorelick RJ, Keele BF, Hu WS, Pathak VK (2016). Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation. PLoS Pathog  12, e1005646.   https://doi.org/10.1371/journal.ppat.1005646|2. Desimmie BA, Smith JL, Matsuo H, Hu WS, Pathak VK (2017). Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function. Retrovirology  14, 19.   https://doi.org/10.1186/s12977-017-0346-5",https://intramural.nih.gov/search/searchview.taf?ipid=98753
111,BC010506-15,"October 01, 2016 -  September 30, 2017","Defining Mechanisms of HIV-1 RNA Trafficking, Virus Assembly,  Virion Structure",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Jianbo  Chen|Yang  Liu; PhD|Sheikh Abdul Rahman|Steven Fernandes Dos Santos|Chijioke Nkemjika Umunnakwe|Show all 9,David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|John  Briggs (European Molecular Biology Laboratory)|Kelvin  Li (University of Pittsburgh School of Medicine),Eric O Freed; PhD (HIV Drug Resistance Program)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),NULL,"1. Chen J, Rahman SA, Nikolaitchik OA, Grunwald D, Sardo L, Burdick RC, Plisov S, Liang E, Tai S, Pathak VK, Hu WS (2016). HIV-1 RNA genome dimerizes on the plasma membrane in the presence of Gag protein. Proc Natl Acad Sci U S A  113, E201-8.   https://doi.org/10.1073/pnas.1518572113|2. Liu Y, Nikolaitchik OA, Rahman SA, Chen J, Pathak VK, Hu WS (2017). HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles. J Mol Biol  429, 2542-2555.   https://doi.org/10.1016/j.jmb.2017.06.018",https://intramural.nih.gov/search/searchview.taf?ipid=98752
112,BC010511-15,"October 01, 2016 -  September 30, 2017",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Diborah Mengistu Yimer|Tomas  Kroupa; PhD|Wei-Shau  Hu; PhD,"Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|John  Briggs (European Molecular Biology Laboratory)|Hans-Georg  Krausslich (Heidelberg University)|Show all 12",Yun Xing M Wang (Structural Biophysics Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Kunio  Nagashima (Office Of The Director)|Thorkell  Andresson (Office Of The Director)|Ruth  Nussinov; PhD (Cancer Inflammation Program)|Stephen J Lockett; PhD (Office Of The Director),Peter W Schuck; PhD (NIBIB),"1. Barros M, Heinrich F, Datta SAK, Rein A, Karageorgos I, Nanda H, Lösche M (2016). Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation. J Virol  90, 4544-4555.   https://doi.org/10.1128/JVI.02820-15|2. Datta SA, Clark PK, Fan L, Ma B, Harvin DP, Sowder RC, Nussinov R, Wang YX, Rein A (2016). Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly. J Virol  90, 1773-87.   https://doi.org/10.1128/JVI.02061-15|3. Dilley K, Nikolaitchik O, Galli A, Burdick R, Levine L, Li K, Rein A, Pathak V, Hu W (2017) Interactions between HIV-1 Gag and viral RNA genome enhance virion assembly. J Virol, in press.|4. Saxena P, He L, Malyutin A, Datta SAK, Rein A, Bond KM, Jarrold MF, Spilotros A, Svergun D, Douglas T, Dragnea B (2016). Virus Matryoshka: A Bacteriophage Particle-Guided Molecular Assembly Approach to a Monodisperse Model of the Immature Human Immunodeficiency Virus. Small  12, 5862-5872.   https://doi.org/10.1002/smll.201601712",https://intramural.nih.gov/search/searchview.taf?ipid=98761
113,BC010512-15,"October 01, 2016 -  September 30, 2017",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Mauricio  Comas Garcia; PhD|Diborah Mengistu Yimer|Tomas  Kroupa; PhD|Wei-Shau  Hu; PhD,Kevin  Weeks (University of North Carolina)|Karin  Musier-Forsyth (Ohio State University)|Rajat  Varma; PhD,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Stephen J Lockett; PhD (Office Of The Director)|Prabhakar R Gudla; PhD (Laboratory of Receptor Biology and Gene Expression)",Peter W Schuck; PhD (NIBIB),"1. Comas-Garcia M, Davis SR, Rein A (2016). On the Selective Packaging of Genomic RNA by HIV-1. Viruses  8.   https://doi.org/10.3390/v8090246|2. Dilley K, Nikolaitchik O, Galli A, Burdick R, Levine L, Li K, Rein A, Pathak V, Hu W (2017) Interactions between HIV-1 Gag and viral RNA genome enhance virion assembly. J Virol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98762
114,BC010516-15,"October 01, 2016 -  September 30, 2017",Gated Optical Detectors-Dose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Holly  Ning|Barbara Chin Arora|Jason Yulin Cheng; PhD|Ying  Zhuge|Peter  Guion|Mary Kathleen Hawes,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98768
115,BC010518-15,"October 01, 2016 -  September 30, 2017",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Matthew J Anderson|Maria  Kaltcheva,"Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)|Trevor  Williams (University of Colarado)",Salvia  Misaghian (Cancer and Developmental Biology Laboratory)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Hung IH, Schoenwolf GC, Lewandoski M, Ornitz DM (2016). A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development. Dev Biol  411, 72-84.   https://doi.org/10.1016/j.ydbio.2016.01.008",https://intramural.nih.gov/search/searchview.taf?ipid=98771
116,BC010523-15,"October 01, 2016 -  September 30, 2017",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),NULL,"1. Taneja N, Zofall M, Balachandran V, Thillainadesan G, Sugiyama T, Wheeler D, Zhou M, Grewal SI (2017). SNF2 Family Protein Fft3 Suppresses Nucleosome Turnover to Promote Epigenetic Inheritance and Proper Replication. Mol Cell  66, 50-62.e6.   https://doi.org/10.1016/j.molcel.2017.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=98641
117,BC010524-15,"October 01, 2016 -  September 30, 2017",HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|Chenzhong  Liao,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Karen  Buckheit (ImQuest Biosciences)",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98769
118,BC010525-15,"October 01, 2016 -  September 30, 2017",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Francis  Flomerfelt; PhD|Philip J Lucas; PhD|Ehydel  Castro|Hye Kyung  Kim|Catherine Virginia Bare|Jiun  Wang|Show all 8,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98751
119,BC010538-15,"October 01, 2016 -  September 30, 2017",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Brunilde M Gril|Anurag Narasimha Paranjape|Lin  Xiao,"Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Paul  Lockman (Texas Tech University)|Jacek  Jassem (Medical University of Gdansk)|Renata  Duchnowska (Military Institute of Medicine,)|Priscilla  Brastianos (MGH)|Scott  Carter (Dana-Farber Cancer Center)|Show all 7",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Lyle LT, Lockman PR, Adkins CE, Mohammad AS, Sechrest E, Hua E, Palmieri D, Liewehr DJ, Steinberg SM, Kloc W, Izycka-Swieszewska E, Duchnowska R, Nayyar N, Brastianos PK, Steeg PS, Gril B (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clin Cancer Res  22, 5287-5299.   https://doi.org/10.1158/1078-0432.CCR-15-1836|2. Sartorius CA, Hanna CT, Gril B, Cruz H, Serkova NJ, Huber KM, Kabos P, Schedin TB, Borges VF, Steeg PS, Cittelly DM (2016). Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism. Oncogene  35, 2881-92.   https://doi.org/10.1038/onc.2015.353|3. Steeg PS, Zimmer A, Gril B (2016). Therapeutics for Brain Metastases, v3. Clin Cancer Res  22, 5953-5955.   https://doi.org/10.1158/1078-0432.CCR-16-2035",https://intramural.nih.gov/search/searchview.taf?ipid=98766
120,BC010547-15,"October 01, 2016 -  September 30, 2017",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Douglas K Price|Edel Marie McCrea|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Show all 8","Brent R Copp; PhD (Chemistry, University of Auckland)|Walter  Jager (University of Vienna)|Wooin  Lee (Seoul National University)|Donald  McDonnel (Duke University School of Medicine)","Emily Mae Harris (Office Of The Clinical Director)|Phoebe Ao-Xue Huang (Office Of The Clinical Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Jane Beth Trepel (Developmental Therapeutics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)",NULL,"1. Beedie S, Figg WD (2016). Resisting resistance: Establishing new treatment options for CRPC patients. Cancer Biol Ther  17, 337-8.   https://doi.org/10.1080/15384047.2016.1139271|2. Chau CH, O'Keefe BR, Figg WD (2016). The canSAR data hub for drug discovery. Lancet Oncol  17, 286.   https://doi.org/10.1016/S1470-2045(16)00095-4|3. Leibrand CR, Price DK, Figg WD (2016). Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion? Cancer Biol Ther  17, 467-9.   https://doi.org/10.1080/15384047.2016.1156274|4. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|5. Rodgers L, Peer CJ, Figg WD (2017). Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects. Cancer Biol Ther  18, 470-472.   https://doi.org/10.1080/15384047.2017.1323600|6. Sissung TM, Ley AM, Strope JD, McCrea EM, Beedie S, Peer CJ, Shukla S, van Velkinburgh J, Reece K, Troutman S, Campbell T, Fernandez E, Huang P, Smith J, Thakkar N, Venzon DJ, Brenner S, Lee W, Merino M, Luo J, Jager W, Price DK, Chau CH, Figg WD (2017). Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. Mol Cancer Res  15, 1096-1105.   https://doi.org/10.1158/1541-7786.MCR-16-0477|7. Strope JD, Price DK, Figg WD (2016). Building a hit list for the fight against metastatic castration resistant prostate cancer. Cancer Biol Ther  17, 231-2.   https://doi.org/10.1080/15384047.2016.1139270|8. Tuerff D, Sissung T, Figg WD (2017). Cellular identity crisis: Antiandrogen resistance by lineage plasticity. Cancer Biol Ther  18, 841-842.   https://doi.org/10.1080/15384047.2017.1323599",https://intramural.nih.gov/search/searchview.taf?ipid=98750
121,BC010549-15,"October 01, 2016 -  September 30, 2017",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98642
122,BC010566-14,"October 01, 2016 -  September 30, 2017",Tumor and Metastasis Biology,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Lizardo MM, Morrow JJ, Miller TE, Hong ES, Ren L, Mendoza A, Halsey CH, Scacheri PC, Helman LJ, Khanna C (2016) Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression. Neoplasia, in press (e-pub ahead of print)  https://doi.org/10.1016/j.neo.2016.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=98778
123,BC010578-14,"October 01, 2016 -  September 30, 2017",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Christopher S Szot|Jonathan  Keller; PhD,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Diana C Haines (Office Of The Director),NULL,"1. Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, Morris K, Szot C, Morris H, Swing DA, Tessarollo L, Smith SW, Degrado S, Borkin D, Jain N, Scheiermann J, Feng Y, Wang Y, Li J, Welsch D, DeCrescenzo G, Chaudhary A, Zudaire E, Klarmann KD, Keller JR, et al. [2 more authors] (2017). Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature. Cancer Cell  31, 501-515.e8.   https://doi.org/10.1016/j.ccell.2017.03.005",https://intramural.nih.gov/search/searchview.taf?ipid=98644
124,BC010579-14,"October 01, 2016 -  September 30, 2017",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",John  Schiller; PhD|Christopher  Buck,NULL,Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,"1. Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv302|2. Collins FS, Anderson JM, Austin CP, Battey JF, Birnbaum LS, Briggs JP, Clayton JA, Cuthbert B, Eisinger RW, Fauci AS, Gallin JI, Gibbons GH, Glass RI, Gottesman MM, Gray PA, Green ED, Greider FB, Hodes R, Hudson KL, Humphreys B, Katz SI, Koob GF, Koroshetz WJ, Lauer MS, Lorsch JR, et al. [15 more authors] (2016). Basic science: Bedrock of progress. Science  351, 1405.   https://doi.org/10.1126/science.351.6280.1405-a|3. Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt LM (2016). Toward a Shared Vision for Cancer Genomic Data. N Engl J Med  375, 1109-12.   https://doi.org/10.1056/NEJMp1607591|4. Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol  215, 212.e1-212.e15.   https://doi.org/10.1016/j.ajog.2016.02.021|5. Kines RC, Cerio RJ, Roberts JN, Thompson CD, de Los Pinos E, Lowy DR, Schiller JT (2016). Human papillomavirus capsids preferentially bind and infect tumor cells. Int J Cancer  138, 901-11.   https://doi.org/10.1002/ijc.29823|6. Lowy D, Singer D, DePinho R, Simon GC, Soon-Shiong P (2016). Cancer moonshot countdown. Nat Biotechnol  34, 596-9.   https://doi.org/10.1038/nbt.3616|7. Lowy DR (2016). HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest  126, 5-11.   https://doi.org/10.1172/JCI85446|8. Lowy DR, Collins FS (2016). Aiming High--Changing the Trajectory for Cancer. N Engl J Med  374, 1901-4.   https://doi.org/10.1056/NEJMp1600894|9. Tripathi BK, Lowy DR (2017). DLC1: a tumor suppressor that regulates Rho signaling. Oncotarget  8, 27674-27675.   https://doi.org/10.18632/oncotarget.16805|10. Wang D, Qian X, Rajaram M, Durkin ME, Lowy DR (2016). DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers. Oncotarget  7, 45144-45157.   https://doi.org/10.18632/oncotarget.9266|11. Zacharchenko T, Qian X, Goult B, Jethwa D, Almeida T, Ballestrem C, Critchley D, Lowy D, Barsukov I (2016) LD Motif Recognition in Talin: Structure of the Talin-DLC1 Complex Structure 24:1130-41|12. Zacharchenko T, Qian X, Goult BT, Jethwa D, Almeida TB, Ballestrem C, Critchley DR, Lowy DR, Barsukov IL (2016). LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex. Structure  24, 1130-41.   https://doi.org/10.1016/j.str.2016.04.016",https://intramural.nih.gov/search/searchview.taf?ipid=98779
125,BC010580-14,"October 01, 2016 -  September 30, 2017",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98772
126,BC010595-14,"October 01, 2016 -  September 30, 2017",Structure and Function of Vif and APOBEC3 (A3) Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Dongfei  Qi|Belete Ayele Desimmie|Michael David Nekorchuk; PhD|John Y Chen|Avamish Chowdhary Yendluri|Show all 7,Yong  Xiong (Yale University)|Hiroshi  Matsuo; PhD (STRUCTURAL BIOPHYSICS LABORATORY)|Eric  Barklis (University of Oregon),Mary  Kearney (Host Virus Interaction Branch)|Frank  Maldarelli (Host Virus Interaction Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98781
127,BC010598-14,"October 01, 2016 -  September 30, 2017",Human Immune Responses to Tumor Antigens for Cancer Immunotherapy,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Martine  Policard|Angela Mae Schwab|Morgan Lee Gargulak|Renee Nicole Donahue|Caroline Mikaela Maria Jochems; PhD|Kwong Yok Tsang|Show all 7,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch),NULL,"1. Grenga I, Donahue RN, Lepone LM, Richards J, Schlom J (2016). A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology  5, e83.   https://doi.org/10.1038/cti.2016.27|2. Khanna S, Thomas A, Abate-Daga D, Zhang J, Morrow B, Steinberg SM, Orlandi A, Ferroni P, Schlom J, Guadagni F, Hassan R (2016). Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab. J Thorac Oncol  11, 1993-2005.   https://doi.org/10.1016/j.jtho.2016.07.033|3. Roselli M, Formica V, Cereda V, Jochems C, Richards J, Grenga I, Orlandi A, Ferroni P, Guadagni F, Schlom J (2016). The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy. Oncoimmunology  5, e1188243.   https://doi.org/10.1080/2162402X.2016.1188243",https://intramural.nih.gov/search/searchview.taf?ipid=98643
128,BC010600-14,"October 01, 2016 -  September 30, 2017",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,NULL,Yihong  Ye (NIDDK),"1. Tang WK, Xia D (2016). Mutations in the Human AAA+ Chaperone p97 and Related Diseases. Front Mol Biosci  3, 79.   https://doi.org/10.3389/fmolb.2016.00079|2. Tang WK, Xia D (2016). Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain. Sci Rep  6, 20037.   https://doi.org/10.1038/srep20037|3. Xia D, Tang WK, Ye Y (2016). Structure and function of the AAA+ ATPase p97/Cdc48p. Gene  583, 64-77.   https://doi.org/10.1016/j.gene.2016.02.042",https://intramural.nih.gov/search/searchview.taf?ipid=98773
129,BC010607-14,"October 01, 2016 -  September 30, 2017",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin|Lechen  Li,NULL,Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98777
130,BC010624-14,"October 01, 2016 -  September 30, 2017",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Rick  Kittles (University of Illinois at Chicago)|Nagireddy  Putluri (Baylor College of Medicine)",Daniel K Lee (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98784
131,BC010627-14,"October 01, 2016 -  September 30, 2017",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Cody John Peer|Tristan  Sissung|Jonathan Dale Strope|Sheryl A Gere|Keith Thomas Schmidt|Emily Mae Harris|Show all 8,C  Landgren (Memorial Sloan Kettering Cancer Center)|Susan  Bates; MD (NCI)|Richard  Horenstein (University of Maryland),"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Heidi H Kong (NIAMS),"1. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|2. Schmidt KT, Chau CH, Price DK, Figg WD (2016). Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment. J Clin Pharmacol  56, 1484-1499.   https://doi.org/10.1002/jcph.765",https://intramural.nih.gov/search/searchview.taf?ipid=98774
132,BC010632-14,"October 01, 2016 -  September 30, 2017",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Rna Biology Laboratory, NCI",Yan Ning H Zhou|Carmen  Mata Martin; PhD|Zhe  Sun|Yixiong  Chen; PhD|Mikhail V Kashlev|Donald L Court; PhD|Show all 8,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Bubunenko MG, Court CB, Rattray AJ, Gotte DR, Kireeva ML, Irizarry-Caro JA, Li X, Jin DJ, Court DL, Strathern JN, Kashlev M (2017). A Cre Transcription Fidelity Reporter Identifies GreA as a Major RNA Proofreading Factor in Escherichia coli. Genetics  206, 179-187.   https://doi.org/10.1534/genetics.116.198960|2. Jin DJ, Mata Martin C, Sun Z, Cagliero C, Zhou YN (2017). Nucleolus-like compartmentalization of the transcription machinery in fast-growing bacterial cells. Crit Rev Biochem Mol Biol  52, 96-106.   https://doi.org/10.1080/10409238.2016.1269717|3. Zhou Q, Zhou YN, Jin DJ, Tse-Dinh YC (2017). Deacetylation of topoisomerase I is an important physiological function of E. coli CobB. Nucleic Acids Res  45, 5349-5358.   https://doi.org/10.1093/nar/gkx250",https://intramural.nih.gov/search/searchview.taf?ipid=98776
133,BC010646-14,"October 01, 2016 -  September 30, 2017",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rodney Louis Schiltz; PhD|Songjoon  Baek|Diego Martin Presman; PhD|Ville Juhani Paakinaho; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98775
134,BC010649-13,"October 01, 2016 -  September 30, 2017",Immunotherapy Strategies for Uveal Melanoma,Udai S Kammula,NULL,"Surgery Branch, NCI",NULL,"J  Harbour (Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine)|Richard  Carvajal (Memorial Sloan-Kettering Cancer Center)",Mark  Raffeld; MD (Laboratory of Pathology)|Eric Alan Stahlberg (Evaluation & Strategic Initiatives Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98794
135,BC010654-13,"October 01, 2016 -  September 30, 2017",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Gaur S, Turkbey B, Choyke P (2017). Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management. Semin Ultrasound CT MR  38, 59-71.   https://doi.org/10.1053/j.sult.2016.10.002|2. Glastonbury CM, Bhosale PR, Choyke PL, D'Orsi CJ, Erasmus JJ, Gill RR, Mukherji SK, Panicek DM, Schwartz LH, Subramaniam RM, Sullivan DC (2016). Do Radiologists Have Stage Fright? Tumor Staging and How We Can Add Value to the Care of Patients with Cancer. Radiology  278, 11-2.   https://doi.org/10.1148/radiol.2015151563",https://intramural.nih.gov/search/searchview.taf?ipid=98788
136,BC010655-13,"October 01, 2016 -  September 30, 2017",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Ismail Baris Turkbey|Dagane  Daar|Philip Charles Eclarinal|Mirna  Martinez|Elaine Marie Jagoda; MS|Maria Liza Lindenberg|Show all 14,Anwar  Padhani (Mt Vernon Hospital)|Jeff  Weinreb (Yale New Haven Hospital)|Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital)|Martin G Pomper|Jelle  Barentsz (Nijmegen University)|Show all 10,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch),"Ronald M Summers; MD, PhD (CC) |Rolf Eric Swenson; PhD (NHLBI)","1. Azizi S, Imani F, Ghavidel S, Tahmasebi A, Kwak JT, Xu S, Turkbey B, Choyke P, Pinto P, Wood B, Mousavi P, Abolmaesumi P (2016). Detection of prostate cancer using temporal sequences of ultrasound data: a large clinical feasibility study. Int J Comput Assist Radiol Surg  11, 947-56.   https://doi.org/10.1007/s11548-016-1395-2|2. Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Shtern F, Padhani AR, Tempany CM, Thoeny HC, Verma S, Weinreb JC (2016). Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40. Eur Urol  70, e137-e138.   https://doi.org/10.1016/j.eururo.2016.04.016|3. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2016). Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol  69, 41-9.   https://doi.org/10.1016/j.eururo.2015.08.038|4. Bouchelouche K, Choyke PL (2016). Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine. Curr Opin Oncol  28, 216-21.   https://doi.org/10.1097/CCO.0000000000000277|5. Choyke PL (2016). Invited Commentary on ""Molecular Imaging of Prostate Cancer"". Radiographics  36, 159-61.   https://doi.org/10.1148/rg.2016150238|6. Lindenberg L, Choyke P, Dahut W (2016). Prostate Cancer Imaging with Novel PET Tracers. Curr Urol Rep  17, 18.   https://doi.org/10.1007/s11934-016-0575-5|7. Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS (2016). Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol  196, 1613-1618.   https://doi.org/10.1016/j.juro.2016.06.079|8. Tosoian JJ, Loeb S, Epstein JI, Turkbey B, Choyke PL, Schaeffer EM (2016). Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools. Am Soc Clin Oncol Educ Book  35, e235-45.   https://doi.org/10.1200/EDBK_159244|9. Turkbey B, Choyke PL (2016). Advanced imaging techniques in genitourinary cancers. Urol Oncol  34, 123.   https://doi.org/10.1016/j.urolonc.2015.11.024|10. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S (2016). PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol  69, 16-40.   https://doi.org/10.1016/j.eururo.2015.08.052",https://intramural.nih.gov/search/searchview.taf?ipid=98789
137,BC010656-13,"October 01, 2016 -  September 30, 2017",Growth Factor Imaging and Photoimmunotherapy,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Karen A Kurdziel; MD|Noriko  Sato; PhD|Mark  Williams|Stephen Scott Adler|Dagane  Daar|Show all 16,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch),Joshua  Farber; MD (NIAID),"1. Cieciera M, Kratochwil C, Moltz J, Kauczor HU, Holland Letz T, Choyke P, Mier W, Haberkorn U, Giesel FL (2016). Semi-automatic 3D-volumetry of liver metastases from neuroendocrine tumors to improve combination therapy with 177Lu-DOTATOC and 90Y-DOTATOC. Diagn Interv Radiol  22, 201-6.   https://doi.org/10.5152/dir.2015.15304|2. Harada T, Nakamura Y, Sato K, Nagaya T, Choyke PL, Seto Y, Kobayashi H (2016). Surgical tissue handling methods to optimize ex vivo fluorescence with the activatable optical probe γ-glutamyl hydroxymethyl rhodamine green. Contrast Media Mol Imaging  11, 572-578.   https://doi.org/10.1002/cmmi.1705|3. Nakamura Y, Harada T, Nagaya T, Sato K, Okuyama S, Choyke PL, Kobayashi H (2016). Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe. Oncotarget  7, 51124-51137.   https://doi.org/10.18632/oncotarget.9898|4. Zhang X, Basuli F, Shi ZD, Xu B, Blackman B, Choyke PL, Swenson RE (2016). Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module. Appl Radiat Isot  112, 110-4.   https://doi.org/10.1016/j.apradiso.2016.02.016",https://intramural.nih.gov/search/searchview.taf?ipid=98790
138,BC010657-13,"October 01, 2016 -  September 30, 2017",Cellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Karen J Wong|Noriko  Sato; PhD|Kingsley O Asiedu|Phuongnga  Ton|Gadi Victor Cohen,NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch),Joshua  Farber; MD (NIAID) |Richard  Childs; MD (NHLBI),"1. Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani SZ, Choyke PL, Kurdziel K, Landgren O (2016). Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging. Leuk Lymphoma  57, 1114-21.   https://doi.org/10.3109/10428194.2015.1090572",https://intramural.nih.gov/search/searchview.taf?ipid=98791
139,BC010661-13,"October 01, 2016 -  September 30, 2017",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,NULL,NULL,"1. Fujii R, Friedman ER, Richards J, Tsang KY, Heery CR, Schlom J, Hodge JW (2016). Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget  7, 33498-511.   https://doi.org/10.18632/oncotarget.9256|2. Gameiro SR, Malamas AS, Tsang KY, Ferrone S, Hodge JW (2016). Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells. Oncotarget  7, 7390-402.   https://doi.org/10.18632/oncotarget.7180|3. Jochems C, Fantini M, Fernando RI, Kwilas AR, Donahue RN, Lepone LM, Grenga I, Kim YS, Brechbiel MW, Gulley JL, Madan RA, Heery CR, Hodge JW, Newton R, Schlom J, Tsang KY (2016). The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells. Oncotarget  7, 37762-37772.   https://doi.org/10.18632/oncotarget.9326|4. Kim PS, Kwilas AR, Xu W, Alter S, Jeng EK, Wong HC, Schlom J, Hodge JW (2016). IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas. Oncotarget  7, 16130-45.   https://doi.org/10.18632/oncotarget.7470|5. Kwilas AR, Ardiani A, Gameiro SR, Richards J, Hall AB, Hodge JW (2016). Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin. Oncotarget  7, 23498-511.   https://doi.org/10.18632/oncotarget.8274|6. Moore EC, Cash HA, Caruso AM, Uppaluri R, Hodge JW, Van Waes C, Allen CT (2016). Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunol Res  4, 611-20.   https://doi.org/10.1158/2326-6066.CIR-15-0252",https://intramural.nih.gov/search/searchview.taf?ipid=98802
140,BC010666-13,"October 01, 2016 -  September 30, 2017",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",William Laurence Dahut; MD|Ravi  Madan,"Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Douglas  McNeel (University of Wisconsin)|Alex  Franzusoff (Research and Development, GlobeImmune)|Paul  Chaplin (Bavarian Nordic, Inc.)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter A Pinto; MD (Urologic Oncology Branch)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch),NULL,"1. Gulley J (2017) Prostate-specific antigen, in Cancer Therapeutic Targets. , pp. 451-458.|2. Schlom J, Gulley J, Hodge J (2017) Vaccines and immunostimulants, in Holland-Frei Cancer Medicine. , pp. 777-792.|3. Bilsuc M, Gulley J (2017) Local immunotherapy: converting tumors from cold to hot. J Natl Cancer Inst, in press.|4. Bilusic M, Madan R, Gulley J (2017) Immunotherapy of prostate cancer: facts and hopes. Clin Cancer Res, in press.|5. Bilusic M, Madan RA, Gulley JL (2017). Immunotherapy of Prostate Cancer: Facts and Hopes. Clin Cancer Res  23, 6764-6770.   https://doi.org/10.1158/1078-0432.CCR-17-0019|6. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017) A novel bifunctional anti-PD-L1TGF- Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology, in press.|7. Farsaci B, Donahue RN, Grenga I, Lepone LM, Kim PS, Dempsey B, Siebert JC, Ibrahim NK, Madan RA, Heery CR, Gulley JL, Schlom J (2016). Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy. Cancer Immunol Res  4, 755-65.   https://doi.org/10.1158/2326-6066.CIR-16-0037|8. Fenerty KE, Folio LR, Patronas NJ, Marté JL, Gulley JL, Heery CR (2016). Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST. BMC Cancer  16, 672.   https://doi.org/10.1186/s12885-016-2699-x|9. Fenerty KE, Patronas NJ, Heery CR, Gulley JL, Folio LR (2016). Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden? J Digit Imaging  29, 357-64.   https://doi.org/10.1007/s10278-015-9846-9|10. Gulley J, Repasky E, Wood L, Butterfield L (2017) Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016. J Immunother Cancer, in press.|11. Gulley JL, Mulders P, Albers P, Banchereau J, Bolla M, Pantel K, Powles T (2016). Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm. Oncoimmunology  5, e1107698.   https://doi.org/10.1080/2162402X.2015.1107698|12. Heery CR, Palena C, McMahon S, Donahue RN, Lepone LM, Grenga I, Dirmeier U, Cordes L, Marté J, Dahut W, Singh H, Madan RA, Fernando RI, Hamilton DH, Schlom J, Gulley JL (2017). Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury. Clin Cancer Res  23, 6833-6845.   https://doi.org/10.1158/1078-0432.CCR-17-1087|13. Lepone L, Donahue R, Grenga I, Metenou S, Richards J, Heery C, Madan R, Gulley J, Schlom J (2016) Analyses of 123 peripheral human immune cell subsets: defining differences with age and between healthy donors and cancer patients not detected in analysis of standard immune cell types J Circ Biomark 5:1-20|14. Madan R, Gulley J (2017) Personalized peptide vaccine in prostate cancer: capitalizing on existing immunity. Transl Cancer Res, in press.|15. Madan RA, Gulley JL (2016). Prospects for the future of prostate cancer vaccines. Expert Rev Vaccines  15, 271-4.   https://doi.org/10.1586/14760584.2015.1118348|16. McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL (2016). The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. J Immunother Cancer  4, 92.   https://doi.org/10.1186/s40425-016-0198-x|17. Wood LV, Fojo A, Roberson BD, Hughes MS, Dahut W, Gulley JL, Madan RA, Arlen PM, Sabatino M, Stroncek DF, Castiello L, Trepel JB, Lee MJ, Parnes HL, Steinberg SM, Terabe M, Wilkerson J, Pastan I, Berzofsky JA (2016). TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer. Oncoimmunology  5, e1197459.   https://doi.org/10.1080/2162402X.2016.1197459",https://intramural.nih.gov/search/searchview.taf?ipid=98801
141,BC010668-13,"October 01, 2016 -  September 30, 2017",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Michael  Green|Jurgen  Seidel; PhD|Stephen Scott Adler,NULL,NULL,Thomas J Pohida; MS (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98787
142,BC010670-13,"October 01, 2016 -  September 30, 2017",Radiation-induced molecular targets,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Molykutty J Aryankalayil|Adeola Yetunde Makinde|Iris Regina Eke; MD|Joel Daniel Levin|Sunita  Chopra; PhD,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University)|Sylvia  Formenti (NYU)|Rocco  Cassagrande (Gryphon Scientific)|Sandra  Demaria (Weill Cornell Medical School),Mansoor Mukhtar Ahmed; PhD (Radiotherapy Development Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Coleman CN (2017). The Radiation Stress Response: Of the People, By the People and For the People. Radiat Res  187, 129-146.   https://doi.org/10.1667/RR0CNC.1|2. Demaria S, Coleman CN, Formenti SC (2016). Radiotherapy: Changing the Game in Immunotherapy. Trends Cancer  2, 286-294.   https://doi.org/10.1016/j.trecan.2016.05.002|3. Eke I, Makinde AY, Aryankalayil MJ, Ahmed MM, Coleman CN (2016). Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine. Cancer Lett  382, 118-126.   https://doi.org/10.1016/j.canlet.2016.01.041|4. Makinde AY, Eke I, Aryankalayil MJ, Ahmed MM, Coleman CN (2016). Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy. Semin Radiat Oncol  26, 254-60.   https://doi.org/10.1016/j.semradonc.2016.07.001",https://intramural.nih.gov/search/searchview.taf?ipid=98783
143,BC010671-13,"October 01, 2016 -  September 30, 2017",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Melanie S Vacchio; PhD|Qi  Xiao|Thomas  Ciucci|Yayi  Gao|Jia  Nie|Laura Beth Chopp|Show all 10,"Albert  Bendelac (University of Chicago)|Marc  Jenkins|Wilfried  Ellmeier (Immunology, University of Vienna)|Matthias Martin Gaida|Georg  Hollander (University of Oxford)|Hai-Hui  Xue; MD, PhD (University of Iowa)|Show all 7","Charles  Vinson; PhD (Nucleic Acids Section)|Avinash  Bhandoola; MD, PhD (Laboratory Of Genome Integrity)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)","Andrea Christine Bohrer (NIAID) |Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |John J O'Shea; MD (NIAMS) |Dorian  McGavern (NINDS)","1. Bosselut R (2016). Pleiotropic Functions of H3K27Me3 Demethylases in Immune Cell Differentiation. Trends Immunol  37, 102-113.   https://doi.org/10.1016/j.it.2015.12.004|2. Bosselut R, Vacchio MS (2016). Preface. T-Cell Development. Methods Mol Biol  1323, v-vi.   https://doi.org/10.1007/978-1-4939-2809-5|3. Carpenter A, Wohlfert E, Chopp L, Vacchio M, Nie J, Zhao Y, Shetty J, Xiao Q, Deng C, Tran B, Cam M, Gaida M, Belkaid Y, Bosselut R (2017) Control of Treg differentiation by the transcription factors Thpok and LRF. Journal of Immunology, in press.|4. Carpenter AC, Kim JK, Bosselut R (2016). Purification of Thymocyte and T Cell Subsets. Methods Mol Biol  1323, 87-97.   https://doi.org/10.1007/978-1-4939-2809-5_7|5. Ciucci T, Bosselut R (2016). A long journey coming to fruition: In sight of the preselection T-cell repertoire. Eur J Immunol  46, 539-42.   https://doi.org/10.1002/eji.201646292|6. Ciucci T, Vacchio MS, Bosselut R (2016). Genetic Tools to Study T Cell Development. Methods Mol Biol  1323, 35-45.   https://doi.org/10.1007/978-1-4939-2809-5_3|7. Vacchio MS, Bosselut R (2016). What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function. J Immunol  196, 4848-56.   https://doi.org/10.4049/jimmunol.1600415|8. Vacchio MS, Ciucci T, Bosselut R (2016). 200 Million Thymocytes and I: A Beginner's Survival Guide to T Cell Development. Methods Mol Biol  1323, 3-21.   https://doi.org/10.1007/978-1-4939-2809-5_1|9. Wohlfert EA, Carpenter AC, Belkaid Y, Bosselut R (2016). In Vitro Analyses of T Cell Effector Differentiation. Methods Mol Biol  1323, 117-28.   https://doi.org/10.1007/978-1-4939-2809-5_10|10. Zhang S, Zhu I, Deng T, Furusawa T, Rochman M, Vacchio MS, Bosselut R, Yamane A, Casellas R, Landsman D, Bustin M (2016). HMGN proteins modulate chromatin regulatory sites and gene expression during activation of naïve B cells. Nucleic Acids Res  44, 7144-58.   https://doi.org/10.1093/nar/gkw323",https://intramural.nih.gov/search/searchview.taf?ipid=98782
144,BC010675-13,"October 01, 2016 -  September 30, 2017",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Molly Day Congdon|Joseph John Barchi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98793
145,BC010677-13,"October 01, 2016 -  September 30, 2017",NADPH Oxidases as Novel Targets for Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Jennifer Lynn Meitzler,NULL,NULL,NULL,"1. Antony S, Jiang G, Wu Y, Meitzler JL, Makhlouf HR, Haines DC, Butcher D, Hoon DS, Ji J, Zhang Y, Juhasz A, Lu J, Liu H, Dahan I, Konate M, Roy KK, Doroshow JH (2017). NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors. Mol Carcinog  56, 2643-2662.   https://doi.org/10.1002/mc.22708|2. Chu FF, Esworthy RS, Doroshow JH, Shen B (2016). NADPH oxidase-1 deficiency offers little protection in Salmonella typhimurium-induced typhlitis in mice. World J Gastroenterol  22, 10158-10165.   https://doi.org/10.3748/wjg.v22.i46.10158|3. Wu Y, Meitzler JL, Antony S, Juhasz A, Lu J, Jiang G, Liu H, Hollingshead M, Haines DC, Butcher D, Panter MS, Roy K, Doroshow JH (2016). Dual oxidase 2 and pancreatic adenocarcinoma: IFN-γ-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1α and VEGF-A. Oncotarget  7, 68412-68433.   https://doi.org/10.18632/oncotarget.12032",https://intramural.nih.gov/search/searchview.taf?ipid=98792
146,BC010681-13,"October 01, 2016 -  September 30, 2017",Development of inhibitors targeting Plk1 polo-box domain,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park|Seongjin  Choe,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Terrence R Burke; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98798
147,BC010683-13,"October 01, 2016 -  September 30, 2017",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Joseph Andrew Baiocco|Rebecca Linda Delisio|William Marston Linehan; MD,YunJin  Jung (Pusan National University)|Sunil  Sudarshan,NULL,Chengyuan  Li (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98800
148,BC010696-13,"October 01, 2016 -  September 30, 2017",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|David D Roberts; PhD,NULL,"Peter A Pinto; MD (Urologic Oncology Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B (2016). Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A  113, 2170-5.   https://doi.org/10.1073/pnas.1525735113|2. Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA, Peterson J, Yang Y, Linehan WM (2017). Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer  56, 484-492.   https://doi.org/10.1002/gcc.22452",https://intramural.nih.gov/search/searchview.taf?ipid=98799
149,BC010701-12,"October 01, 2016 -  September 30, 2017",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Zhongyu  Zhu|Yang  Feng|Yanping  Wang|Dontcho Videv Jelev; PhD|Wei  Li; PhD|Tianlei  Ying|Show all 10,Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Philip  Low (Perdue University)|Kurt  Ghelsen (RCT)|Nancy  Ip (Hong University of Science and Technology)|David  Miao (Concortis)|Qi  Zhao (Institute of Biomedicine and Biotechnology)|Show all 8,Ira H Pastan; MD (Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Bradley D St Croix (Mouse Cancer Genetics Program)|Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS, Jones DR, Sadelain M, Adusumilli PS (2016). Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. J Clin Invest  126, 3130-44.   https://doi.org/10.1172/JCI83092|2. Feng Y, Wang Y, Zhu Z, Li W, Sussman RT, Randall M, Bosse KR, Maris JM, Dimitrov DS (2016). Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes. MAbs  8, 799-810.   https://doi.org/10.1080/19420862.2016.1155014|3. Li D, Gong R, Zheng J, Chen X, Dimitrov DS, Zhao Q (2017). Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation. Biochem Biophys Res Commun  485, 446-453.   https://doi.org/10.1016/j.bbrc.2017.02.058|4. Li W, Yang H, Dimitrov DS (2016). Identification of high-affinity anti-CD16A allotype-independent human antibody domains. Exp Mol Pathol  101, 281-289.   https://doi.org/10.1016/j.yexmp.2016.10.001|5. Lynn RC, Feng Y, Schutsky K, Poussin M, Kalota A, Dimitrov DS, Powell DJ (2016). High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity. Leukemia  30, 1355-64.   https://doi.org/10.1038/leu.2016.35|6. van Doremalen N, Falzarano D, Ying T, de Wit E, Bushmaker T, Feldmann F, Okumura A, Wang Y, Scott DP, Hanley PW, Feldmann H, Dimitrov DS, Munster VJ (2017). Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res  143, 30-37.   https://doi.org/10.1016/j.antiviral.2017.03.025|7. Ying T, Wen Y, Dimitrov DS (2017). Precision immunomedicine. Emerg Microbes Infect  6, e25.   https://doi.org/10.1038/emi.2017.22",https://intramural.nih.gov/search/searchview.taf?ipid=98804
150,BC010707-12,"October 01, 2016 -  September 30, 2017",Role of T Regulatory Cell Suppression in Autoimmunity and Cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Xin  Chen|De  Yang|Anna Lee  Trivett,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98806
151,BC010709-12,"October 01, 2016 -  September 30, 2017",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98816
152,BC010717-12,"October 01, 2016 -  September 30, 2017",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98817
153,BC010719-12,"October 01, 2016 -  September 30, 2017",Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98818
154,BC010725-12,"October 01, 2016 -  September 30, 2017",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,"Ronald N Germain; MD, PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID)","1. Bussi C, Peralta Ramos JM, Arroyo DS, Gaviglio EA, Gallea JI, Wang JM, Celej MS, Iribarren P (2017). Autophagy down regulates pro-inflammatory mediators in BV2 microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death. Sci Rep  7, 43153.   https://doi.org/10.1038/srep43153|2. Chen K, Bao Z, Gong W, Yoshimura T, Wang J (2017) Regulation of inflammation by members of the FPR family. Journal of Autoimmunity, in press.|3. Chen K, Wang JM, Yuan R, Yi X, Li L, Gong W, Yang T, Li L, Su S (2016). Tissue-resident dendritic cells and diseases involving dendritic cell malfunction. Int Immunopharmacol  34, 1-15.   https://doi.org/10.1016/j.intimp.2016.02.007|4. Holdfeldt A, Skovbakke SL, Winther M, Gabl M, Nielsen C, Perez-Gassol I, Larsen CJ, Wang JM, Karlsson A, Dahlgren C, Forsman H, Franzyk H (2016). The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase. J Biol Chem  291, 19888-99.   https://doi.org/10.1074/jbc.M116.736850|5. Li L, Chen K, Xiang Y, Yoshimura T, Su S, Zhu J, Bian XW, Wang JM (2016). New development in studies of formyl-peptide receptors: critical roles in host defense. J Leukoc Biol  99, 425-35.   https://doi.org/10.1189/jlb.2RI0815-354RR|6. Pan Y, Lin S, Xing R, Zhu M, Lin B, Cui J, Li W, Gao J, Shen L, Zhao Y, Guo M, Wang JM, Huang J, Lu Y (2016). Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation. Antioxid Redox Signal  24, 839-54.   https://doi.org/10.1089/ars.2014.6128",https://intramural.nih.gov/search/searchview.taf?ipid=98809
155,BC010728-12,"October 01, 2016 -  September 30, 2017",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98819
156,BC010735-12,"October 01, 2016 -  September 30, 2017",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",NULL,NULL,NULL,NULL,"1. Bao R, Liu Y, Savarino SJ, Xia D (2016). Off-pathway assembly of fimbria subunits is prevented by chaperone CfaA of CFA/I fimbriae from enterotoxigenic E. coli. Mol Microbiol  102, 975-991.   https://doi.org/10.1111/mmi.13530",https://intramural.nih.gov/search/searchview.taf?ipid=98810
157,BC010736-12,"October 01, 2016 -  September 30, 2017",Unraveling the function of CD276,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Jonathan  Keller; PhD,Gary  DeCrescenzo (BioMed Valley Discoveries)|Saurabh  Saha (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98815
158,BC010738-12,"October 01, 2016 -  September 30, 2017","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Hyunhee  Shin|Shree Ram  Singh|Jiangsha  Zhao; PhD|Hanhan  Liu|Guohao  Wang|Chen-Yuan  Tseng,NULL,NULL,NULL,"1. Liu Y, Ge Q, Chan B, Liu H, Singh SR, Manley J, Lee J, Weideman AM, Hou G, Hou SX (2016). Whole-animal genome-wide RNAi screen identifies networks regulating male germline stem cells in Drosophila. Nat Commun  7, 12149.   https://doi.org/10.1038/ncomms12149|2. Singh SR, Liu Y, Zhao J, Zeng X, Hou SX (2016). The novel tumour suppressor Madm regulates stem cell competition in the Drosophila testis. Nat Commun  7, 10473.   https://doi.org/10.1038/ncomms10473|3. Zhao J, Li J, Fan T, Hou SX (2017) Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells. Oncotarget, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98812
159,BC010740-12,"October 01, 2016 -  September 30, 2017",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Eric Russell Sterner|Li  Xia|Aislinn Katherine McMillan|Molly Day Congdon|Marc C Nicklaus|Megan L Peach,"Lara  Mahal (Chemistry, University of Texas at Austin)|Mai  Xu; PhD|Lynn  Morris (National Institute for Communicable Diseases)|James  Fleckenstein (Washington University School of Medicine, St. Louis)|Hanping  Feng (University of Maryland)|Paul  Lampe (Fred Hutchinson Cancer Research Center)",Jacek Tadeusz Lubkowski (Macromolecular Crystallography Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Gildersleeve JC, Wright WS (2016). Diverse molecular recognition properties of blood group A binding monoclonal antibodies. Glycobiology  26, 443-8.   https://doi.org/10.1093/glycob/cwv171|2. Sterner E, Flanagan N, Gildersleeve JC (2016). Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database. ACS Chem Biol  11, 1773-83.   https://doi.org/10.1021/acschembio.6b00244",https://intramural.nih.gov/search/searchview.taf?ipid=98811
160,BC010747-12,"October 01, 2016 -  September 30, 2017",Characterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jeffrey J Subleski|Geraldine Martina O'Connor|Stephen K Anderson; PhD,"Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|David  Price (Cardiff University)|Alain  Rook (University of Pennsylvania)|Simon  Kollnberger (University of Oxford)",NULL,"Suk See De Ravin; MD, PhD (NIAID) |Michael  Ward; MD (NIAMS) |Robert A Colbert; MD, PhD (NIAMS)","1. McCullen MV, Li H, Cam M, Sen SK, McVicar DW, Anderson SK (2016). Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression. Genes Immun  17, 349-57.   https://doi.org/10.1038/gene.2016.31|2. Saunders PM, Pymm P, Pietra G, Hughes VA, Hitchen C, O'Connor GM, Loiacono F, Widjaja J, Price DA, Falco M, Mingari MC, Moretta L, McVicar DW, Rossjohn J, Brooks AG, Vivian JP (2016). Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med  213, 791-807.   https://doi.org/10.1084/jem.20152023",https://intramural.nih.gov/search/searchview.taf?ipid=98805
161,BC010749-12,"October 01, 2016 -  September 30, 2017",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Antonio L Valentin|Bhabadeb S Chowdhury; PhD|Margherita  Rosati|Sotirios P Fortis|Marjorie  Robert-Guroff; PhD|Barbara K Felber|Show all 8,"David C Montefiori; PhD (Department of Surgery, NIAID)|James  Mullins; PhD (Microbiology, University of Washington)|Dan  Barouch (Harvard University)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Show all 23",Brandon Frank Keele (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section),Rajeev  Gautam (NIAID) |Malcolm A Martin; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98807
162,BC010750-12,"October 01, 2016 -  September 30, 2017",Cytokines in AIDS and Cancer Immunotherapy,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Antonio L Valentin|Bhabadeb S Chowdhury; PhD|Margherita  Rosati|Konstantinos  Dimas; MD|Dionysios Christos Watson|Dimitrios  Stellas|Show all 10,"Karen  Gaensler (University of California)|Rafick-Pierre  Sekaly (Centre de Recherche du Centre Hospitalier de l'Universite de Montreal)|Morten  Thaysen-Andersen (Macquarie University)|Galit  Alter; PhD (Division of Medical Sciences, Harvard Medical School)|Kate  Broderick (Inovio Pharmaceuticals, Inc.)|Bernard  Fox (Oregon Cancer Center)|Show all 12","Bethany Anne Nagy (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)|Jacob D Estes (Office Of The Director)",Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID) |Mario  Roederer; PhD (NIAID) |Bryant Chinung Yung (NIBIB),"1. Hong E, Usiskin IM, Bergamaschi C, Hanlon DJ, Edelson RL, Justesen S, Pavlakis GN, Flavell RA, Fahmy TM (2016). Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity. J Biol Chem  291, 8931-50.   https://doi.org/10.1074/jbc.M115.695304",https://intramural.nih.gov/search/searchview.taf?ipid=98808
163,BC010759-12,"October 01, 2016 -  September 30, 2017",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","John E Lueders|Robert L Walker; BS|Yuan  Jiang; MD|Arthur A Glatfelter; MS|Fan  Yang|Sean Richard Davis; MD, PhD|Show all 10","Heinrich  Kovar (St. Anna's Children's Hospital)|Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Ashok  Venkitaraman (University of Cambridge)",Sharon Ann Savage (Clinical Genetics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Lisa  Mirabello (Clinical Genetics Branch),NULL,"1. Hingorani P, Janeway K, Crompton BD, Kadoch C, Mackall CL, Khan J, Shern JF, Schiffman J, Mirabello L, Savage SA, Ladanyi M, Meltzer P, Bult CJ, Adamson PC, Lupo PJ, Mody R, DuBois SG, Parsons DW, Khanna C, Lau C, Hawkins DS, Randall RL, Smith M, Sorensen PH, Plon SE, et al. [4 more authors] (2016). Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop. Cancer Genet  209, 182-94.   https://doi.org/10.1016/j.cancergen.2016.03.004|2. Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, Dirksen U, van der Ent W, Grohar P, Grünewald TG, Helman L, Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou T, Radic Sarikas B, et al. [21 more authors] (2016). The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. Oncotarget  7, 8613-24.   https://doi.org/10.18632/oncotarget.6937",https://intramural.nih.gov/search/searchview.taf?ipid=98813
164,BC010763-12,"October 01, 2016 -  September 30, 2017",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Douglas  Palmer|Zhiya  Yu|Devikala  Gurusamy|Arash D Eidizadeh|Robert Langland Eil|Ping-Hsien  Lee; PhD|Show all 20,Paul  Antony (Univeristy of Maryland)|Vincenzo  Bronte,Jae Ho  Kim (Experimental Transplantation and Immunology Branch)|Giorgio  Trinchieri (Cancer Inflammation Program),David Isaac Lieberman (NIDDK),"1. Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M, Klebanoff CA, Eil RL, Hickman HD, Yu Z, Pan JH, Palmer DC, Phan AT, Goulding J, Gattinoni L, Goldrath AW, Belkaid Y, Restifo NP (2016). Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell  166, 1117-1131.e14.   https://doi.org/10.1016/j.cell.2016.07.032|2. Crompton JG, Sukumar M, Restifo NP (2016). Targeting Akt in cell transfer immunotherapy for cancer. Oncoimmunology  5, e1014776.   https://doi.org/10.1080/2162402X.2015.1014776|3. Cruz AC, Ramaswamy M, Ouyang C, Klebanoff CA, Sengupta P, Yamamoto TN, Meylan F, Thomas SK, Richoz N, Eil R, Price S, Casellas R, Rao VK, Lippincott-Schwartz J, Restifo NP, Siegel RM (2016). Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nat Commun  7, 13895.   https://doi.org/10.1038/ncomms13895|4. Eil R, Vodnala SK, Clever D, Klebanoff CA, Sukumar M, Pan JH, Palmer DC, Gros A, Yamamoto TN, Patel SJ, Guittard GC, Yu Z, Carbonaro V, Okkenhaug K, Schrump DS, Linehan WM, Roychoudhuri R, Restifo NP (2016). Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature  537, 539-543.   https://doi.org/10.1038/nature19364|5. Goff SL, Dudley ME, Citrin DE, Somerville RP, Wunderlich JR, Danforth DN, Zlott DA, Yang JC, Sherry RM, Kammula US, Klebanoff CA, Hughes MS, Restifo NP, Langhan MM, Shelton TE, Lu L, Kwong ML, Ilyas S, Klemen ND, Payabyab EC, Morton KE, Toomey MA, Steinberg SM, White DE, Rosenberg SA (2016). Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. J Clin Oncol  34, 2389-97.   https://doi.org/10.1200/JCO.2016.66.7220|6. Kishton RJ, Sukumar M, Restifo NP (2016). Arginine Arms T Cells to Thrive and Survive. Cell Metab  24, 647-648.   https://doi.org/10.1016/j.cmet.2016.10.019|7. Klebanoff CA, Restifo NP (2016). Customizing Functionality and Payload Delivery for Receptor-Engineered T Cells. Cell  167, 304-306.   https://doi.org/10.1016/j.cell.2016.09.033|8. Klebanoff CA, Rosenberg SA, Restifo NP (2016). Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med  22, 26-36.   https://doi.org/10.1038/nm.4015|9. Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto TN, Cruz AC, Ouyang C, Ramaswamy M, Roychoudhuri R, Ji Y, Eil RL, Sukumar M, Crompton JG, Palmer DC, Borman ZA, Clever D, Thomas SK, Patel S, Yu Z, Muranski P, Liu H, Wang E, Marincola FM, Gros A, Gattinoni L, Rosenberg SA, et al. [2 more authors] (2016). Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J Clin Invest  126, 318-34.   https://doi.org/10.1172/JCI81217|10. Moogk D, Zhong S, Yu Z, Liadi I, Rittase W, Fang V, Dougherty J, Perez-Garcia A, Osman I, Zhu C, Varadarajan N, Restifo NP, Frey AB, Krogsgaard M (2016). Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets. J Immunol  197, 644-54.   https://doi.org/10.4049/jimmunol.1600178|11. Nelson MH, Bowers JS, Bailey SR, Diven MA, Fugle CW, Kaiser AD, Wrzesinski C, Liu B, Restifo NP, Paulos CM (2016). Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. J Immunother Cancer  4, 6.   https://doi.org/10.1186/s40425-016-0110-8|12. Restifo NP, Smyth MJ, Snyder A (2016). Acquired resistance to immunotherapy and future challenges. Nat Rev Cancer  16, 121-6.   https://doi.org/10.1038/nrc.2016.2|13. Roychoudhuri R, Clever D, Li P, Wakabayashi Y, Quinn KM, Klebanoff CA, Ji Y, Sukumar M, Eil RL, Yu Z, Spolski R, Palmer DC, Pan JH, Patel SJ, Macallan DC, Fabozzi G, Shih HY, Kanno Y, Muto A, Zhu J, Gattinoni L, O'Shea JJ, Okkenhaug K, Igarashi K, Leonard WJ, et al. [1 more author] (2016). BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers. Nat Immunol  17, 851-860.   https://doi.org/10.1038/ni.3441|14. Roychoudhuri R, Eil RL, Clever D, Klebanoff CA, Sukumar M, Grant FM, Yu Z, Mehta G, Liu H, Jin P, Ji Y, Palmer DC, Pan JH, Chichura A, Crompton JG, Patel SJ, Stroncek D, Wang E, Marincola FM, Okkenhaug K, Gattinoni L, Restifo NP (2016). The transcription factor BACH2 promotes tumor immunosuppression. J Clin Invest  126, 599-604.   https://doi.org/10.1172/JCI82884|15. Sukumar M, Liu J, Mehta GU, Patel SJ, Roychoudhuri R, Crompton JG, Klebanoff CA, Ji Y, Li P, Yu Z, Whitehill GD, Clever D, Eil RL, Palmer DC, Mitra S, Rao M, Keyvanfar K, Schrump DS, Wang E, Marincola FM, Gattinoni L, Leonard WJ, Muranski P, Finkel T, Restifo NP (2016). Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. Cell Metab  23, 63-76.   https://doi.org/10.1016/j.cmet.2015.11.002|16. Wang QJ, Yu Z, Griffith K, Hanada K, Restifo NP, Yang JC (2016). Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors. Cancer Immunol Res  4, 204-14.   https://doi.org/10.1158/2326-6066.CIR-15-0188|17. Wang QJ, Yu Z, Hanada KI, Patel K, Kleiner D, Restifo NP, Yang JC (2017). Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers. Clin Cancer Res  23, 2267-2276.   https://doi.org/10.1158/1078-0432.CCR-16-1421",https://intramural.nih.gov/search/searchview.taf?ipid=98814
165,BC010766-11,"October 01, 2016 -  September 30, 2017",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",NULL,NULL,Mark  Raffeld; MD (Laboratory of Pathology)|Eric Alan Stahlberg (Evaluation & Strategic Initiatives Branch),NULL,"1. Chandran SS, Somerville RPT, Yang JC, Sherry RM, Klebanoff CA, Goff SL, Wunderlich JR, Danforth DN, Zlott D, Paria BC, Sabesan AC, Srivastava AK, Xi L, Pham TH, Raffeld M, White DE, Toomey MA, Rosenberg SA, Kammula US (2017). Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. Lancet Oncol  18, 792-802.   https://doi.org/10.1016/S1470-2045(17)30251-6",https://intramural.nih.gov/search/searchview.taf?ipid=98860
166,BC010770-11,"October 01, 2016 -  September 30, 2017",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,"Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Vernon  Walker (University of Vermont)",NULL,William Chenery Copeland; PhD (NIEHS),"1. Liu Y, Shim Park E, Gibbons AT, Shide ED, Divi RL, Woodward RA, Poirier MC (2016). Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies. Environ Mol Mutagen  57, 526-34.   https://doi.org/10.1002/em.22033",https://intramural.nih.gov/search/searchview.taf?ipid=98862
167,BC010773-11,"October 01, 2016 -  September 30, 2017",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Diborah Mengistu Yimer,John  Coffin (Tufts University)|Mark  Williams (Northeastern University),Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98861
168,BC010774-11,"October 01, 2016 -  September 30, 2017",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Muhammad Shamsul Alam|June  Guha; PhD|Shizuka  Otsuka,Al  Fornace (Georgetown University)|Matthias Martin Gaida,Ettore  Appella; MD (Chemical Immunology Section),NULL,"1. Dutta D, Barr VA, Akpan I, Mittelstadt PR, Singha LI, Samelson LE, Ashwell JD (2017). Recruitment of calcineurin to the TCR positively regulates T cell activation. Nat Immunol  18, 196-204.   https://doi.org/10.1038/ni.3640",https://intramural.nih.gov/search/searchview.taf?ipid=98820
169,BC010778-11,"October 01, 2016 -  September 30, 2017",HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,Tatyana  Polenova; PhD (University of Delaware)|Feng  Li; PhD|Ritu  Gaur|Carl  Wild (Panacos Pharmaceuticals)|-  Hetero Drugs (Hetero Research Foundation)|Owen  Pornillos (University of Virginia)|Show all 7,Sherimay  Ablan (Retroviral Replication Laboratory)|Phuong Nhat Pham (Retroviral Replication Laboratory)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Alasdair C Steven; PhD (NIAMS),"1. Fontana J, Keller PW, Urano E, Ablan SD, Steven AC, Freed EO (2016). Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice. J Virol  90, 972-8.   https://doi.org/10.1128/JVI.02204-15|2. Freed EO (2016). Getting IN on Viral RNA Condensation and Virion Maturation. Cell  166, 1082-1083.   https://doi.org/10.1016/j.cell.2016.08.013|3. Timilsina U, Ghimire D, Timalsina B, Nitz TJ, Wild CT, Freed EO, Gaur R (2016). Identification of potent maturation inhibitors against HIV-1 clade C. Sci Rep  6, 27403.   https://doi.org/10.1038/srep27403",https://intramural.nih.gov/search/searchview.taf?ipid=98826
170,BC010782-11,"October 01, 2016 -  September 30, 2017",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Hidetaka  Ohnuki|Michael Joseph Diprima|Douglas  Lowy; MD,Frederick  Wang (Harvard Univ)|Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),"Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David  Levens; PhD (Laboratory of Pathology)|Roberto  Weigert; MSc Chemistry, PhD (Laboratory of Cellular and Molecular Biology)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)",Yosuke  Mukoyama; PhD (NHLBI),"1. Kwak H, Salvucci O, Weigert R, Martinez-Torrecuadrada JL, Henkemeyer M, Poulos MG, Butler JM, Tosato G (2016). Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow. J Clin Invest  126, 4554-4568.   https://doi.org/10.1172/JCI87848",https://intramural.nih.gov/search/searchview.taf?ipid=98830
171,BC010783-11,"October 01, 2016 -  September 30, 2017","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Hyung Joon  Kwon; PhD,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)",NULL,Chengyu  Liu; PhD (NHLBI),"1. Xu Q, Choksi S, Qu J, Jang J, Choe M, Banfi B, Engelhardt JF, Liu ZG (2016). NADPH Oxidases Are Essential for Macrophage Differentiation. J Biol Chem  291, 20030-41.   https://doi.org/10.1074/jbc.M116.731216",https://intramural.nih.gov/search/searchview.taf?ipid=98831
172,BC010788-11,"October 01, 2016 -  September 30, 2017",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhihui  Liu|Veronica  Veschi|Deblina  Banerjee|Ming  Sun|Man  Xu|Kenneth H Lieuw|Show all 8,"Jinhua  Zhang (Hematology, 2nd China Medical School)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Chesler  Louis (The Royal Marsden NHS Foundation Trust)|Cheryl  Arrowsmith (University of Toronto)|Jian  Jin (Icahn School of Medicine at Mt. Sinai)",Ettore  Appella; MD (Chemical Immunology Section)|Javed  Khan; MD (Cancer Genetics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Chunhua  Yan (Cancer Informatics Branch),NULL,"1. Liu Z, Thiele Galetto C (2017) Molecular Genetics of Neuroblastoma, in Radionuclide Imaging and Therapy for Endocriine Tumors. , pp. in press.|2. Liu Z, Lam N, Wang E, Virden RA, Pawel B, Attiyeh EF, Maris JM, Thiele CJ (2017). Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene  36, 97-109.   https://doi.org/10.1038/onc.2016.179|3. Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ, Lam N, Souza BK, Giannini G, Hager GL, Arrowsmith CH, Khan J, Appella E, Thiele CJ (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell  31, 50-63.   https://doi.org/10.1016/j.ccell.2016.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=98832
173,BC010789-11,"October 01, 2016 -  September 30, 2017",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhihui  Liu|Veronica  Veschi,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|Zhijie  Li (China Medical University)|Richard  Woessner (AstraZeneca Pharmaceuticals)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Liewehr (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98833
174,BC010791-11,"October 01, 2016 -  September 30, 2017","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Maureen P Martin|Xiaojiang  Gao|Yuko  Yuki|Arman A Bashirova|Veron  Ramsuran|Marjan  Akdag|Show all 11,"Amalio  Telenti (University Hospital of Lausanne)|Howard  Strickler (Albert Einstein College of Medicine)|Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Show all 25",Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch)|Denise  Whitby (Office Of The Director),Daniel C Douek; MD (NIAID),"1. Ahn RS, Moslehi H, Martin MP, Abad-Santos M, Bowcock AM, Carrington M, Liao W (2016). Inhibitory KIR3DL1 alleles are associated with psoriasis. Br J Dermatol  174, 449-51.   https://doi.org/10.1111/bjd.14081|2. Apps R, Del Prete GQ, Chatterjee P, Lara A, Brumme ZL, Brockman MA, Neil S, Pickering S, Schneider DK, Piechocka-Trocha A, Walker BD, Thomas R, Shaw GM, Hahn BH, Keele BF, Lifson JD, Carrington M (2016). HIV-1 Vpu Mediates HLA-C Downregulation. Cell Host Microbe  19, 686-95.   https://doi.org/10.1016/j.chom.2016.04.005|3. Garcia-Beltran WF, Hölzemer A, Martrus G, Chung AW, Pacheco Y, Simoneau CR, Rucevic M, Lamothe-Molina PA, Pertel T, Kim TE, Dugan H, Alter G, Dechanet-Merville J, Jost S, Carrington M, Altfeld M (2016). Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol  17, 1067-74.   https://doi.org/10.1038/ni.3513|4. Jarret A, McFarland AP, Horner SM, Kell A, Schwerk J, Hong M, Badil S, Joslyn RC, Baker DP, Carrington M, Hagedorn CH, Gale M, Savan R (2016). Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat Med  22, 1475-1481.   https://doi.org/10.1038/nm.4211|5. Kinloch NN, MacMillan DR, Le AQ, Cotton LA, Bangsberg DR, Buchbinder S, Carrington M, Fuchs J, Harrigan PR, Koblin B, Kushel M, Markowitz M, Mayer K, Milloy MJ, Schechter MT, Wagner T, Walker BD, Carlson JM, Poon AF, Brumme ZL (2016). Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic. J Virol  90, 1244-58.   https://doi.org/10.1128/JVI.02353-15|6. Leitman E, Willberg C, Tsai M, Chen H, Buss S, Chen F, Riddell L, Haas D, Fellay J, Goedert J, PiechockaTrocha A, Walker B, Martin J, Deeks S, Wolinsky S, Martinson J, Martin M, Qi Y, SaezCirion A, Yang O, Matthews P, Carrington M, Goulder P (2017) HLA-B14:02-restricted ENV-specific CD8+ T-cell activity has highly potent anti-viral efficacy associated with immune control of HIV-1 infection. J Virol, in press.|7. Lin Z, Kuroki K, Kuse N, Sun X, Akahoshi T, Qi Y, Chikata T, Naruto T, Koyanagi M, Murakoshi H, Gatanaga H, Oka S, Carrington M, Maenaka K, Takiguchi M (2016). HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03. Cell Rep  17, 2210-2220.   https://doi.org/10.1016/j.celrep.2016.10.075|8. Lunemann S, Martrus G, Hölzemer A, Chapel A, Ziegler M, Körner C, Garcia Beltran W, Carrington M, Wedemeyer H, Altfeld M (2016). Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function. J Hepatol  65, 252-8.   https://doi.org/10.1016/j.jhep.2016.03.016|9. Martinez-Picado J, McLaren PJ, Erkizia I, Martin MP, Benet S, Rotger M, Dalmau J, Ouchi D, Wolinsky SM, Penugonda S, Günthard HF, Fellay J, Carrington M, Izquierdo-Useros N, Telenti A (2016). Identification of Siglec-1 null individuals infected with HIV-1. Nat Commun  7, 12412.   https://doi.org/10.1038/ncomms12412|10. Matthews PC, Carlson JM, Beloukas A, Malik A, Jooste P, Ogwu A, Shapiro R, Riddell L, Chen F, Luzzi G, Jesuthasan G, Jeffery K, Jojic N, Ndung'u T, Carrington M, Goulder PJ, Geretti AM, Klenerman P (2016). HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults. J Infect Dis  213, 1248-52.   https://doi.org/10.1093/infdis/jiv592|11. Pavlos R, McKinnon E, Ostrov D, Peters B, Buus S, Koelle D, Chopra A, Schutte R, Rive C, Redwood A, Restrepo S, Bracey A, Kaever T, Myers P, Speers E, Malaker S, Shabanowitz J, Yuan J, Gaudieri S, Hunt D, Carrington M, Haas D, Mallal S, Phillips E (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Sci Rep, in press.|12. Ranasinghe S, Soghoian DZ, Lindqvist M, Ghebremichael M, Donaghey F, Carrington M, Seaman MS, Kaufmann DE, Walker BD, Porichis F (2015). HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses. J Virol  90, 2208-20.   https://doi.org/10.1128/JVI.02278-15|13. Strickland N, Muller T, Berkowitz N, Goliath R, Carrington M, Wilkinson R, Burgers W, Riou C (2017) Characterization of mycobacterium tuberculosis-specific cells using MHC class II tetramers reveals phenotypic differences related to HIV infection and TB disease. J Immunol, in press.|14. Townsley E, O'Connor G, Cosgrove C, Woda M, Co M, Thomas SJ, Kalayanarooj S, Yoon IK, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Gostick E, Price DA, Carrington M, Alter G, McVicar DW, Rothman AL, Mathew A (2016). Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol  183, 419-30.   https://doi.org/10.1111/cei.12722|15. Wang Y, Hwangpo T, Martin MP, Vince N, Qi Y, Reynolds RJ, Absher D, Gao X, Ballinger CA, Burrows PD, Atkinson TP, Brown EE, Elgavish A, Liu C, Carrington M, Schroeder HW (2016). Killer cell immunoglobulin-like receptors are associated with common variable immune deficiency pathogenesis. J Allergy Clin Immunol  138, 1495-1498.   https://doi.org/10.1016/j.jaci.2016.07.011",https://intramural.nih.gov/search/searchview.taf?ipid=98824
175,BC010792-11,"October 01, 2016 -  September 30, 2017",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Maureen P Martin|Xiaojiang  Gao|Yuko  Yuki|Arman A Bashirova|Veron  Ramsuran|Marjan  Akdag|Show all 9,John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Kenneth  Kidd (Yale University)|Bruce  Walker (Harvard Medical School)|Judith  Kidd (Yale University)|Daniel  Geraghty (Fred Hutchinson Cancer Research Center)|Show all 9,NULL,NULL,"1. Vince N, Li H, Ramsuran V, Naranbhai V, Duh FM, Fairfax BP, Saleh B, Knight JC, Anderson SK, Carrington M (2016). HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region. Am J Hum Genet  99, 1353-1358.   https://doi.org/10.1016/j.ajhg.2016.09.023",https://intramural.nih.gov/search/searchview.taf?ipid=98823
176,BC010793-11,"October 01, 2016 -  September 30, 2017","Role of inflammation, innate resistance, and immunity in carcinogenesis",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ren Ming  Dai|Rosalba  Salcedo|Amiran  Dzutsev; PhD|Loretta R Smith|Sharon A Bargo|Ernesto  Perez Chanona|Show all 12,"Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Yasmine  Belkaid; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98834
177,BC010795-11,"October 01, 2016 -  September 30, 2017",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Maria L Kireeva|Lucyna E Lubkowska|Joshua Ray Turek-Herman|Donald L Court; PhD|Bruce Allen Shapiro; PhD,Carlos  Bustamante (University of California - Berkeley)|Michelle  Wang (Cornell University)|Michael  Poirier (Ohio State University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98835
178,BC010801-11,"October 01, 2016 -  September 30, 2017",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Eva  Dombi|Andrea Maria Baldwin|Andrea Michelle Gross; MD|Marielle Christina Holmblad|Souvik  Karmakar|Christine Sarah Higham|Show all 9,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Bruce  Korf (University of Alabama)|Victor  Mautner (Genetics, Hamburg University)|Nancy  Ratner (Division of Experimental Hematology, Children's Hospital Medical Center)|Ludwine  Messiaen; PhD (Dept of Genetics, University of Alabama)|Jaishri  Blakeley (Johns Hopkins)|Show all 8","Kara Suzanne Heisey (Office Of The Clinical Director)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Abby  Sandler (Office Of The Director)","Constantine Argyrios Stratakis; MD, DSc (NICHD) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI) |James C Reynolds; MD (CC) |Leslie Glenn Biesecker; MD (NHGRI)","1. Avery R, Katowitz J, Fisher M, Heidary G, Dombi E, Packer R, Widemann B (2016) OrbitalPeri-Orbital Plexiform Neurofibromas in Children with Neurofibromatosis type 1: Multi-disciplinary Recommendations for Care. Ophthalmology, in press.|2. Blakeley JO, Ye X, Duda DG, Halpin CF, Bergner AL, Muzikansky A, Merker VL, Gerstner ER, Fayad LM, Ahlawat S, Jacobs MA, Jain RK, Zalewski C, Dombi E, Widemann BC, Plotkin SR (2016). Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas. J Clin Oncol  34, 1669-75.   https://doi.org/10.1200/JCO.2015.64.3817|3. Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC (2016). Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas. N Engl J Med  375, 2550-2560.   https://doi.org/10.1056/NEJMoa1605943|4. Hanemann CO, Blakeley JO, Nunes FP, Robertson K, Stemmer-Rachamimov A, Mautner V, Kurtz A, Ferguson M, Widemann BC, Evans DG, Ferner R, Carroll SL, Korf B, Wolkenstein P, Knight P, Plotkin SR, REiNS International Collaboration (2016). Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology  87, S40-8.   https://doi.org/10.1212/WNL.0000000000002932|5. Jakacki R, Dombi E, Steinberg S, Goldman S, Kieran M, Ullrich N, Pollack I, Goodwin A, Manley P, Fangusaro J, Allen R, Widemann B (2016) Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro-Oncology, in press.|6. Plotkin S, Davis S, Robertson K, Akshintala S, Allen J, Fisher M, Blakeley J, Widemann B, Ferner R, Marcus C (2016) Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1. Neurology, in press.|7. Plotkin SR, Davis SD, Robertson KA, Akshintala S, Allen J, Fisher MJ, Blakeley JO, Widemann BC, Ferner RE, Marcus CL, REiNS International Collaboration (2016). Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1. Neurology  87, S13-20.   https://doi.org/10.1212/WNL.0000000000002933|8. Reilly K, Kim A, Blakeley J, Ferner R, Gutmann D, Legius E, Miettinen M, Randall L, Ratner N, Jumbe S, Bakker A, Viskochil D, Widemann B, Stewart D (2017) Neurofibromatosis Type-1 associated MPNST State of the Science: Outlining a Research Agenda for the Future. JNCI, in press.|9. Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AA (2016) Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1-Erratum. Ther Drug Monit, in press (e-pub ahead of print)  https://doi.org/10.1097/FTD.0000000000000275|10. Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P, Burkitt-Wright E, Chatfield K, Elefteriou F, Elgersma Y, Fisher MJ, Franz D, Gelb BD, Goriely A, Gripp KW, Hardan AY, Keppler-Noreuil KM, Kerr B, Korf B, Leoni C, McCormick F, Plotkin SR, Rauen KA, Reilly K, Roberts A, et al. [4 more authors] (2016). The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. Am J Med Genet A  170, 1959-66.   https://doi.org/10.1002/ajmg.a.37723|11. Widemann B (2016) Recommendations of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. Neurology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98836
179,BC010802-11,"October 01, 2016 -  September 30, 2017",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Keith Henry Jansson|Supreet  Agarwal|Kerry Alexandra McGowen,NULL,NULL,NULL,"1. Pan H, Jansson K, Beshiri M, Yin J, Fang L, Agarwal S, Nguyen H, Corey E, Zhang Y, Liu J, Fan H, Lin H, Siebenlist K (2017) Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98837
180,BC010806-11,"October 01, 2016 -  September 30, 2017",Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)",Carol J Thiele (Pediatric Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch),Craig Joseph Thomas (NCATS),"1. Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, Coarfa C, Tolman C, Hurd L, Liao H, He J, Wen X, Liu Z, Thiele CJ, Westermann F, Asgharzadeh S, Seeger RC, Maris JM, Guidry Auvil JM, Smith MA, Kolaczyk ED, Shohet J, Khan J (2016). MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma. Cancer Lett  371, 214-24.   https://doi.org/10.1016/j.canlet.2015.11.045",https://intramural.nih.gov/search/searchview.taf?ipid=98838
181,BC010808-11,"October 01, 2016 -  September 30, 2017",Chromatin structure and dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Ping  Zhang (Structural Biophysics Laboratory)|Victor  Zhurkin; PhD (Laboratory of Cell Biology),Rodolfo  Ghirlando; PhD (NIDDK) |Jiansheng  Jiang; PhD (NIAID),"1. Zhou BR, Feng H, Ghirlando R, Li S, Schwieters CD, Bai Y (2016). A Small Number of Residues Can Determine if Linker Histones Are Bound On or Off Dyad in the Chromatosome. J Mol Biol  428, 3948-3959.   https://doi.org/10.1016/j.jmb.2016.08.016",https://intramural.nih.gov/search/searchview.taf?ipid=98821
182,BC010814-11,"October 01, 2016 -  September 30, 2017",Elucidating the Regulation of HIV RNA Functions and Genome Packaging,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Jianbo  Chen|Yang  Liu; PhD|Sheikh Abdul Rahman|Steven Fernandes Dos Santos|Chijioke Nkemjika Umunnakwe|Show all 9,"David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|Jeffrey  Chao (Friedrich Miescher Institute for Biomedical Research)|Kevin  Weeks (University of North Carolina, Chapel Hill)",Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Brandon Frank Keele (Office Of The Director),Madhu A Lal (NCATS),"1. Desimmie BA, Burdick RC, Izumi T, Doi H, Shao W, Alvord WG, Sato K, Koyanagi Y, Jones S, Wilson E, Hill S, Maldarelli F, Hu WS, Pathak VK (2016). APOBEC3 proteins can copackage and comutate HIV-1 genomes. Nucleic Acids Res  44, 7848-65.   https://doi.org/10.1093/nar/gkw653",https://intramural.nih.gov/search/searchview.taf?ipid=98839
183,BC010816-11,"October 01, 2016 -  September 30, 2017","Immunotherapy for  Malignant Mesothelioma, Lung Cancer and Thymic Malignancies",Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Markku Martti Miettinen (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98840
184,BC010819-11,"October 01, 2016 -  September 30, 2017",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Mary  Kearney,John W Mellors|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|James Coston Brooks|John  Coffin (Tufts University),Paul L Boyer (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Joseph A Kovacs; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98841
185,BC010822-11,"October 01, 2016 -  September 30, 2017",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Prashant  Mishra|Kentaro  Ohkuni|Roshan Lal Shrestha|Tianyi  Zhang|Jessica Rose Eisenstatt|Show all 13,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Kerry  Bloom (University of North Carolina (UNC) @ Chapel HIll)|Brenda  Andrews; PhD (University of Toronto)|Show all 10",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|Thorkell  Andresson (Office Of The Director)|Gianluca  Pegoraro (Laboratory of Receptor Biology and Gene Expression),David Johannes Clark; PhD (NICHD) |David  Landsman; PhD (NLM),"1. Mishra PK, Ciftci-Yilmaz S, Reynolds D, Au WC, Boeckmann L, Dittman LE, Jowhar Z, Pachpor T, Yeh E, Baker RE, Hoyt MA, D'Amours D, Bloom K, Basrai MA (2016). Polo kinase Cdc5 associates with centromeres to facilitate the removal of centromeric cohesin during mitosis. Mol Biol Cell  27, 2286-300.   https://doi.org/10.1091/mbc.E16-01-0004|2. Ohkuni K, Takahashi Y, Fulp A, Lawrimore J, Au WC, Pasupala N, Levy-Myers R, Warren J, Strunnikov A, Baker RE, Kerscher O, Bloom K, Basrai MA (2016) SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell, in press (e-pub ahead of print)  https://doi.org/10.1091/mbc.E15-12-0827",https://intramural.nih.gov/search/searchview.taf?ipid=98822
186,BC010824-11,"October 01, 2016 -  September 30, 2017",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Prashant Arkalgud Rao|Doreen  Matthies|Soojay  Banerjee; PhD|Veronica Marie Falconieri|Sagar  Chittori,Frank  McCormick (UCSF School of Medicine)|Eduardo  Perozo (University of Chicago)|John  Kuriyan (UC Berkeley),Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NINDS) |Sanjay Arvind Desai; MD, PhD (NIAID) |Kenton J Swartz; PhD (NINDS)","1. Frank GA, Shukla S, Rao P, Borgnia MJ, Bartesaghi A, Merk A, Mobin A, Esser L, Earl LA, Gottesman MM, Xia D, Ambudkar SV, Subramaniam S (2016). Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle. Mol Pharmacol  90, 35-41.   https://doi.org/10.1124/mol.116.104190|2. Matthies D, Dalmas O, Borgnia MJ, Dominik PK, Merk A, Rao P, Reddy BG, Islam S, Bartesaghi A, Perozo E, Subramaniam S (2016). Cryo-EM Structures of the Magnesium Channel CorA Reveal Symmetry Break upon Gating. Cell  164, 747-56.   https://doi.org/10.1016/j.cell.2015.12.055|3. Meyerson JR, Chittori S, Merk A, Rao P, Han TH, Serpe M, Mayer ML, Subramaniam S (2016). Structural basis of kainate subtype glutamate receptor desensitization. Nature  537, 567-571.   https://doi.org/10.1038/nature19352|4. Stuart DI, Subramaniam S, Abrescia NG (2016). The democratization of cryo-EM. Nat Methods  13, 607-8.   https://doi.org/10.1038/nmeth.3946|5. Subramaniam S, Earl LA, Falconieri V, Milne JL, Egelman EH (2016). Resolution advances in cryo-EM enable application to drug discovery. Curr Opin Struct Biol  41, 194-202.   https://doi.org/10.1016/j.sbi.2016.07.009|6. Subramaniam S, Kühlbrandt W, Henderson R (2016). CryoEM at IUCrJ: a new era. IUCrJ  3, 3-7.   https://doi.org/10.1107/S2052252515023738",https://intramural.nih.gov/search/searchview.taf?ipid=98842
187,BC010825-11,"October 01, 2016 -  September 30, 2017",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Erin E Tran|Lesley Ann Earl; PhD|Soojay  Banerjee; PhD|Jean-Philippe  Demers|Joseph Edgar Darling,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Judith  White (University of Virginia)|Florian  Krammer (Mt. Sinai School of Medicine)|Peter  Palese (Mount Sinai School of Medicine)|Michael  Rossman (Purdue University)|Raghavan  Varadarajan (Indian Institute of Science)",Jeffrey D Lifson; MD (Office Of The Director)|Oleg  Kuybeda; PhD (Office of the Director),Donald F Bliss (NLM),"1. Earl LA, Subramaniam S (2016). Cryo-EM of viruses and vaccine design. Proc Natl Acad Sci U S A  113, 8903-5.   https://doi.org/10.1073/pnas.1609721113|2. Tran EE, Nelson EA, Bonagiri P, Simmons JA, Shoemaker CJ, Schmaljohn CS, Kobinger GP, Zeitlin L, Subramaniam S, White JM (2016). Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. J Virol  90, 7618-27.   https://doi.org/10.1128/JVI.00406-16|3. Tran EE, Podolsky KA, Bartesaghi A, Kuybeda O, Grandinetti G, Wohlbold TJ, Tan GS, Nachbagauer R, Palese P, Krammer F, Subramaniam S (2016). Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate. MBio  7, e00257.   https://doi.org/10.1128/mBio.00257-16",https://intramural.nih.gov/search/searchview.taf?ipid=98843
188,BC010826-11,"October 01, 2016 -  September 30, 2017",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Lesley Ann Earl; PhD|Prashant Arkalgud Rao|Soojay  Banerjee; PhD|Veronica Marie Falconieri|Joseph Edgar Darling|Show all 10,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Frank  McCormick (UCSF School of Medicine)|Michael  Rossman (Purdue University)|Miljan  Simonovic (University of Illinois at Chicago)",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Oleg  Kuybeda; PhD (Office of the Director)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Bernard R Brooks; PhD (NHLBI) |Xiongwu  Wu; PhD (NHLBI),"1. Banerjee S, Bartesaghi A, Merk A, Rao P, Bulfer SL, Yan Y, Green N, Mroczkowski B, Neitz RJ, Wipf P, Falconieri V, Deshaies RJ, Milne JL, Huryn D, Arkin M, Subramaniam S (2016). 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science  351, 871-5.   https://doi.org/10.1126/science.aad7974|2. Borgnia MJ, Banerjee S, Merk A, Matthies D, Bartesaghi A, Rao P, Pierson J, Earl LA, Falconieri V, Subramaniam S, Milne JL (2016). Using Cryo-EM to Map Small Ligands on Dynamic Metabolic Enzymes: Studies with Glutamate Dehydrogenase. Mol Pharmacol  89, 645-51.   https://doi.org/10.1124/mol.116.103382|3. Merk A, Bartesaghi A, Banerjee S, Falconieri V, Rao P, Davis MI, Pragani R, Boxer MB, Earl LA, Milne JLS, Subramaniam S (2016). Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. Cell  165, 1698-1707.   https://doi.org/10.1016/j.cell.2016.05.040|4. Ognjenović J, Wu J, Matthies D, Baxa U, Subramaniam S, Ling J, Simonović M (2016). The crystal structure of human GlnRS provides basis for the development of neurological disorders. Nucleic Acids Res  44, 3420-31.   https://doi.org/10.1093/nar/gkw082|5. Puppala AK, French RL, Matthies D, Baxa U, Subramaniam S, Simonović M (2016). Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase. Sci Rep  6, 32563.   https://doi.org/10.1038/srep32563",https://intramural.nih.gov/search/searchview.taf?ipid=98844
189,BC010827-11,"October 01, 2016 -  September 30, 2017",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk|Sriram  Subramaniam; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98845
190,BC010830-11,"October 01, 2016 -  September 30, 2017",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lyn Ann J Mickley|Robert W Robey|Sachi  Horibata|Pedro Jorge De Oliveira Rodrigues Batista; PhD,"Doron  Levy (University of Maryland)|Bates  Susan (Columbia University)|Antonio  Fojo; MD, PhD (NCI)|Ram  Ganapathi (Univ of North Carolina, Charlotte)|Nathan  Sheffield (Univ of Virginia)",Wilfred D Vieira (Multidrug Resistence Section)|Carol O Cardarelli (Multidrug Resistence Section)|Rajalakshm L Padmanabhan (Multidrug Resistence Section)|James Patrick Madigan (Multidrug Resistence Section)|Ashley A Jaeger; BS (Multidrug Resistence Section)|Andrea Nicole Robinson (Multidrug Resistence Section),Thomas J Pohida; MS (CIT) |Matthew David Hall (NCATS) |Nicole Yen-I Morgan; PhD (NIBIB),"1. Collins FS, Anderson JM, Austin CP, Battey JF, Birnbaum LS, Briggs JP, Clayton JA, Cuthbert B, Eisinger RW, Fauci AS, Gallin JI, Gibbons GH, Glass RI, Gottesman MM, Gray PA, Green ED, Greider FB, Hodes R, Hudson KL, Humphreys B, Katz SI, Koob GF, Koroshetz WJ, Lauer MS, Lorsch JR, et al. [15 more authors] (2016). Basic science: Bedrock of progress. Science  351, 1405.   https://doi.org/10.1126/science.351.6280.1405-a|2. Gillet JP, Andersen JB, Madigan JP, Varma S, Bagni RK, Powell K, Burgan WE, Wu CP, Calcagno AM, Ambudkar SV, Thorgeirsson SS, Gottesman MM (2016). A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy. Mol Pharmacol  89, 263-72.   https://doi.org/10.1124/mol.115.101360|3. Gottesman MM, Lavi O, Hall MD, Gillet JP (2016). Toward a Better Understanding of the Complexity of Cancer Drug Resistance. Annu Rev Pharmacol Toxicol  56, 85-102.   https://doi.org/10.1146/annurev-pharmtox-010715-103111|4. Greene JM, Levy D, Herrada SP, Gottesman MM, Lavi O (2016). Mathematical Modeling Reveals That Changes to Local Cell Density Dynamically Modulate Baseline Variations in Cell Growth and Drug Response. Cancer Res  76, 2882-90.   https://doi.org/10.1158/0008-5472.CAN-15-3232",https://intramural.nih.gov/search/searchview.taf?ipid=98846
191,BC010832-11,"October 01, 2016 -  September 30, 2017",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ulf  Ryde (Lund University)|Alberto  Podjarny (IGBMC),Raul Eduardo Cachau (Office Of The Director)|Igor  Topol (Office Of The Director),NULL,"1. Adams PD, Aertgeerts K, Bauer C, Bell JA, Berman HM, Bhat TN, Blaney JM, Bolton E, Bricogne G, Brown D, Burley SK, Case DA, Clark KL, Darden T, Emsley P, Feher VA, Feng Z, Groom CR, Harris SF, Hendle J, Holder T, Joachimiak A, Kleywegt GJ, Krojer T, Marcotrigiano J, et al. [32 more authors] (2016). Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop. Structure  24, 502-508.   https://doi.org/10.1016/j.str.2016.02.017",https://intramural.nih.gov/search/searchview.taf?ipid=98847
192,BC010833-11,"October 01, 2016 -  September 30, 2017",Global consequences of aneuploidy on gene expression and nuclear architecture,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Darawalee  Wangsa|Yue  Hu|Adihe Rachel Lokanga; BS|Wei-Dong  Chen|Markus Alexander Brown|Chi Chung  Cheng|Show all 8,"Michael  Ghadimi (Surgery, U. of Goettingen)|Daniel Paul Rosenberg|Jens  Habermann",NULL,NULL,"1. Acun T, Doberstein N, Habermann JK, Gemoll T, Thorns C, Oztas E, Ried T (2017). HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer. OMICS  21, 257-265.   https://doi.org/10.1089/omi.2017.0016|2. Yuan H, Krawczyk E, Blancato J, Albanese C, Zhou D, Wang N, Paul S, Alkhilaiwi F, Palechor-Ceron N, Dakic A, Fang S, Choudhary S, Hou TW, Zheng YL, Haddad BR, Usuda Y, Hartmann D, Symer D, Gillison M, Agarwal S, Wangsa D, Ried T, Liu X, Schlegel R (2017). HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes. Sci Rep  7, 45617.   https://doi.org/10.1038/srep45617",https://intramural.nih.gov/search/searchview.taf?ipid=98848
193,BC010834-11,"October 01, 2016 -  September 30, 2017",Intratumor heterogeneity and tumor evolution,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Kerstin  Heselmeyer|Damrong M Wangsa|Bernard N Chen|Darawalee  Wangsa|Chi Chung  Cheng|Yue  Hu|Show all 8,Gert  Auer|Timo  Gaiser|Philipp  Stroebel (Georg August University GÃ¶ttingen),NULL,Alejandro Alberto Schaffer; PhD (NLM),"1. Gertz EM, Chowdhury SA, Lee WJ, Wangsa D, Heselmeyer-Haddad K, Ried T, Schwartz R, Schäffer AA (2016). FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe. PLoS One  11, e0158569.   https://doi.org/10.1371/journal.pone.0158569",https://intramural.nih.gov/search/searchview.taf?ipid=98849
194,BC010837-11,"October 01, 2016 -  September 30, 2017",Disease prognostication and treatment response in rectal cancer patients,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Damrong M Wangsa|Bernard N Chen|Darawalee  Wangsa|Chi Chung  Cheng|Yue  Hu|Markus Alexander Brown,"Michael  Ghadimi (Surgery, U. of Goettingen)|Gert  Auer",NULL,NULL,"1. Hirsch D, Ried T (2016). Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates. Ann Transl Med  4, 508.   https://doi.org/10.21037/atm.2016.11.78",https://intramural.nih.gov/search/searchview.taf?ipid=98852
195,BC010844-11,"October 01, 2016 -  September 30, 2017",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui (Rochester Institute of Technology)",Sankar  Adhya; PhD (Developmental Genetics Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),David Johannes Clark; PhD (NICHD),"1. Buckwalter J, Norouzi D, Harutyunyan A, Zhurkin V, Grigoryev S (2017) Regulation of chromatin folding by conformational variations of nucleosome linker DNA. Nucleic Acids Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98853
196,BC010845-11,"October 01, 2016 -  September 30, 2017",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98829
197,BC010846-11,"October 01, 2016 -  September 30, 2017",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","Michael  Thirman (Medicine, University of Chicago)|Olufunmilayo  Olopade (University of Chicago)|Eytan  Ruppin; MD/PhD (Department of Computer Science, University of Maryland)|Melissa  Troester (University of North Carolina at Chape)|Clayton  Yates (Tuskegee University)|Juliet  Daniel (McMaster University)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Maria  Merino; PhD (Laboratory of Pathology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Maxwell P Lee; PhD (Laboratory of Cancer Biology and Genetics)",Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98827
198,BC010847-11,"October 01, 2016 -  September 30, 2017",Molecular linkages between epigenetic regulation and metabolism in breast cancer,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD",NULL,Maria  Merino; PhD (Laboratory of Pathology)|David D Roberts; PhD (Laboratory of Pathology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Maxwell P Lee; PhD (Laboratory of Cancer Biology and Genetics),Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98828
199,BC010850-11,"October 01, 2016 -  September 30, 2017",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Ayla Oksuz White|Bradley T Scroggins|Seok Joo  Kwon; PhD|Hong G Zhang; PhD,NULL,James B Mitchell; PhD (Radiation Biology Branch),Thomas Anthony Wynn; PhD (NIAID),"1. Chung EJ, McKay-Corkum G, Chung S, White A, Scroggins BT, Mitchell JB, Mulligan-Kehoe MJ, Citrin D (2016). Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model. Int J Radiat Oncol Biol Phys  94, 1163-72.   https://doi.org/10.1016/j.ijrobp.2015.11.044|2. Chung EJ, Sowers A, Thetford A, McKay-Corkum G, Chung SI, Mitchell JB, Citrin DE (2016). Mammalian Target of Rapamycin Inhibition With Rapamycin Mitigates Radiation-Induced Pulmonary Fibrosis in a Murine Model. Int J Radiat Oncol Biol Phys  96, 857-866.   https://doi.org/10.1016/j.ijrobp.2016.07.026|3. Chung SI, Horton JA, Ramalingam TR, White AO, Chung EJ, Hudak KE, Scroggins BT, Arron JR, Wynn TA, Citrin DE (2016). IL-13 is a therapeutic target in radiation lung injury. Sci Rep  6, 39714.   https://doi.org/10.1038/srep39714",https://intramural.nih.gov/search/searchview.taf?ipid=98854
200,BC010852-11,"October 01, 2016 -  September 30, 2017",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Debra  Tross|Defne  Bayik Watson|Emilie  Goguet; PhD|Neslihan  Turan|Begum Han Horuluoglu; MSC|Joost J Oppenheim; MD|Show all 9,Ihsan  Gursel|Jay  Hooper (USAMRIID)|Sven  Klaschik|Masuhiro  Takahashi (Niigata University)|John  Vasilakos (3M Corporation)|Christian Hans Bode; MD|Show all 9,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Igal  Gery; PhD (NEI),"1. Bode C, Fox M, Tewary P, Steinhagen A, Ellerkmann RK, Klinman D, Baumgarten G, Hornung V, Steinhagen F (2016). Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway. Eur J Immunol  46, 1615-21.   https://doi.org/10.1002/eji.201546113|2. Klinman DM, Sato T, Shimosato T (2016). Use of nanoparticles to deliver immunomodulatory oligonucleotides. Wiley Interdiscip Rev Nanomed Nanobiotechnol  8, 631-7.   https://doi.org/10.1002/wnan.1382|3. Steinhagen F, Rodriguez LG, Tross D, Tewary P, Bode C, Klinman DM (2016). IRF5 and IRF8 modulate the CAL-1 human plasmacytoid dendritic cell line response following TLR9 ligation. Eur J Immunol  46, 647-55.   https://doi.org/10.1002/eji.201545911",https://intramural.nih.gov/search/searchview.taf?ipid=98858
201,BC010853-11,"October 01, 2016 -  September 30, 2017",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Debra  Tross|Neslihan  Turan|Joost J Oppenheim; MD|Giorgio  Trinchieri,Sven  Klaschik|Takashi  Sato,NULL,Igal  Gery; PhD (NEI),"1. Bayik D, Gursel I, Klinman DM (2016). Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides. Pharmacol Res  105, 216-25.   https://doi.org/10.1016/j.phrs.2015.11.010|2. Scheiermann J, Klinman DM (2016). Suppressive oligonucleotides inhibit inflammation in a murine model of mechanical ventilator induced lung injury. J Thorac Dis  8, 2434-2443.   https://doi.org/10.21037/jtd.2016.08.18",https://intramural.nih.gov/search/searchview.taf?ipid=98859
202,BC010870-10,"October 01, 2016 -  September 30, 2017",Hematopoietic Stem Cell Transplant for GATA2 Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Laura M Tuschong|Robert R West|Julia  Scheiermann|Hind  Rafei,NULL,NULL,Steven M Holland; MD (NIAID),"1. Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD (2016). Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. J Allergy Clin Immunol  138, 628-630.e2.   https://doi.org/10.1016/j.jaci.2016.03.016",https://intramural.nih.gov/search/searchview.taf?ipid=98897
203,BC010871-10,"October 01, 2016 -  September 30, 2017",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Melinda  Hollingshead (Biological Testing Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98973
204,BC010876-10,"October 01, 2016 -  September 30, 2017",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Valerie Fako Miller|Heelah Miriam Gholian,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Takahiro  Uenishi (Osaka City University)|Hui-Chuan  Sun (Liver Cancer Institute)|Lola  Reid (University of North Carolina)|Show all 8,"Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)|Mitchell  Ho (Laboratory of Molecular Biology)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,"1. Dang H, Takai A, Forgues M, Pomyen Y, Mou H, Xue W, Ray D, Ha KCH, Morris QD, Hughes TR, Wang XW (2017). Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Cancer Cell  32, 101-114.e8.   https://doi.org/10.1016/j.ccell.2017.06.002|2. Fako V, Yu Z, Henrich CJ, Ransom T, Budhu AS, Wang XW (2016). Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide. Int J Biol Sci  12, 768-75.   https://doi.org/10.7150/ijbs.14718|3. Takai A, Fako V, Dang H, Forgues M, Yu Z, Budhu A, Wang XW (2016). Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma. Sci Rep  6, 21174.   https://doi.org/10.1038/srep21174",https://intramural.nih.gov/search/searchview.taf?ipid=98940
205,BC010877-10,"October 01, 2016 -  September 30, 2017",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Hui-Chuan  Sun (Liver Cancer Institute),Marshonna J Forgues (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98939
206,BC010881-10,"October 01, 2016 -  September 30, 2017",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yu-an  Yang|Kent W Hunter; PhD|Maxwell P Lee; PhD|Howard H Yang,"Amer  Mirza (XOMA (US) LLC)|Peter  Watson (Pathology, University of Manitoba)|Caroline  Hill (Francis Crick Institute)|Maureen  O'Connor-McCourt (Formation Biologics Inc)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Patricia  Steeg; PhD (Womens Malignancies Branch)","Sushil Gopal Rane; MS, PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98937
207,BC010885-10,"October 01, 2016 -  September 30, 2017",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Victoria Y Wang|David A Davis; MD|Prabha  Shrestha; PhD|Hong Seok  Choi|Alexandra Joyce Stream|Yi-Quan  Wu|Show all 8,"Rolf  Renne (Case Western Reserave University, Cleveland, OH)|Jiannis  Ragoussis (McGill University)|Francesco  Pezzella (University of Oxford)|Martin  Reczko (Institute of Molecular Oncology)|Jerome  Zeldis (Celgene Corporation)","Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Paul T Wingfield; PhD (NIAMS),"1. Davis D, Mishra S, Anagho HA, Aisabor AI, Shrestha P, Wang VY, Takamatsu Y, Maeda K, Mitsuya H, Zeldis J, Yarchoan R (2017) Restoration of immune surface molecules in Kaposi sarcoma-associated herpesvirus infected cells by lenalidomide and pomalidomide Oncotarget 8:50342-58",https://intramural.nih.gov/search/searchview.taf?ipid=98946
208,BC010886-10,"October 01, 2016 -  September 30, 2017",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,NULL,Daniel K Lee (Office Of The Clinical Director)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Qian F, Feng Y, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Blot W, Ambrosone CB, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Nathanson KL, Hennis A, Nemesure B, Ambs S, Kolonel LN, Olopade OI, Haiman CA, Huo D (2016). Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry. Hum Genet  135, 1145-59.   https://doi.org/10.1007/s00439-016-1707-1",https://intramural.nih.gov/search/searchview.taf?ipid=98863
209,BC010887-10,"October 01, 2016 -  September 30, 2017",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,Arun  Sreekumar (Baylor College of Medicine)|Olufunmilayo  Olopade (University of Chicago)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University)|Ruppin  Eytan (University of Maryland),Prachi  Mishra (Molecular Genetics and Carcinogenesis Section)|Obadi Mohammed Obadi (Molecular Genetics and Carcinogenesis Section)|Tsion Zewdu Minas (Molecular Genetics and Carcinogenesis Section)|David Anderson Wink (Cancer Inflammation Program)|Ashish Kumar Lal (Cancer Genetics Branch),NULL,"1. Auslander N, Yizhak K, Weinstock A, Budhu A, Tang W, Wang XW, Ambs S, Ruppin E (2016). A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer. Sci Rep  6, 29662.   https://doi.org/10.1038/srep29662",https://intramural.nih.gov/search/searchview.taf?ipid=98864
210,BC010888-10,"October 01, 2016 -  September 30, 2017",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Victoria Y Wang|David A Davis; MD|Joseph M Ziegelbauer,Mac  Cheever (Fred Hutchinson Cancer Research Center)|Jerry  Zeldis (Celgene Corporation)|Michelle A Rudek,Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|William D Figg; PharmD (Genitourinary Malignancies Branch),Amir Hossein Gandjbakhche; PhD (NICHD) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID) |Corina M Millo; MD (CC),"1. Goncalves PH, Montezuma-Rusca JM, Yarchoan R, Uldrick TS (2016). Cancer prevention in HIV-infected populations. Semin Oncol  43, 173-188.   https://doi.org/10.1053/j.seminoncol.2015.09.011",https://intramural.nih.gov/search/searchview.taf?ipid=98945
211,BC010891-10,"October 01, 2016 -  September 30, 2017",Development of new antibody-based cancer therapies,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Nan  Li|Holly E Holden|Ying  Fu|Hejiao  Bian|Yifan  Zhang,Min  Qian (East China Normal University)|Martin  Flajnik (University of Maryland)|Samuel  So (Stanford University),"Ira H Pastan; MD (Molecular Biology Section)|Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Fleming BD, Ho M (2016). Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer. Toxins (Basel)  8.   https://doi.org/10.3390/toxins8100274|2. Gao W, Xu Y, Liu J, Ho M (2016). Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate. Sci Rep  6, 26245.   https://doi.org/10.1038/srep26245",https://intramural.nih.gov/search/searchview.taf?ipid=98898
212,BC010898-10,"October 01, 2016 -  September 30, 2017",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Robert  Wiltrout; PhD (Office Of The Director),NULL,"1. Baseler WA, Davies LC, Quigley L, Ridnour LA, Weiss JM, Hussain SP, Wink DA, McVicar DW (2016). Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production. Redox Biol  10, 12-23.   https://doi.org/10.1016/j.redox.2016.09.005",https://intramural.nih.gov/search/searchview.taf?ipid=98942
213,BC010899-10,"October 01, 2016 -  September 30, 2017",Inflammation and cancer treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD|Giorgio  Trinchieri,"Bruce  King (Department of Chemistry, Wake Forest University)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",David D Roberts; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Robert  Wiltrout; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98943
214,BC010914-10,"October 01, 2016 -  September 30, 2017",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,Christophe  Cataisson (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98956
215,BC010938-10,"October 01, 2016 -  September 30, 2017",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Eric  Simpson (Oregon Health and Sciences University)|Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Alan  Irvine (Trinity College)|Lloyd  Miller (Johns Hopkins),NULL,Valentina Shobhana Pillai; CRNP (NIAMS) |Iryna Leonidivna Chub (NIAMS) |Sheila E Phang (NIAMS) |Julia A Segre; PhD (NHGRI) |Alexandra  Freeman (NIAID) |Steven M Holland; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98957
216,BC010940-10,"October 01, 2016 -  September 30, 2017",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)",Monica Elizabeth Taylor (NIAMS) |Valentina Shobhana Pillai; CRNP (NIAMS) |Edward W Cowen (NIAMS),"1. Pichard DC, Cardones AR, Chu EY, Dahut WL, Kong HH (2016). Sorafenib-Induced Eruption Mimicking Erythema Multiforme. JAMA Dermatol  152, 227-8.   https://doi.org/10.1001/jamadermatol.2015.2930",https://intramural.nih.gov/search/searchview.taf?ipid=98955
217,BC010944-10,"October 01, 2016 -  September 30, 2017",Strategies for Cancer Immunotherapy Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Duane Howard Hamilton|Sarah Renee Tritsch|Laura Bihnui Minang|Karin Le-Shi Lee|Samuel Troy Pellom; PhD|Caroline Mikaela Maria Jochems; PhD|Show all 14,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Paul  Chaplin (Bavarian Nordic, Inc.)|Frank E Jones; PhD (Tulane School of Medicine)",NULL,NULL,"1. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017) A novel bifunctional anti-PD-L1TGF- Trap fusion protein (M7824) efficiently reverts mesenchymaliz-ation of human lung cancer cells. OncoImmunology, in press.|2. Fujii R, Schlom J, Hodge J (2017) A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab. J Neurosug, in press.|3. Heery C, Palena C, McMahon S, Donahue N R, Lepone L, Grenga I, Dirmeier U, Cordes L, Mart J, Dahut W, Singh H, Madan R, Fernando R, Hamilton D, Schlom J, Gulley J (2017) Phase I study of a poxviral TRICOM-based vaccine directed against the transcription factor brachyury. Clin Cancer Res, in press.|4. Jochems C, Hodge JW, Fantini M, Fujii R, Morillon YM, Greiner JW, Padget MR, Tritsch SR, Tsang KY, Campbell KS, Klingemann H, Boissel L, Rabizadeh S, Soon-Shiong P, Schlom J (2016). An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget  7, 86359-86373.   https://doi.org/10.18632/oncotarget.13411|5. Vandeveer AJ, Fallon JK, Tighe R, Sabzevari H, Schlom J, Greiner JW (2016). Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res  4, 452-62.   https://doi.org/10.1158/2326-6066.CIR-15-0176",https://intramural.nih.gov/search/searchview.taf?ipid=98908
218,BC010945-10,"October 01, 2016 -  September 30, 2017",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",William Laurence Dahut; MD|Ravi  Madan,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)|Paul  Chaplin (Bavarian Nordic, Inc.)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch),NULL,"1. Bilsuc M, Gulley J (2017) Local immunotherapy: converting tumors from cold to hot. J Natl Cancer Inst, in press.|2. Bilusic M, Madan RA, Gulley JL (2017). Immunotherapy of Prostate Cancer: Facts and Hopes. Clin Cancer Res  23, 6764-6770.   https://doi.org/10.1158/1078-0432.CCR-17-0019|3. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017) A novel bifunctional anti-PD-L1TGF- Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology, in press.|4. Gulley J, Madan R (2016) Developing immunotherapy strategies in the treatment of prostate cancer Asian J Urol 3:278-285|5. Gulley JL, Rajan A, Spigel DR, Iannotti N, Chandler J, Wong DJL, Leach J, Edenfield WJ, Wang D, Grote HJ, Heydebreck AV, Chin K, Cuillerot JM, Kelly K (2017). Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial. Lancet Oncol  18, 599-610.   https://doi.org/10.1016/S1470-2045(17)30240-1|6. Lepone L, Donahue R, Grenga I, Metenou S, Richards J, Heery C, Madan R, Gulley J, Schlom J (2016) Analyses of 123 peripheral human immune cell subsets: defining differences with age and between healthy donors and cancer patients not detected in analysis of standard immune cell types J Circ Biomark 5:1-20|7. Madan RA, Gulley JL, Dahut WL (2016). Radium-223 in prostate cancer: emitting the right signals. Lancet Oncol  17, 1186-7.   https://doi.org/10.1016/S1470-2045(16)30248-0|8. Rajan A, Kim C, Heery CR, Guha U, Gulley JL (2016). Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers. Hum Vaccin Immunother  12, 2219-31.   https://doi.org/10.1080/21645515.2016.1175694|9. Wattenberg MM, Fong L, Madan RA, Gulley JL (2016). Immunotherapy in genitourinary malignancies. Curr Opin Urol  26, 501-7.   https://doi.org/10.1097/MOU.0000000000000331",https://intramural.nih.gov/search/searchview.taf?ipid=98894
219,BC010946-10,"October 01, 2016 -  September 30, 2017",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Janet W Gamson|Anastasia L Sowers|Rajani  Choudhuri|Askale Y Mathias|Sarwat  Naz; PhD|Show all 8,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Cook JA, Chandramouli GV, Anver MR, Sowers AL, Thetford A, Krausz KW, Gonzalez FJ, Mitchell JB, Patterson AD (2016). Mass Spectrometry-Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer. Cancer Res  76, 1569-77.   https://doi.org/10.1158/0008-5472.CAN-15-2416",https://intramural.nih.gov/search/searchview.taf?ipid=98974
220,BC010956-10,"October 01, 2016 -  September 30, 2017",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,Maria Irene Morasso; PhD (NIAMS),"1. Ouchi T, Nakato G, Udey MC (2016). EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen. J Invest Dermatol  136, 1627-1635.   https://doi.org/10.1016/j.jid.2016.04.005|2. Udey MC (2017). Following in the Footsteps…. J Invest Dermatol  137, 1193-1195.   https://doi.org/10.1016/j.jid.2017.04.014|3. Udey MC (2017). Looking Back while Stepping Forward-A Path Made Possible by Serendipity, a Few Good Decisions, and Helpful Colleagues. J Invest Dermatol  137, 2-3.   https://doi.org/10.1016/j.jid.2016.11.002|4. Wu CJ, Feng X, Lu M, Morimura S, Udey MC (2017). Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis. J Clin Invest  127, 623-634.   https://doi.org/10.1172/JCI88428|5. Yamada K, Uchiyama A, Uehara A, Perera B, Ogino S, Yokoyama Y, Takeuchi Y, Udey MC, Ishikawa O, Motegi S (2016). MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages. Cancer Res  76, 4283-92.   https://doi.org/10.1158/0008-5472.CAN-15-2812",https://intramural.nih.gov/search/searchview.taf?ipid=98934
221,BC010958-10,"October 01, 2016 -  September 30, 2017","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Yoo-Seok  Hwang|Jaeho  Yoon; PhD|Moonsup  Lee,NULL,NULL,NULL,"1. Gaur S, Mandelbaum M, Herold M, Majumdar HD, Neilson KM, Maynard TM, Mood K, Daar IO, Moody SA (2016). Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. Genesis  54, 334-49.   https://doi.org/10.1002/dvg.22943|2. Hwang YS, Daar IO (2017). A frog's view of EphrinB signaling. Genesis  55.   https://doi.org/10.1002/dvg.23002",https://intramural.nih.gov/search/searchview.taf?ipid=98878
222,BC010959-10,"October 01, 2016 -  September 30, 2017",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Hua Tang  Chen|Nancy  Wong|Maria Elsa  Callen Moreu|Andres  Canela Rodriguez|Dali  Zong|Andre  Stanlie|Show all 13,"Barry P. Sleckman; MD, PhD (Department of Pathology and Immunology, Washington University School of Medicine)|Eraz Lieberman  Aiden (Baylor College of Medicine)|Samuel  Bunting|Oscar  Fernandez-Capetillo (Spanish National Cancer Research Centre, CNIO)|Lee  Zou (Harvard University)","Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Kai  Ge; PhD (NIDDK) |Rafael Cristian Casellas; PhD (NIAMS) |Clare M Waterman (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98981
223,BC010960-10,"October 01, 2016 -  September 30, 2017",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniele N Avila|Hua  Zhang|Megan Irene Kenyon|Hong  Ye|Lauren R Skeffington|Jennifer Sproul Wilder|Show all 8,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98893
224,BC010975-10,"October 01, 2016 -  September 30, 2017",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Bernstein MB, Krishnan S, Hodge JW, Chang JY (2016). Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? Nat Rev Clin Oncol  13, 516-24.   https://doi.org/10.1038/nrclinonc.2016.30|2. Gameiro SR, Malamas AS, Bernstein MB, Tsang KY, Vassantachart A, Sahoo N, Tailor R, Pidikiti R, Guha CP, Hahn SM, Krishnan S, Hodge JW (2016). Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. Int J Radiat Oncol Biol Phys  95, 120-30.   https://doi.org/10.1016/j.ijrobp.2016.02.022",https://intramural.nih.gov/search/searchview.taf?ipid=98947
225,BC010976-10,"October 01, 2016 -  September 30, 2017",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98935
226,BC010977-10,"October 01, 2016 -  September 30, 2017",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Mariya Sergeyevna Liyasova; PhD|Donna M Voeller,NULL,Anand S Merchant (Office of the Director)|Barry R O'Keefe (Molecular Targets Laboratory),Richard  Childs; MD (NHLBI),"1. Li M, Kales SC, Ma K, Shoemaker BA, Crespo-Barreto J, Cangelosi AL, Lipkowitz S, Panchenko AR (2016). Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. Cancer Res  76, 561-71.   https://doi.org/10.1158/0008-5472.CAN-14-3812",https://intramural.nih.gov/search/searchview.taf?ipid=98966
227,BC010982-10,"October 01, 2016 -  September 30, 2017",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD",Trang  Hoang (U. Montreal)|Steven  Nimer (MSKCC)|Donald  Small (Johns Hopkins University School of Medicine),Terry J Fry (Pediatric Oncology Branch),NULL,"1. Bhagat TD, Chen S, Bartenstein M, Barlowe AT, Von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA, Hoogenboezem RM, Kambhampati S, Ramachandra N, Mantzaris I, Sukrithan V, Laurence R, Lopez R, Bhagat P, Giricz O, Sohal D, Wickrema A, Yeung C, Gritsman K, Aplan P, Hochedlinger K, et al. [13 more authors] (2017). Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation. Cancer Res  77, 4846-4857.   https://doi.org/10.1158/0008-5472.CAN-17-0282|2. Goldberg L, Gough SM, Lee F, Dang C, Walker RL, Zhu YJ, Bilke S, Pineda M, Onozawa M, Jo Chung Y, Meltzer PS, Aplan PD (2017). Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance. Genes Chromosomes Cancer  56, 472-483.   https://doi.org/10.1002/gcc.22451|3. Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D (2016). All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood  127, 2867-78.   https://doi.org/10.1182/blood-2015-05-646786",https://intramural.nih.gov/search/searchview.taf?ipid=98866
228,BC010983-10,"October 01, 2016 -  September 30, 2017",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Ghanwa Naveed Khawaja,Steven  Nimer (MSKCC)|JP  Issa (MD Anderson)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98867
229,BC010984-10,"October 01, 2016 -  September 30, 2017",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Richard  Sherry; MD|Lien T Ngo|Stephanie  Goff|Jared Joseph Gartner|Anna  Pasetto; PhD|Drew Caldwell Deniger; PhD|Show all 12,NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),Vid  Leko (NHLBI),"1. Assadipour Y, Zacharakis N, Crystal JS, Prickett TD, Gartner JJ, Somerville RPT, Xu H, Black MA, Jia L, Chinnasamy H, Kriley I, Lu L, Wunderlich JR, Zheng Z, Lu YC, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2017). Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer. Clin Cancer Res  23, 4347-4353.   https://doi.org/10.1158/1078-0432.CCR-16-1423|2. Deniger DC, Kwong ML, Pasetto A, Dudley ME, Wunderlich JR, Langhan MM, Lee CR, Rosenberg SA (2017). A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma. Clin Cancer Res  23, 351-362.   https://doi.org/10.1158/1078-0432.CCR-16-0906|3. Kalaora S, Barnea E, Merhavi-Shoham E, Qutob N, Teer JK, Shimony N, Schachter J, Rosenberg SA, Besser MJ, Admon A, Samuels Y (2016). Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget  7, 5110-7.   https://doi.org/10.18632/oncotarget.6960|4. Park TS, Groh EM, Patel K, Kerkar SP, Lee CC, Rosenberg SA (2016). Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers. J Immunother  39, 1-7.   https://doi.org/10.1097/CJI.0000000000000101|5. Park TS, Phan GQ, Yang JC, Kammula U, Hughes MS, Trebska-McGowan K, Morton KE, White DE, Rosenberg SA, Sherry RM (2017). Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients. Ann Surg Oncol  24, 947-951.   https://doi.org/10.1245/s10434-017-5768-8|6. Parkhurst M, Gros A, Pasetto A, Prickett T, Crystal JS, Robbins P, Rosenberg SA (2017). Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression. Clin Cancer Res  23, 2491-2505.   https://doi.org/10.1158/1078-0432.CCR-16-2680|7. Prickett TD, Crystal JS, Cohen CJ, Pasetto A, Parkhurst MR, Gartner JJ, Yao X, Wang R, Gros A, Li YF, El-Gamil M, Trebska-McGowan K, Rosenberg SA, Robbins PF (2016). Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens. Cancer Immunol Res  4, 669-78.   https://doi.org/10.1158/2326-6066.CIR-15-0215|8. Rosenberg SA, Tran E, Robbins PF (2017). T-Cell Transfer Therapy Targeting Mutant KRAS. N Engl J Med  376, e11.   https://doi.org/10.1056/NEJMc1616637|9. Slaney CY, von Scheidt B, Davenport AJ, Beavis PA, Westwood JA, Mardiana S, Tscharke DC, Ellis S, Prince HM, Trapani JA, Johnstone RW, Smyth MJ, Teng MW, Ali A, Yu Z, Rosenberg SA, Restifo NP, Neeson P, Darcy PK, Kershaw MH (2017). Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clin Cancer Res  23, 2478-2490.   https://doi.org/10.1158/1078-0432.CCR-16-1860|10. Stevanović S, Pasetto A, Helman SR, Gartner JJ, Prickett TD, Howie B, Robins HS, Robbins PF, Klebanoff CA, Rosenberg SA, Hinrichs CS (2017). Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science  356, 200-205.   https://doi.org/10.1126/science.aak9510|11. Tran E, Robbins PF, Rosenberg SA (2017). 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations. Nat Immunol  18, 255-262.   https://doi.org/10.1038/ni.3682|12. Bot A, Go W, Kochenderfer J, Rosenberg S, Wiezorek J (submitted in 2016) Methods For Pre-conditioning Patients For Cell Therapy. Patent issued: 9,855,298 (US in 2018). Patents pending: BR112017025166-3 (BR application); 2,986,798 (CA application); 201703006 (CL application); 201680030892.7 (CN application); P2017-0271 (DO application); 201792649 (EA application); 16800847.2 (EP application); A2017-000250 (GT application); P00201709434 (ID application); 255887 (IL application); 2017-561794 (JP application); 10-2017-7037017 (KR application); MX/A/2017/015186 (MX application); PI 2017001745 (MY application); NG/PT/C/2017/2529 (NG application); 737359 (NZ application); 1201700457 (OP application); PCT/US2016/034888 (PC application); 1-2017-502154 (PH application); 517390394 (SA application); 11201709424U (SG application); TT/A/2017/00165 ( application); 105116879 (TW application); 201712872 (UA application); 15/295,931 (US application); 15/649,369 (US application); 1-2017-05303 (VN application); AP/P/2017/010387 (AP application); 2016268864 (AU application); 2017/07900 (SA application).",https://intramural.nih.gov/search/searchview.taf?ipid=98906
230,BC010985-10,"October 01, 2016 -  September 30, 2017",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Lien T Ngo|Richard  Sherry; MD|Gal  Cafri|Stephanie  Goff|Todd  Prickett|Drew Caldwell Deniger; PhD|Show all 14,NULL,NULL,Vid  Leko (NHLBI),"1. Deniger DC, Pasetto A, Tran E, Parkhurst MR, Cohen CJ, Robbins PF, Cooper LJ, Rosenberg SA (2016). Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System. Mol Ther  24, 1078-1089.   https://doi.org/10.1038/mt.2016.51|2. Jaigirdar A, Rosenberg SA, Parkhurst M (2016). A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells. J Immunother  39, 105-16.   https://doi.org/10.1097/CJI.0000000000000116|3. Lu TL, Pugach O, Somerville R, Rosenberg SA, Kochenderfer JN, Better M, Feldman SA (2016). A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies. Hum Gene Ther Methods  27, 209-218.   https://doi.org/10.1089/hgtb.2016.120|4. Parkhurst M, Gros A, Pasetto A, Prickett T, Crystal JS, Robbins P, Rosenberg SA (2017). Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression. Clin Cancer Res  23, 2491-2505.   https://doi.org/10.1158/1078-0432.CCR-16-2680|5. Pasetto A, Gros A, Robbins PF, Deniger DC, Prickett TD, Matus-Nicodemos R, Douek DC, Howie B, Robins H, Parkhurst MR, Gartner J, Trebska-McGowan K, Crystal JS, Rosenberg SA (2016). Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunol Res  4, 734-43.   https://doi.org/10.1158/2326-6066.CIR-16-0001|6. Rosenberg SA, Tran E, Robbins PF (2017). T-Cell Transfer Therapy Targeting Mutant KRAS. N Engl J Med  376, e11.   https://doi.org/10.1056/NEJMc1616637|7. Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, Kriley IR, Rosenberg SA (2016). T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. N Engl J Med  375, 2255-2262.   https://doi.org/10.1056/NEJMoa1609279|8. Yao X, Lu YC, Parker LL, Li YF, El-Gamil M, Black MA, Xu H, Feldman SA, van der Bruggen P, Rosenberg SA, Robbins PF (2016). Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy. J Immunother  39, 191-201.   https://doi.org/10.1097/CJI.0000000000000123",https://intramural.nih.gov/search/searchview.taf?ipid=98905
231,BC010998-10,"October 01, 2016 -  September 30, 2017",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|David  Azorsa (NHGRI)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Show all 7",Carol J Thiele (Pediatric Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98953
232,BC010999-10,"October 01, 2016 -  September 30, 2017","Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma",Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,Crystal L. Mackall; MD (Pediatric Oncology Branch)|Terry J Fry (Pediatric Oncology Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98954
233,BC011002-10,"October 01, 2016 -  September 30, 2017",Bioinformatics: Systems Biology of Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)|Jeffrey  Trent (TGen)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98952
234,BC011006-10,"October 01, 2016 -  September 30, 2017",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Da Wei  Huang|Wyndham H Wilson; MD, PhD|Mark Jason Roschewski",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Kieron Michael Dunleavy (Office Of The Clinical Director),John I Powell (CIT),"1. Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Wu CI, Staudt LM, D'Amore F, McKeithan TW, Chan WC (2017). Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia  31, 83-91.   https://doi.org/10.1038/leu.2016.175|2. Rohr J, Guo S, Huo J, Bouska A, Lachel C, Li Y, Simone PD, Zhang W, Gong Q, Wang C, Cannon A, Heavican T, Mottok A, Hung S, Rosenwald A, Gascoyne R, Fu K, Greiner TC, Weisenburger DD, Vose JM, Staudt LM, Xiao W, Borgstahl GE, Davis S, Steidl C, et al. [3 more authors] (2016). Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia  30, 1062-70.   https://doi.org/10.1038/leu.2015.357",https://intramural.nih.gov/search/searchview.taf?ipid=98922
235,BC011007-10,"October 01, 2016 -  September 30, 2017",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Hong  Zhao|Weihong  Xu|James Daniel Phelan|Da Wei  Huang|Sandrine Anne Roulland|Yandan  Yang; PhD|Show all 7,NULL,George W Wright (Computational & Systems Biology Branch),NULL,"1. Ceribelli M, Hou ZE, Kelly PN, Huang DW, Wright G, Ganapathi K, Evbuomwan MO, Pittaluga S, Shaffer AL, Marcucci G, Forman SJ, Xiao W, Guha R, Zhang X, Ferrer M, Chaperot L, Plumas J, Jaffe ES, Thomas CJ, Reizis B, Staudt LM (2016). A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancer Cell  30, 764-778.   https://doi.org/10.1016/j.ccell.2016.10.002|2. Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM (2016). Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc Natl Acad Sci U S A  113, E2039-46.   https://doi.org/10.1073/pnas.1600557113|3. Rui L, Drennan AC, Ceribelli M, Zhu F, Wright GW, Huang DW, Xiao W, Li Y, Grindle KM, Lu L, Hodson DJ, Shaffer AL, Zhao H, Xu W, Yang Y, Staudt LM (2016). Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A  113, E7260-E7267.   https://doi.org/10.1073/pnas.1610970113",https://intramural.nih.gov/search/searchview.taf?ipid=98923
236,BC011008-10,"October 01, 2016 -  September 30, 2017",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Roland  Schmitz|Ryan Matthew Young|James Daniel Phelan|Xin H Yu|James Q Wang|Show all 8,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Kieron Michael Dunleavy (Office Of The Clinical Director),John I Powell (CIT),"1. Dekker JD, Park D, Shaffer AL, Kohlhammer H, Deng W, Lee BK, Ippolito GC, Georgiou G, Iyer VR, Staudt LM, Tucker HO (2016). Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1. Proc Natl Acad Sci U S A  113, E577-86.   https://doi.org/10.1073/pnas.1524677113|2. Knittel G, Liedgens P, Korovkina D, Seeger JM, Al-Baldawi Y, Al-Maarri M, Fritz C, Vlantis K, Bezhanova S, Scheel AH, Wolz OO, Reimann M, Möller P, López C, Schlesner M, Lohneis P, Weber AN, Trümper L, German International Cancer Genome Consortium Molecular Mechanisms in Malignant Lymphoma by Sequencing Project Consortium, Staudt LM, Ortmann M, Pasparakis M, Siebert R, Schmitt CA, Klatt AR, Wunderlich FT, et al. [8 more authors] (2016). B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice. Blood  127, 2732-41.   https://doi.org/10.1182/blood-2015-11-684183|3. Yang Y, Kelly P, Shaffer AL, Schmitz R, Yoo HM, Liu X, Huang DW, Webster D, Young RM, Nakagawa M, Ceribelli M, Wright GW, Yang Y, Zhao H, Yu X, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza L, Staudt LM (2016). Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. Cancer Cell  29, 494-507.   https://doi.org/10.1016/j.ccell.2016.03.006",https://intramural.nih.gov/search/searchview.taf?ipid=98920
237,BC011010-10,"October 01, 2016 -  September 30, 2017",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98921
238,BC011011-10,"October 01, 2016 -  September 30, 2017",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Suzanne Laurie Sanford|Laura  Baranello|Ying  Zheng,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Baranello L, Kouzine F, Sanford S, Levens D (2016). ChIP bias as a function of cross-linking time. Chromosome Res  24, 175-81.   https://doi.org/10.1007/s10577-015-9509-1|2. Dao P, Wojtowicz D, Nelson S, Levens D, Przytycka TM (2016). Ups and Downs of Poised RNA Polymerase II in B-Cells. PLoS Comput Biol  12, e1004821.   https://doi.org/10.1371/journal.pcbi.1004821|3. Levens D, Baranello L, Kouzine F (2016). Controlling gene expression by DNA mechanics: emerging insights and challenges. Biophys Rev  8, 23-32.   https://doi.org/10.1007/s12551-016-0243-5|4. Levens D, Baranello L, Kouzine F (2016). Controlling gene expression by DNA mechanics: emerging insights and challenges. Biophys Rev  8, 259-268.   https://doi.org/10.1007/s12551-016-0216-8",https://intramural.nih.gov/search/searchview.taf?ipid=98960
239,BC011028-10,"October 01, 2016 -  September 30, 2017",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)","1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. Yang Y, Vocke CD, Ricketts CJ, Wei D, Padilla-Nash HM, Lang M, Sourbier C, Killian JK, Boyle SL, Worrell R, Meltzer PS, Ried T, Merino MJ, Metwalli AR, Linehan WM (2017). Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276). Genes Chromosomes Cancer  56, 719-729.   https://doi.org/10.1002/gcc.22476",https://intramural.nih.gov/search/searchview.taf?ipid=98964
240,BC011032-10,"October 01, 2016 -  September 30, 2017",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Wanping  Xu|Kristin  Eckfeld|Abbey Dyanne Zuehlke|Nobu  Oshima|Megan Leighann Tigue|Li  Dai,"Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Nicolas  Winssinger (University of Strassbourg)|Show all 11",NULL,Joe K Jackson (OD),"1. Woodford MR, Truman AW, Dunn DM, Jensen SM, Cotran R, Bullard R, Abouelleil M, Beebe K, Wolfgeher D, Wierzbicki S, Post DE, Caza T, Tsutsumi S, Panaretou B, Kron SJ, Trepel JB, Landas S, Prodromou C, Shapiro O, Stetler-Stevenson WG, Bourboulia D, Neckers L, Bratslavsky G, Mollapour M (2016). Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors. Cell Rep  14, 872-884.   https://doi.org/10.1016/j.celrep.2015.12.084",https://intramural.nih.gov/search/searchview.taf?ipid=98980
241,BC011033-10,"October 01, 2016 -  September 30, 2017",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Satoshi  Ishido (Riken Center for Allergy and Immunology)|James  Drake (NCI),NULL,NULL,"1. Roche PA, Cresswell P (2016). Antigen Processing and Presentation Mechanisms in Myeloid Cells. Microbiol Spectr  4.   https://doi.org/10.1128/microbiolspec.MCHD-0008-2015",https://intramural.nih.gov/search/searchview.taf?ipid=98904
242,BC011035-10,"October 01, 2016 -  September 30, 2017",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Burton  Dickey (University of Texas MD Anderson Cancer Center)|Vinod  Vijayan (Baylor College of Medicine),Lino  Tessarollo (Mouse Cancer Genetics Program),Katherine Walton Roche; PhD (NINDS),"1. Da Q, Shaw T, Pradhan S, Roche PA, Cruz MA, Vijayan KV (2017). Disruption of protein complexes containing protein phosphatase 2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost  15, 1032-1039.   https://doi.org/10.1111/jth.13671",https://intramural.nih.gov/search/searchview.taf?ipid=98903
243,BC011038-10,"October 01, 2016 -  September 30, 2017",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)","1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. M B, LS S, WM L (2016) Hereditary Renal Cell Carcinoma - Molecular Features and Updates, in Hereditary Renal Cell Carcinoma, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98965
244,BC011043-10,"October 01, 2016 -  September 30, 2017",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Laura  Schmidt|Carole  Sourbier|Lernik Namagerdi Ohanjanian|Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. M B, LS S, WM L (2016) Hereditary Renal Cell Carcinoma - Molecular Features and Updates, in Hereditary Renal Cell Carcinoma, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=98961
245,BC011053-10,"October 01, 2016 -  September 30, 2017",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin|Aian Neil Seno Alilin,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98951
246,BC011054-10,"October 01, 2016 -  September 30, 2017",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Lidia F Hernandez|Carrie D House|Michelle K Ozaki,NULL,Natasha  Caplen (Cancer Genetics Branch)|George W Wright (Computational & Systems Biology Branch)|Margaret  Cam; PhD (Office of the Director)|Fathi  Elloumi (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS) |Madhu A Lal (NCATS),"1. Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM (2016). Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecol Oncol  142, 332-40.   https://doi.org/10.1016/j.ygyno.2016.05.028|2. Kim M, Hernandez L, Annunziata CM (2016). Caspase 8 expression may determine the survival of women with ovarian cancer. Cell Death Dis  7, e2045.   https://doi.org/10.1038/cddis.2015.398|3. Kim MK, Caplen N, Chakka S, Hernandez L, House C, Pongas G, Jordan E, Annunziata CM (2016). Identification of therapeutic targets applicable to clinical strategies in ovarian cancer. BMC Cancer  16, 678.   https://doi.org/10.1186/s12885-016-2675-5|4. Zeligs KP, Neuman MK, Annunziata CM (2016). Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment. Clin Cancer Res  22, 4302-8.   https://doi.org/10.1158/1078-0432.CCR-15-1374",https://intramural.nih.gov/search/searchview.taf?ipid=98865
247,BC011055-10,"October 01, 2016 -  September 30, 2017",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Molly Day Congdon,Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases)|Julie  Lucas (MRI Global),"Lisa  Mcshane (Biostatistics Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Howard A Young; PhD (Cancer Inflammation Program)",NULL,"1. Muthana SM, Gildersleeve JC (2016). Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum. Sci Rep  6, 19509.   https://doi.org/10.1038/srep19509|2. Xia L, Schrump DS, Gildersleeve JC (2016). Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins. Cell Chem Biol  23, 1515-1525.   https://doi.org/10.1016/j.chembiol.2016.10.012",https://intramural.nih.gov/search/searchview.taf?ipid=98889
248,BC011056-10,"October 01, 2016 -  September 30, 2017",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",NULL,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Avi  Ashkenazi (Genentech, Inc.)|Robert  Rees (John van Geest Cancer Centre)|Neil  Cross (Sheffield Hallam University)|AA Leslie  Gunatilaka (University of Arizona)",Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,"1. Tewary P, Gunatilaka AA, Sayers TJ (2017). Using natural products to promote caspase-8-dependent cancer cell death. Cancer Immunol Immunother  66, 223-231.   https://doi.org/10.1007/s00262-016-1855-0",https://intramural.nih.gov/search/searchview.taf?ipid=98907
249,BC011058-10,"October 01, 2016 -  September 30, 2017",Development of a Vaccine for HIV-AIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Leia Kaye Miller; PhD|Tanya N Hoang|Sabrina  Helmold Hait|Zuena  Mushtaq|Ruth Mesfin  Hunegnaw; PhD|Gospel Menakam Enyindah-Asonye|Show all 14,"Susan  Barnett (Chiron Corporation)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Timothy  Fouts (Profectus BioSciences, Inc.)|David C Montefiori; PhD (Department of Surgery, NIAID)|Susan  Zolla-Pazner (NYU Med School)|miroslaw  gorny; PhD (NYU Medical School)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section)|Jacob D Estes (Office Of The Director)|Ettore  Appella; MD (Chemical Immunology Section)|Brandon Frank Keele (Office Of The Director)|Colm  Ohuigin (Cancer Inflammation Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Daniel  Appella; PhD (NIDDK) |Mark  Connors; MD (NIAID),"1. Mohanram V, Demberg T, Musich T, Tuero I, Vargas-Inchaustegui DA, Miller-Novak L, Venzon D, Robert-Guroff M (2016). B Cell Responses Associated with Vaccine-Induced Delayed SIVmac251 Acquisition in Female Rhesus Macaques. J Immunol  197, 2316-24.   https://doi.org/10.4049/jimmunol.1600544|2. Musich T, Robert-Guroff M (2016). New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. Expert Rev Vaccines  15, 1015-27.   https://doi.org/10.1586/14760584.2016.1158108|3. Robert-Guroff M (2016). The Yin and Yang of ADCC-Mediating Antibodies. EBioMedicine  3, 10-11.   https://doi.org/10.1016/j.ebiom.2016.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=98901
250,BC011061-10,"October 01, 2016 -  September 30, 2017",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Kazimierz Wojcieck Kasprzak|Anu  Puri; PhD|Tae Jin  Kim|Mathias  Viard|Brigit  Shields|Manav  Mathur|Show all 18,Hanan  Samet (University of Maryland)|Paloma  Giangrande (University of Iowa)|Eliahu  Heldman|Michael  Nantz (University of Louisville)|Amit Shridhar Joshi (LIPID TRAFCING & ORGNLE BIOGN SEC)|Mohamed  El Sayed (University of Michigan)|Show all 11,Stuart F J Le Grice; PhD (Basic Research Laboratory)|Marina A Dobrovolskaia (Office Cancer Nanotechnology Research)|Eric O Freed; PhD (HIV Drug Resistance Program)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Vineet Narain KewalRamani; PhD (Basic Research Laboratory)|Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Kim T, Kasprzak W, Shapiro B (2017) Protocols for Molecular Dynamics Simulations of RNA Nanostructures, in RNA Nanostructures, in press.|2. Kireeva M, Afonin K, Shapiro B, Kashlev M (2017) Cotranscriptional Production of Chemically Modified RNA Nanoparticles, in RNA Nanostructures, in press.|3. Puri A, Zampino S, Viard M, Shapiro B (2017) Oxime Ether Lipids as Transfection Agents: Assembly and Complexation with siRNA, in RNA Nanostructures, in press.|4. Sharan R, Bindewald E, Kasprzak W, Shapiro B (2017) Computational Generation of RNA Nanorings, in RNA Nanostructures, in press.|5. Zakrevsky P, Parlea L, Viard M, Bindewald E, Afonin K, Shapiro B (2017) Preparation of a Conditional RNA Switch, in RNA Nanostructures, in press.|6. Bindewald E, Afonin KA, Viard M, Zakrevsky P, Kim T, Shapiro BA (2016). Multistrand Structure Prediction of Nucleic Acid Assemblies and Design of RNA Switches. Nano Lett  16, 1726-35.   https://doi.org/10.1021/acs.nanolett.5b04651|7. Gupta K, Puri A, Shapiro B (2017) Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy DNA and RNA Nanotechnology 4:1-20|8. Halman J, Satterwhite E, Smollett J, Bindewald E, Parlea L, Viard M, Zakrevsky P, Kasprzak W, Afonin K, Shapiro B (2016) Triggerable RNA nanodevices RNA and Disease 3:1-4|9. Parlea L, Bindewald E, Sharan R, Bartlett N, Moriarty D, Oliver J, Afonin KA, Shapiro BA (2016). Ring Catalog: A resource for designing self-assembling RNA nanostructures. Methods  103, 128-37.   https://doi.org/10.1016/j.ymeth.2016.04.016|10. Parlea L, Puri A, Kasprzak W, Bindewald E, Zakrevsky P, Satterwhite E, Joseph K, Afonin KA, Shapiro BA (2016). Cellular Delivery of RNA Nanoparticles. ACS Comb Sci  18, 527-47.   https://doi.org/10.1021/acscombsci.6b00073|11. Zarkrevsky P, Bindewald E, Shapiro B (2016) RNA Toehold Interactions Initiate Conditional Gene Silencing DNA and RNA Nanotechnology 3:11-13",https://intramural.nih.gov/search/searchview.taf?ipid=98910
251,BC011062-10,"October 01, 2016 -  September 30, 2017",Development of a Vaccine for HIV-AIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Tanya N Hoang|Namal Prasanna Malimbada-Liyanage|Mohammad Arif  Rahman; PhD|Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Genoveffa  Franchini; MD|Show all 7,Susan  Barnett (Chiron Corporation)|Qingsheng  Li (University of Nebraska Lincoln),David J Venzon; PhD (Biostatistics and Data Management Section)|Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98902
252,BC011063-10,"October 01, 2016 -  September 30, 2017",Development of a Vaccine for HIV-AIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Tanya N Hoang|Kotou  Sangare|Jennifer Clare Jones; MD, PhD|Lauren V Wood; MD",NULL,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Brandon Frank Keele (Office Of The Director),Mark  Connors; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98900
253,BC011064-10,"October 01, 2016 -  September 30, 2017",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD|Ke  Zhang",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98977
254,BC011065-10,"October 01, 2016 -  September 30, 2017","Preclinical Testing of HDAC, mTOR and MYC Inhibitors",Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD|John K Simmons|Daniel George Connors|Snehal Mahendra Gaikwad|Robert Mark Simpson; DVM, PhD",NULL,Ola Anders Landgren (Lymphoid Malignancies Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Eiden AM, Zhang S, Gary JM, Simmons JK, Mock BA (2016). Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy. Clin Cancer Res  22, 277-83.   https://doi.org/10.1158/1078-0432.CCR-14-3239|2. Felsenstein KM, Saunders LB, Simmons JK, Leon E, Calabrese DR, Zhang S, Michalowski A, Gareiss P, Mock BA, Schneekloth JS (2016). Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. ACS Chem Biol  11, 139-48.   https://doi.org/10.1021/acschembio.5b00577",https://intramural.nih.gov/search/searchview.taf?ipid=98978
255,BC011070-10,"October 01, 2016 -  September 30, 2017",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Stefania  Pittaluga|Nancy Ellen Diener|Hao-Wei  Wang|Princess Yah Dorley|Alison Rozmus Huppmann; MD|Show all 11,NULL,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",Jeffrey  Cohen; MD (NIAID),"1. Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G (2016). Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol  29, 1173-82.   https://doi.org/10.1038/modpathol.2016.113|2. Gratzinger D, Jaffe ES (2016). Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting. Leuk Lymphoma  57, 1982-3.   https://doi.org/10.3109/10428194.2016.1166492|3. Jaffe ES (2017). The Microscope as a Tool for Disease Discovery-A Personal Voyage. Annu Rev Pathol  12, 1-24.   https://doi.org/10.1146/annurev-pathol-052016-100351|4. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood  127, 2375-90.   https://doi.org/10.1182/blood-2016-01-643569|5. Wang HW, Pittaluga S, Jaffe ES (2016). Multicentric Castleman disease: Where are we now? Semin Diagn Pathol  33, 294-306.   https://doi.org/10.1053/j.semdp.2016.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=98948
256,BC011078-10,"October 01, 2016 -  September 30, 2017",Phase 0-1 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",William M Bonner; PhD|Yves  Pommier; PhD,Edward  Newman (City of Hope Comprehensive Cancer Center)|Shivaani  Kummar (Stanford University School of Medicine),Ralph  Parchment (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. FerryGalow K, Makhlouf H, Wilsker D, Lawrence S, Pfister T, Marrero A, Bigelow K, Yutzy W, Ji J, Butcher D, Gouker B, Kummar S, Chen A, Kinders R, Parchment R, Doroshow J (2016) The root causes of pharmacodynamic assay failure Sem Oncol 43:483-491|2. Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y (2016). Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. J Exp Clin Cancer Res  35, 56.   https://doi.org/10.1186/s13046-016-0335-x|3. Kamat AM, Agarwal P, Bivalacqua T, Chisolm S, Daneshmand S, Doroshow JH, Efstathiou JA, Galsky M, Iyer G, Kassouf W, Shah J, Taylor J, Williams SB, Quale DZ, Rosenberg JE (2016). Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank. Bladder Cancer  2, 203-213.   https://doi.org/10.3233/BLC-169007|4. Krushkal J, Zhao Y, Hose C, Monks A, Doroshow JH, Simon R (2016). Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment. Clin Epigenetics  8, 73.   https://doi.org/10.1186/s13148-016-0240-3|5. Kummar S, Chen A, Gutierrez M, Pfister TD, Wang L, Redon C, Bonner WM, Yutzy W, Zhang Y, Kinders RJ, Ji J, Allen D, Covey JM, Eiseman JL, Holleran JL, Beumer JH, Rubinstein L, Collins J, Tomaszewski J, Parchment R, Pommier Y, Doroshow JH (2016). Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors. Cancer Chemother Pharmacol  78, 73-81.   https://doi.org/10.1007/s00280-016-2998-6|6. Kummar S, Do K, O'SullivanCoyne G, Chen A, Ji J, Rubenstein L, Doroshow J (2016) Establishing proof of mechanism: assessing target modulation in early-phase clinical trials Sem Oncol 43:446-452|7. Kummar S, Wade JL, Oza AM, Sullivan D, Chen AP, Gandara DR, Ji J, Kinders RJ, Wang L, Allen D, Coyne GO, Steinberg SM, Doroshow JH (2016). Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer. Invest New Drugs  34, 355-63.   https://doi.org/10.1007/s10637-016-0335-x|8. Lih CJ, Sims DJ, Harrington RD, Polley EC, Zhao Y, Mehaffey MG, Forbes TD, Das B, Walsh WD, Datta V, Harper KN, Bouk CH, Rubinstein LV, Simon RM, Conley BA, Chen AP, Kummar S, Doroshow JH, Williams PM (2016). Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. J Mol Diagn  18, 51-67.   https://doi.org/10.1016/j.jmoldx.2015.07.006|9. Meehan R, Chen A, Doroshow J (2016) Role of Adaptive Randomization in Developing Novel Therapies for Patients with Breast Cancer Transl Cancer Res 5:S1119-S1122|10. Parchment R, Doroshow J (2016) Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development Sem Oncol 43:514-525|11. Parchment R, Doroshow J (2016) Theory and practice of clinical pharmacodynamics Sem Oncol 43:427-435|12. Parchment R, Voth A, Doroshow J, Berzofsky J (2016) Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations Sem Oncol 43:501-513|13. Reinhold WC, Varma S, Sunshine M, Rajapakse V, Luna A, Kohn KW, Stevenson H, Wang Y, Heyn H, Nogales V, Moran S, Goldstein DJ, Doroshow JH, Meltzer PS, Esteller M, Pommier Y (2017). The NCI-60 Methylome and Its Integration into CellMiner. Cancer Res  77, 601-612.   https://doi.org/10.1158/0008-5472.CAN-16-0655|14. Sims DJ, Harrington RD, Polley EC, Forbes TD, Mehaffey MG, McGregor PM, Camalier CE, Harper KN, Bouk CH, Das B, Conley BA, Doroshow JH, Williams PM, Lih CJ (2016). Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays. J Mol Diagn  18, 336-349.   https://doi.org/10.1016/j.jmoldx.2015.11.008|15. Srivastava AK, Jaganathan S, Stephen L, Hollingshead MG, Layhee A, Damour E, Govindharajulu JP, Donohue J, Esposito D, Mapes JP, Kinders RJ, Takebe N, Tomaszewski JE, Kummar S, Doroshow JH, Parchment RE (2016). Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use. Clin Cancer Res  22, 1000-10.   https://doi.org/10.1158/1078-0432.CCR-14-3156|16. Srivastava AK, Navas T, Herrick WG, Hollingshead MG, Bottaro DP, Doroshow JH, Parchment RE (2017). Effective implementation of novel MET pharmacodynamic assays in translational studies. Ann Transl Med  5, 3.   https://doi.org/10.21037/atm.2016.12.78",https://intramural.nih.gov/search/searchview.taf?ipid=98880
257,BC011081-10,"October 01, 2016 -  September 30, 2017",Prostate Section,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Maria Russum Trattler|Stephanie Daniela Knights Purnell|Sherif  Mehralivand|Charlotte Sophronia Payne|Donald P Bottaro; PhD|Leonard  Neckers; PhD|Show all 7,Arul Moli Chinnaiyan|Mohummad Minhaj Siddiqui,Nida T Hussain (Office Of The Clinical Director)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),Brian Patrick Calio (CC) |Dordaneh Eureka Sugano (CC) |Sheng  Xu (CC),"1. Agarwal HK, Mertan FV, Sankineni S, Bernardo M, Senegas J, Keupp J, Daar D, Merino M, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2017). Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging  45, 125-131.   https://doi.org/10.1002/jmri.25353|2. Berman RM, Brown AM, Chang SD, Sankineni S, Kadakia M, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2016). DCE MRI of prostate cancer. Abdom Radiol (NY)  41, 844-53.   https://doi.org/10.1007/s00261-015-0589-3|3. Freidlin RZ, Agarwal HK, Sankineni S, Brown AM, Mertan F, Bernardo M, Daar D, Merino M, Citrin D, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2016). Application of an unsupervised multi-characteristic framework for intermediate-high risk prostate cancer localization using diffusion-weighted MRI. Magn Reson Imaging  34, 1227-1234.   https://doi.org/10.1016/j.mri.2016.06.004|4. Greer MD, Shih JH, Lay N, Barrett T, Kayat Bittencourt L, Borofsky S, Kabakus IM, Law YM, Marko J, Shebel H, Mertan FV, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B (2017). Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2. Radiology  285, 859-869.   https://doi.org/10.1148/radiol.2017161316|5. Ho R, Siddiqui MM, George AK, Frye T, Kilchevsky A, Fascelli M, Shakir NA, Chelluri R, Abboud SF, Walton-Diaz A, Sankineni S, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA (2016). Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy. PLoS One  11, e0157313.   https://doi.org/10.1371/journal.pone.0157313|6. Kaye DR, Pinto PA, Cecchi F, Reilly J, Semerjian A, Rabe DC, Gupta G, Choyke PL, Bottaro DP (2016). Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer. PLoS One  11, e0157130.   https://doi.org/10.1371/journal.pone.0157130|7. Kongnyuy M, Frye T, George AK, Kilchevsky A, Iyer A, Kadakia M, Muthigi A, Turkbey B, Wood BJ, Pinto PA (2016). Corrigendum to ""A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis"". Case Rep Urol  2016, 3012941.   https://doi.org/10.1155/2016/3012941|8. Kongnyuy M, George AK, Rastinehad AR, Pinto PA (2016). Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes. Curr Urol Rep  17, 32.   https://doi.org/10.1007/s11934-016-0589-z|9. Kwak JT, Sankineni S, Xu S, Turkbey B, Choyke PL, Pinto PA, Merino M, Wood BJ (2016). Correlation of magnetic resonance imaging with digital histopathology in prostate. Int J Comput Assist Radiol Surg  11, 657-66.   https://doi.org/10.1007/s11548-015-1287-x|10. Kwak JT, Sankineni S, Xu S, Turkbey B, Choyke PL, Pinto PA, Moreno V, Merino M, Wood BJ (2017). Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology. Radiology  285, 147-156.   https://doi.org/10.1148/radiol.2017160906|11. Mertan FV, Berman R, Szajek K, Pinto PA, Choyke PL, Turkbey B (2016). Evaluating the Role of mpMRI in Prostate Cancer Assessment. Expert Rev Med Devices  13, 129-41.   https://doi.org/10.1586/17434440.2016.1134311|12. Mertan FV, Greer MD, Borofsky S, Kabakus IM, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2016). Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. Top Magn Reson Imaging  25, 139-47.   https://doi.org/10.1097/RMR.0000000000000088|13. Muthigi A, George AK, Sidana A, Kongnyuy M, Simon R, Moreno V, Merino MJ, Choyke PL, Turkbey B, Wood BJ, Pinto PA (2017). Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy. J Urol  197, 327-334.   https://doi.org/10.1016/j.juro.2016.08.097|14. Muthigi A, Sidana A, George AK, Kongnyuy M, Maruf M, Valayil S, Wood BJ, Pinto PA (2017). Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. Urol Oncol  35, 32.e1-32.e7.   https://doi.org/10.1016/j.urolonc.2016.08.008|15. Siddiqui MM, George AK, Rubin R, Rais-Bahrami S, Parnes HL, Merino MJ, Simon RM, Turkbey B, Choyke PL, Wood BJ, Pinto PA (2016). Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djw039|16. Watson MJ, George AK, Maruf M, Frye TP, Muthigi A, Kongnyuy M, Valayil SG, Pinto PA (2016). Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers. Future Oncol  12, 2417-2430.   https://doi.org/10.2217/fon-2016-0178",https://intramural.nih.gov/search/searchview.taf?ipid=98985
258,BC011090-10,"October 01, 2016 -  September 30, 2017",Molecular biology of human polyomaviruses,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Alberto  Peretti; PhD|Michael Joseph Tisza|Nicole Lynne Welch|Brittany Michelle Stewart,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School)|Jianxin  You (U Penn)|Paola  Cinque (San Raffaele Milan)|Ellen  Cahir-McFarland (Biogen),NULL,Alison Anne McBride; PhD (NIAID) |Pawel J Muranski (NHLBI),"1. Buck CB, Van Doorslaer K, Peretti A, Geoghegan EM, Tisza MJ, An P, Katz JP, Pipas JM, McBride AA, Camus AC, McDermott AJ, Dill JA, Delwart E, Ng TF, Farkas K, Austin C, Kraberger S, Davison W, Pastrana DV, Varsani A (2016). The Ancient Evolutionary History of Polyomaviruses. PLoS Pathog  12, e1005574.   https://doi.org/10.1371/journal.ppat.1005574|2. Cerqueira C, Pang YY, Day PM, Thompson CD, Buck CB, Lowy DR, Schiller JT (2016). A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging. J Virol  90, 1096-107.   https://doi.org/10.1128/JVI.02497-15|3. Gupta T, Robles MT, Schowalter RM, Buck CB, Pipas JM (2016). Expression of the small T antigen of Lymphotropic Papovavirus is sufficient to transform primary mouse embryo fibroblasts. Virology  487, 112-20.   https://doi.org/10.1016/j.virol.2015.10.003|4. Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, Xu X, Buck CB, You J (2016). Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection. Cell Host Microbe  19, 775-87.   https://doi.org/10.1016/j.chom.2016.04.024|5. Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB (2016). Erratum for Pastrana et al, BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropism. J Virol  90, 624.   https://doi.org/10.1128/JVI.02585-15|6. Tisza MJ, Yuan H, Schlegel R, Buck CB (2016). Genomic Sequence of Canine Papillomavirus 19. Genome Announc  4.   https://doi.org/10.1128/genomeA.01380-16|7. Tsang SH, Wang R, Nakamaru-Ogiso E, Knight SA, Buck CB, You J (2016). The Oncogenic Small Tumor Antigen of Merkel Cell Polyomavirus Is an Iron-Sulfur Cluster Protein That Enhances Viral DNA Replication. J Virol  90, 1544-56.   https://doi.org/10.1128/JVI.02121-15",https://intramural.nih.gov/search/searchview.taf?ipid=98871
259,BC011091-10,"October 01, 2016 -  September 30, 2017",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","John E Lueders|Yuan  Jiang; MD|Arthur A Glatfelter; MS|Fan  Yang|Sean Richard Davis; MD, PhD|Yuelin  Zhu|Show all 13",Albert  Fornace Jr (Georgetown University)|Jerry  Shay (UT Southwestern),Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|James Halpern Doroshow (Developmental Therapeutics Branch)|Katherine Elizabeth Warren; MD (Pediatric Oncology Branch)|Mirit I Aladjem; PhD (Developmental Therapeutics Branch),Leslie Glenn Biesecker; MD (NHGRI),"1. Biswas R, Gao S, Cultraro CM, Maity TK, Venugopalan A, Abdullaev Z, Shaytan AK, Carter CA, Thomas A, Rajan A, Song Y, Pitts S, Chen K, Bass S, Boland J, Hanada KI, Chen J, Meltzer PS, Panchenko AR, Yang JC, Pack S, Giaccone G, Schrump DS, Khan J, Guha U (2016). Genomic profiling of multiple sequentially acquired tumor metastatic sites from an ""exceptional responder"" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response. Cold Spring Harb Mol Case Stud  2, a001263.   https://doi.org/10.1101/mcs.a001263|2. Canela A, Sridharan S, Sciascia N, Tubbs A, Meltzer P, Sleckman BP, Nussenzweig A (2016). DNA Breaks and End Resection Measured Genome-wide by End Sequencing. Mol Cell  63, 898-911.   https://doi.org/10.1016/j.molcel.2016.06.034|3. Enomoto K, Zhu X, Park S, Zhao L, Zhu YJ, Willingham MC, Qi J, Copland JA, Meltzer P, Cheng SY (2017). Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer. J Clin Endocrinol Metab  102, 2268-2280.   https://doi.org/10.1210/jc.2016-3771|4. Killian JK, Dorssers LC, Trabert B, Gillis AJ, Cook MB, Wang Y, Waterfall JJ, Stevenson H, Smith WI, Noyes N, Retnakumar P, Stoop JH, Oosterhuis JW, Meltzer PS, McGlynn KA, Looijenga LH (2016). Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res  26, 1490-1504.   https://doi.org/10.1101/gr.201293.115|5. Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, Sivakumaran H, Wayte N, Nones K, Waterfall JJ, Pearson J, Patch AM, Senz J, Ferreira MA, Kaurah P, Mackenzie R, Heravi-Moussavi A, Hansford S, Lannagan TRM, Spurdle AB, Simpson PT, da Silva L, Lakhani SR, Clouston AD, Bettington M, et al. [50 more authors] (2016). Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. Am J Hum Genet  98, 830-842.   https://doi.org/10.1016/j.ajhg.2016.03.001|6. Neychev V, Sadowski SM, Zhu J, Allgaeuer M, Kilian K, Meltzer P, Kebebew E (2016). Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report. J Clin Endocrinol Metab  101, 353-8.   https://doi.org/10.1210/jc.2015-3684|7. Si H, Lu H, Yang X, Mattox A, Jang M, Bian Y, Sano E, Viadiu H, Yan B, Yau C, Ng S, Lee SK, Romano RA, Davis S, Walker RL, Xiao W, Sun H, Wei L, Sinha S, Benz CC, Stuart JM, Meltzer PS, Van Waes C, Chen Z (2016). TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. Oncogene  35, 5781-5794.   https://doi.org/10.1038/onc.2016.112|8. Sorber R, Teper Y, Abisoye-Ogunniyan A, Waterfall JJ, Davis S, Killian JK, Pineda M, Ray S, McCord MR, Pflicke H, Burkett SS, Meltzer PS, Rudloff U (2016). Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion. PLoS One  11, e0149833.   https://doi.org/10.1371/journal.pone.0149833|9. Yang B, Shebl FM, Sternberg LR, Warner AC, Kleiner DE, Edelman DC, Gomez A, Dagnall CL, Hicks BD, Altekruse SF, Hernandez BY, Lynch CF, Meltzer PS, McGlynn KA (2016). Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States. PLoS One  11, e0166828.   https://doi.org/10.1371/journal.pone.0166828|10. Yang Y, Vocke CD, Ricketts CJ, Wei D, Padilla-Nash HM, Lang M, Sourbier C, Killian JK, Boyle SL, Worrell R, Meltzer PS, Ried T, Merino MJ, Metwalli AR, Linehan WM (2017). Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276). Genes Chromosomes Cancer  56, 719-729.   https://doi.org/10.1002/gcc.22476|11. Zhang H, Meltzer PS, Davis SR (2016). caOmicsV: an R package for visualizing multidimensional cancer genomic data. BMC Bioinformatics  17, 141.   https://doi.org/10.1186/s12859-016-0989-6|12. Zhu X, Enomoto K, Zhao L, Zhu YJ, Willingham MC, Meltzer P, Qi J, Cheng SY (2017). Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. Clin Cancer Res  23, 430-440.   https://doi.org/10.1158/1078-0432.CCR-16-0914",https://intramural.nih.gov/search/searchview.taf?ipid=98972
260,BC011095-10,"October 01, 2016 -  September 30, 2017",Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Dinuka Mihirani de Silva; PhD|Molly Marie Lee|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Peter A Pinto; MD",Brian M Shuch|Jean-Baptiste  Lattouf|Paul  Dent (Virginia Commonwealth University)|Ching-Shih  Chen (The Ohio State University),"Young Hwan Lee (Endocrinology Section)|Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,"1. Booth L, Shuch B, Albers T, Roberts JL, Tavallai M, Proniuk S, Zukiwski A, Wang D, Chen CS, Bottaro D, Ecroyd H, Lebedyeva IO, Dent P (2016). Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Oncotarget  7, 12975-96.   https://doi.org/10.18632/oncotarget.7349|2. Chen F, Zhang Y, Şenbabaoğlu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, et al. [15 more authors] (2016). Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep  14, 2476-89.   https://doi.org/10.1016/j.celrep.2016.02.024",https://intramural.nih.gov/search/searchview.taf?ipid=98869
261,BC011105-10,"October 01, 2016 -  September 30, 2017",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Yuki  Takamatsu; MD|Manabu  Aoki; PhD|Hiromi  Aoki|Haydar  Bulut; PhD|Nicole  Delino,"Arun  Ghosh|Masayuki  Amano (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)|Hiroanori  Hayashi (Kumamoto University School of Medicine)",NULL,NULL,"1. Amano M, Salcedo-Gómez PM, Zhao R, Yedidi RS, Das D, Bulut H, Delino NS, Sheri VR, Ghosh AK, Mitsuya H (2016). A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413. Antimicrob Agents Chemother  60, 7046-7059.   https://doi.org/10.1128/AAC.01428-16|2. Aoki M, Hayashi H, Yedidi RS, Martyr CD, Takamatsu Y, Aoki-Ogata H, Nakamura T, Nakata H, Das D, Yamagata Y, Ghosh AK, Mitsuya H (2015). C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir. J Virol  90, 2180-94.   https://doi.org/10.1128/JVI.01829-15|3. Ghosh AK, Osswald HL, Glauninger K, Agniswamy J, Wang YF, Hayashi H, Aoki M, Weber IT, Mitsuya H (2016). Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation. J Med Chem  59, 6826-37.   https://doi.org/10.1021/acs.jmedchem.6b00639",https://intramural.nih.gov/search/searchview.taf?ipid=98975
262,BC011106-10,"October 01, 2016 -  September 30, 2017",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)","Paul E Love; MD, PhD (NICHD)","1. Kimura MY, Thomas J, Tai X, Guinter TI, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016). Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors. Nat Immunol  17, 1415-1423.   https://doi.org/10.1038/ni.3560",https://intramural.nih.gov/search/searchview.taf?ipid=98918
263,BC011107-10,"October 01, 2016 -  September 30, 2017",Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Suzanne I Specht|Konstadinos  Moissoglu|Christopher John Westlake; PhD,NULL,NULL,NULL,"1. Sandi M, Marshall C, Balan M, Coyaud E, Zhou M, Monson D, Ishiyama N, Chandrakumar A, La Rose J, Couzens A, Gingras A, Raught B, Xu W, Ikura M, Morrison D, Rottapel R (2017) MARK2-mediated phosphorylation of ARHGEF2 couples the actin and tubulin cytoskeletons to established cell polarity. Science Signaling, in press.|2. Zhou B, Ritt DA, Morrison DK, Der CJ, Cox AD (2016). Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma. J Biol Chem  291, 17804-15.   https://doi.org/10.1074/jbc.M115.712885",https://intramural.nih.gov/search/searchview.taf?ipid=98979
264,BC011109-10,"October 01, 2016 -  September 30, 2017",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98976
265,BC011111-10,"October 01, 2016 -  September 30, 2017",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98919
266,BC011112-10,"October 01, 2016 -  September 30, 2017",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dinah  Singer; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98915
267,BC011113-10,"October 01, 2016 -  September 30, 2017",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98916
268,BC011114-10,"October 01, 2016 -  September 30, 2017",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98917
269,BC011115-10,"October 01, 2016 -  September 30, 2017",Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Mary R Zhang|Sichuan  Xi|Vivek  Shukla; BSc, MSc|Shih-Hsin  Hsiao; MD|Elvin  Hekimoglu|Yin  Xiong; PhD|Show all 7","Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|David  Beer (Thoracic Surgery, University of Michigan)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"1. McLoughlin KC, Kaufman AS, Schrump DS (2017). Targeting the epigenome in malignant pleural mesothelioma. Transl Lung Cancer Res  6, 350-365.   https://doi.org/10.21037/tlcr.2017.06.06|2. Rao M, Atay SM, Shukla V, Hong Y, Upham T, Ripley RT, Hong JA, Zhang M, Reardon E, Fetsch P, Miettinen M, Li X, Peer CJ, Sissung T, Figg WD, De Rienzo A, Bueno R, Schrump DS (2016). Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells. Clin Cancer Res  22, 1197-210.   https://doi.org/10.1158/1078-0432.CCR-14-3379",https://intramural.nih.gov/search/searchview.taf?ipid=98909
270,BC011116-10,"October 01, 2016 -  September 30, 2017",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,Batu M Erman|Gunter  Bernhardt (Hannover Medical School),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98913
271,BC011117-10,"October 01, 2016 -  September 30, 2017",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98914
272,BC011118-10,"October 01, 2016 -  September 30, 2017",Role of Shh in developmental patterning and growth of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianjian  Zhu|Xiaozhong  Bao|Anna Marie Trofka,"Steve  Vokes (U. Texas, Austin)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)",Stephen J Lockett; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98969
273,BC011119-10,"October 01, 2016 -  September 30, 2017",Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianjian  Zhu|Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,"John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Steve  Vokes (U. Texas, Austin)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Marian  Ros; PhD (Universidad de Cantabria)","Mark B Lewandoski (Genetics of Vertebrate Development Section)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)","1. Huang BL, Trofka A, Furusawa A, Norrie JL, Rabinowitz AH, Vokes SA, Mark Taketo M, Zakany J, Mackem S (2016). An interdigit signalling centre instructs coordinate phalanx-joint formation governed by 5'Hoxd-Gli3 antagonism. Nat Commun  7, 12903.   https://doi.org/10.1038/ncomms12903|2. Norrie JL, Li Q, Co S, Huang BL, Ding D, Uy JC, Ji Z, Mackem S, Bedford MT, Galli A, Ji H, Vokes SA (2016). PRMT5 is essential for the maintenance of chondrogenic progenitor cells in the limb bud. Development  143, 4608-4619.   https://doi.org/10.1242/dev.140715",https://intramural.nih.gov/search/searchview.taf?ipid=98970
274,BC011120-10,"October 01, 2016 -  September 30, 2017",Genome-wide target analysis of Shh-activated transcription network in limb bud,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu|Bau Lin Huang|Anna Marie Trofka,NULL,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98967
275,BC011121-10,"October 01, 2016 -  September 30, 2017",Role of Brachyury in regulating notochord development and neoplasia,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jianjian  Zhu|Xiaozhong  Bao,NULL,Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology),NULL,"1. Zhu J, Kwan KM, Mackem S (2016). Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT. Proc Natl Acad Sci U S A  113, 3820-5.   https://doi.org/10.1073/pnas.1601252113",https://intramural.nih.gov/search/searchview.taf?ipid=98968
276,BC011124-10,"October 01, 2016 -  September 30, 2017",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Dinuka Mihirani de Silva; PhD|Arpita Avijit Roy; PhD|Molly Marie Lee|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Show all 9","Angela  Coxon (Amgen)|Regina  Day (NCI)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Anne-Marie  Martin (GlaxoSmithKline)|Freidmann  Muller (Curacyte AG)|Andreas  van de Locht (Department of Pathology, Curacyte AG)|Show all 15",Young Hwan Lee (Endocrinology Section)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Ettore  Appella; MD (Chemical Immunology Section)|Melinda  Hollingshead (Biological Testing Branch),Rolf Eric Swenson; PhD (NHLBI),"1. Chu C, Bottaro DP, Betenbaugh MJ, Shiloach J (2016). Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells. PLoS One  11, e0148075.   https://doi.org/10.1371/journal.pone.0148075|2. Xie Z, Lee YH, Boeke M, Jilaveanu LB, Liu Z, Bottaro DP, Kluger HM, Shuch B (2016). MET Inhibition in Clear Cell Renal Cell Carcinoma. J Cancer  7, 1205-14.   https://doi.org/10.7150/jca.14604",https://intramural.nih.gov/search/searchview.taf?ipid=98870
277,BC011126-10,"October 01, 2016 -  September 30, 2017",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Monica  Vaccari|Veronica  Galli|Beverly Sue Packard; PhD|Isabela  Silva De Castro|Massimiliano  Bissa; MBA|Giacomo  Gorini|Show all 10,"Donald  Forthal (School of Medicine, Univ of CA)|Chris  Miller; MS|Guido  Ferrari (Duke University)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Georgia Doris Tomaras; PhD|Mangala  Rao (USMHRP at the Walter Reed Army Institute of Research)|Show all 15",Brandon Frank Keele (Office Of The Director),Nancy R Miller (NIAID) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |Steven J Jacobson; PhD (NINDS) |James  Arthos; PhD (NIAID),"1. Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, et al. [28 more authors] (2016). Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med  22, 762-70.   https://doi.org/10.1038/nm.4105",https://intramural.nih.gov/search/searchview.taf?ipid=98888
278,BC011131-10,"October 01, 2016 -  September 30, 2017",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98873
279,BC011132-10,"October 01, 2016 -  September 30, 2017",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Fa-An  Chao|Olivier Francois Andre  Soubias; PhD,Hagn  Franz (Technical University of Munich)|Arthur  Palmer (Columbia University),NULL,Nico  Tjandra; PhD (NHLBI),"1. Chao FA, Byrd RA (2016). Geometric Approximation: A New Computational Approach To Characterize Protein Dynamics from NMR Adiabatic Relaxation Dispersion Experiments. J Am Chem Soc  138, 7337-45.   https://doi.org/10.1021/jacs.6b02786|2. Gill ML, Byrd RA, Palmer AG (2016). Dynamics of GCN4 facilitate DNA interaction: a model-free analysis of an intrinsically disordered region. Phys Chem Chem Phys  18, 5839-49.   https://doi.org/10.1039/c5cp06197k|3. Opina A, Strickland M, Lee Y, Tjandra N, Byrd R, Swenson R, Vasalatiy O (2016) Analysis of the isomer ratios of polymethylated-DOTA complexes and the implications on protein structural studies Dalton Transactions 45:4673-4687",https://intramural.nih.gov/search/searchview.taf?ipid=98872
280,BC011150-09,"October 01, 2016 -  September 30, 2017",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD,NULL,NULL,Sandip  Datta (NIAID),"1. Andrews C, McLean MH, Durum SK (2016). Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature. Inflamm Bowel Dis  22, 2255-64.   https://doi.org/10.1097/MIB.0000000000000818",https://intramural.nih.gov/search/searchview.taf?ipid=98999
281,BC011152-09,"October 01, 2016 -  September 30, 2017",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Indira Narsimhan Rao|Pramita  Chatterjee|Jonathan Harold Badger|Sharon A Bargo|Amiran  Dzutsev; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99027
282,BC011153-09,"October 01, 2016 -  September 30, 2017",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ren Ming  Dai|Rosalba  Salcedo|Amiran  Dzutsev; PhD|Loretta R Smith|Soumen  Roy; PhD|Sharon A Bargo|Show all 17,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),"Stephanie Mullis Prescott; MSN, NNP-BC, RN, NRP (NINR) |Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC) |Heidi H Kong (NIAMS)","1. Dutzan N, Abusleme L, Bridgeman H, Greenwell-Wild T, Zangerle-Murray T, Fife ME, Bouladoux N, Linley H, Brenchley L, Wemyss K, Calderon G, Hong BY, Break TJ, Bowdish DME, Lionakis MS, Jones SA, Trinchieri G, Diaz PI, Belkaid Y, Konkel JE, Moutsopoulos NM (2017). On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier. Immunity  46, 133-147.   https://doi.org/10.1016/j.immuni.2016.12.010|2. Namasivayam S, Maiga M, Yuan W, Thovarai V, Costa DL, Mittereder LR, Wipperman MF, Glickman MS, Dzutsev A, Trinchieri G, Sher A (2017). Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome  5, 71.   https://doi.org/10.1186/s40168-017-0286-2|3. Perez-Chanona E, Trinchieri G (2016). The role of microbiota in cancer therapy. Curr Opin Immunol  39, 75-81.   https://doi.org/10.1016/j.coi.2016.01.003|4. Stroncek DF, Butterfield LH, Cannarile MA, Dhodapkar MV, Greten TF, Grivel JC, Kaufman DR, Kong HH, Korangy F, Lee PP, Marincola F, Rutella S, Siebert JC, Trinchieri G, Seliger B (2017). Systematic evaluation of immune regulation and modulation. J Immunother Cancer  5, 21.   https://doi.org/10.1186/s40425-017-0223-8",https://intramural.nih.gov/search/searchview.taf?ipid=99026
283,BC011154-09,"October 01, 2016 -  September 30, 2017",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",NULL,NULL,Joost J Oppenheim; MD (Cancer Inflammation Program),NULL,"1. Bustin M, Misteli T (2016). Nongenetic functions of the genome. Science  352, aad6933.   https://doi.org/10.1126/science.aad6933|2. Deng T, Postnikov Y, Zhang S, Garrett L, Becker L, Rácz I, Hölter SM, Wurst W, Fuchs H, Gailus-Durner V, de Angelis MH, Bustin M (2017). Interplay between H1 and HMGN epigenetically regulates OLIG1&2 expression and oligodendrocyte differentiation. Nucleic Acids Res  45, 3031-3045.   https://doi.org/10.1093/nar/gkw1222|3. Kugler J, Postnikov YV, Furusawa T, Kimura S, Bustin M (2017). Elevated HMGN4 expression potentiates thyroid tumorigenesis. Carcinogenesis  38, 391-401.   https://doi.org/10.1093/carcin/bgx015|4. Postnikov YV, Bustin M (2016). Functional interplay between histone H1 and HMG proteins in chromatin. Biochim Biophys Acta  1859, 462-7.   https://doi.org/10.1016/j.bbagrm.2015.10.006",https://intramural.nih.gov/search/searchview.taf?ipid=98992
284,BC011155-09,"October 01, 2016 -  September 30, 2017",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Zhongyu  Zhu|Yang  Feng|Wei  Li; PhD|Tianlei  Ying|Jiping  Shao,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|MeiYun  Zhang (University of Hong Kong)|Rui  Gong; PhD|Yuxian  He (Chinese Academy of Medical Sciences)|Liying  Ma (Chinese Center for Disease Control and Prevention,)",NULL,NULL,"1. Chen W, Bardhi A, Feng Y, Wang Y, Qi Q, Li W, Zhu Z, Dyba MA, Ying T, Jiang S, Goldstein H, Dimitrov DS (2016). Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1. MAbs  8, 761-74.   https://doi.org/10.1080/19420862.2016.1160180|2. Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RG, Hötzel I, Popplewell AG, Parren PW, Enzelberger M, Rademaker HJ, Clark MR, Lowe DC, Dahiyat BI, Smith V, Lambert JM, Wu H, Reilly M, Haurum JS, Dübel S, Huston JS, Schirrmann T, Janssen RA, Steegmaier M, Gross JA, Bradbury AR, et al. [9 more authors] (2016). The INNs and outs of antibody nonproprietary names. MAbs  8, 1-9.   https://doi.org/10.1080/19420862.2015.1114320|3. Pincus SH, Song K, Maresh GA, Hamer DH, Dimitrov DS, Chen W, Zhang MY, Ghetie VF, Chan-Hui PY, Robinson JE, Vitetta ES (2017). Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins. J Virol  91.   https://doi.org/10.1128/JVI.01955-16|4. Qi Q, Wang Q, Chen W, Yu F, Du L, Dimitrov DS, Lu L, Jiang S (2017). Anti-HIV antibody and drug combinations exhibit synergistic activity against drug-resistant HIV-1 strains. J Infect  75, 68-71.   https://doi.org/10.1016/j.jinf.2017.03.006",https://intramural.nih.gov/search/searchview.taf?ipid=98998
285,BC011156-09,"October 01, 2016 -  September 30, 2017",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Yang  Feng|Tianlei  Ying,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Linfa  Wang (Duke-NUS Graduate Medical School)",NULL,NULL,"1. Agrawal AS, Ying T, Tao X, Garron T, Algaissi A, Wang Y, Wang L, Peng BH, Jiang S, Dimitrov DS, Tseng CT (2016). Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Sci Rep  6, 31629.   https://doi.org/10.1038/srep31629|2. Houser KV, Gretebeck L, Ying T, Wang Y, Vogel L, Lamirande EW, Bock KW, Moore IN, Dimitrov DS, Subbarao K (2016). Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection. J Infect Dis  213, 1557-61.   https://doi.org/10.1093/infdis/jiw080|3. van Doremalen N, Falzarano D, Ying T, de Wit E, Bushmaker T, Feldmann F, Okumura A, Wang Y, Scott DP, Hanley PW, Feldmann H, Dimitrov DS, Munster VJ (2017). Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res  143, 30-37.   https://doi.org/10.1016/j.antiviral.2017.03.025|4. Ying T, Li W, Dimitrov DS (2016). Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus. J Infect Dis  213, 877-9.   https://doi.org/10.1093/infdis/jiv381",https://intramural.nih.gov/search/searchview.taf?ipid=98997
286,BC011158-09,"October 01, 2016 -  September 30, 2017",The roles of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99008
287,BC011162-09,"October 01, 2016 -  September 30, 2017",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",NULL,"Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Frank  Bergmann (University of Heidelberg)|Katsuhiko  Yanaga (Jikei University School of Medicine)|Michael  Ghadimi (Surgery, U. of Goettingen)|H Richard  Alexander (University of Maryland Medical System)|Show all 7",David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Wang J, Yang S, He P, Schetter AJ, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Gaida MM, Hanna N, Alexander HR, Hussain SP (2016). Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Clin Cancer Res  22, 5992-6001.   https://doi.org/10.1158/1078-0432.CCR-16-0511",https://intramural.nih.gov/search/searchview.taf?ipid=99009
288,BC011163-09,"October 01, 2016 -  September 30, 2017",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|Pengnian Charles Lin; PhD (Cancer Inflammation Program),Manfred  Boehm; MD (NHLBI) |Lawrence L Latour; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99029
289,BC011165-09,"October 01, 2016 -  September 30, 2017",Role of inflammation in epigenetic alterations of metastatic cancer cells,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Maxwell P Lee; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99030
290,BC011167-09,"October 01, 2016 -  September 30, 2017",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Antonella  Sassano|Helen Thompson Michael|Eva Eugenia Perez Guijarro|Chi-Ping  Day,"Thomas  Tuting (Dermatology, University of Bonn)|Norman  Sharpless (University of North Carolina)|Martin  McMahon (University of Californial at San Francisco)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School)|Jennifer A Wargo|Show all 7",Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch),NULL,"1. Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, et al. [17 more authors] (2016). The state of melanoma: challenges and opportunities. Pigment Cell Melanoma Res  29, 404-16.   https://doi.org/10.1111/pcmr.12475|2. Thomas RM, Van Dyke T, Merlino G, Day CP (2016). Concepts in Cancer Modeling: A Brief History. Cancer Res  76, 5921-5925.   https://doi.org/10.1158/0008-5472.CAN-16-1293|3. Wei BR, Michael HT, Halsey CH, Peer CJ, Adhikari A, Dwyer JE, Hoover SB, El Meskini R, Kozlov S, Weaver Ohler Z, Figg WD, Merlino G, Simpson RM (2016). Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. Pigment Cell Melanoma Res  29, 643-655.   https://doi.org/10.1111/pcmr.12512",https://intramural.nih.gov/search/searchview.taf?ipid=99015
291,BC011168-09,"October 01, 2016 -  September 30, 2017",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yi  Tang|Xuan  Xu|Kun  Zhu; PhD,NULL,Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99031
292,BC011176-09,"October 01, 2016 -  September 30, 2017",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Anna  Serquina|Insun  Kook|Tagawa  Takanobu|Thomas S Uldrick,NULL,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","John Lawrence Spouge; MD, PhD (NLM)","1. Happel C, Ramalingam D, Ziegelbauer JM (2016). Virus-Mediated Alterations in miRNA Factors and Degradation of Viral miRNAs by MCPIP1. PLoS Biol  14, e2000998.   https://doi.org/10.1371/journal.pbio.2000998",https://intramural.nih.gov/search/searchview.taf?ipid=99032
293,BC011181-09,"October 01, 2016 -  September 30, 2017",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Kajal  Biswas|Stacey S Stauffer,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Linda S Cleveland (Mouse Cancer Genetics Program)|Teresa L Sullivan (Mouse Cancer Genetics Program),NULL,"1. Thirthagiri E, Klarmann KD, Shukla AK, Southon E, Biswas K, Martin BK, North SL, Magidson V, Burkett S, Haines DC, Noer K, Matthai R, Tessarollo L, Loncarek J, Keller JR, Sharan SK (2016). BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation. Hum Mol Genet  25, 1934-1945.   https://doi.org/10.1093/hmg/ddw066",https://intramural.nih.gov/search/searchview.taf?ipid=99022
294,BC011185-09,"October 01, 2016 -  September 30, 2017",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",NULL,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Richard  Bucala (Yale University)|Fleming  Jason (MD Anderson Cancer Center)|Diane  Simeone (University of Michigan),David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Christine Campo Alewine (Laboratory of Molecular Biology),NULL,"1. Hussain SP (2016). Pancreatic Cancer: Current Progress and Future Challenges. Int J Biol Sci  12, 270-2.   https://doi.org/10.7150/ijbs.14950|2. Wang J, He P, Gaida M, Yang S, Schetter AJ, Gaedcke J, Ghadimi BM, Ried T, Yfantis H, Lee D, Weiss JM, Stauffer J, Hanna N, Alexander HR, Hussain SP (2016). Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Oncotarget  7, 52993-53004.   https://doi.org/10.18632/oncotarget.10323|3. Wang J, Hussain SP (2017). NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential. Antioxid Redox Signal  26, 1000-1008.   https://doi.org/10.1089/ars.2016.6809|4. Yang S, He P, Wang J, Schetter A, Tang W, Funamizu N, Yanaga K, Uwagawa T, Satoskar AR, Gaedcke J, Bernhardt M, Ghadimi BM, Gaida MM, Bergmann F, Werner J, Ried T, Hanna N, Alexander HR, Hussain SP (2016). A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Cancer Res  76, 3838-50.   https://doi.org/10.1158/0008-5472.CAN-15-2841",https://intramural.nih.gov/search/searchview.taf?ipid=99010
295,BC011187-09,"October 01, 2016 -  September 30, 2017",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Parthibane  Velayoudame|Dru Gabriel Myerscough|Kenneth Min Kim|Lavanya  Bondada; PhD|Varna  Kishore|Shika Naidu Inala|Show all 8,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98989
296,BC011190-09,"October 01, 2016 -  September 30, 2017",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",James B Mitchell; PhD (Radiation Biology Branch)|Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99028
297,BC011191-09,"October 01, 2016 -  September 30, 2017",Preclinical Mouse Models of Thyroid Cancer,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Li  Zhao|Xuguang  Zhu|Sunmi  Park|Keisuke  Enomoto|Minkyung  Kang,John  Copland (Mayo Clinic College of Medicine)|Jun  Qi (Harvard Medical School),"Erik Kristian Holmsen (Biochemical Genetics Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Park J, Kim WG, Zhao L, Enomoto K, Willingham M, Cheng SY (2016). Metformin blocks progression of obesity-activated thyroid cancer in a mouse model. Oncotarget  7, 34832-44.   https://doi.org/10.18632/oncotarget.8989|2. Park JW, Han CR, Zhao L, Willingham MC, Cheng SY (2016). Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model. Endocr Relat Cancer  23, 53-63.   https://doi.org/10.1530/ERC-15-0417|3. Zhu X, Kim DW, Zhao L, Willingham MC, Cheng SY (2016). SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. Endocr Relat Cancer  23, 521-33.   https://doi.org/10.1530/ERC-16-0103",https://intramural.nih.gov/search/searchview.taf?ipid=98993
298,BC011197-09,"October 01, 2016 -  September 30, 2017",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD|Subrata  Debnath; PhD|Aamir  Akbarali,Oleg  Demidov|Barbara  Stecca (Istituto Toscano Tumori Azienda),Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98990
299,BC011202-09,"October 01, 2016 -  September 30, 2017",Mechanism of transcription-coupled DNA repair and transcription mutagenesis,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Lucyna E Lubkowska|Ludmila Vladimirova Petrova,Michelle  Wang (Cornell University)|Paul  Doetsch (Emory University),Yun Xing M Wang (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99012
300,BC011203-09,"October 01, 2016 -  September 30, 2017",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nadim  Majdalani|Arti  Tripathi|Issam Nihad Hamdallah|Song  Tong,Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER)|Aurelia  Battesti,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Rna Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99002
301,BC011204-09,"October 01, 2016 -  September 30, 2017",Preclinical development of TIMP-2 as a biologic therapy for cancer,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Sandra  Jensen-Taubman|Sarvesh  Kumar|Ananda  Chowdhury; PhD|David  Peeney; PhD|Beiyang  Wei|Kevin A Camphausen; MD,John  Caterina; PhD (NIDR)|Robert G Brinson; PhD,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",Rolf Eric Swenson; PhD (NHLBI) |Olga  Vasalatiy; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99025
302,BC011206-09,"October 01, 2016 -  September 30, 2017",Genome wide profiling of histone variants in tumors,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Jonathan Douglas Nye|Mary Elizabeth Pitman,NULL,NULL,Aleksandra Urszula Nita-Lazar; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98994
303,BC011207-09,"October 01, 2016 -  September 30, 2017",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Haiqing  Zhao|Mary Elizabeth Pitman,"Jennifer  Otteson (Ohio State University)|Garegin  Papaoin (University of Maryland)|Cees  Dekker (Delft University of Technology)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Kim SH, Vlijm R, van der Torre J, Dalal Y, Dekker C (2016). CENP-A and H3 Nucleosomes Display a Similar Stability to Force-Mediated Disassembly. PLoS One  11, e0165078.   https://doi.org/10.1371/journal.pone.0165078|2. Nuccio AG, Bui M, Dalal Y, Nita-Lazar A (2017). Mass Spectrometry-Based Methodology for Identification of Native Histone Variant Modifications From Mammalian Tissues and Solid Tumors. Methods Enzymol  586, 275-290.   https://doi.org/10.1016/bs.mie.2016.09.035",https://intramural.nih.gov/search/searchview.taf?ipid=98995
304,BC011208-09,"October 01, 2016 -  September 30, 2017",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Peter C Fitzgerald (Office of the Director),Henry L Levin; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99004
305,BC011209-09,"October 01, 2016 -  September 30, 2017",Formation of Centromeres in vivo,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Daniel Patrick Melters|David  Sturgill|Mary Elizabeth Pitman,"Garegin  Papaoin (University of Maryland)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",Karl Thomas Ried; MD (Cancer Genetics Branch),Aleksandra Urszula Nita-Lazar; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98996
306,BC011211-09,"October 01, 2016 -  September 30, 2017",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Jailynn A Harke|Thomas  Delerue|Taylor B Updegrove; PhD|Minsuk  Kong,"Fang  Tian (Penn State University, College of Medicine)|Kerwyn  Huang (Stanford University)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Hari  Shroff; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Ramamurthi KS (2016). Editorial overview: Growth and development: prokaryotes. Curr Opin Microbiol  34, vii-viii.   https://doi.org/10.1016/j.mib.2016.09.001|2. Wu Y, Chandris P, Winter PW, Kim EY, Jaumouillé V, Kumar A, Guo M, Leung JM, Smith C, Rey-Suarez I, Liu H, Waterman CM, Ramamurthi KS, La Riviere PJ, Shroff H (2016). Simultaneous multiview capture and fusion improves spatial resolution in wide-field and light-sheet microscopy. Optica  3, 897-910.   https://doi.org/10.1364/OPTICA.3.000897",https://intramural.nih.gov/search/searchview.taf?ipid=99021
307,BC011212-09,"October 01, 2016 -  September 30, 2017",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jami D Willette brown|Feng  Zhu; PhD|Na-Young  Song; PhD|Giorgio  Trinchieri,NULL,NULL,NULL,"1. Marien E, Meister M, Muley T, Gomez Del Pulgar T, Derua R, Spraggins JM, Van de Plas R, Vanderhoydonc F, Machiels J, Binda MM, Dehairs J, Willette-Brown J, Hu Y, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, Lacal JC, Waelkens E, Swinnen JV (2016). Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma. Oncotarget  7, 12582-97.   https://doi.org/10.18632/oncotarget.7179|2. Zhu F, Willette-Brown J, Song NY, Lomada D, Song Y, Xue L, Gray Z, Zhao Z, Davis SR, Sun Z, Zhang P, Wu X, Zhan Q, Richie ER, Hu Y (2017). Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis. Cell Host Microbe  21, 478-493.e7.   https://doi.org/10.1016/j.chom.2017.03.006",https://intramural.nih.gov/search/searchview.taf?ipid=99007
308,BC011214-09,"October 01, 2016 -  September 30, 2017",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Vanja  Lazarevic,Thomas  Hunig (University of Wuerzburg)|Batu M Erman|Youngnim  Choi (Seoul National University),NULL,Bibiana  Bielekova; MD (NINDS),"1. Park JY, Jo Y, Ko E, Luckey MA, Park YK, Park SH, Park JH, Hong C (2016). Soluble γc cytokine receptor suppresses IL-15 signaling and impairs iNKT cell development in the thymus. Sci Rep  6, 36962.   https://doi.org/10.1038/srep36962|2. Waickman AT, Park JY, Park JH (2016). The common γ-chain cytokine receptor: tricks-and-treats for T cells. Cell Mol Life Sci  73, 253-69.   https://doi.org/10.1007/s00018-015-2062-4",https://intramural.nih.gov/search/searchview.taf?ipid=99019
309,BC011215-09,"October 01, 2016 -  September 30, 2017",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devon Thomas Dipalma|Alfred  Singer; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99020
310,BC011216-09,"October 01, 2016 -  September 30, 2017",Chemotactic Signals Regulating Human Neutrophil and Breast Metastatic Migration,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Wolfgang  Losert; PhD|Christina  Stuelten|Ritankar  Majumdar|Bhagawat Chandrasekar  Subramanian; PhD|Jeannie Yoojin Park|Tirhas G Dempsey|Show all 7,Wolfgang  Losert (University of Maryland)|Denise J Montell,"Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)",Ralph J Nossal; PhD (NICHD),"1. Lee R, Stuelten C, Parent C, Losert W (2016) Collective cell migration over long time scales reveals distinct phenotypes Convergent Science Physical Oncology 2:025001|2. Liao XH, Meena NP, Southall N, Liu L, Swaroop M, Zhang AL, Xiang JJ, Parent CA, Zheng W, Kimmel AR (2016). A High-Throughput, Multi-Cell Phenotype Assay for the Identification of Novel Inhibitors of Chemotaxis/Migration. Sci Rep  6, 22273.   https://doi.org/10.1038/srep22273|3. Majumdar R, Tavakoli Tameh A, Parent CA (2016). Exosomes Mediate LTB4 Release during Neutrophil Chemotaxis. PLoS Biol  14, e1002336.   https://doi.org/10.1371/journal.pbio.1002336|4. Saha P, Yeoh BS, Olvera RA, Xiao X, Singh V, Awasthi D, Subramanian BC, Chen Q, Dikshit M, Wang Y, Parent CA, Vijay-Kumar M (2017). Bacterial Siderophores Hijack Neutrophil Functions. J Immunol  198, 4293-4303.   https://doi.org/10.4049/jimmunol.1700261",https://intramural.nih.gov/search/searchview.taf?ipid=99018
311,BC011219-09,"October 01, 2016 -  September 30, 2017",Combination Gene Therapy and Th1-Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)|Lawrence  Lum (University of Virginia)",Raffit  Hassan (Thoracic & Oncologic Surgery Branch),David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99000
312,BC011220-09,"October 01, 2016 -  September 30, 2017",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99001
313,BC011222-09,"October 01, 2016 -  September 30, 2017",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99024
314,BC011232-09,"October 01, 2016 -  September 30, 2017",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",M A Siddiqui,Susan  Keay|Alex  Mackerell Jr (University of Maryland),NULL,Daron  Freedberg (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98991
315,BC011255-08,"October 01, 2016 -  September 30, 2017",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ngoc-Han  Ha|Sarah Kimberly Deasy|Md Ruhul Amin|Devin Eugene Jackson|Christina Ruth Ross|Laura  Vera Ramirez|Show all 12,"Yijun  Ruan; PhD (Department of Genetic and Development Biology, Jackson Laboratory for Genomic Medicine)|Eran  Andrecheck (Michigan State University)|Michael  Lewis (Baylor University)|Sophia  Lunt (Michigan State University)",Cameron Claire Lingenfelter (Office of the Director),Robert Joseph Crouch; PhD (NICHD),"1. Bai L, Yang HH, Hu Y, Shukla A, Ha NH, Doran A, Faraji F, Goldberger N, Lee MP, Keane T, Hunter KW (2016). An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes. PLoS Genet  12, e1005989.   https://doi.org/10.1371/journal.pgen.1005989|2. Doran AG, Wong K, Flint J, Adams DJ, Hunter KW, Keane TM (2016). Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations. Genome Biol  17, 167.   https://doi.org/10.1186/s13059-016-1024-y|3. Faraji F, Hu Y, Yang HH, Lee MP, Winkler GS, Hafner M, Hunter KW (2016). Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7. PLoS Genet  12, e1005820.   https://doi.org/10.1371/journal.pgen.1005820|4. Ha NH, Long J, Cai Q, Shu XO, Hunter KW (2016). The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer. PLoS Genet  12, e1006267.   https://doi.org/10.1371/journal.pgen.1006267|5. Yang Y, Yang HH, Hu Y, Watson PH, Liu H, Geiger TR, Anver MR, Haines DC, Martin P, Green JE, Lee MP, Hunter KW, Wakefield LM (2017). Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis. Oncotarget  8, 30621-30643.   https://doi.org/10.18632/oncotarget.15695",https://intramural.nih.gov/search/searchview.taf?ipid=99034
316,BC011264-08,"October 01, 2016 -  September 30, 2017",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Paul  Mittelstadt; PhD|Matthew Donald Taves,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Kugler DG, Flomerfelt FA, Costa DL, Laky K, Kamenyeva O, Mittelstadt PR, Gress RE, Rosshart SP, Rehermann B, Ashwell JD, Sher A, Jankovic D (2016). Systemic toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes. J Exp Med  213, 3041-3056.   https://doi.org/10.1084/jem.20151636",https://intramural.nih.gov/search/searchview.taf?ipid=99035
317,BC011267-08,"October 01, 2016 -  September 30, 2017",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Dandan  Li|Yansong  Bian; MD, PhD|Zachary Daniel Knotts|Tatiana  Beresnev|Paul J Nolen|Yvonne  Shutack|Show all 8",Duncan  Jodrell (CRUK Cambridge Research Institute)|Jesse  Jaynes (Tuskegee University)|Sui  Huang (Northwestern University)|Clayton  Yates (Tuskegee University)|Michael  Baltezor (University of Kansas),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thorkell  Andresson (Office Of The Director)|Serguei V Kozlov (Office of the Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director)",Craig Joseph Thomas (NCATS) |Xin  Xu (NCATS) |Marc  Ferrer-Alegre (NCATS) |Xin  Hu; PhD (NCATS) |Juan  Marugan (NCATS),"1. Quadri HS, Aiken TJ, Allgaeuer M, Moravec R, Altekruse S, Hussain SP, Miettinen MM, Hewitt SM, Rudloff U (2017). Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer. BMC Cancer  17, 495.   https://doi.org/10.1186/s12885-017-3481-4|2. Xin HW, Ambe CM, Miller TC, Chen JQ, Wiegand GW, Anderson AJ, Ray S, Mullinax JE, Hari DM, Koizumi T, Godbout JD, Goldsmith PK, Stojadinovic A, Rudloff U, Thorgeirsson SS, Avital I (2016). Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin. J Cancer  7, 1142-51.   https://doi.org/10.7150/jca.10047",https://intramural.nih.gov/search/searchview.taf?ipid=99037
318,BC011275-08,"October 01, 2016 -  September 30, 2017",Genomic and genetic studies of endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99038
319,BC011282-08,"October 01, 2016 -  September 30, 2017",RNAi screen for modifiers of homologous recombination,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Andy Dong-Anh Tran; PhD,NULL,Jinping  Liu (Molecular Genetics and Carcinogenesis Section)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Liu J, Kruswick A, Dang H, Tran AD, Kwon SM, Wang XW, Oberdoerffer P (2017). Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth. Nat Commun  8, 137.   https://doi.org/10.1038/s41467-017-00206-2",https://intramural.nih.gov/search/searchview.taf?ipid=99039
320,BC011283-08,"October 01, 2016 -  September 30, 2017","Investigating the link between DNA damage, chromatin and nuclear dysfunction",Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jeongkyu  Kim; PhD|Andy Dong-Anh Tran; PhD|David  Sturgill|Eri  Hosogane; PhD|Robin  Sebastian|William Walter Hannon,"David  Sinclair (Harvard Medical School)|karolin  Luger (Biochemsitry, Univ. of Colorado)",Mirit I Aladjem; PhD (Developmental Therapeutics Branch),Yie  Liu; PhD (NIA),"1. Sebastian R, Oberdoerffer P (2017) Friend or Foe: RNA in (epi)genome maintenance. Philos Trans R Soc Lond B Biol Sci, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99040
321,BC011286-08,"October 01, 2016 -  September 30, 2017",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99042
322,BC011287-08,"October 01, 2016 -  September 30, 2017",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99043
323,BC011293-08,"October 01, 2016 -  September 30, 2017",Cytidine modifications in mRNA processing and function,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Maria Fernanda Prigge|David  Sturgill|Mariana D Mandler|Kyster Krsna Nanan|Allissa  Dillman|Daniel Alejandro Arango Tamayo|Show all 7,NULL,Jordan Leslie Meier; PhD (Chemical Biology Laboratory),NULL,"1. Marina RJ, Oberdoerffer S (2016). Epigenomics meets splicing through the TETs and CTCF. Cell Cycle  15, 1397-9.   https://doi.org/10.1080/15384101.2016.1171650|2. Marina RJ, Sturgill D, Bailly MA, Thenoz M, Varma G, Prigge MF, Nanan KK, Shukla S, Haque N, Oberdoerffer S (2016). TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing. EMBO J  35, 335-55.   https://doi.org/10.15252/embj.201593235",https://intramural.nih.gov/search/searchview.taf?ipid=99045
324,BC011295-08,"October 01, 2016 -  September 30, 2017",ALL immunobiology and the bone marrow niche,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Peter D Aplan; MD (Cancer Genetics Branch),NULL,"1. Giles AJ, Chien CD, Reid CM, Fry TJ, Park DM, Kaplan RN, Gilbert MR (2016). The functional interplay between systemic cancer and the hematopoietic stem cell niche. Pharmacol Ther  168, 53-60.   https://doi.org/10.1016/j.pharmthera.2016.09.006|2. Jacoby E, Nguyen SM, Fountaine TJ, Welp K, Gryder B, Qin H, Yang Y, Chien CD, Seif AE, Lei H, Song YK, Khan J, Lee DW, Mackall CL, Gardner RA, Jensen MC, Shern JF, Fry TJ (2016). CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun  7, 12320.   https://doi.org/10.1038/ncomms12320|3. Jacoby E, Yang Y, Qin H, Chien CD, Kochenderfer JN, Fry TJ (2016). Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD. Blood  127, 1361-70.   https://doi.org/10.1182/blood-2015-08-664250|4. Wendler D, Shah NN, Pulsipher MA, Fry T, Grady C (2016). Research involving pediatric stem cell donors: A way forward. Clin Trials  13, 304-10.   https://doi.org/10.1177/1740774515627156",https://intramural.nih.gov/search/searchview.taf?ipid=99046
325,BC011298-08,"October 01, 2016 -  September 30, 2017",Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Sean Joseph Hipp|Mark  Atlas (Cohen Children's Medical Center)|Jason  Fangusaro (Lurie Children's Hospital)|Adam  Levy",Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99047
326,BC011299-08,"October 01, 2016 -  September 30, 2017",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Roger  Packer (CNMC)|Darren  Hargrave (Great ormond Street Hospital for Children)|Gilbert  Vezina (Children's National Medical Center)|Tina  Young Poussaint (Children's Hospital)|Mark  Kieran (Children's Hospital)|Sean Joseph Hipp|Show all 7,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Peter  Herscovitch; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99048
327,BC011303-08,"October 01, 2016 -  September 30, 2017",Role of the protein SUMOylation pathway in Ras-driven oncogenesis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD,NULL,NULL,NULL,"1. Zhang H, Luo J (2016). SUMO wrestling with Ras. Small GTPases  7, 39-46.   https://doi.org/10.1080/21541248.2016.1161698",https://intramural.nih.gov/search/searchview.taf?ipid=99049
328,BC011304-08,"October 01, 2016 -  September 30, 2017",Methods for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Fehad Jamil Khan,NULL,Eric  Batchelor; PhD (Laboratory of Pathology)|James  Gao (Thoracic & Oncologic Surgery Branch),NULL,"1. Luo J (2016). CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery. Trends Cancer  2, 313-324.   https://doi.org/10.1016/j.trecan.2016.05.001|2. Smith JL, Lee LC, Read A, Li Q, Yu B, Lee CS, Luo J (2016). One-step immortalization of primary human airway epithelial cells capable of oncogenic transformation. Cell Biosci  6, 57.   https://doi.org/10.1186/s13578-016-0122-6",https://intramural.nih.gov/search/searchview.taf?ipid=99050
329,BC011306-08,"October 01, 2016 -  September 30, 2017",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Joost J Oppenheim; MD|Howard A Young; PhD|Ruth  Nussinov; PhD,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  Gonzalez-Juarrero (Colorado State University)|Philip  Kim (University of Toronto)|Show all 7,Michael  Dean; PhD (Laboratory Translational Genomics)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory),NULL,"1. Nim S, Jeon J, Corbi-Verge C, Seo MH, Ivarsson Y, Moffat J, Tarasova N, Kim PM (2016). Pooled screening for antiproliferative inhibitors of protein-protein interactions. Nat Chem Biol  12, 275-81.   https://doi.org/10.1038/nchembio.2026|2. Zdanov S, Mandapathil M, Abu Eid R, Adamson-Fadeyi S, Wilson W, Qian J, Carnie A, Tarasova N, Mkrtichyan M, Berzofsky JA, Whiteside TL, Khleif SN (2016). Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells. Cancer Immunol Res  4, 354-65.   https://doi.org/10.1158/2326-6066.CIR-15-0241",https://intramural.nih.gov/search/searchview.taf?ipid=99051
330,BC011307-08,"October 01, 2016 -  September 30, 2017",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Joost J Oppenheim; MD,Joseph R Kates|Vadim  Gaponenko|Mattheas  Majestachak (Loyola University Chicago)|Steven  Ackerman; PhD (University of Illinois at Chicago),Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Raul Eduardo Cachau (Office Of The Director),NULL,"1. Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M (2016). New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci  17.   https://doi.org/10.3390/ijms17060971",https://intramural.nih.gov/search/searchview.taf?ipid=99052
331,BC011311-08,"October 01, 2016 -  September 30, 2017",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Kajal  Biswas,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Suhas Sampat Kharat; PhD (Mouse Cancer Genetics Program),NULL,"1. Ding X, Ray Chaudhuri A, Callen E, Pang Y, Biswas K, Klarmann KD, Martin BK, Burkett S, Cleveland L, Stauffer S, Sullivan T, Dewan A, Marks H, Tubbs AT, Wong N, Buehler E, Akagi K, Martin SE, Keller JR, Nussenzweig A, Sharan SK (2016). Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. Nat Commun  7, 12425.   https://doi.org/10.1038/ncomms12425|2. Ray Chaudhuri A, Callen E, Ding X, Gogola E, Duarte AA, Lee JE, Wong N, Lafarga V, Calvo JA, Panzarino NJ, John S, Day A, Crespo AV, Shen B, Starnes LM, de Ruiter JR, Daniel JA, Konstantinopoulos PA, Cortez D, Cantor SB, Fernandez-Capetillo O, Ge K, Jonkers J, Rottenberg S, Sharan SK, et al. [1 more author] (2016). Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature  535, 382-7.   https://doi.org/10.1038/nature18325",https://intramural.nih.gov/search/searchview.taf?ipid=99055
332,BC011313-08,"October 01, 2016 -  September 30, 2017",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Poulami  Majumder|Stephen Edward Miller; PhD|Galit  Fichman|Junfeng  Shi|Yuji  Yamada; PhD|Allix Marie Settemia Sanders|Show all 7,Darrin  Pochan (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Eric  Furst (University of Delaware),"Scott K Durum; PhD (Cancer Inflammation Program)|Joost J Oppenheim; MD (Cancer Inflammation Program)|William G Stetler-Stevenson; MD, PhD (Radiation Oncology Branch)",Robert  Tycko; PhD (NIDDK),"1. NagySmith K, Schneider J (2016) Peptide Hydrogel Network Electrostatics Govern Release of Encapsulated Proteins J Mat Chem B 4:1999|2. NagySmith K, Yamada Y, Schneider J (2016) Protein release from highly charged peptide hydrogel networks Journal of Materials Chemistry B 4:1999-2007|3. Smith DJ, Brat GA, Medina SH, Tong D, Huang Y, Grahammer J, Furtmüller GJ, Oh BC, Nagy-Smith KJ, Walczak P, Brandacher G, Schneider JP (2016). A multiphase transitioning peptide hydrogel for suturing ultrasmall vessels. Nat Nanotechnol  11, 95-102.   https://doi.org/10.1038/nnano.2015.238",https://intramural.nih.gov/search/searchview.taf?ipid=99056
333,BC011314-08,"October 01, 2016 -  September 30, 2017",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Yuji  Yamada; PhD|Galit  Fichman|Junfeng  Shi|Allix Marie Settemia Sanders|Ken  Ishikawa|Scott Thomas Walsh|Show all 8,Gerald  Brandacher (Johns Hopkins University)|Brian  Bush (NIST)|Darrin  Pochan (University of Delaware),NULL,NULL,"1. Medina SH, Miller SE, Keim AI, Gorka AP, Schnermann MJ, Schneider JP (2016). An Intrinsically Disordered Peptide Facilitates Non-Endosomal Cell Entry. Angew Chem Int Ed Engl  55, 3369-72.   https://doi.org/10.1002/anie.201510518|2. Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO (2016). Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors. Antimicrob Agents Chemother  60, 190-7.   https://doi.org/10.1128/AAC.02121-15",https://intramural.nih.gov/search/searchview.taf?ipid=99057
334,BC011319-08,"October 01, 2016 -  September 30, 2017",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99060
335,BC011321-08,"October 01, 2016 -  September 30, 2017",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Matthew J Anderson|Michael Graham Stanley Boylan|Mccauley Grace Brown,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99061
336,BC011324-08,"October 01, 2016 -  September 30, 2017",Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jong Il  Ahn,Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99062
337,BC011325-08,"October 01, 2016 -  September 30, 2017",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Yadvinder Singh Ahi|Diborah Mengistu Yimer|Tomas  Kroupa; PhD,Stephen P Goff|Heinrich  Gottlinger (University of Massachusetts Medical School)|Sara  Sukumar (Johns Hopkins Oncology Center)|Delphine  Muriaux (Centre d'Ã‰tudes d'Agents PathogÃ¨nes et Biotechnologies pour la SantÃ©)|Rahm  Gummuluru (Boston University)|Ina  O'Carroll|Show all 7,Yun Xing M Wang (Structural Biophysics Laboratory)|Kunio  Nagashima (Office Of The Director)|Thorkell  Andresson (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Ulrich  Baxa; PhD (Office Of The Director),NULL,"1. Ahi YS, Zhang S, Thappeta Y, Denman A, Feizpour A, Gummuluru S, Reinhard B, Muriaux D, Fivash MJ, Rein A (2016). Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins. MBio  7.   https://doi.org/10.1128/mBio.01985-16",https://intramural.nih.gov/search/searchview.taf?ipid=99063
338,BC011328-08,"October 01, 2016 -  September 30, 2017",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","John E Lueders|Robert L Walker; BS|Arthur A Glatfelter; MS|Sean Richard Davis; MD, PhD|Yuelin  Zhu|Heiko  Horn; PhD|Show all 7","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|John  Healey (Memorial Sloan Kettering Cancer Center)|Jeffrey  Trent (TGen)",Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Clinical Genetics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Amy Kathleen Leblanc; DVM (Molecular Imaging Program),NULL,"1. Nakka M, Allen-Rhoades W, Li Y, Kelly A, Shen J, Taylor A, Barkauskas D, Yustein J, Andrulis I, Wunder J, Gorlick R, Meltzer PS, Lau C, Man T (2017) Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma. Oncotarget, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99064
339,BC011330-08,"October 01, 2016 -  September 30, 2017",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Ahreum  Yoo,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99065
340,BC011332-08,"October 01, 2016 -  September 30, 2017",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Meera  Murgai|Daniel Wirth Beury|Wei  Ju|Sabina Anna Kaczanowska|Carol J Thiele|Lee Jay Helman; MD,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Show all 7",Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Giles AJ, Reid CM, Evans JD, Murgai M, Vicioso Y, Highfill SL, Kasai M, Vahdat L, Mackall CL, Lyden D, Wexler L, Kaplan RN (2016). Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche. Cancer Res  76, 1335-47.   https://doi.org/10.1158/0008-5472.CAN-15-0204",https://intramural.nih.gov/search/searchview.taf?ipid=99067
341,BC011333-08,"October 01, 2016 -  September 30, 2017",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99068
342,BC011334-08,"October 01, 2016 -  September 30, 2017",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Wei  Ju|Meera  Murgai|Daniel Wirth Beury|Lauren Myrbeck Hittson|Sabina Anna Kaczanowska|Lee Jay Helman; MD|Show all 8,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 7",Javed  Khan; MD (Cancer Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99069
343,BC011336-08,"October 01, 2016 -  September 30, 2017",Tools for Prediction of ADMETox Properties,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,"Ann  Richard (EPA)|Antony  Williams|Huixiao  Hong (NCI)|Kamel  Mansouri (EPA)|Barry  Bunin (Collaborative Drug Discovery (CDD), Inc.)|Alex  Clark (Molecular Materials Informatics, Inc.)",NULL,"Christopher P Austin; AB, MD (NCATS)","1. Mansouri K, Abdelaziz A, Rybacka A, Roncaglioni A, Tropsha A, Varnek A, Zakharov A, Worth A, Richard AM, Grulke CM, Trisciuzzi D, Fourches D, Horvath D, Benfenati E, Muratov E, Wedebye EB, Grisoni F, Mangiatordi GF, Incisivo GM, Hong H, Ng HW, Tetko IV, Balabin I, Kancherla J, Shen J, et al. [16 more authors] (2016). CERAPP: Collaborative Estrogen Receptor Activity Prediction Project. Environ Health Perspect  124, 1023-33.   https://doi.org/10.1289/ehp.1510267",https://intramural.nih.gov/search/searchview.taf?ipid=99070
344,BC011337-08,"October 01, 2016 -  September 30, 2017",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Nicholas Phillip Restifo; MD,NULL,NULL,NULL,"1. Klemen ND, Feingold PL, Goff SL, Hughes MS, Kammula US, Yang JC, Schrump DS, Rosenberg SA, Sherry RM (2017). Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma. Ann Surg Oncol  24, 135-141.   https://doi.org/10.1245/s10434-016-5537-0|2. Yang JC (2016). The Immunotherapy Roadmap. Clin Cancer Res  22, 275-6.   https://doi.org/10.1158/1078-0432.CCR-15-2144|3. Yang JC (2017). Debugging the Black Box. Cancer Discov  7, 250-251.   https://doi.org/10.1158/2159-8290.CD-17-0070|4. Yang JC, Rosenberg SA (2016). Adoptive T-Cell Therapy for Cancer. Adv Immunol  130, 279-94.   https://doi.org/10.1016/bs.ai.2015.12.006",https://intramural.nih.gov/search/searchview.taf?ipid=99071
345,BC011340-08,"October 01, 2016 -  September 30, 2017",Preclinical evaluation of novel therapeutics for CNS tumor therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully|Robert F Murphy|Srivandana  Akshintala|Brigitte  Widemann; MD,NULL,Rafael  Cruz Garcia (Office Of The Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director),NULL,"1. Shah NN, Cole DE, Lester-McCully CM, Wayne AS, Warren KE, Widemann BC (2016). Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates. Invest New Drugs  34, 61-5.   https://doi.org/10.1007/s10637-015-0311-x",https://intramural.nih.gov/search/searchview.taf?ipid=99072
346,BC011343-08,"October 01, 2016 -  September 30, 2017",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Donna  Mabry|Haleluya Gedlu Yimamu,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Liang  Cao (Cancer Genetics Branch)|Douglas K Price (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)",Theo  Heller; MD (NIDDK) |Venkatesh P Krishnasamy (CC) |Elliot Brian Levy (CC),"1. Baradaran Noveiry B, Hirbod-Mobarakeh A, Khalili N, Hourshad N, Greten TF, Abou-Alfa GK, Rezaei N (2017). Specific immunotherapy in hepatocellular cancer: A systematic review. J Gastroenterol Hepatol  32, 339-351.   https://doi.org/10.1111/jgh.13449|2. Deming DA, Cavalcante LL, Lubner SJ, Mulkerin DL, LoConte NK, Eickhoff JC, Kolesar JM, Fioravanti S, Greten TF, Compton K, Doyle AG, Wilding G, Duffy A, Liu G (2016). A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer. Invest New Drugs  34, 168-75.   https://doi.org/10.1007/s10637-015-0314-7|3. Duffy AG, Makarova-Rusher OV, Greten TF (2016). The case for immune-based approaches in biliary tract carcinoma. Hepatology  64, 1785-1791.   https://doi.org/10.1002/hep.28635|4. Makarova-Rusher OV, Altekruse SF, McNeel TS, Ulahannan S, Duffy AG, Graubard BI, Greten TF, McGlynn KA (2016). Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer  122, 1757-65.   https://doi.org/10.1002/cncr.29971|5. Makarova-Rusher OV, Ulahannan S, Greten TF, Duffy A (2016). Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes. Pancreas  45, 1432-1437.   https://doi.org/10.1097/MPA.0000000000000658",https://intramural.nih.gov/search/searchview.taf?ipid=99073
347,BC011344-08,"October 01, 2016 -  September 30, 2017",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",David Michael Agdashian|Milan Singh Sandhu,NULL,NULL,NULL,"1. Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF (2017). Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol  66, 545-551.   https://doi.org/10.1016/j.jhep.2016.10.029",https://intramural.nih.gov/search/searchview.taf?ipid=99074
348,BC011345-08,"October 01, 2016 -  September 30, 2017",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Chi  Ma|Qiong  Fu|Bernd  Heinrich|Qianfei  Zhang|Zachary John Brown; DO|Su Jong  Yu,"Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Mathias  Heikenwlder (University of Munich)|Lars  Zender (University of Tubingen)","Bradford J Wood; MD (Office of the Director)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Masaki  Terabe (Vaccine Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|William G Telford (Experimental Transplantation and Immunology Branch)",NULL,"1. Eggert T, Greten TF (2017). Tumor regulation of the tissue environment in the liver. Pharmacol Ther  173, 47-57.   https://doi.org/10.1016/j.pharmthera.2017.02.005|2. Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, Han M, Thornton AM, Zhang H, Egger M, Luo J, Felsher DW, McVicar DW, Weber A, Heikenwalder M, Greten TF (2016). NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature  531, 253-7.   https://doi.org/10.1038/nature16969",https://intramural.nih.gov/search/searchview.taf?ipid=99075
349,BC011351-08,"October 01, 2016 -  September 30, 2017",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","James L Gulley; MD, PhD",Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Dan  Theodorescu (University of Colorado)|Jean  Hoffman-Censits (Jefferson University Hospital)|Sumanta  Pal (City of Hope)|Arthur  DeCillis (Exelixis),Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),Les Roger Folio (CC) |Ashkan A Malayeri (CC),"1. Abida W, Milowsky MI, Ostrovnaya I, Gerst SR, Rosenberg JE, Voss MH, Apolo AB, Regazzi AM, McCoy AS, Boyd ME, Bajorin DF (2016). Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma. Bladder Cancer  2, 111-117.   https://doi.org/10.3233/BLC-150038|2. Apolo A (2016) The illusion of an ideal biomarker Eur Urol Focus 1 (3):269-71|3. Apolo AB (2016). PDL1: The Illusion of an Ideal Biomarker. Eur Urol Focus  1, 269-271.   https://doi.org/10.1016/j.euf.2015.04.005|4. Apolo AB, Infante JR, Balmanoukian A, Patel MR, Wang D, Kelly K, Mega AE, Britten CD, Ravaud A, Mita AC, Safran H, Stinchcombe TE, Srdanov M, Gelb AB, Schlichting M, Chin K, Gulley JL (2017). Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study. J Clin Oncol  35, 2117-2124.   https://doi.org/10.1200/JCO.2016.71.6795|5. Apolo AB, Lindenberg L, Shih JH, Mena E, Kim JW, Park JC, Alikhani A, McKinney YY, Weaver J, Turkbey B, Parnes HL, Wood LV, Madan RA, Gulley JL, Dahut WL, Kurdziel KA, Choyke PL (2016). Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer. J Nucl Med  57, 886-92.   https://doi.org/10.2967/jnumed.115.166512|6. Davarpanah NN, Yuno A, Trepel JB, Apolo AB (2017) Immunotherapy: a new treatment paradigm in bladder cancer. Curr Opin Oncol, in press (e-pub ahead of print)  https://doi.org/10.1097/CCO.0000000000000366|7. Harmon SA, Perk T, Lin C, Eickhoff J, Choyke PL, Dahut WL, Apolo AB, Humm JL, Larson SM, Morris MJ, Liu G, Jeraj R (2017). Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone. J Clin Oncol  35, 2829-2837.   https://doi.org/10.1200/JCO.2017.72.2348|8. Lerner SP, Bajorin DF, Dinney CP, Efstathiou JA, Groshen S, Hahn NM, Hansel D, Kwiatkowski D, O'Donnell M, Rosenberg J, Svatek R, Abrams JS, Al-Ahmadie H, Apolo AB, Bellmunt J, Callahan M, Cha EK, Drake C, Jarow J, Kamat A, Kim W, Knowles M, Mann B, Marchionni L, McConkey D, et al. [11 more authors] (2016). Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer. Bladder Cancer  2, 165-202.   https://doi.org/10.3233/BLC-160053|9. Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF (2016). The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer  122, 712-21.   https://doi.org/10.1002/cncr.29801",https://intramural.nih.gov/search/searchview.taf?ipid=99076
350,BC011354-08,"October 01, 2016 -  September 30, 2017",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99077
351,BC011372-07,"October 01, 2016 -  September 30, 2017",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Maachani UB, Shankavaram U, Kramp T, Tofilon PJ, Camphausen K, Tandle AT (2016). FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells. Oncotarget  7, 77365-77377.   https://doi.org/10.18632/oncotarget.12670|2. Rath B, Camphausen K, Tofilon P (2016) Glioblastoma Radiosensitization by Pimozide Transl Cancer Res 5:S1029-S1032|3. Wahba A, Rath BH, Bisht K, Camphausen K, Tofilon PJ (2016). Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells. Cancer Res  76, 3078-87.   https://doi.org/10.1158/0008-5472.CAN-15-3050",https://intramural.nih.gov/search/searchview.taf?ipid=99078
352,BC011373-07,"October 01, 2016 -  September 30, 2017",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Marwa Wahba Foreman|Theresa Faith Wechsler|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Wahba A, Lehman S, Tofilon P (2017) Radiation-induced Translational Control of Gene Expression Translation 5:e12690731 (9 pages)",https://intramural.nih.gov/search/searchview.taf?ipid=99079
353,BC011374-07,"October 01, 2016 -  September 30, 2017",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Steven M Holland; MD (NIAID) |Helen C Su; MD, PhD (NIAID)","1. Freeman AF, Shah NN, Parta M, Su HC, Brofferio A, Gradus-Pizlo I, Butty S, Hughes TE, Kleiner DE, Avila D, Heller T, Kong HH, Holland SM, Hickstein DD (2016). Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency. J Allergy Clin Immunol Pract  4, 1239-1242.e1.   https://doi.org/10.1016/j.jaip.2016.06.028|2. Happel CS, Stone KD, Freeman AF, Shah NN, Wang A, Lyons JJ, Guerrerio PA, Hickstein DD, Su HC (2016). Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients. J Allergy Clin Immunol  137, 1895-1898.e5.   https://doi.org/10.1016/j.jaci.2015.11.017|3. Shah NN, Freeman AF, Su H, Cole K, Parta M, Moutsopoulos NM, Baris S, Karakoc-Aydiner E, Hughes TE, Kong HH, Holland SM, Hickstein DD (2017). Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide. Biol Blood Marrow Transplant  23, 980-990.   https://doi.org/10.1016/j.bbmt.2017.03.016",https://intramural.nih.gov/search/searchview.taf?ipid=99080
354,BC011378-07,"October 01, 2016 -  September 30, 2017",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Wenyue  Sun|Prasantha Lakshmi Vemu|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch),NULL,"1. Arnold MA, Barr FG (2017). Molecular diagnostics in the management of rhabdomyosarcoma. Expert Rev Mol Diagn  17, 189-194.   https://doi.org/10.1080/14737159.2017.1275965|2. Pandey PR, Chatterjee B, Olanich ME, Khan J, Miettinen MM, Hewitt SM, Barr FG (2017). PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. J Pathol  241, 626-637.   https://doi.org/10.1002/path.4867",https://intramural.nih.gov/search/searchview.taf?ipid=99081
355,BC011379-07,"October 01, 2016 -  September 30, 2017",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),"1. Mazur SJ, Gallagher ES, Debnath S, Durell SR, Anderson KW, Miller Jenkins LM, Appella E, Hudgens JW (2017). Conformational Changes in Active and Inactive States of Human PP2Cα Characterized by Hydrogen/Deuterium Exchange-Mass Spectrometry. Biochemistry  56, 2676-2689.   https://doi.org/10.1021/acs.biochem.6b01220",https://intramural.nih.gov/search/searchview.taf?ipid=99082
356,BC011381-07,"October 01, 2016 -  September 30, 2017",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Jocelyn D Weissman (Molecular Regulation Section)|Jie  Mu (Molecular Regulation Section)|Oliver James Hendy (Immune Regulation Section)|Devaiah Nanjappa Ballachanda (Molecular Regulation Section)|David  Levens; PhD (Laboratory of Pathology)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory),Sheetal  Uppal (NEI) |S Stoney  Simons; PhD (NIDDK),"1. Baranello L, Wojtowicz D, Cui K, Devaiah BN, Chung HJ, Chan-Salis KY, Guha R, Wilson K, Zhang X, Zhang H, Piotrowski J, Thomas CJ, Singer DS, Pugh BF, Pommier Y, Przytycka TM, Kouzine F, Lewis BA, Zhao K, Levens D (2016). RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription. Cell  165, 357-71.   https://doi.org/10.1016/j.cell.2016.02.036|2. Devaiah BN, Gegonne A, Singer DS (2016). Bromodomain 4: a cellular Swiss army knife. J Leukoc Biol  100, 679-686.   https://doi.org/10.1189/jlb.2RI0616-250R|3. Pradhan MA, Blackford JA, Devaiah BN, Thompson PS, Chow CC, Singer DS, Simons SS (2016). Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction. J Biol Chem  291, 342-54.   https://doi.org/10.1074/jbc.M115.683722",https://intramural.nih.gov/search/searchview.taf?ipid=99084
357,BC011382-07,"October 01, 2016 -  September 30, 2017",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Joshua R Porter|Woo Seuk  Koh|Marie Deborah Gaynelle Harton; PhD|Ryan Lee Hanson; PhD|Mark  Raffeld; MD,NULL,William G Telford (Experimental Transplantation and Immunology Branch),NULL,"1. Batchelor E, Loewer A (2017) Mathematical modeling of p53 dynamics in single cells. Curr Opin Syst Biol, in press.|2. Harton MD, Batchelor E (2017). Determining the Limitations and Benefits of Noise in Gene Regulation and Signal Transduction through Single Cell, Microscopy-Based Analysis. J Mol Biol  429, 1143-1154.   https://doi.org/10.1016/j.jmb.2017.03.007|3. Porter JR, Fisher BE, Batchelor E (2016). p53 Pulses Diversify Target Gene Expression Dynamics in an mRNA Half-Life-Dependent Manner and Delineate Co-regulated Target Gene Subnetworks. Cell Syst  2, 272-82.   https://doi.org/10.1016/j.cels.2016.03.006|4. Porter JR, Telford WG, Batchelor E (2017). Single-cell Gene Expression Profiling Using FACS and qPCR with Internal Standards. J Vis Exp  .  https://doi.org/10.3791/55219",https://intramural.nih.gov/search/searchview.taf?ipid=99085
358,BC011383-07,"October 01, 2016 -  September 30, 2017",Transcription and Splicing Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Eric  Drier (Mad City Labs)|David  Auble (Univ. Virginia)|Siddhartha  Mukherjee (Columbia University Medical Center)|Michael  Poirier (Ohio State University)|Eytan  Ruppin; MD/PhD (Department of Computer Science, University of Maryland)",Dinah  Singer; PhD (Experimental Immunology Branch)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|David  Levens; PhD (Laboratory of Pathology)|Harold  Varmus; MD  (Office Of The Director),"Carson C Chow; BASc, PhD (NIDDK) |Markus  Hafner (NIAMS)","1. Chen H, Larson DR (2016). What have single-molecule studies taught us about gene expression? Genes Dev  30, 1796-810.   https://doi.org/10.1101/gad.281725.116|2. Coulon A, Larson DR (2016). Fluctuation Analysis: Dissecting Transcriptional Kinetics with Signal Theory. Methods Enzymol  572, 159-91.   https://doi.org/10.1016/bs.mie.2016.03.017|3. Day CR, Chen H, Coulon A, Meier JL, Larson DR (2016). High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics. Methods  96, 59-68.   https://doi.org/10.1016/j.ymeth.2015.11.025|4. Lenstra TL, Larson DR (2016). Single-Molecule mRNA Detection in Live Yeast. Curr Protoc Mol Biol  113, 14.24.1-14.24.15.   https://doi.org/10.1002/0471142727.mb1424s113|5. Lenstra TL, Rodriguez J, Chen H, Larson DR (2016). Transcription Dynamics in Living Cells. Annu Rev Biophys  45, 25-47.   https://doi.org/10.1146/annurev-biophys-062215-010838|6. Ren G, Jin W, Cui K, Rodriguez J, Larson D, Zhao K (2017) CTCF-mediated enhancer-promoter interaction is a critical regulator of cell-to-cell variation of gene expression. Molecular Cell, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99086
359,BC011387-07,"October 01, 2016 -  September 30, 2017",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Wenyue  Sun|Salah  Boudjadi|Prasantha Lakshmi Vemu|Markku Martti Miettinen,"Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Stephen  Skapek (The University of Chicago)|Lisa  Teot (Children's Hospital)|Mariusz  Ratajczak (University of Louisville)|Erin  Rudzinski (Oregon Health and Science University)|Julie  Gastier-Foster (Nationwide Children's Hospital)|Show all 10",Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch),NULL,"1. Arnold MA, Anderson JR, Gastier-Foster JM, Barr FG, Skapek SX, Hawkins DS, Raney RB, Parham DM, Teot LA, Rudzinski ER, Walterhouse DO (2016). Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer  63, 634-9.   https://doi.org/10.1002/pbc.25862|2. Barr FG (2016). Fusion genes in solid tumors: the possibilities and the pitfalls. Expert Rev Mol Diagn  16, 921-3.   https://doi.org/10.1080/14737159.2016.1220835|3. Poniewierska-Baran A, Schneider G, Sun W, Abdelbaset-Ismail A, Barr FG, Ratajczak MZ (2016). Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications. Int J Oncol  48, 1815-24.   https://doi.org/10.3892/ijo.2016.3439|4. Xie Z, Babiceanu M, Kumar S, Jia Y, Qin F, Barr FG, Li H (2016). Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A  113, 13126-13131.   https://doi.org/10.1073/pnas.1612734113",https://intramural.nih.gov/search/searchview.taf?ipid=99088
360,BC011390-07,"October 01, 2016 -  September 30, 2017",Vascular Biology Section,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD,"Michelle A. Petri; MD (Internal Medicine, Johns Hopkins University)|Dan  Berkowitz; MD (Johns Hopkins School of Medicine)|S  Wang (Adimmune Corporation)|Chuanshu  Huang (Nelson Institute of Environmental Medicine, New York University)|Peter  Zhou (UNiversity of Kentuky)",Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Ilias  Alevizos; DMD (NIDCR),"1. Babaev VR, Ding L, Zhang Y, May JM, Lin PC, Fazio S, Linton MF (2016). Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis. Arterioscler Thromb Vasc Biol  36, 598-607.   https://doi.org/10.1161/ATVBAHA.115.306931|2. Jian J, Pang Y, Yan HH, Min Y, Achyut BR, Hollander MC, Lin PC, Liang X, Yang L (2017). Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget  8, 27725-27739.   https://doi.org/10.18632/oncotarget.9486|3. Min Y, Li J, Qu P, Lin P (2017) C/EBP-δ positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development Oncotarget 8:50582-93|4. Wang Y, Liu J, Ying X, Lin PC, Zhou BP (2016). Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway. Sci Rep  6, 24606.   https://doi.org/10.1038/srep24606",https://intramural.nih.gov/search/searchview.taf?ipid=99089
361,BC011391-07,"October 01, 2016 -  September 30, 2017",Role of IKK alpha in lung cancer development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jami D Willette brown|Feng  Zhu; PhD|Na-Young  Song; PhD|Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Nancy  Jenkins (Houston Methodist Research Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99090
362,BC011393-07,"October 01, 2016 -  September 30, 2017",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Sunny  Wong (University of Michigan)|Radhika  Atit (Case Western Reserve University),Mark  Udey; MD (Office Of The Clinical Director),Ying  Xiao (NIAMS) |Amy B Coxon (NIAMS) |Lingling  Miao (NIAMS) |Savannah Thomas Barkdull (NIAMS) |Keisuke  Nagao (NIAMS),"1. Peterson SC, Brownell I, Wong SY (2016). Cutaneous Surgical Denervation: A Method for Testing the Requirement for Nerves in Mouse Models of Skin Disease. J Vis Exp  .  https://doi.org/10.3791/54050|2. Xiao Y, Thoresen DT, Miao L, Williams JS, Wang C, Atit RP, Wong SY, Brownell I (2016). A Cascade of Wnt, Eda, and Shh Signaling Is Essential for Touch Dome Merkel Cell Development. PLoS Genet  12, e1006150.   https://doi.org/10.1371/journal.pgen.1006150",https://intramural.nih.gov/search/searchview.taf?ipid=99092
363,BC011394-07,"October 01, 2016 -  September 30, 2017",Molecular pathogenesis and therapy innovation for Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,"Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Clayton  Green (Marshfield Clinic)|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)|Show all 9","Mark  Udey; MD (Office Of The Clinical Director)|Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)",Ying  Xiao (NIAMS) |Amy B Coxon (NIAMS) |Tara Beth Gelb (NIAMS) |Lingling  Miao (NIAMS) |Natasha Tremayne Hill; PhD (NIAMS) |Savannah Thomas Barkdull (NIAMS),"1. Carroll TM, Williams JS, Daily K, Rogers T, Gelb T, Coxon A, Wang SQ, Crago AM, Busam KJ, Brownell I (2017). Hedgehog Signaling Inhibitors Fail to Reduce Merkel Cell Carcinoma Viability. J Invest Dermatol  137, 1187-1190.   https://doi.org/10.1016/j.jid.2017.01.008|2. Cassler NM, Merrill D, Bichakjian CK, Brownell I (2016). Merkel Cell Carcinoma Therapeutic Update. Curr Treat Options Oncol  17, 36.   https://doi.org/10.1007/s11864-016-0409-1|3. Eid M, Nguyen J, Brownell I (2017). Seeking Standards for the Detection of Merkel Cell Polyomavirus and its Clinical Significance. J Invest Dermatol  137, 797-799.   https://doi.org/10.1016/j.jid.2016.12.024",https://intramural.nih.gov/search/searchview.taf?ipid=99093
364,BC011398-07,"October 01, 2016 -  September 30, 2017",Regulation of Ciliogenesis and Ciliary-related signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI","Quanlong  Lu; PhD|Christine Antoinette Kettenhofen; PhD|Adrian Alejandro Cuenca; MHS, PhD|Elizabeth Marangela Semler|Huijie  Zhao|Deborah K Morrison",Andrew  Peden (University of Sheffield)|Esben  Lorentzen (Max Plank Institute for  Biochemistry)|Jeffery  Axelrod (Standford),Kedar  Narayan (Office of the Director),Anand  Swaroop; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99094
365,BC011405-07,"October 01, 2016 -  September 30, 2017",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|Mark  Raffeld; MD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Sidana A, Kadakia M, Friend JC, Krane LS, Su D, Merino MJ, Srinivasan R (2017). Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol  35, 114.e9-114.e14.   https://doi.org/10.1016/j.urolonc.2016.10.023|2. Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA, Peterson J, Yang Y, Linehan WM (2017). Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer  56, 484-492.   https://doi.org/10.1002/gcc.22452",https://intramural.nih.gov/search/searchview.taf?ipid=99095
366,BC011406-07,"October 01, 2016 -  September 30, 2017",miRNA profiling  of prostate cancer in young and older male patients,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99096
367,BC011407-07,"October 01, 2016 -  September 30, 2017",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Dannis  van Vuurden (VU University medical Center)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Gilbert  Vezina (Children's National Medical Center)|Tina  Young Poussaint (Children's Hospital)|Show all 7,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99097
368,BC011408-07,"October 01, 2016 -  September 30, 2017",Comparison of substrate specificities of wild type and mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99098
369,BC011410-07,"October 01, 2016 -  September 30, 2017",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang|Constance M Cultraro,"Andrea  Califano; PhD|Cathy  Wu (Protein Information Resource, Georgetown University)|Teresa  Fan (University of Louisville)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99099
370,BC011412-07,"October 01, 2016 -  September 30, 2017",Role of MIG6 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,"Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99100
371,BC011414-07,"October 01, 2016 -  September 30, 2017",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity|Stephanie Caroline Pitts,Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center)|Todd  Golub (Broad Institute of MIT and Harvard),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99102
372,BC011415-07,"October 01, 2016 -  September 30, 2017",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Norris Lio Lam|Steven Dustin Hartman|Ronald E Gress; MD|Frances  Hakim; PhD|Luca  Gattinoni,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Brudno JN, Somerville RP, Shi V, Rose JJ, Halverson DC, Fowler DH, Gea-Banacloche JC, Pavletic SZ, Hickstein DD, Lu TL, Feldman SA, Iwamoto AT, Kurlander R, Maric I, Goy A, Hansen BG, Wilder JS, Blacklock-Schuver B, Hakim FT, Rosenberg SA, Gress RE, Kochenderfer JN (2016). Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease. J Clin Oncol  34, 1112-21.   https://doi.org/10.1200/JCO.2015.64.5929|2. Sabatino M, Hu J, Sommariva M, Gautam S, Fellowes V, Hocker JD, Dougherty S, Qin H, Klebanoff CA, Fry TJ, Gress RE, Kochenderfer JN, Stroncek DF, Ji Y, Gattinoni L (2016). Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies. Blood  128, 519-28.   https://doi.org/10.1182/blood-2015-11-683847",https://intramural.nih.gov/search/searchview.taf?ipid=99103
373,BC011417-07,"October 01, 2016 -  September 30, 2017",Improved Chimeric Antigen Receptor Therapies B-cell Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Leah Marie Alabanza|Shicheng  Yang|Norris Lio Lam|Steven Dustin Hartman|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Alabanza L, Pegues M, Geldres C, Shi V, Wiltzius J, Sievers S, Yang S, Kochenderfer J (2017) The function of a novel anti-CD19 chimeric antigen receptor with human variable regions is affected by choice of hinge and transmembrane domains. Molecular Therapy, in press.|2. Brudno J, Kochenderfer J (2017) Chimeric antigen receptor T-cell therapies for lymphoma. Nature Reviews Clinical Oncology, in press.|3. Brudno JN, Kochenderfer JN (2016). Toxicities of chimeric antigen receptor T cells: recognition and management. Blood  127, 3321-30.   https://doi.org/10.1182/blood-2016-04-703751|4. Elumogo CO, Kochenderfer JN, Civelek AC, Bluemke DA (2016). Pigmented villonodular synovitis mimics metastases on fluorine 18 fluorodeoxyglucose position emission tomography-computed tomography. Quant Imaging Med Surg  6, 218-23.   https://doi.org/10.21037/qims.2016.01.04|5. Kochenderfer J, Somerville R, Lu T, Yang J, Sherry R, Feldman S, McIntyre L, Bot A, Rossi J, Lam N, Rosenberg S (2017) Long-duration Complete Remissions of Diffuse Large B-cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor Therapy. Molecular Therapy, in press.|6. Kochenderfer JN, Somerville RPT, Lu T, Shi V, Bot A, Rossi J, Xue A, Goff SL, Yang JC, Sherry RM, Klebanoff CA, Kammula US, Sherman M, Perez A, Yuan CM, Feldman T, Friedberg JW, Roschewski MJ, Feldman SA, McIntyre L, Toomey MA, Rosenberg SA (2017). Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. J Clin Oncol  35, 1803-1813.   https://doi.org/10.1200/JCO.2016.71.3024",https://intramural.nih.gov/search/searchview.taf?ipid=99104
374,BC011418-07,"October 01, 2016 -  September 30, 2017",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Julie A Hong|Mary R Zhang|Sichuan  Xi|Vivek  Shukla; BSc, MSc",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99105
375,BC011419-07,"October 01, 2016 -  September 30, 2017",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Yifei  Li|Olivier Francois Andre  Soubias; PhD,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99106
376,BC011422-06,"October 01, 2016 -  September 30, 2017",Role of IKK alpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99125
377,BC011423-06,"October 01, 2016 -  September 30, 2017",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Wenyue  Sun,Mariusz  Ratajczak (University of Louisville)|Corinne  Linardic (Duke University)|Peter  Houghton (Greehey Children's Cancer Research Institute),"Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99131
378,BC011426-06,"October 01, 2016 -  September 30, 2017",HIV-1 Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Andrea L Ferris|Steven J Smith|David  Wells|Shuang  Guo; PhD|Dimiter  Demirov; PhD|Twan Wang Sia,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Peter  Cherepanov (Imperial College London)|Eric  Poeschla (University of Colorado)|Show all 9",Gary T Pauly (Chemical Biology Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)|Xiaolin  Wu; PhD (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory),Henry L Levin; PhD (NICHD) |Daniel C Douek; MD (NIAID),"1. Boritz EA, Darko S, Swaszek L, Wolf G, Wells D, Wu X, Henry AR, Laboune F, Hu J, Ambrozak D, Hughes MS, Hoh R, Casazza JP, Vostal A, Bunis D, Nganou-Makamdop K, Lee JS, Migueles SA, Koup RA, Connors M, Moir S, Schacker T, Maldarelli F, Hughes SH, Deeks SG, et al. [1 more author] (2016). Multiple Origins of Virus Persistence during Natural Control of HIV Infection. Cell  166, 1004-1015.   https://doi.org/10.1016/j.cell.2016.06.039|2. Hughes SH, Coffin JM (2016). What Integration Sites Tell Us about HIV Persistence. Cell Host Microbe  19, 588-98.   https://doi.org/10.1016/j.chom.2016.04.010|3. Métifiot M, Johnson BC, Kiselev E, Marler L, Zhao XZ, Burke TR, Marchand C, Hughes SH, Pommier Y (2016). Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site. Nucleic Acids Res  44, 6896-906.   https://doi.org/10.1093/nar/gkw592|4. Shao W, Shan J, Kearney MF, Wu X, Maldarelli F, Mellors JW, Luke B, Coffin JM, Hughes SH (2016). Retrovirus Integration Database (RID): a public database for retroviral insertion sites into host genomes. Retrovirology  13, 47.   https://doi.org/10.1186/s12977-016-0277-6|5. Varadarajan J, McWilliams MJ, Mott BT, Thomas CJ, Smith SJ, Hughes SH (2016). Drug resistant integrase mutants cause aberrant HIV integrations. Retrovirology  13, 71.   https://doi.org/10.1186/s12977-016-0305-6|6. Zhao XZ, Metifiot M, Smith SJ, Maddali K, Marchand C, Hughes SH, Pommier Y, Burke TR (2016). 6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors. Curr Top Med Chem  16, 435-40.   https://doi.org/10.2174/1568026615666150813150058|7. Zhao XZ, Smith SJ, Maskell DP, Metifiot M, Pye VE, Fesen K, Marchand C, Pommier Y, Cherepanov P, Hughes SH, Burke TR (2016). HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. ACS Chem Biol  11, 1074-81.   https://doi.org/10.1021/acschembio.5b00948",https://intramural.nih.gov/search/searchview.taf?ipid=99107
379,BC011427-06,"October 01, 2016 -  September 30, 2017",Immunohistochemical analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jerzy P Lasota|Zengfeng  Wang; PhD|Irena  Manukyan,NULL,NULL,NULL,"1. Inaguma S, Wang Z, Lasota J, Onda M, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Pastan I, Miettinen M (2017). Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma. Oncotarget  8, 26744-26754.   https://doi.org/10.18632/oncotarget.15814|2. Inaguma S, Wang Z, Lasota J, Sarlomo-Rikala M, McCue PA, Ikeda H, Miettinen M (2016). Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors. Am J Surg Pathol  40, 1133-42.   https://doi.org/10.1097/PAS.0000000000000653|3. Inaguma S, Wang Z, Lasota JP, Miettinen MM (2016). Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors. Oncotarget  7, 55276-55289.   https://doi.org/10.18632/oncotarget.10527|4. Kerkar SP, Wang ZF, Lasota J, Park T, Patel K, Groh E, Rosenberg SA, Miettinen MM (2016). MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases. J Immunother  39, 181-7.   https://doi.org/10.1097/CJI.0000000000000119|5. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J (2017). GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Am J Surg Pathol  41, 577-585.   https://doi.org/10.1097/PAS.0000000000000807|6. Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R, Lasota J (2016). Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases. Am J Surg Pathol  40, 1661-1669.   https://doi.org/10.1097/PAS.0000000000000703",https://intramural.nih.gov/search/searchview.taf?ipid=99132
380,BC011429-06,"October 01, 2016 -  September 30, 2017",Zbtb family members in lymphocyte differentiation and function,Damian  Kovalovsky; PhD,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99137
381,BC011431-06,"October 01, 2016 -  September 30, 2017",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Tiffany Taylor Loo|Yuanyuan  Gao; PhD|Michael C Lu,NULL,Yan  Wang (Immune Targeting Section),Dorian  McGavern (NINDS),"1. Kwong B, Rua R, Gao Y, Flickinger Jr J, Wang Y, Kruhlak M, Zhu J, McGavern D, Lazarevic V (2017) T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nature Immunology, in press.|2. Liu CF, Brandt GS, Hoang QQ, Naumova N, Lazarevic V, Hwang ES, Dekker J, Glimcher LH, Ringe D, Petsko GA (2016). Crystal structure of the DNA binding domain of the transcription factor T-bet suggests simultaneous recognition of distant genome sites. Proc Natl Acad Sci U S A  113, E6572-E6581.   https://doi.org/10.1073/pnas.1613914113",https://intramural.nih.gov/search/searchview.taf?ipid=99135
382,BC011433-06,"October 01, 2016 -  September 30, 2017",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99139
383,BC011436-06,"October 01, 2016 -  September 30, 2017",Retroviral Replication and Interactions with Host Factors,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Ryan C Burdick|Mohamed Husen Mohamedhabib Munshi; PhD|Chenglei  Li; PhD|John Y Chen|Wei-Shau  Hu; PhD,NULL,Robert  Gorelick (Office Of The Director),NULL,"1. Liu Y, Nikolaitchik OA, Rahman SA, Chen J, Pathak VK, Hu WS (2017). HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles. J Mol Biol  429, 2542-2555.   https://doi.org/10.1016/j.jmb.2017.06.018",https://intramural.nih.gov/search/searchview.taf?ipid=99110
384,BC011437-06,"October 01, 2016 -  September 30, 2017",Combinatorial genetic analysis using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee,Frank  McCormick (UCSF School of Medicine)|Scott  Lowe (Cold Spring Harbor Laboratory),Natasha  Caplen (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99127
385,BC011438-06,"October 01, 2016 -  September 30, 2017",Genetic screens for target discovery in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Glenn  Merlino; PhD|Li  Yang; PhD|Stuart H Yuspa; MD,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch),J Silvio  Gutkind; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99128
386,BC011439-06,"October 01, 2016 -  September 30, 2017",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Norris Lio Lam|Leah Marie Alabanza|Judith Lorraine Lawrence; RN|Steven Dustin Hartman|Ronald E Gress; MD|Frances  Hakim; PhD,"Richard A Morgan; PhD (NHGRI)|Benjamin  Buelow (TeneoBio, Inc.)",Steven A Feldman (Surgery Branch),David F Stroncek; MD (CC) |Irina  Maric; MD (CC),"1. Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN (2016). T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood  128, 1688-700.   https://doi.org/10.1182/blood-2016-04-711903",https://intramural.nih.gov/search/searchview.taf?ipid=99124
387,BC011441-06,"October 01, 2016 -  September 30, 2017",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Qian  Sun|Alan Surya Halim|Deven Shankarbhai Patel|Fahim  Ahmad; PhD|Kevin A Camphausen; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,"1. Kambach DM, Halim AS, Cauer AG, Sun Q, Tristan CA, Celiku O, Kesarwala AH, Shankavaram U, Batchelor E, Stommel JM (2017). Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma. Oncotarget  8, 14860-14875.   https://doi.org/10.18632/oncotarget.14740",https://intramural.nih.gov/search/searchview.taf?ipid=99129
388,BC011443-06,"October 01, 2016 -  September 30, 2017",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Nicolas  Sluis-Cremer; PhD (Department of Medicine, University of Pittsburgh)|Elio  Abbondanzieri (Delft University)",NULL,NULL,"1. Ganji M, Docter M, Le Grice SF, Abbondanzieri EA (2016). DNA binding proteins explore multiple local configurations during docking via rapid rebinding. Nucleic Acids Res  44, 8376-84.   https://doi.org/10.1093/nar/gkw666",https://intramural.nih.gov/search/searchview.taf?ipid=99109
389,BC011446-06,"October 01, 2016 -  September 30, 2017",The ClpP protease as a therapeutic target in bacterial and mammalian cells,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",NULL,NULL,NULL,Anton  Simeonov (NCATS),"1. Zhang Y, Maurizi MR (2016). Mitochondrial ClpP activity is required for cisplatin resistance in human cells. Biochim Biophys Acta  1862, 252-64.   https://doi.org/10.1016/j.bbadis.2015.12.005",https://intramural.nih.gov/search/searchview.taf?ipid=99111
390,BC011447-06,"October 01, 2016 -  September 30, 2017",Early Clinical Trials for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters|John Walter Glod,"Roger  Packer (CNMC)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Mark  Kieran (Children's Hospital)|Michelle  Monje-Deisseroth (Stanford)|Sean Joseph Hipp|Show all 8",William D Figg; PharmD (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |John D Heiss; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99121
391,BC011449-06,"October 01, 2016 -  September 30, 2017",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Connelly CM, Abulwerdi FA, Schneekloth JS (2017). Discovery of RNA Binding Small Molecules Using Small Molecule Microarrays. Methods Mol Biol  1518, 157-175.   https://doi.org/10.1007/978-1-4939-6584-7_11|2. Hewitt WM, Lountos GT, Zlotkowski K, Dahlhauser SD, Saunders LB, Needle D, Tropea JE, Zhan C, Wei G, Ma B, Nussinov R, Waugh DS, Schneekloth JS (2016). Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9. Angew Chem Int Ed Engl  55, 5703-7.   https://doi.org/10.1002/anie.201511351|3. Zlotkowski K, Hewitt WM, Sinniah RS, Tropea JE, Needle D, Lountos GT, Barchi JJ, Waugh DS, Schneekloth JS (2017). A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways. SLAS Discov  22, 760-766.   https://doi.org/10.1177/2472555216683937|4. Zlotkowski K, Hewitt WM, Yan P, Bokesch HR, Peach ML, Nicklaus MC, O'Keefe BR, McMahon JB, Gustafson KR, Schneekloth JS (2017). Macrophilone A: Structure Elucidation, Total Synthesis, and Functional Evaluation of a Biologically Active Iminoquinone from the Marine Hydroid Macrorhynchia philippina. Org Lett  19, 1726-1729.   https://doi.org/10.1021/acs.orglett.7b00496",https://intramural.nih.gov/search/searchview.taf?ipid=99133
392,BC011450-06,"October 01, 2016 -  September 30, 2017",Clinical treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Sacha  Gnjatic (Icahn School of Medicine Mount Sinai),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Heidi H Kong (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99130
393,BC011458-06,"October 01, 2016 -  September 30, 2017",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar|Mohammad Rashid Siddiqui,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Anu  Puri; PhD (Rna Biology Laboratory)|Mathias  Viard (Rna Biology Laboratory)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK (2017). Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther  16, 2201-2214.   https://doi.org/10.1158/1535-7163.MCT-16-0924",https://intramural.nih.gov/search/searchview.taf?ipid=99138
394,BC011459-06,"October 01, 2016 -  September 30, 2017",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Dong  Kong; PhD|Alejandra  Vasquez Limeta; PhD|Wooram  Jung,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99134
395,BC011460-06,"October 01, 2016 -  September 30, 2017",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Alberto  Peretti; PhD,Paola  Cinque (San Raffaele Milan)|Patrick  McTamney,NULL,NULL,"1. Buck CB (2016). Exposing the Molecular Machinery of BK Polyomavirus. Structure  24, 495.   https://doi.org/10.1016/j.str.2016.03.011",https://intramural.nih.gov/search/searchview.taf?ipid=99113
396,BC011461-06,"October 01, 2016 -  September 30, 2017",HIV-1 evasion of cytosolic factors,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,Jeremy  Luban (Columbia University)|Irene  Pedersen (University of California - Irvine),Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99108
397,BC011464-06,"October 01, 2016 -  September 30, 2017",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Mary  Kearney,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Erin  Reid (University of California San Diego)|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Show all 12,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Kieron Michael Dunleavy (Office Of The Clinical Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Bradford J Wood; MD (Office of the Director)|Robert  Gorelick (Office Of The Director)",Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Stephen A Migueles; MD (NIAID) |Irini  Sereti; MD (NIAID),"1. Maldarelli F (2016). The role of HIV integration in viral persistence: no more whistling past the proviral graveyard. J Clin Invest  126, 438-47.   https://doi.org/10.1172/JCI80564|2. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R (2016). Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. J Clin Oncol  34, 4125-4131.   https://doi.org/10.1200/JCO.2016.69.3812|3. Watters SA, Mlcochova P, Maldarelli F, Goonetilleke N, Pillay D, Gupta RK (2016). Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control. PLoS One  11, e0158854.   https://doi.org/10.1371/journal.pone.0158854",https://intramural.nih.gov/search/searchview.taf?ipid=99114
398,BC011465-06,"October 01, 2016 -  September 30, 2017",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Suzanne Laurie Sanford|Zuqin  Nie; PhD|Lipeng  Wu|Ying  Zheng|Emil Francis Michelotti; PhD,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Craig Joseph Thomas (NCATS),"1. Guo L, Zaysteva O, Nie Z, Mitchell NC, Amanda Lee JE, Ware T, Parsons L, Luwor R, Poortinga G, Hannan RD, Levens DL, Quinn LM (2016). Defining the essential function of FBP/KSRP proteins: Drosophila Psi interacts with the mediator complex to modulate MYC transcription and tissue growth. Nucleic Acids Res  44, 7646-58.   https://doi.org/10.1093/nar/gkw461|2. Zheng Y, Levens D (2016). Tuning the MYC response. Elife  5.   https://doi.org/10.7554/eLife.18871",https://intramural.nih.gov/search/searchview.taf?ipid=99112
399,BC011466-06,"October 01, 2016 -  September 30, 2017",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Mary  Kearney,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University),Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Michael  Polis; MD (NIAID) |Mark  Connors; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID),"1. Simonetti FR, Sobolewski MD, Fyne E, Shao W, Spindler J, Hattori J, Anderson EM, Watters SA, Hill S, Wu X, Wells D, Su L, Luke BT, Halvas EK, Besson G, Penrose KJ, Yang Z, Kwan RW, Van Waes C, Uldrick T, Citrin DE, Kovacs J, Polis MA, Rehm CA, Gorelick R, et al. [7 more authors] (2016). Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc Natl Acad Sci U S A  113, 1883-8.   https://doi.org/10.1073/pnas.1522675113",https://intramural.nih.gov/search/searchview.taf?ipid=99115
400,BC011469-06,"October 01, 2016 -  September 30, 2017",Building Libraries with Chemical Diversity for Screening,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Cheryl L Thomas|Dinara Faritovna Iskhakova,John  Porco (Boston University)|Peter  Wipf (University of Pittsburgh)|B.  Shen (Scripps Research Institute)|Sergazy  Adekenov (International Research and Production Holding Phytochemistry)|Darkan  Balpanaov (Biomedpreparat)|Young Ho  Kim|Show all 9,Ekaterina  Goncharo (Office Of The Director)|Timothy Leonard Bostaph (Office Of The Director),NULL,"1. da Cunha MG, Rosalen PL, Franchin M, de Alencar SM, Ikegaki M, Ransom T, Beutler JA (2016). Antiproliferative Constituents of Geopropolis from the Bee Melipona scutellaris. Planta Med  82, 190-4.   https://doi.org/10.1055/s-0035-1558142",https://intramural.nih.gov/search/searchview.taf?ipid=99117
401,BC011470-06,"October 01, 2016 -  September 30, 2017",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Sarah Ann Long|Esra  Eroglu Ozkan|Marshall Steven Darby|Dongdong  Wang,"William  Chain (University of Hawaii)|Kathlyn  Parker (Stony Brook University)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Ryan  Murelli (Brooklyn College)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|David  Beech (University of Leeds School of Medicine)","Stuart F J Le Grice; PhD (Basic Research Laboratory)|Karlyne M Reilly; BS, PhD (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)",Kapil  Bharti; PhD (NEI),"1. Cho N, Kim HW, Kim TB, Ransom TT, Beutler JA, Sung SH (2016). Preparative Purification of Anti-Proliferative Diarylheptanoids from Betula platyphylla by High-Speed Counter-Current Chromatography. Molecules  21.   https://doi.org/10.3390/molecules21060700|2. Cho N, Moon EH, Kim HW, Hong J, Beutler JA, Sung SH (2016). Inhibition of Nitric Oxide Production in BV2 Microglial Cells by Triterpenes from Tetrapanax papyriferus. Molecules  21, 459.   https://doi.org/10.3390/molecules21040459|3. Elliott D, Beutler J, Parker K (2017) The importance of a 4-alkyl substituent for activity in the englerin series ACS Med Chem Lett 8:746-750|4. Fash DM, Peer CJ, Li Z, Talisman IJ, Hayavi S, Sulzmaier FJ, Ramos JW, Sourbier C, Neckers L, Figg WD, Beutler JA, Chain WJ (2016). Synthesis of a stable and orally bioavailable englerin analogue. Bioorg Med Chem Lett  26, 2641-4.   https://doi.org/10.1016/j.bmcl.2016.04.016|5. López-Suárez L, Riesgo L, Bravo F, Ransom TT, Beutler JA, Echavarren AM (2016). Synthesis and Biological Evaluation of New (-)-Englerin Analogues. ChemMedChem  11, 1003-7.   https://doi.org/10.1002/cmdc.201600040",https://intramural.nih.gov/search/searchview.taf?ipid=99118
402,BC011471-06,"October 01, 2016 -  September 30, 2017",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Tadeusz P Guszczynski|Lauren R Haugh Krumpe|Shilpa R Kurian|Joe Sumagang Matarlo; PhD|Kirk R Gustafson; PhD,NULL,"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|John Stephen Schneekloth (Chemical Biology Laboratory)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99119
403,BC011472-06,"October 01, 2016 -  September 30, 2017",Isolation of bioactive proteins from natural product extracts,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Lauren R Haugh Krumpe|Carter Alexander Mitchell; PhD,"Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Paul  Christou (Universitat de Lleida)|Robert Walter Buckheit (RETROVIRAL REPLICATION LABORATORY)|Romero  Jose (The Population Council)|Heinz  Feldmann (National Microbiology Laboratory, Winnipeg)|Show all 8",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Mitchell CA, Ramessar K, O'Keefe BR (2017). Antiviral lectins: Selective inhibitors of viral entry. Antiviral Res  142, 37-54.   https://doi.org/10.1016/j.antiviral.2017.03.007|2. Vamvaka E, Arcalis E, Ramessar K, Evans A, O'Keefe BR, Shattock RJ, Medina V, Stöger E, Christou P, Capell T (2016). Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV. Plant Biotechnol J  14, 1427-37.   https://doi.org/10.1111/pbi.12507|3. Woodrum BW, Maxwell J, Allen DM, Wilson J, Krumpe LR, Bobkov AA, Hill RB, Kibler KV, O'Keefe BR, Ghirlanda G (2016). A Designed ""Nested"" Dimer of Cyanovirin-N Increases Antiviral Activity. Viruses  8.   https://doi.org/10.3390/v8060158",https://intramural.nih.gov/search/searchview.taf?ipid=99120
404,BC011476-05,"October 01, 2016 -  September 30, 2017",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Marian  Pavuk (CDC)|Arnold  Schecter (NIEHS)|Hoang  Quynh (University of Hanoi)|Steven T Szabo|Kristina  Thayer (United States Environmental Protection Agency),Sherry Jones Coulter; BS (Basic Research Laboratory)|Gabriel Arther Knudsen (Basic Research Laboratory)|Samantha Marie Hall (Basic Research Laboratory)|Alicia Carolyn Richards (Basic Research Laboratory),"Gaylia Jean Harry; PhD (NIEHS) |Stavros  Garantziotis; MD (NIEHS) |Douglas  Bell; PhD (NIEHS) |Suzanne Elizabeth Fenton; MS, PhD (NIEHS) |Shepherd H Schurman; MD (NIEHS)","1. Balbus JM, Tart KG, Dilworth CH, Birnbaum LS (2016). Changing the Climate of Respiratory Clinical Practice. Insights from the 2016 Climate and Health Assessment of the U.S. Global Change Research Program. Ann Am Thorac Soc  13, 1202-4.   https://doi.org/10.1513/AnnalsATS.201607-535ED|2. Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, Engel SM, Fallin MD, Halladay A, Hauser R, Hertz-Picciotto I, Kwiatkowski CF, Lanphear BP, Marquez E, Marty M, McPartland J, Newschaffer CJ, Payne-Sturges D, Patisaul HB, Perera FP, Ritz B, Sass J, Schantz SL, Webster TF, Whyatt RM, American College of Obstetricians and Gynecologists (ACOG), Child Neurology Society, Endocrine Society, International Neurotoxicology Association, International Society for Children’s Health and the Environment, International Society for Environmental Epidemiology, National Council of Asian Pacific Islander Physicians, National Hispanic Medical Association, National Medical Association, et al. [22 more authors] (2016). Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect  124, A118-22.   https://doi.org/10.1289/EHP358|3. Cote I, Andersen ME, Ankley GT, Barone S, Birnbaum LS, Boekelheide K, Bois FY, Burgoon LD, Chiu WA, Crawford-Brown D, Crofton KM, DeVito M, Devlin RB, Edwards SW, Guyton KZ, Hattis D, Judson RS, Knight D, Krewski D, Lambert J, Maull EA, Mendrick D, Paoli GM, Patel CJ, Perkins EJ, et al. [21 more authors] (2016). The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions. Environ Health Perspect  124, 1671-1682.   https://doi.org/10.1289/EHP233|4. Cui Y, Balshaw DM, Kwok RK, Thompson CL, Collman GW, Birnbaum LS (2016). The Exposome: Embracing the Complexity for Discovery in Environmental Health. Environ Health Perspect  124, A137-40.   https://doi.org/10.1289/EHP412|5. Emond C, DeVito M, Warner M, Eskenazi B, Mocarelli P, Birnbaum LS (2016). An assessment of dioxin exposure across gestation and lactation using a PBPK model and new data from Seveso. Environ Int  92-93, 23-32.   https://doi.org/10.1016/j.envint.2016.03.015|6. Hall SM, Coulter SJ, Knudsen GA, Sanders JM, Birnbaum LS (2017). Gene expression changes in immune response pathways following oral administration of tetrabromobisphenol A (TBBPA) in female Wistar Han rats. Toxicol Lett  272, 68-74.   https://doi.org/10.1016/j.toxlet.2017.03.008|7. Knudsen GA, Hughes MF, Sanders JM, Hall SM, Birnbaum LS (2016). Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP). Toxicol Appl Pharmacol  311, 117-127.   https://doi.org/10.1016/j.taap.2016.10.005|8. Knudsen GA, Sanders JM, Birnbaum LS (2016). Disposition of the Emerging Brominated Flame Retardant, 2-Ethylhexyl 2,3,4,5-Tetrabromobenzoate, in Female SD Rats and Male B6C3F1 Mice: Effects of Dose, Route, and Repeated Administration. Toxicol Sci  154, 392-402.   https://doi.org/10.1093/toxsci/kfw176|9. Knudsen GA, Sanders JM, Birnbaum LS (2017). Disposition of the emerging brominated flame retardant, bis(2-ethylhexyl) tetrabromophthalate, in female Sprague Dawley rats: effects of dose, route and repeated administration. Xenobiotica  47, 245-254.   https://doi.org/10.1080/00498254.2016.1174793|10. Kwok RK, Engel LS, Miller AK, Blair A, Curry MD, Jackson WB, Stewart PA, Stenzel MR, Birnbaum LS, Sandler DP, GuLF STUDY Research Team (2017). The GuLF STUDY: A Prospective Study of Persons Involved in the Deepwater Horizon Oil Spill Response and Clean-Up. Environ Health Perspect  125, 570-578.   https://doi.org/10.1289/EHP715|11. Lind L, Lind PM, Lejonklou MH, Dunder L, Bergman Å, Guerrero-Bosagna C, Lampa E, Lee HK, Legler J, Nadal A, Pak YK, Phipps RP, Vandenberg LN, Zalko D, Ågerstrand M, Öberg M, Blumberg B, Heindel JJ, Birnbaum LS (2016). Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity Epidemic. Environ Health Perspect  124, A81-3.   https://doi.org/10.1289/ehp.1511115|12. Mitro SD, Birnbaum LS, Needham BL, Zota AR (2016). Cross-sectional Associations between Exposure to Persistent Organic Pollutants and Leukocyte Telomere Length among U.S. Adults in NHANES, 2001-2002. Environ Health Perspect  124, 651-8.   https://doi.org/10.1289/ehp.1510187|13. Sanders JM, Coulter SJ, Knudsen GA, Dunnick JK, Kissling GE, Birnbaum LS (2016). Disruption of estrogen homeostasis as a mechanism for uterine toxicity in Wistar Han rats treated with tetrabromobisphenol A. Toxicol Appl Pharmacol  298, 31-9.   https://doi.org/10.1016/j.taap.2016.03.007|14. Schug TT, Johnson AF, Birnbaum LS, Colborn T, Guillette LJ, Crews DP, Collins T, Soto AM, Vom Saal FS, McLachlan JA, Sonnenschein C, Heindel JJ (2016). Minireview: Endocrine Disruptors: Past Lessons and Future Directions. Mol Endocrinol  30, 833-47.   https://doi.org/10.1210/me.2016-1096|15. Szabo DT, Pathmasiri W, Sumner S, Birnbaum LS (2017). Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture. Environ Health Perspect  125, 651-659.   https://doi.org/10.1289/EHP242|16. Thayer KA, Taylor KW, Garantziotis S, Schurman SH, Kissling GE, Hunt D, Herbert B, Church R, Jankowich R, Churchwell MI, Scheri RC, Birnbaum LS, Bucher JR (2016). Bisphenol A, Bisphenol S, and 4-Hydro​xyphenyl 4-Isopro​oxyphenyl​sulfone (BPSIP) in Urine and Blood of Cashiers. Environ Health Perspect  124, 437-44.   https://doi.org/10.1289/ehp.1409427",https://intramural.nih.gov/search/searchview.taf?ipid=99179
405,BC011478-05,"October 01, 2016 -  September 30, 2017",Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Hinrichs CS (2016). Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy. Clin Cancer Res  22, 1559-64.   https://doi.org/10.1158/1078-0432.CCR-15-1294|2. Stevanović S, Pasetto A, Helman SR, Gartner JJ, Prickett TD, Howie B, Robins HS, Robbins PF, Klebanoff CA, Rosenberg SA, Hinrichs CS (2017). Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science  356, 200-205.   https://doi.org/10.1126/science.aak9510",https://intramural.nih.gov/search/searchview.taf?ipid=99163
406,BC011479-05,"October 01, 2016 -  September 30, 2017",T-cell receptor gene therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Christina M Annunziata (Womens Malignancies Branch),David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99164
407,BC011480-05,"October 01, 2016 -  September 30, 2017",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Yun  Ji|Sanjivan  Gautam|Jinhui  Hu|Jessica  Fioravanti; PhD|Neal Edward Lacey|Stephen  Calderon|Show all 7,"Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Yi  Zhang (Temple University)|Timothy  Bender (University of Virginia)",John Brian Le Gall (Pediatric Oncology Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)|Terry J Fry (Pediatric Oncology Branch),David F Stroncek; MD (CC) |Mario  Roederer; PhD (NIAID) |Stefan Adi Muljo; PhD (NIAID),"1. Gattinoni L (2016). Adoptive T cell transfer: Imagining the next generation of cancer immunotherapies. Semin Immunol  28, 1-2.   https://doi.org/10.1016/j.smim.2016.03.019|2. Gattinoni L, Speiser DE, Lichterfeld M, Bonini C (2017). T memory stem cells in health and disease. Nat Med  23, 18-27.   https://doi.org/10.1038/nm.4241|3. Ji Y, Hocker JD, Gattinoni L (2016). Enhancing adoptive T cell immunotherapy with microRNA therapeutics. Semin Immunol  28, 45-53.   https://doi.org/10.1016/j.smim.2015.11.006",https://intramural.nih.gov/search/searchview.taf?ipid=99148
408,BC011485-05,"October 01, 2016 -  September 30, 2017",Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",NULL,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99147
409,BC011486-05,"October 01, 2016 -  September 30, 2017",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Yuki  Takamatsu; MD|Haydar  Bulut; PhD,"Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Nobuyo  Kuwata (National Center for Global Health & Medicine)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Satoru  Kohgo (National Center for Global Health & Medicine)|Yasuhito  Tanaka (na)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Salie ZL, Kirby KA, Michailidis E, Marchand B, Singh K, Rohan LC, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG (2016). Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA). Proc Natl Acad Sci U S A  113, 9274-9.   https://doi.org/10.1073/pnas.1605223113",https://intramural.nih.gov/search/searchview.taf?ipid=99142
410,BC011487-05,"October 01, 2016 -  September 30, 2017",Systems-level analysis of the regulation and function of MYC,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Joshua R Porter|Woo Seuk  Koh|David  Levens; PhD,NULL,Ji  Luo (Laboratory of Cancer Biology and Genetics)|Jayne M Stommel (Radiation Oncology Branch),NULL,"1. Porter J, Fisher B, Baranello L, Liu J, Kambach D, Nie Z, Koh W, Luo J, Stommel J, Levens D, Batchelor E (2017) Global inhibition with specific activation: how p53 and c-Myc redistribute the transcriptome in the DNA double-strand break response. Mol Cell, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99166
411,BC011488-05,"October 01, 2016 -  September 30, 2017",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Rhushikesh Arun Kulkarni; PhD|Jonathan Harold Shrimp|Chloe Ann Briney|Sarah Elizabeth Bergholtz|Abigail Lane Thorpe|Marc C Nicklaus,NULL,Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),Anton  Simeonov (NCATS) |Ajit  Jadhav (NCATS),"1. Barajas JF, Finzel K, Valentic TR, Shakya G, Gamarra N, Martinez D, Meier JL, Vagstad AL, Newman AG, Townsend CA, Burkart MD, Tsai SC (2016). Structural and Biochemical Analysis of Protein-Protein Interactions Between the Acyl-Carrier Protein and Product Template Domain. Angew Chem Int Ed Engl  55, 13005-13009.   https://doi.org/10.1002/anie.201605401|2. Kulkarni RA, Worth AJ, Zengeya TT, Shrimp JH, Garlick JM, Roberts AM, Montgomery DC, Sourbier C, Gibbs BK, Mesaros C, Tsai YC, Das S, Chan KC, Zhou M, Andresson T, Weissman AM, Linehan WM, Blair IA, Snyder NW, Meier JL (2017). Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity Profiling. Cell Chem Biol  24, 231-242.   https://doi.org/10.1016/j.chembiol.2017.01.002|3. Montgomery DC, Garlick JM, Kulkarni RA, Kennedy S, Allali-Hassani A, Kuo YM, Andrews AJ, Wu H, Vedadi M, Meier JL (2016). Global Profiling of Acetyltransferase Feedback Regulation. J Am Chem Soc  138, 6388-91.   https://doi.org/10.1021/jacs.6b03036|4. Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E (2016). Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. Elife  5.   https://doi.org/10.7554/eLife.11156|5. Shrimp JH, Sorum AW, Garlick JM, Guasch L, Nicklaus MC, Meier JL (2016). Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300. ACS Med Chem Lett  7, 151-5.   https://doi.org/10.1021/acsmedchemlett.5b00385|6. Sorum AW, Shrimp JH, Roberts AM, Montgomery DC, Tiwari NK, Lal-Nag M, Simeonov A, Jadhav A, Meier JL (2016). Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors. ACS Chem Biol  11, 734-41.   https://doi.org/10.1021/acschembio.5b00709|7. Zengeya TT, Garlick JM, Kulkarni RA, Miley M, Roberts AM, Yang Y, Crooks DR, Sourbier C, Linehan WM, Meier JL (2016). Co-opting a Bioorthogonal Reaction for Oncometabolite Detection. J Am Chem Soc  138, 15813-15816.   https://doi.org/10.1021/jacs.6b09706",https://intramural.nih.gov/search/searchview.taf?ipid=99175
412,BC011490-05,"October 01, 2016 -  September 30, 2017",Ubiquitin signaling for protein degradation,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Xiang  Chen|Xiuxiu  Lu|Vinidhra  Sridharan|Olumide R Kayode|Jacob David Vannoy|Evan Douglas Hooper|Show all 7,Daniel  Finley (Harvard Medical School)|Richard  Roden (The Johns Hopkins University)|Lan  Huang,Danielle  Ebelle (Office Of Workforce Planning & Development)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Chen X, Randles L, Shi K, Tarasov SG, Aihara H, Walters KJ (2016). Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome. Structure  24, 1257-1270.   https://doi.org/10.1016/j.str.2016.05.018|2. Chen X, Walters KJ (2016). (1)H, (15)N, (13)C resonance assignments for Saccharomyces cerevisiae Rad23 UBL domain. Biomol NMR Assign  10, 291-5.   https://doi.org/10.1007/s12104-016-9686-7|3. Finley D, Chen X, Walters KJ (2016). Gates, Channels, and Switches: Elements of the Proteasome Machine. Trends Biochem Sci  41, 77-93.   https://doi.org/10.1016/j.tibs.2015.10.009|4. Lu X, Nowicka U, Sridharan V, Liu F, Randles L, Hymel D, Dyba M, Tarasov SG, Tarasova NI, Zhao XZ, Hamazaki J, Murata S, Burke TR, Walters KJ (2017). Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets. Nat Commun  8, 15540.   https://doi.org/10.1038/ncomms15540|5. Nowicka U, Hoffman M, Randles L, Shi X, Khavrutskii L, Stefanisko K, Tarasova NI, Darwin KH, Walters KJ (2016). Mycobacterium tuberculosis copper-regulated protein SocB is an intrinsically disordered protein that folds upon interaction with a synthetic phospholipid bilayer. Proteins  84, 193-200.   https://doi.org/10.1002/prot.24970|6. Randles L, Anchoori RK, Roden RB, Walters KJ (2016). The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression. J Biol Chem  291, 8773-83.   https://doi.org/10.1074/jbc.M115.694588|7. Rao T, Gao R, Takada S, Al Abo M, Chen X, Walters KJ, Pommier Y, Aihara H (2016). Novel TDP2-ubiquitin interactions and their importance for the repair of topoisomerase II-mediated DNA damage. Nucleic Acids Res  44, 10201-10215.   https://doi.org/10.1093/nar/gkw719|8. Shi Y, Chen X, Elsasser S, Stocks BB, Tian G, Lee BH, Shi Y, Zhang N, de Poot SA, Tuebing F, Sun S, Vannoy J, Tarasov SG, Engen JR, Finley D, Walters KJ (2016). Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome. Science  351.   https://doi.org/10.1126/science.aad9421|9. Yu C, Yang Y, Wang X, Guan S, Fang L, Liu F, Walters KJ, Kaiser P, Huang L (2016). Characterization of Dynamic UbR-Proteasome Subcomplexes by In vivo Cross-linking (X) Assisted Bimolecular Tandem Affinity Purification (XBAP) and Label-free Quantitation. Mol Cell Proteomics  15, 2279-92.   https://doi.org/10.1074/mcp.M116.058271",https://intramural.nih.gov/search/searchview.taf?ipid=99176
413,BC011491-05,"October 01, 2016 -  September 30, 2017",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Mary Kate  Bonner; PhD|Julian Bernd Haase|Hayden Samuel Saunders|Yawen  Bai; PhD,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),Hyunmi Kim Halas; PhD (OD) |Jason T Swinderman (NHGRI) |Nasser M Rusan; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99174
414,BC011492-05,"October 01, 2016 -  September 30, 2017","Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Ana  Robles,"Ping  Yang; MD, PhD (Mayo Clinic)|Wataru  Yasui (Hiroshima University)",Kanke  Yasuyuki; MD (Molecular Genetics and Carcinogenesis Section)|Amelia Louise Parker (Molecular Genetics and Carcinogenesis Section)|Elise Dawn Bowman (Molecular Genetics and Carcinogenesis Section)|Mohammed A. Khan; PhD (Molecular Genetics and Carcinogenesis Section)|Judith A Welsh (Molecular Genetics and Carcinogenesis Section)|Elisa A Spillare (Molecular Genetics and Carcinogenesis Section),NULL,"1. Haznadar M, Cai Q, Krausz KW, Bowman ED, Margono E, Noro R, Thompson MD, Mathé EA, Munro HM, Steinwandel MD, Gonzalez FJ, Blot WJ, Harris CC (2016). Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev  25, 978-86.   https://doi.org/10.1158/1055-9965.EPI-15-1191|2. Inamura K, Song M, Jung S, Nishihara R, Yamauchi M, Lochhead P, Qian ZR, Kim SA, Mima K, Sukawa Y, Masuda A, Imamura Y, Zhang X, Pollak MN, Mantzoros CS, Harris CC, Giovannucci E, Fuchs CS, Cho E, Chan AT, Wu K, Ogino S (2016). Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv363|3. Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC (2016). Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans. Cancer Epidemiol Biomarkers Prev  25, 488-97.   https://doi.org/10.1158/1055-9965.EPI-15-0378|4. Robles AI, Harris CC (2017). Integration of multiple ""OMIC"" biomarkers: A precision medicine strategy for lung cancer. Lung Cancer  107, 50-58.   https://doi.org/10.1016/j.lungcan.2016.06.003|5. Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, Lauwers GY, Selaru FM, Popoli M, Pittman ME, Ke X, Hruban RH, Meltzer SJ, Kinzler KW, Vogelstein B, Harris CC, Papadopoulos N (2016). Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology  150, 931-43.   https://doi.org/10.1053/j.gastro.2015.12.036|6. Vargas AJ, Harris CC (2016). Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer  16, 525-37.   https://doi.org/10.1038/nrc.2016.56",https://intramural.nih.gov/search/searchview.taf?ipid=99143
415,BC011495-05,"October 01, 2016 -  September 30, 2017",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Ana  Robles,NULL,Elise Dawn Bowman (Molecular Genetics and Carcinogenesis Section)|Mohammed A. Khan; PhD (Molecular Genetics and Carcinogenesis Section)|Judith A Welsh (Molecular Genetics and Carcinogenesis Section)|Elisa A Spillare (Molecular Genetics and Carcinogenesis Section)|Takahiro  Oike (Molecular Genetics and Carcinogenesis Section)|Akihiko  Miyanaga; MD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Ben Khedher S, Neri M, Papadopoulos A, Christiani DC, Diao N, Harris CC, Olivo-Marston S, Schwartz AG, Cote M, Koushik A, Siemiatycki J, Landi MT, Hung RJ, McLaughlin J, Duell EJ, Andrew AS, Orlow I, Park BJ, Brenner H, Saum KU, Pesatori AC, Stücker I (2017). Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium. Int J Cancer  141, 309-323.   https://doi.org/10.1002/ijc.30750|2. Gansmo LB, Vatten L, Romundstad P, Hveem K, Ryan BM, Harris CC, Knappskog S, Lønning PE (2016). Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate. Oncotarget  7, 28637-46.   https://doi.org/10.18632/oncotarget.8705|3. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Büttner R, Harris CC, Yokota J, Thomas RK, Kohno T (2017). Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res  23, 1220-1226.   https://doi.org/10.1158/1078-0432.CCR-16-1069|4. Helwa R, Gansmo LB, Romundstad P, Hveem K, Vatten L, Ryan BM, Harris CC, Lønning PE, Knappskog S (2016). MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer. Sci Rep  6, 33153.   https://doi.org/10.1038/srep33153|5. Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, Marchand LL, Li S, McNeill LH, Ryan BM, Schwartz AG, Sison JD, Spitz MR, Tucker M, Wenzlaff AS, Wiencke JK, et al. [17 more authors] (2016). Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer  98, 33-42.   https://doi.org/10.1016/j.lungcan.2016.05.008",https://intramural.nih.gov/search/searchview.taf?ipid=99144
416,BC011496-05,"October 01, 2016 -  September 30, 2017","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Izumi  Horikawa|Natalia  von Muhlinen; PhD|Akriti  Trehan|Jessica Ann Beck,NULL,"Elisa A Spillare (Molecular Genetics and Carcinogenesis Section)|Tomer  Cooks (Molecular Genetics and Carcinogenesis Section)|Delphine  Lissa; PHARMD, PhD (Molecular Genetics and Carcinogenesis Section)|Kazunobu  Isogaya (Molecular Genetics and Carcinogenesis Section)|Ettore  Appella; MD (Chemical Immunology Section)",NULL,"1. Robles AI, Jen J, Harris CC (2016). Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harb Perspect Med  6.   https://doi.org/10.1101/cshperspect.a026294|2. Tang W, Robles AI, Beyer RP, Gray LT, Nguyen GH, Oshima J, Maizels N, Harris CC, Monnat RJ (2016). The Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription. Hum Mol Genet  25, 2060-2069.   https://doi.org/10.1093/hmg/ddw079|3. Turnquist C, Horikawa I, Foran E, Major EO, Vojtesek B, Lane DP, Lu X, Harris BT, Harris CC (2016). p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ  23, 1515-28.   https://doi.org/10.1038/cdd.2016.37",https://intramural.nih.gov/search/searchview.taf?ipid=99145
417,BC011501-05,"October 01, 2016 -  September 30, 2017",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Tianhong  Wang|Kyota  Yasuda; PhD|Michael Scott Stueland|Asma Maryam Azam|George Constantine Chrisafis,Helim  Aranda-Espinoza (University of Maryland)|James  Shorter (MIT),Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Wang T, Hamilla S, Cam M, ArandaEspinoza H, Mili S (2017) Extracellular Matrix Stiffness and Cell Contractility Control RNA Localization to Promote Cell Migration. Nature Communications, in press.|2. Yasuda K, Mili S (2016). Dysregulated axonal RNA translation in amyotrophic lateral sclerosis. Wiley Interdiscip Rev RNA  7, 589-603.   https://doi.org/10.1002/wrna.1352",https://intramural.nih.gov/search/searchview.taf?ipid=99171
418,BC011502-05,"October 01, 2016 -  September 30, 2017",Characterization of Biological Nanoparticle Subsets,"Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",NULL,Marty  Bigos (Stanford)|David  Park (Stanford)|Gordon  Freeman (Harvard)|Susan  Knox (Stanford)|Vasilis  Toxavidis (Beth Israel Deaconess Medical Center)|Tigges  John (BIDMC)|Show all 8,"Marjorie  Robert-Guroff; PhD (Vaccine Branch)|William G Telford (Experimental Transplantation and Immunology Branch)|Masaki  Terabe (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Anu  Puri; PhD (Rna Biology Laboratory)",Marc  Ferrer-Alegre (NCATS),"1. Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, Rosner A, Demberg T, Watson DC, Karpova TS, Freeman GJ, DeKruyff RH, Pavlakis GN, Terabe M, Robert-Guroff M, Berzofsky JA, Jones JC (2017). Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep  7, 1878.   https://doi.org/10.1038/s41598-017-01731-2|2. Musich T, Jones JC, Keele BF, Jenkins LMM, Demberg T, Uldrick TS, Yarchoan R, Robert-Guroff M (2017). Flow virometric sorting and analysis of HIV quasispecies from plasma. JCI Insight  2, e90626.   https://doi.org/10.1172/jci.insight.90626",https://intramural.nih.gov/search/searchview.taf?ipid=99172
419,BC011503-05,"October 01, 2016 -  September 30, 2017",Novel Combinations of Radiation and Immunotherapy,"Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",NULL,Gordon  Freeman (Harvard)|Dale  Umetsu (Children's Hospital Boston)|Rosemarie  DeKruyff (Children's Hospital Boston)|Susan  Knox (Stanford),"Kevin A Camphausen; MD (Radiation Oncology Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)",NULL,"1. Danielson KM, Estanislau J, Tigges J, Toxavidis V, Camacho V, Felton EJ, Khoory J, Kreimer S, Ivanov AR, Mantel PY, Jones J, Akuthota P, Das S, Ghiran I (2016). Diurnal Variations of Circulating Extracellular Vesicles Measured by Nano Flow Cytometry. PLoS One  11, e0144678.   https://doi.org/10.1371/journal.pone.0144678|2. Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FW, Das S, Driedonks TA, Fernández-Messina L, Haderk F, Hill AF, Jones JC, Van Keuren-Jensen KR, Lai CP, Lässer C, Liegro ID, Lunavat TR, Lorenowicz MJ, Maas SL, Mäger I, Mittelbrunn M, Momma S, et al. [11 more authors] (2017). Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracell Vesicles  6, 1286095.   https://doi.org/10.1080/20013078.2017.1286095|3. Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, Rosner A, Demberg T, Watson DC, Karpova TS, Freeman GJ, DeKruyff RH, Pavlakis GN, Terabe M, Robert-Guroff M, Berzofsky JA, Jones JC (2017). Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep  7, 1878.   https://doi.org/10.1038/s41598-017-01731-2|4. Musich T, Jones JC, Keele BF, Jenkins LMM, Demberg T, Uldrick TS, Yarchoan R, Robert-Guroff M (2017). Flow virometric sorting and analysis of HIV quasispecies from plasma. JCI Insight  2, e90626.   https://doi.org/10.1172/jci.insight.90626|5. Nolan JP, Jones JC (2017). Detection of platelet vesicles by flow cytometry. Platelets  28, 256-262.   https://doi.org/10.1080/09537104.2017.1280602",https://intramural.nih.gov/search/searchview.taf?ipid=99173
420,BC011504-05,"October 01, 2016 -  September 30, 2017",Study the roles of p53 and p53 mutants in mesenchymal stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shunlin  Jiang|Navdeep  Malik|Zhuo  Cai|Jian  Xu|Beverly  Mock; PhD,NULL,NULL,Chengyu  Liu; PhD (NHLBI),"1. He Y, Zhu W, Shin MH, Gary J, Liu C, Dubois W, Hoover SB, Jiang S, Marrogi E, Mock B, Simpson RM, Huang J (2017). cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma. Stem Cell Reports  8, 1630-1644.   https://doi.org/10.1016/j.stemcr.2017.04.029|2. Shin MH, He Y, Marrogi E, Piperdi S, Ren L, Khanna C, Gorlick R, Liu C, Huang J (2016). A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells. PLoS Genet  12, e1005884.   https://doi.org/10.1371/journal.pgen.1005884",https://intramural.nih.gov/search/searchview.taf?ipid=99156
421,BC011505-05,"October 01, 2016 -  September 30, 2017",Characterization of the hematopoietic stem cell lineage,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Matthew J Anderson,NULL,Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99141
422,BC011506-05,"October 01, 2016 -  September 30, 2017",New Synthetic Approaches to Small Molecules for Imaging,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Venu Gopal Bandi|Gabrielle Renee Hammersley|Gabriel Moshe Kline,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),NULL,"1. Chan ST, Nani RR, Schauer EA, Martin GE, Williamson RT, Saurí J, Buevich AV, Schafer WA, Joyce LA, Goey AK, Figg WD, Ransom TT, Henrich CJ, McKee TC, Moser A, MacDonald SA, Khan S, McMahon JB, Schnermann MJ, Gustafson KR (2016). Characterization and Synthesis of Eudistidine C, a Bioactive Marine Alkaloid with an Intriguing Molecular Scaffold. J Org Chem  81, 10631-10640.   https://doi.org/10.1021/acs.joc.6b02380|2. Sato K, Gorka AP, Nagaya T, Michie MS, Nakamura Y, Nani RR, Coble VL, Vasalatiy OV, Swenson RE, Choyke PL, Schnermann MJ, Kobayashi H (2016). Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates. Mol Biosyst  12, 3046-56.   https://doi.org/10.1039/c6mb00371k",https://intramural.nih.gov/search/searchview.taf?ipid=99170
423,BC011511-05,"October 01, 2016 -  September 30, 2017",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Amanda Lee Whiting|Francisco Antonio Aguilar Alonso; PhD|Ye Joon  Kim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99161
424,BC011512-05,"October 01, 2016 -  September 30, 2017",Activatable molecular cancer imaging probe,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Yasuteru  Urano|Marcin  Ptaszek (UMBC)|Yu  Chen (Univ of Maryland)|Neil  Bander (Cornell Univ),Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Kobayashi H, Choyke PL, Ogawa M (2016). Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology. Curr Opin Chem Biol  33, 32-8.   https://doi.org/10.1016/j.cbpa.2016.05.015|2. Nakamura Y, Mochida A, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H (2017). A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-βGal for detecting cancer: Advantages of anchoring to cellular proteins after activation. Oncotarget  8, 39512-39521.   https://doi.org/10.18632/oncotarget.17080|3. Nakamura Y, Shen RF, Harada T, Nagaya T, Sato N, Okuyama S, Ogata F, Choyke PL, McCarley R, Kobayashi H (2017) Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1). Oncotarget 8:61181-92|4. Shinden Y, Ueo H, Tobo T, Gamachi A, Utou M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, et al. [10 more authors] (2016). Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green. Sci Rep  6, 27525.   https://doi.org/10.1038/srep27525",https://intramural.nih.gov/search/searchview.taf?ipid=99154
425,BC011513-05,"October 01, 2016 -  September 30, 2017",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Mikako  Ogawa|Yu  Chen (Univ of Maryland)|Peter  Marinkovich (Stnford Univ)|Zaver  Bhujwalla (Johns Hopkins)|Toshiyoshi  Fujiwara (Okayama Univ),Mitchell  Ho (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Harada T, Nakamura Y, Sato K, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H (2016). Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Oncotarget  7, 79408-79416.   https://doi.org/10.18632/oncotarget.12710|2. Ishida M, Kagawa S, Shimoyama K, Takehara K, Noma K, Tanabe S, Shirakawa Y, Tazawa H, Kobayashi H, Fujiwara T (2016). Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer. Mol Cancer Ther  15, 402-11.   https://doi.org/10.1158/1535-7163.MCT-15-0644|3. Ito K, Mitsunaga M, Arihiro S, Saruta M, Matsuoka M, Kobayashi H, Tajiri H (2016). Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms. BMC Cancer  16, 37.   https://doi.org/10.1186/s12885-016-2072-0|4. Ito K, Mitsunaga M, Nishimura T, Kobayashi H, Tajiri H (2016). Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging. Oncotarget  7, 14143-52.   https://doi.org/10.18632/oncotarget.7490|5. Jin J, Krishnamachary B, Mironchik Y, Kobayashi H, Bhujwalla ZM (2016). Phototheranostics of CD44-positive cell populations in triple negative breast cancer. Sci Rep  6, 27871.   https://doi.org/10.1038/srep27871|6. Jing H, Weidensteiner C, Reichardt W, Gaedicke S, Zhu X, Grosu AL, Kobayashi H, Niedermann G (2016). Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies. Theranostics  6, 862-74.   https://doi.org/10.7150/thno.12890|7. Kobayashi H, Choyke PL (2016). Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy. Nanoscale  8, 12504-9.   https://doi.org/10.1039/c5nr05552k|8. Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2017). Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody. Mol Cancer Res  15, 1153-1162.   https://doi.org/10.1158/1541-7786.MCR-17-0164|9. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Hodge JW, Schlom J, Kobayashi H (2017). Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Oncotarget  8, 8807-8817.   https://doi.org/10.18632/oncotarget.12410|10. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H (2016). Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). J Control Release  232, 1-8.   https://doi.org/10.1016/j.jconrel.2016.04.003|11. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H (2016). Near infrared photoimmunotherapy of B-cell lymphoma. Mol Oncol  10, 1404-1414.   https://doi.org/10.1016/j.molonc.2016.07.010|12. Nagaya T, Nakamura Y, Sato K, Zhang YF, Ni M, Choyke PL, Ho M, Kobayashi H (2016). Near infrared photoimmunotherapy with an anti-mesothelin antibody. Oncotarget  7, 23361-9.   https://doi.org/10.18632/oncotarget.8025|13. Nakamura Y, Bernardo M, Nagaya T, Sato K, Harada T, Choyke PL, Kobayashi H (2016). MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy. Oncotarget  7, 17254-64.   https://doi.org/10.18632/oncotarget.7357|14. Nakamura Y, Nagaya T, Sato K, Harada T, Okuyama S, Choyke PL, Yamauchi T, Kobayashi H (2016). Alterations of filopodia by near infrared photoimmunotherapy: evaluation with 3D low-coherent quantitative phase microscopy. Biomed Opt Express  7, 2738-48.   https://doi.org/10.1364/BOE.7.002738|15. Nakamura Y, Nagaya T, Sato K, Okuyama S, Ogata F, Wong K, Adler S, Choyke PL, Kobayashi H (2017). Cerenkov Radiation-Induced Photoimmunotherapy with 18F-FDG. J Nucl Med  58, 1395-1400.   https://doi.org/10.2967/jnumed.116.188789|16. Nakamura Y, Ohler ZW, Householder D, Nagaya T, Sato K, Okuyama S, Ogata F, Daar D, Hoa T, Choyke PL, Kobayashi H (2017). Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Mol Cancer Ther  16, 408-414.   https://doi.org/10.1158/1535-7163.MCT-16-0663|17. Ogata F, Nagaya T, Nakamura Y, Sato K, Okuyama S, Maruoka Y, Choyke PL, Kobayashi H (2017). Near-infrared photoimmunotherapy: a comparison of light dosing schedules. Oncotarget  8, 35069-35075.   https://doi.org/10.18632/oncotarget.17047|18. Ogawa M, Tomita Y, Nakamura Y, Lee MJ, Lee S, Tomita S, Nagaya T, Sato K, Yamauchi T, Iwai H, Kumar A, Haystead T, Shroff H, Choyke PL, Trepel JB, Kobayashi H (2017). Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget  8, 10425-10436.   https://doi.org/10.18632/oncotarget.14425|19. Sato K, Choyke PL, Hisataka K (2016). Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique. J Vis Exp  .  https://doi.org/10.3791/53633|20. Sato K, Watanabe R, Hanaoka H, Nakajima T, Choyke PL, Kobayashi H (2016). Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy. Oncotarget  7, 14324-35.   https://doi.org/10.18632/oncotarget.7365",https://intramural.nih.gov/search/searchview.taf?ipid=99155
426,BC011514-05,"October 01, 2016 -  September 30, 2017",Investigating Pediatric CNS tumor biology,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Eric H Raabe|Javad  Nazarian (Children's National Medical Center)|Michelle  Monje-Deisseroth (Stanford)|Nada  Jabado (McGill University)",Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),NULL,"1. Miyahara H, Yadavilli S, Natsumeda M, Rubens JA, Rodgers L, Kambhampati M, Taylor IC, Kaur H, Asnaghi L, Eberhart CG, Warren KE, Nazarian J, Raabe EH (2017). The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma. Cancer Lett  400, 110-116.   https://doi.org/10.1016/j.canlet.2017.04.019|2. Nikbakht H, Panditharatna E, Mikael LG, Li R, Gayden T, Osmond M, Ho CY, Kambhampati M, Hwang EI, Faury D, Siu A, Papillon-Cavanagh S, Bechet D, Ligon KL, Ellezam B, Ingram WJ, Stinson C, Moore AS, Warren KE, Karamchandani J, Packer RJ, Jabado N, Majewski J, Nazarian J (2016). Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun  7, 11185.   https://doi.org/10.1038/ncomms11185",https://intramural.nih.gov/search/searchview.taf?ipid=99153
427,BC011518-05,"October 01, 2016 -  September 30, 2017",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park|Yang  Chen|Liang  Zhang; PhD|Jong Il  Ahn|Seongjin  Choe,Jeong Kyu Bang|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology),Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)|Yun Xing M Wang (Structural Biophysics Laboratory),Rodolfo  Ghirlando; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99146
428,BC011519-05,"October 01, 2016 -  September 30, 2017",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Adenrele Madeline Gleason; PhD,"Nevan  Krogan (Univ of California, San Francisco)|Mark  Winey (Mol. Cell and Dev. Biology, Univ. of Colorado)",NULL,NULL,"1. Ebrahimi H, Cooper JP (2016). Finding a place in the SUN: telomere maintenance in a diverse nuclear landscape. Curr Opin Cell Biol  40, 145-152.   https://doi.org/10.1016/j.ceb.2016.03.011|2. Fernández-Álvarez A, Bez C, O'Toole ET, Morphew M, Cooper JP (2016). Mitotic Nuclear Envelope Breakdown and Spindle Nucleation Are Controlled by Interphase Contacts between Centromeres and the Nuclear Envelope. Dev Cell  39, 544-559.   https://doi.org/10.1016/j.devcel.2016.10.021|3. Zaaijer S, Shaikh N, Nageshan RK, Cooper JP (2016). Rif1 Regulates the Fate of DNA Entanglements during Mitosis. Cell Rep  16, 148-160.   https://doi.org/10.1016/j.celrep.2016.05.077",https://intramural.nih.gov/search/searchview.taf?ipid=99177
429,BC011524-05,"October 01, 2016 -  September 30, 2017",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,"1. Afasizheva A, Devine A, Tillman H, Fung KL, Vieira WD, Blehm BH, Kotobuki Y, Busby B, Chen EI, Tanner K (2016). Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival. BMC Cancer  16, 186.   https://doi.org/10.1186/s12885-016-2211-7|2. Staunton J, Blehm B, Devine A, Tanner K (2017) In situ calibration of position detection in an optical trap for active microrheology in viscous materials Optics Express 25:1746-1761",https://intramural.nih.gov/search/searchview.taf?ipid=99169
430,BC011525-05,"October 01, 2016 -  September 30, 2017",Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Dana-Adriana  Botesteanu|Ethan S Brill|Jayakumar Ramachandran Nair|Tzu-Ting  Huang|Mitchell James Gillard,NULL,Bradford J Wood; MD (Office of the Director)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Liang  Cao (Cancer Genetics Branch),Craig Joseph Thomas (NCATS),"1. Botesteanu DA, Lee JM, Levy D (2016). Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection. PLoS One  11, e0156661.   https://doi.org/10.1371/journal.pone.0156661|2. Botesteanu DA, Lipkowitz S, Lee JM, Levy D (2016). Mathematical models of breast and ovarian cancers. Wiley Interdiscip Rev Syst Biol Med  8, 337-62.   https://doi.org/10.1002/wsbm.1343|3. Peer CJ, Lee JM, Roth J, Rodgers L, Nguyen J, Annunziata CM, Minasian L, Kohn EC, Figg WD (2017). Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women's cancers. Cancer Chemother Pharmacol  80, 165-175.   https://doi.org/10.1007/s00280-017-3346-1",https://intramural.nih.gov/search/searchview.taf?ipid=99159
431,BC011528-05,"October 01, 2016 -  September 30, 2017","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Yvonne  Wall|Rebecca Christine Dolan,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99167
432,BC011529-05,"October 01, 2016 -  September 30, 2017",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang|Constance M Cultraro|Shivangi  Awasthi,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99165
433,BC011547-04,"October 01, 2016 -  September 30, 2017",Cancer Immunotherapy Clinical Trials,Julius Yehuda Strauss; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Andrea Danielle Burmeister|Bonnie L Casey|Camilo  Pacheco|Margaret Elena Gatti-Mays|Cynthia Ann Moye|Renee Nicole Donahue|Show all 9,"Olaf  Christensen (EMD Serono, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Zhen  Su (EMD Serono-Merck)","Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)","Lisa Marie Cordes; PHARMD, BCACP (CC)","1. Strauss J, Madan RA (2016). Therapeutic vaccines for prostate cancer: recent advances and future directions. Expert Rev Vaccines  15, 907-14.   https://doi.org/10.1586/14760584.2016.1155988|2. Strauss J, Madan RA, Gulley JL (2016). Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors. Expert Opin Biol Ther  16, 895-901.   https://doi.org/10.1517/14712598.2016.1170805",https://intramural.nih.gov/search/searchview.taf?ipid=99211
434,BC011549-04,"October 01, 2016 -  September 30, 2017",Chronic graft-versus-host disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",Dominique C Pichard (NIAMS),"1. Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, Gress RE (2016). Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease. J Immunol  197, 3490-3503.   https://doi.org/10.4049/jimmunol.1601054",https://intramural.nih.gov/search/searchview.taf?ipid=99208
435,BC011550-04,"October 01, 2016 -  September 30, 2017",Anakinra for neutrophilic pustular skin disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Dominique C Pichard (NIAMS) |Alison Anne McBride; PhD (NIAID) |Maria Irene Morasso; PhD (NIAMS) |Nehal N Mehta (NHLBI) |Raphaela  Goldbach-Mansky; MD, MHS (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99209
436,BC011551-04,"October 01, 2016 -  September 30, 2017",Structural studies of molecular targets for drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",George T Lountos|Danielle  Needle|Rajesh  Gumpena|Anna Maria Mielech|Wonchull  Kang,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Kamal  Saikh (USAMRIID)",John Stephen Schneekloth (Chemical Biology Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,"1. Waugh DS (2016). Crystal structures of MBP fusion proteins. Protein Sci  25, 559-71.   https://doi.org/10.1002/pro.2863",https://intramural.nih.gov/search/searchview.taf?ipid=99210
437,BC011552-04,"October 01, 2016 -  September 30, 2017",Targeting mechanisms of radiation resistance,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Ayla Oksuz White|Bradley T Scroggins|Shilpa Shantinath Patil; PhD|Jessica Leigh Reedy|Hong G Zhang; PhD,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Bradford J Wood; MD (Office of the Director),NULL,"1. Citrin DE (2016). Short-Term Screening Assays for the Identification of Therapeutics for Cancer. Cancer Res  76, 3443-5.   https://doi.org/10.1158/0008-5472.CAN-16-1299|2. Reed A, Valle LF, Shankavaram U, Krauze A, Kaushal A, Schott E, Cooley-Zgela T, Wood B, Pinto P, Choyke P, Turkbey B, Citrin DE (2017). Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. Int J Radiat Oncol Biol Phys  97, 947-951.   https://doi.org/10.1016/j.ijrobp.2016.12.016|3. Valle L, Thomas J, Kim C, Szabo E, Brown GT, Citrin D, Rajan A (2017). Hepatoid adenocarcinoma of the lung metastasizing to the tonsil. Mol Clin Oncol  6, 705-707.   https://doi.org/10.3892/mco.2017.1215",https://intramural.nih.gov/search/searchview.taf?ipid=99207
438,BC011554-04,"October 01, 2016 -  September 30, 2017",Lung Cancer Health Disparities,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Adriana  Zingone; MD|Curtis  Harris; MD,Pine  Sharon (Rutgers Cancer Institute of New Jersey)|Rick  Kittles (University of Arizona Cancer Center)|Keisha  Houston (Centers for Disease Control and Prevention),"Khadijah A Mitchell (Molecular Genetics and Carcinogenesis Section)|Claire Laurie Anne Meaney (Cancer Prevention Fellowship Program)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Bin  Zhu (Biostatistics Branch)",Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),"1. Meaney CL, Zingone A, Brown D, Yu Y, Cao L, Ryan BM (2017). Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma. Oncotarget  8, 40946-40957.   https://doi.org/10.18632/oncotarget.16784|2. Mitchell K, Zingone A, Toulabi L, Boeckelman J, Ryan B (2017) Comparative Transcriptome Profiling Reveals Coding and Non-Coding RNA Differences in Lung Cancer from African and European Americans. Clinical Cancer Research, in press.|3. Ryan BM (2016). Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines. BMJ Open Respir Res  3, e000166.   https://doi.org/10.1136/bmjresp-2016-000166",https://intramural.nih.gov/search/searchview.taf?ipid=99205
439,BC011555-04,"October 01, 2016 -  September 30, 2017",Gene-Environment Interactions in Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Adriana  Zingone; MD,NULL,Leila Bahadori Toulabi; PhD (Molecular Genetics and Carcinogenesis Section)|Jinqiu  Chen (Laboratory of Cancer Biology and Genetics)|Rachael Zoe Solomon (Hormonal and Reproductive Epidemiology Branch),Miguel  Skirzewski Prieto; PhD (NICHD),"1. Zingone A, Brown D, Bowman E, Vidal O, Sage J, Neal J, Ryan B (2017) Relationship between anti-depressant use and lung cancer survival Cancer Research and Treatment Communications 10:33-39",https://intramural.nih.gov/search/searchview.taf?ipid=99206
440,BC011558-04,"October 01, 2016 -  September 30, 2017",Effects of systemic and topical perturbations on human microbes,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Eric  Simpson (Oregon Health and Sciences University)|Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Alan  Irvine (Trinity College)|Lloyd  Miller (Johns Hopkins),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)",Jay Hyun  Jo; PhD (NIAMS) |Monica Elizabeth Taylor (NIAMS) |Valentina Shobhana Pillai; CRNP (NIAMS) |Iryna Leonidivna Chub (NIAMS) |Sheila E Phang (NIAMS) |Julia A Segre; PhD (NHGRI),"1. Byrd AL, Deming C, Cassidy SKB, Harrison OJ, Ng WI, Conlan S, NISC Comparative Sequencing Program, Belkaid Y, Segre JA, Kong HH (2017). Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med  9.   https://doi.org/10.1126/scitranslmed.aal4651|2. Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, et al. [19 more authors] (2016). Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight  1.   https://doi.org/10.1172/jci.insight.88782|3. Jo JH, Deming C, Kennedy EA, Conlan S, Polley EC, Ng WI, NISC Comparative Sequencing Program, Segre JA, Kong HH (2016). Diverse Human Skin Fungal Communities in Children Converge in Adulthood. J Invest Dermatol  136, 2356-2363.   https://doi.org/10.1016/j.jid.2016.05.130|4. Jo JH, Kennedy EA, Kong HH (2016). Research Techniques Made Simple: Bacterial 16S Ribosomal RNA Gene Sequencing in Cutaneous Research. J Invest Dermatol  136, e23-e27.   https://doi.org/10.1016/j.jid.2016.01.005|5. Jo JH, Kennedy EA, Kong HH (2017). Topographical and physiological differences of the skin mycobiome in health and disease. Virulence  8, 324-333.   https://doi.org/10.1080/21505594.2016.1249093|6. Kennedy EA, Connolly J, Hourihane JO, Fallon PG, McLean WHI, Murray D, Jo JH, Segre JA, Kong HH, Irvine AD (2017). Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol  139, 166-172.   https://doi.org/10.1016/j.jaci.2016.07.029|7. Kong HH (2016). Details Matter: Designing Skin Microbiome Studies. J Invest Dermatol  136, 900-902.   https://doi.org/10.1016/j.jid.2016.03.004|8. Kong HH, Andersson B, Clavel T, Common JE, Jackson SA, Olson ND, Segre JA, Traidl-Hoffmann C (2017). Performing Skin Microbiome Research: A Method to the Madness. J Invest Dermatol  137, 561-568.   https://doi.org/10.1016/j.jid.2016.10.033|9. Kong HH, Morris A (2017). The emerging importance and challenges of the human mycobiome. Virulence  8, 310-312.   https://doi.org/10.1080/21505594.2017.1279780|10. Oh J, Byrd AL, Park M, NISC Comparative Sequencing Program, Kong HH, Segre JA (2016). Temporal Stability of the Human Skin Microbiome. Cell  165, 854-66.   https://doi.org/10.1016/j.cell.2016.04.008|11. Tsai YC, Conlan S, Deming C, NISC Comparative Sequencing Program, Segre JA, Kong HH, Korlach J, Oh J (2016). Resolving the Complexity of Human Skin Metagenomes Using Single-Molecule Sequencing. MBio  7, e01948-15.   https://doi.org/10.1128/mBio.01948-15",https://intramural.nih.gov/search/searchview.taf?ipid=99204
441,BC011559-04,"October 01, 2016 -  September 30, 2017",The role of the tumor biofilm in determining tissue tropism,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99202
442,BC011561-04,"October 01, 2016 -  September 30, 2017",Exploring mechanisms that govern immune homeostasis in skin,Keisuke  Nagao|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,"Daniel M Kaplan|Masayuki  Amagai (Keio University School of Medicine)|Mike  Rosenblum (University of California, San Francisco)",Mark  Udey; MD (Office Of The Clinical Director)|Stefania  Pittaluga (Laboratory of Pathology)|Bao D Quoe  Tran (Office of the Director),Heidi H Kong (NIAMS) |Julia A Segre; PhD (NHGRI) |Warren J Leonard; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99200
443,BC011564-04,"October 01, 2016 -  September 30, 2017",Near-IR Photorelease Chemistry: Discovery and Applications,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Tsuyoshi  Yamamoto; PhD,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Anderson ED, Gorka AP, Schnermann MJ (2016). Near-infrared uncaging or photosensitizing dictated by oxygen tension. Nat Commun  7, 13378.   https://doi.org/10.1038/ncomms13378|2. Nani RR, Gorka AP, Nagaya T, Yamamoto T, Ivanic J, Kobayashi H, Schnermann MJ (2017). In Vivo Activation of Duocarmycin-Antibody Conjugates by Near-Infrared Light. ACS Cent Sci  3, 329-337.   https://doi.org/10.1021/acscentsci.7b00026",https://intramural.nih.gov/search/searchview.taf?ipid=99201
444,BC011565-04,"October 01, 2016 -  September 30, 2017",Adoptive T cell Therapy for Pediatric Leukemia,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Boro  Dropulic|Stephen  Grupp (University of Pennsylvania Cancer Center,)|Sarah  Tasian (Children's Hospital of Philadelphia)|Mark  Gilbert (Juno Therapeutics)|David  Hilbert (HGSI, Inc.)",Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99199
445,BC011566-04,"October 01, 2016 -  September 30, 2017","Mechanism, Regulation and Application of miRNA pathway in cancer",Shuo  Gu|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI","Mikhail V Kashlev|Zhi Ming  Zheng; MD, PhD|Bruce Allen Shapiro; PhD","Mark  Kay (Stanford University, School of Medicine)|Peng  Ye (Texas A&M University)",Xinhua  Ji; PhD (Biomolecular Structure Section)|John Stephen Schneekloth (Chemical Biology Laboratory)|Yun Xing M Wang (Structural Biophysics Laboratory),Markus  Hafner (NIAMS),"1. Bofill-De Ros X, Gu S (2016). Guidelines for the optimal design of miRNA-based shRNAs. Methods  103, 157-66.   https://doi.org/10.1016/j.ymeth.2016.04.003|2. Dai L, Chen K, Youngren B, Kulina J, Yang A, Guo Z, Li J, Yu P, Gu S (2016). Cytoplasmic Drosha activity generated by alternative splicing. Nucleic Acids Res  44, 10454-10466.   https://doi.org/10.1093/nar/gkw668",https://intramural.nih.gov/search/searchview.taf?ipid=99196
446,BC011568-04,"October 01, 2016 -  September 30, 2017",Natural Products Discovery and Characterization Through Network Collaborations,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",Heidi  Bokesch|Laura  Cartner|Richard W Fuller,NULL,Thomas Joseph Sayers; PhD (Cancer Inflammation Program)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|David  Covell (Screening Technologies Branch)|Megan L Peach (Chemical Biology Laboratory),NULL,"1. Goey AK, Chau CH, Sissung TM, Cook KM, Venzon DJ, Castro A, Ransom TR, Henrich CJ, McKee TC, McMahon JB, Grkovic T, Cadelis MM, Copp BR, Gustafson KR, Figg WD (2016). Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction. J Nat Prod  79, 1267-75.   https://doi.org/10.1021/acs.jnatprod.5b00846|2. Yuan W, Cheng S, Fu W, Zhao M, Li X, Cai Y, Dong J, Huang K, Gustafson KR, Yan P (2016). Structurally Diverse Metabolites from the Soft Coral Sinularia verruca Collected in the South China Sea. J Nat Prod  79, 1124-31.   https://doi.org/10.1021/acs.jnatprod.6b00031|3. Zhao M, Cheng S, Yuan W, Xi Y, Li X, Dong J, Huang K, Gustafson KR, Yan P (2016). Cembranoids from a Chinese Collection of the Soft Coral Lobophytum crassum. Mar Drugs  14.   https://doi.org/10.3390/md14060111",https://intramural.nih.gov/search/searchview.taf?ipid=99198
447,BC011575-04,"October 01, 2016 -  September 30, 2017",Modulation of Radiation Response and Metabolism,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Graham Hart Read|Kelsey Theresa Kines,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|David Anderson Wink (Cancer Inflammation Program)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99190
448,BC011577-04,"October 01, 2016 -  September 30, 2017",Novel Imaging Approaches to Solid Tumors,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Graham Hart Read|Kelsey Theresa Kines,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99191
449,BC011584-04,"October 01, 2016 -  September 30, 2017",Clinical trials in womens cancers,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Michelle K Ozaki|Stanley  Lipkowitz; MD, PhD|Jung-Min  Lee",NULL,Jinqiu  Chen (Laboratory of Cancer Biology and Genetics),Kathryn C Zoon; PhD (NIAID),"1. Zorn KK, Annunziata CM (2016). Editorial: Inhibiting PARP as a Strategic Target in Cancer. Front Oncol  6, 91.   https://doi.org/10.3389/fonc.2016.00091",https://intramural.nih.gov/search/searchview.taf?ipid=99186
450,BC011585-04,"October 01, 2016 -  September 30, 2017",Identification of Nucleic Acid Binding Small Molecules,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Thomas A Misteli; PhD (Office of the Director)|Natasha  Caplen (Cancer Genetics Branch)|Kylie Janice Walters (Structural Biophysics Laboratory),NULL,"1. Abulwerdi FA, Schneekloth JS (2016). Microarray-based technologies for the discovery of selective, RNA-binding molecules. Methods  103, 188-95.   https://doi.org/10.1016/j.ymeth.2016.04.022|2. Abulwerdi FA, Shortridge MD, Sztuba-Solinska J, Wilson R, Le Grice SF, Varani G, Schneekloth JS (2016). Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA. J Med Chem  59, 11148-11160.   https://doi.org/10.1021/acs.jmedchem.6b01450|3. Connelly CM, Moon MH, Schneekloth JS (2016). The Emerging Role of RNA as a Therapeutic Target for Small Molecules. Cell Chem Biol  23, 1077-1090.   https://doi.org/10.1016/j.chembiol.2016.05.021",https://intramural.nih.gov/search/searchview.taf?ipid=99187
451,BC011592-04,"October 01, 2016 -  September 30, 2017",Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99183
452,BC011593-04,"October 01, 2016 -  September 30, 2017",Investigation of Epigenetic Modifiers in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li|Leonard  Neckers; PhD,NULL,Jane Beth Trepel (Developmental Therapeutics Branch),NULL,"1. Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK (2017). Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep  7, 201.   https://doi.org/10.1038/s41598-017-00143-6",https://intramural.nih.gov/search/searchview.taf?ipid=99184
453,BC011594-04,"October 01, 2016 -  September 30, 2017",Targeting the MET pathway in urothelial carcinoma,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",NULL,NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,1. Apolo A (2016) The illusion of an ideal biomarker Eur Urol Focus 1 (3):269-71,https://intramural.nih.gov/search/searchview.taf?ipid=99181
454,BC011627-03,"October 01, 2016 -  September 30, 2017",Myosin VI: a new ubiquitin receptor,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Gwen Rebecca Buel,NULL,NULL,NULL,"1. He F, Wollscheid HP, Nowicka U, Biancospino M, Valentini E, Ehlinger A, Acconcia F, Magistrati E, Polo S, Walters KJ (2016). Myosin VI Contains a Compact Structural Motif that Binds to Ubiquitin Chains. Cell Rep  14, 2683-94.   https://doi.org/10.1016/j.celrep.2016.01.079|2. Wollscheid HP, Biancospino M, He F, Magistrati E, Molteni E, Lupia M, Soffientini P, Rottner K, Cavallaro U, Pozzoli U, Mapelli M, Walters KJ, Polo S (2016). Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain. Nat Struct Mol Biol  23, 300-308.   https://doi.org/10.1038/nsmb.3187",https://intramural.nih.gov/search/searchview.taf?ipid=99230
455,BC011630-03,"October 01, 2016 -  September 30, 2017",Metabolomic Profiling of Esophageal Cancers,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Deborah Rae Surman|Yuan  Xu; PhD|David  Schrump; MD|Udayan  Guha,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99232
456,BC011631-03,"October 01, 2016 -  September 30, 2017",Synergy of Bile Acid and Cigarette Smoke on Esophageal Cancer Progression,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Yuan  Xu; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99233
457,BC011632-03,"October 01, 2016 -  September 30, 2017",Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Kate Elizabeth Brown|David  Schrump; MD,NULL,Ettore  Appella; MD (Chemical Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99227
458,BC011633-03,"October 01, 2016 -  September 30, 2017",T cell Development and Regeneration,"Avinash  Bhandoola; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Of Genome Integrity, NCI",Christelle Mathilde Charlotte Harly|Jennifer Elizabeth Cowan|Qi  Yang|Brian Matthew Larsen|Devin James Kenney|Yongge  Zhao|Show all 8,David  Allman (University of Pennsylvania)|Golnaz  Vahedi,NULL,NULL,"1. Cowan J, Bhandoola A (2016). Progress on thymic function from Maui. Nat Immunol  17, 1129-32.   https://doi.org/10.1038/ni.3555|2. Harly C, Bhandoola A (2016). A doppelgänger of T cell development. Cell Cycle  15, 479-80.   https://doi.org/10.1080/15384101.2015.1125244|3. Lin WW, Nish SA, Yen B, Chen YH, Adams WC, Kratchmarov R, Rothman NJ, Bhandoola A, Xue HH, Reiner SL (2016). CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination. Cell Rep  17, 1773-1782.   https://doi.org/10.1016/j.celrep.2016.10.032|4. Manna S, Bhandoola A (2016). Intrathymic Injection. Methods Mol Biol  1323, 203-9.   https://doi.org/10.1007/978-1-4939-2809-5_17|5. Morgado-Palacin I, Day A, Murga M, Lafarga V, Anton ME, Tubbs A, Chen HT, Ergan A, Anderson R, Bhandoola A, Pike KG, Barlaam B, Cadogan E, Wang X, Pierce AJ, Hubbard C, Armstrong SA, Nussenzweig A, Fernandez-Capetillo O (2016). Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML. Sci Signal  9, ra91.   https://doi.org/10.1126/scisignal.aad8243|6. Yang Q, Bhandoola A (2016). The development of adult innate lymphoid cells. Curr Opin Immunol  39, 114-20.   https://doi.org/10.1016/j.coi.2016.01.006|7. Yang Q, Ge MQ, Kokalari B, Redai IG, Wang X, Kemeny DM, Bhandoola A, Haczku A (2016). Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol  137, 571-8.   https://doi.org/10.1016/j.jaci.2015.06.037",https://intramural.nih.gov/search/searchview.taf?ipid=99226
459,BC011637-03,"October 01, 2016 -  September 30, 2017",BRD4 is a HAT,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Jie  Mu (Molecular Regulation Section)|Devaiah Nanjappa Ballachanda (Molecular Regulation Section)|Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch),Sheetal  Uppal (NEI) |Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |Anup  Dey; PhD (NICHD),"1. Devaiah BN, Case-Borden C, Gegonne A, Hsu CH, Chen Q, Meerzaman D, Dey A, Ozato K, Singer DS (2016). BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol  23, 540-8.   https://doi.org/10.1038/nsmb.3228",https://intramural.nih.gov/search/searchview.taf?ipid=99228
460,BC011640-03,"October 01, 2016 -  September 30, 2017",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Aiguo  Li|Virginia W Rodriguez|Wei  Zhang|Hua  Song,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99239
461,BC011643-03,"October 01, 2016 -  September 30, 2017",Rare Central Nervous System Cancers Initiative,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Brett James Theeler|Susie  Ahn|Nancy B Garren|Deric Minwoo Park|Wei  Zhang|Lisa Marie Boris|Show all 9,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Rosandra N Kaplan (Pediatric Oncology Branch)|Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Markku Martti Miettinen (Laboratory of Pathology)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),"John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Elizabeth A Erickson (NHGRI) |Prashant  Chittiboina; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99238
462,BC011646-03,"October 01, 2016 -  September 30, 2017",Role of long non-coding RNAs in p53 signaling,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99249
463,BC011647-03,"October 01, 2016 -  September 30, 2017",Identifying New Glioma-Associated Tumor Suppressors  Oncogenes,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Aiguo  Li|Xiaoyu  Cao|Jinkyu  Jung|Orieta  Celiku|Yu-Ting  Su|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99248
464,BC011648-03,"October 01, 2016 -  September 30, 2017",Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC,"Ramaprasad  Srinivasan; MD, PhD|IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Julia C Friend; PA|Roma  Pahwa|Janet  Gichonge|Abhigya  Giri|William Marston Linehan; MD|Donald P Bottaro; PhD|Show all 8,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|John Walter Glod (Pediatric Oncology Branch)|Joanna H Shih (Biostatistics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Heidi H Kong (NIAMS) |Edward W Cowen (NIAMS) |Pamela  Stratton; MD (NINDS) |Wadih Michel Zein; MD (NEI) |Ashkan A Malayeri (CC)","1. Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, Yokoyama H, Srinivasan R, Linehan WM, Lerman MI, Childs RW (2016). Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer. Cancer Res  76, 2177-85.   https://doi.org/10.1158/0008-5472.CAN-15-3139|2. Giles RH, Choueiri TK, Heng DY, Albiges L, Hsieh JJ, Linehan WM, Pal S, Maskens D, Paseman B, Jonasch E, Malouf G, Molina AM, Pickering L, Shuch B, Srinivas S, Srinivasan R, Tannir NM, Bex A (2017). Recommendations for the Management of Rare Kidney Cancers. Eur Urol  72, 974-983.   https://doi.org/10.1016/j.eururo.2017.06.040|3. Sidana A, Kadakia M, Friend JC, Krane LS, Su D, Merino MJ, Srinivasan R (2017). Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol  35, 114.e9-114.e14.   https://doi.org/10.1016/j.urolonc.2016.10.023",https://intramural.nih.gov/search/searchview.taf?ipid=99247
465,BC011649-03,"October 01, 2016 -  September 30, 2017",The Hippo Pathway in Human Gliomas,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Qian  Sun|Alan Surya Halim|Deven Shankarbhai Patel|Fahim  Ahmad; PhD|Kevin A Camphausen; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99246
466,BC011650-03,"October 01, 2016 -  September 30, 2017",Genomic characterization of breast cancer in high risk subsets of breast cancer,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Patricia  Steeg; PhD|Alexandra Dos Santos Zimmer,Hai  Hu (Windber Research Institute)|Kangmin  Zhu|Jeremy  Perkins|Craig David Shriver (Office Of The Clinical Director),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99244
467,BC011651-03,"October 01, 2016 -  September 30, 2017",Laboratory and Clinical studies on T-cells recognizing NSCLC,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",NULL,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99245
468,BC011652-03,"October 01, 2016 -  September 30, 2017",Mesothelin-targeted immunotoxins in Pancreatic Cancer,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Xianyu  Zhang; MS|Salma E El-Behaedi|Leela Rani  Avula,NULL,Syed Perwez  Hussain (Molecular Genetics and Carcinogenesis Section)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)|Serguei V Kozlov (Office of the Director)|William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Kolyvas E, Rudloff M, Poruchynsky M, Landsman R, Hollevoet K, Venzon D, Alewine C (2017). Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes. Oncotarget  8, 9189-9199.   https://doi.org/10.18632/oncotarget.13984",https://intramural.nih.gov/search/searchview.taf?ipid=99243
469,BC011654-03,"October 01, 2016 -  September 30, 2017",TEDDI-R in PCNSL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99242
470,BC011655-03,"October 01, 2016 -  September 30, 2017",Targeting protein-DNA interactions in prokaryotic systems,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Amanda Lee Whiting|Sterling Robert Alan Payne|Ye Joon  Kim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99223
471,BC011657-03,"October 01, 2016 -  September 30, 2017",microRNA regulatory networks in thoracic cancers,Chuong Dinh Hoang|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Li  Zhang; PhD|Anand  Singh; PhD|Nathanael David Pruett; PhD|David  Schrump; MD,NULL,"Margaret  Cam; PhD (Office of the Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)",Yanli  Wang; PhD (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99225
472,BC011659-03,"October 01, 2016 -  September 30, 2017",Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplant,Christopher George Kanakry|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lucas Paul Wachsmuth|Michael Tyrone Patterson,NULL,NULL,Michael  Eckhaus; DVM (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99221
473,BC011660-03,"October 01, 2016 -  September 30, 2017",Development of fully-human anti-CD30 chimeric antigen receptors,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Leah Marie Alabanza|Norris Lio Lam|Steven Dustin Hartman|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99222
474,BC011666-03,"October 01, 2016 -  September 30, 2017",Synthetically Accessible Virtual Inventory (SAVI),Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,"Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Peter  Ertl (Novartis)|Martin  Ott (Lhasa Limited)|Philip  Judson (Lhasa Limited)|Alex  Sukharevsky (LHASA, LLC)|Alan  Long (LHASA, LLC)|Show all 9",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99220
475,BC011669-03,"October 01, 2016 -  September 30, 2017",NCI X-ray free electron laser (XFEL) initiative,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,John  Spence (Arizona State University)|Henry  Chapman (CFEL/DESY/University of Hamburg),NULL,NULL,"1. Stagno JR, Bhandari YR, Conrad CE, Liu Y, Wang YX (2017). Real-time crystallographic studies of the adenine riboswitch using an X-ray free-electron laser. FEBS J  284, 3374-3380.   https://doi.org/10.1111/febs.14110",https://intramural.nih.gov/search/searchview.taf?ipid=99219
476,BC011670-03,"October 01, 2016 -  September 30, 2017",Role of the microbiota in regulating the mononuclear phagocyte system,Silvana Romina Goldszmid|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Romina Elizabeth Araya|Luisa Mourao Dias Magalhaes; PhD|Khiem Chi Lam|Nicole Alexis Mihelson|Gregoire Yves Altan-Bonnet,Marilia  Seelaender (University of Sao Paulo)|Eliane  Piaggio (Institut Curie)|Leonard  Seymour (University of Oxford),NULL,NULL,"1. Gorjifard S, Goldszmid RS (2016). Microbiota-myeloid cell crosstalk beyond the gut. J Leukoc Biol  100, 865-879.   https://doi.org/10.1189/jlb.3RI0516-222R",https://intramural.nih.gov/search/searchview.taf?ipid=99218
477,BC011672-02,"October 01, 2016 -  September 30, 2017",Clinical Protocols in the Cancer Signaling Networks Section,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity|Constance M Cultraro|Maryam Siddika Waris|David  Schrump; MD,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99251
478,BC011679-02,"October 01, 2016 -  September 30, 2017",Mechanisms driving evolution of aggressive prostate cancer,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Huihui  Ye|Nichelle Chantil Whitlock; PhD|Scott Christopher Wilkinson|David James Vanderweele|Kathleen  Kelly; PhD|Ross G Lake,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Ismail Baris Turkbey (Molecular Imaging Program)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch),NULL,"1. VanderWeele DJ, Turkbey B, Sowalsky AG (2016). PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER. Expert Rev Precis Med Drug Dev  1, 505-515.   https://doi.org/10.1080/23808993.2016.1267562",https://intramural.nih.gov/search/searchview.taf?ipid=99252
479,BC011680-02,"October 01, 2016 -  September 30, 2017",Early detection of prostate cancer using circulating tumor DNA,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sean Thomas Hennigan|Shana Y Trostel,Steven  Balk (Beth Israel Deaconess Medical Center)|Glenn  Bubley (Beth Israel Deaconess Medical Center)|Huihui  Ye (Laboratory Of Genitourinary Cancer Pathogenesis),Peter A Pinto; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99253
480,BC011681-02,"October 01, 2016 -  September 30, 2017",Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Valerie F Boltz|Wei  Shao; PhD|Ann P Wiegand|Jonathan E Spindler|Andrew Timothy Rajendra Musick|Michael Javier Bale|Show all 8,"John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|John W Mellors|Mark  Cotton (Stellenbosch University)|Gert  van Zyl (Stellenbosch University)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Van Zyl G, Katusiime M, Wiegand A, McManus W, Bale M, Halvas E, Luke B, Boltz V, Spindler J, Laughton B, Engelbrecht S, Coffin J, Cotton M, Shao W, Mellors J, Kearney M (2017) No evidence of HIV replication in children on antiretroviral therapy. J Clin Invest, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99254
481,BC011682-02,"October 01, 2016 -  September 30, 2017",Molecular mechanisms of membrane remodeling,"Roberto  Weigert; MSc Chemistry, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Seham  Ebrahim; PhD|Nicolas Gregory Emile Alain Melis|Yun  Chen; PhD|Yeap Shen Ng|Lenka Nicole Malec|Esther Onyinyechi Maidoh,Marino  Zerial (Max Planck Institute)|Peter  Gunning (University of New South Wales)|Douglas  Brooks (University of South Australia)|Alexander  Sorkin (Univeristy of Pittsburgh),NULL,"Kelly G Ten Hagen; BS, PhD (NIDCR) |Irwin Monroe Arias; BS, MD (CC)","1. Amornphimoltham P, Thompson J, Melis N, Weigert R (2017) Non-Invasive Intravital Imaging of Head and Neck Squamous Cell Carcinomas in Live Mice. Methods, in press.|2. Gonzalez JM, Ko MK, Masedunskas A, Hong YK, Weigert R, Tan JCH (2017). Toward in vivo two-photon analysis of mouse aqueous outflow structure and function. Exp Eye Res  158, 161-170.   https://doi.org/10.1016/j.exer.2016.05.009|3. Motley MP, Madsen DH, Jürgensen HJ, Spencer DE, Szabo R, Holmbeck K, Flick MJ, Lawrence DA, Castellino FJ, Weigert R, Bugge TH (2016). A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. Blood  127, 1085-96.   https://doi.org/10.1182/blood-2015-05-644260|4. Porat-Shliom N, Tietgens AJ, Van Itallie CM, Vitale-Cross L, Jarnik M, Harding OJ, Anderson JM, Gutkind JS, Weigert R, Arias IM (2016). Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo. Hepatology  64, 1317-29.   https://doi.org/10.1002/hep.28724|5. Weigert R (2017) Implanted biomaterials: Dissecting fibrosis Nat. biomedical engineering Nature Biomedical Engineering 1:16",https://intramural.nih.gov/search/searchview.taf?ipid=99307
482,BC011684-02,"October 01, 2016 -  September 30, 2017",Investigation on the biology of IDH mutant glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Yang  Liu|Yanxin  Lu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99256
483,BC011685-02,"October 01, 2016 -  September 30, 2017",Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Mark Richard Gilbert; MD,"Stuart  Grossman (Neuro-Oncology, Johns Hopkins Oncology Center)|Michelle A Rudek",Christine M Bryla (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch),Edjah K Nduom (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99257
484,BC011686-02,"October 01, 2016 -  September 30, 2017",Modulating BBB Permeability in Malignant Glioma,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Amelie  Vezina,NULL,Kunio  Nagashima (Office Of The Director),"Kenneth A Jacobson; BA, MS, PhD (NIDDK) |Dorian  McGavern (NINDS) |Christina Margaret Van Itallie; PhD (NHLBI) |Marsha J Merrill; PhD (NINDS) |Patricia M Zerfas (OD)","1. Jackson S, ElAli A, Virgintino D, Gilbert MR (2017). Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's disease. Neuro Oncol  19, 1173-1182.   https://doi.org/10.1093/neuonc/nox058",https://intramural.nih.gov/search/searchview.taf?ipid=99258
485,BC011687-02,"October 01, 2016 -  September 30, 2017",Dysregulation of Antigen Presenting Cell Function in Cancer,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Even  Walseng|Joanna Marta Bandola-Simon; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99259
486,BC011688-02,"October 01, 2016 -  September 30, 2017",In vivo function of BRD4,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Alfred  Singer; MD,NULL,Anne G M Gegonne Bosselut (Molecular Regulation Section)|Jie  Mu (Molecular Regulation Section)|Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch)|Xuguang C Tai (Lymphocyte Development Section),Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |Anup  Dey; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99261
487,BC011690-02,"October 01, 2016 -  September 30, 2017",Novel Tumor Suppressing Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Christina  Walker,Alexandra  Newton (University of California at San Diego)|Tony C Hunter|Crispin  Miller (CRUK Manchester Institute)|Owen  Sansom (CRUK Beatson Institute)|Jon  Read (Astrazeneca),NULL,NULL,"1. Marusiak AA, Stephenson NL, Baik H, Trotter EW, Li Y, Blyth K, Mason S, Chapman P, Puto LA, Read JA, Brassington C, Pollard HK, Phillips C, Green I, Overman R, Collier M, Testoni E, Miller CJ, Hunter T, Sansom OJ, Brognard J (2016). Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis. Cancer Res  76, 724-35.   https://doi.org/10.1158/0008-5472.CAN-15-0701-T",https://intramural.nih.gov/search/searchview.taf?ipid=99264
488,BC011691-02,"October 01, 2016 -  September 30, 2017",Oncogenic Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Pedro  Torres-Ayuso|Van Tuyet Hoang|Katherine M Nyswaner|Christina  Walker,Richard  Marais (CRUK Manchester Institute)|Crispin  Miller (CRUK Manchester Institute)|Caroline  Dive (CRUK Manchester Institute),Christina M Annunziata (Womens Malignancies Branch),NULL,"1. Edwards Z, Trotter E, TorresAyuso P, Chapman P, Wood H, Nyswaner K, Brognard J (2017) Survival of head and neck cancer cells relies upon LZK kinase-mediated stabilization of mutant p53. Cancer Research, in press.|2. Testoni E, Stephenson NL, Torres-Ayuso P, Marusiak AA, Trotter EW, Hudson A, Hodgkinson CL, Morrow CJ, Dive C, Brognard J (2016). Somatically mutated ABL1 is an actionable and essential NSCLC survival gene. EMBO Mol Med  8, 105-16.   https://doi.org/10.15252/emmm.201505456",https://intramural.nih.gov/search/searchview.taf?ipid=99265
489,BC011692-02,"October 01, 2016 -  September 30, 2017",COP Laboratory,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Ling  Ren|Hongsheng  Wang|Elaine Marie Jagoda; MS|Hisataka  Kobayashi,"Louis  Stancato (NCI)|Pete  Dickinson (University of California)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Cheryl  London (Center for Comparative Medicine, University Of California)|Nicola Teresa Mason|Shruthi  Naik (Mayo Clinic - Rochester)|Show all 9","Lee Jay Helman; MD (Pediatric Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch)",Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI) |Gregory James Tawa (NCATS) |Xiang  Zhang; PhD (NHLBI),"1. Yu P, Gardner H, Roberts R, Cam H, Hariharan S, Ren L, Leblanc A, Xiao H, Lin J, Guttridge D, Mo X, Bennett C, Coss C, Ling Y, Phelps M, Houghton P (2017) Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PLoS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99262
490,BC011696-02,"October 01, 2016 -  September 30, 2017",Comparative Brain Tumor Consortium,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",NULL,"Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Michael  Kent (UC Davis)|William  Kisseberth (Veterinary Medicine, Ohio State University)|John  Rossmeisl (Virginia Polytechnical University)|Jey  Koehler (Auburn University)|Show all 19","Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Kara Nichole Corps (NINDS) |Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI) |Gregory James Tawa (NCATS),"1. Leblanc A, Packer R, Kent M, Rossmeisl J, Griffin J, Mazcko C (2017) Consensus recommendations for harmonized imaging standards for multicenter canine brain tumor clinical trials. Veterinary Radiology and Ultrasound, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99266
491,BC011697-02,"October 01, 2016 -  September 30, 2017",Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Wei  Shao; PhD|Ann P Wiegand|Jonathan E Spindler|Andrew Timothy Rajendra Musick|Michael Javier Bale|William Richard McManus,"John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|David M Margolis|John W Mellors",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Kearney MF, Wiegand A, Shao W, Coffin JM, Mellors JW, Lederman M, Gandhi RT, Keele BF, Li JZ (2016). Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy. J Virol  90, 1369-76.   https://doi.org/10.1128/JVI.02139-15",https://intramural.nih.gov/search/searchview.taf?ipid=99267
492,BC011698-02,"October 01, 2016 -  September 30, 2017",Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Ann P Wiegand,David M Margolis|John W Mellors,NULL,NULL,"1. Bui JK, Halvas EK, Fyne E, Sobolewski MD, Koontz D, Shao W, Luke B, Hong FF, Kearney MF, Mellors JW (2017). Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells. PLoS Pathog  13, e1006230.   https://doi.org/10.1371/journal.ppat.1006230|2. Macatangay BJ, Riddler SA, Wheeler ND, Spindler J, Lawani M, Hong F, Buffo MJ, Whiteside TL, Kearney MF, Mellors JW, Rinaldo CR (2016). Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells. J Infect Dis  213, 1400-9.   https://doi.org/10.1093/infdis/jiv582|3. Wiegand A, Spindler J, Hong FF, Shao W, Cyktor JC, Cillo AR, Halvas EK, Coffin JM, Mellors JW, Kearney MF (2017). Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. Proc Natl Acad Sci U S A  114, E3659-E3668.   https://doi.org/10.1073/pnas.1617961114",https://intramural.nih.gov/search/searchview.taf?ipid=99250
493,BC011699-02,"October 01, 2016 -  September 30, 2017",Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Valerie F Boltz|Wei  Shao; PhD,John  Coffin (Tufts University)|Mark  Cotton (Stellenbosch University)|Michael  Hughes (U.S. Environmental Protection Agency)|Shahin  Lockman (Harvard University)|Sharon  Riddler (University of Pittsburgh)|Gert  van Zyl (Stellenbosch University),NULL,NULL,"1. Boltz VF, Rausch J, Shao W, Hattori J, Luke B, Maldarelli F, Mellors JW, Kearney MF, Coffin JM (2016). Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA. Retrovirology  13, 87.   https://doi.org/10.1186/s12977-016-0321-6|2. Van Zyl G, Katusiime M, Wiegand A, McManus W, Bale M, Halvas E, Luke B, Boltz V, Spindler J, Laughton B, Engelbrecht S, Coffin J, Cotton M, Shao W, Mellors J, Kearney M (2017) No evidence of HIV replication in children on antiretroviral therapy. J Clin Invest, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99268
494,BC011700-02,"October 01, 2016 -  September 30, 2017",Patient Oriented Research in Viral Malignancies and HIV-associated Cancers,Thomas S Uldrick|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Robert  Yarchoan; MD|Joseph M Ziegelbauer,Martin A Cheever|Sharon  Lewin (University of Melbourne)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Nicholas  Chomont (University of Montreal)|Anisa  Mosam (University of KwaZulu-Natal)|Mark Niccolo Polizzotto; MD,"Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Frank  Maldarelli (Host Virus Interaction Branch)|Deborah E Citrin (Radiation Oncology Branch)|Denise  Whitby (Office Of The Director)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Irini  Sereti; MD (NIAID) |Mark  Connors; MD (NIAID),"1. Gonçalves PH, Uldrick TS, Yarchoan R (2017). HIV-associated Kaposi sarcoma and related diseases. AIDS  31, 1903-1916.   https://doi.org/10.1097/QAD.0000000000001567|2. Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R (2017). Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS  12, 47-56.   https://doi.org/10.1097/COH.0000000000000330|3. Pratt D, Uldrick TS (2016). Primary effusion lymphoma and concurrent progressive Kaposi sarcoma associated with elevated interleukin-6. Blood  127, 2940.   https://doi.org/10.1182/blood-2016-02-700575|4. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH (2017). Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood  129, 1658-1668.   https://doi.org/10.1182/blood-2016-11-748855",https://intramural.nih.gov/search/searchview.taf?ipid=99269
495,BC011701-02,"October 01, 2016 -  September 30, 2017",Metabolic characterization of FH- and SDH-deficient RCC cell lines,Jeffrey Arnold Moscow,NULL,"Urologic Oncology Branch, NCI","Rony  Panarsky; PhD, BPHARM|William Marston Linehan; MD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99270
496,BC011704-02,"October 01, 2016 -  September 30, 2017",Discovery of genes required for expression or activity of fusion oncogenes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Sahil  Sahni|Allison Margarethe Cross; PhD,Philip L Lorenzi|Amanda  Hummon,Lee Jay Helman; MD (Pediatric Oncology Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),Madhu A Lal (NCATS),"1. Grohar PJ, Kim S, Rangel Rivera GO, Sen N, Haddock S, Harlow ML, Maloney NK, Zhu J, O'Neill M, Jones TL, Huppi K, Grandin M, Gehlhaus K, Klumpp-Thomas CA, Buehler E, Helman LJ, Martin SE, Caplen NJ (2016). Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma. Cell Rep  14, 598-610.   https://doi.org/10.1016/j.celrep.2015.12.063",https://intramural.nih.gov/search/searchview.taf?ipid=99272
497,BC011707-02,"October 01, 2016 -  September 30, 2017",The effect of therapeutics on mutated IDH1 cell lines and mice tumor models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99273
498,BC011708-02,"October 01, 2016 -  September 30, 2017",Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Victor  Ruiz Rodado,NULL,Kylie Janice Walters (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99274
499,BC011709-02,"October 01, 2016 -  September 30, 2017","Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue",Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Tyrone Maurice Dowdy|Victor  Ruiz Rodado|Deric Minwoo Park|Amber Jin Giles|Mark Richard Gilbert; MD|Jing  Wu; MD, PhD|Show all 7",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99275
500,BC011710-02,"October 01, 2016 -  September 30, 2017",In vivo and in vitro metabolic flux analysis in preclinical mouse models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Adrian  Lita|Tyrone Maurice Dowdy,NULL,Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99276
501,BC011711-02,"October 01, 2016 -  September 30, 2017",Develop RAMAN imaging to visualize metabolism in cell lines and tissue,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Adrian  Lita|Deric Minwoo Park|Amber Jin Giles|Jing  Wu; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99277
502,BC011713-02,"October 01, 2016 -  September 30, 2017",Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Yen Thi Minh  Nguyen|Jose Antonio Rodriguez-Nieves; PhD|Remi Maryam Adelaiye-Ogala|Kathleen  Kelly; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99278
503,BC011714-02,"October 01, 2016 -  September 30, 2017",Brain Tumor Immunotherapy,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Heather Marie Sonneman|Orieta  Celiku|Amber Jin Giles|Marsha-Kay Norissa Deanna Hutchinson|Wei  Zhang|Yunlong  Yang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99279
504,BC011715-02,"October 01, 2016 -  September 30, 2017",T cell receptor proximal signaling,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Debjani  Dutta; PhD|June  Guha; PhD|Shizuka  Otsuka,NULL,Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology)|Ettore  Appella; MD (Chemical Immunology Section),NULL,"1. Dutta D, Barr VA, Akpan I, Mittelstadt PR, Singha LI, Samelson LE, Ashwell JD (2017). Recruitment of calcineurin to the TCR positively regulates T cell activation. Nat Immunol  18, 196-204.   https://doi.org/10.1038/ni.3640",https://intramural.nih.gov/search/searchview.taf?ipid=99280
505,BC011717-02,"October 01, 2016 -  September 30, 2017",Structural studies of biomolecules related to cancer and HIV-AIDS,Hiroshi  Matsuo; PhD,Joel Patrick Schneider; PhD,"Basic Research Laboratory, NCI",Tapan  Kanai|Atanu  Maiti; PhD,"Celia  Schiffer (University of Massachusetts)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",Marzeena  Dyba (Structural Biophysics Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,"1. Kouno T, Silvas TV, Hilbert BJ, Shandilya SMD, Bohn MF, Kelch BA, Royer WE, Somasundaran M, Kurt Yilmaz N, Matsuo H, Schiffer CA (2017). Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity. Nat Commun  8, 15024.   https://doi.org/10.1038/ncomms15024|2. Pan Y, Sun Z, Maiti A, Kanai T, Matsuo H, Li M, Harris RS, Shlyakhtenko LS, Lyubchenko YL (2017). Nanoscale Characterization of Interaction of APOBEC3G with RNA. Biochemistry  56, 1473-1481.   https://doi.org/10.1021/acs.biochem.6b01189",https://intramural.nih.gov/search/searchview.taf?ipid=99282
506,BC011718-02,"October 01, 2016 -  September 30, 2017",Breast cancer aggressiveness in young patients,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Alex Man Lai Wu,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99283
507,BC011719-02,"October 01, 2016 -  September 30, 2017",Multiregion sequencing of localized prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Yen Thi Minh  Nguyen|Jose Antonio Rodriguez-Nieves; PhD|Adam G Sowalsky,Hidewaki  Nakagawa (RIKEN Center for Integrative Medical Sciences)|Satoru  Miyano (University of Tokyo Institute of Medical Science)|Gladell  paner (University of Chicago),Margaret  Cam; PhD (Office of the Director)|Richard Phillip Finney (Cancer Informatics Branch)|David Lee Wheeler (Laboratory Of Biochemistry & Molecular Biology)|Justin Britt Lack (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99284
508,BC011720-02,"October 01, 2016 -  September 30, 2017","Gag Trafficking, Assembly, and Release",Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Katherine  Seley-Radtke (University of Maryland, Baltimore County)|James  Hurley (University of California, Berkeley)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Schuyler Bergren van Engelenburg|Show all 7",James Kiprotich Kirui (Retroviral Replication Laboratory)|Sherimay  Ablan (Retroviral Replication Laboratory)|Abdul Latheef Abdul Waheed (Retroviral Replication Laboratory)|Rachel  van Duyne (Retroviral Replication Laboratory)|Mariia  Novikova; PhD (Retroviral Replication Laboratory)|Melissa Victoria Fernandez; PhD (Retroviral Replication Laboratory),Yihong  Ye (NIDDK) |Juan S Bonifacino; PhD (NICHD),"1. Afonin KA, Viard M, Tedbury P, Bindewald E, Parlea L, Howington M, Valdman M, Johns-Boehme A, Brainerd C, Freed EO, Shapiro BA (2016). The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities. Nano Lett  16, 1746-53.   https://doi.org/10.1021/acs.nanolett.5b04676|2. Martins AN, Waheed AA, Ablan SD, Huang W, Newton A, Petropoulos CJ, Brindeiro RD, Freed EO (2016). Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain. J Virol  90, 768-79.   https://doi.org/10.1128/JVI.01640-15|3. Mercredi PY, Bucca N, Loeliger B, Gaines CR, Mehta M, Bhargava P, Tedbury PR, Charlier L, Floquet N, Muriaux D, Favard C, Sanders CR, Freed EO, Marchant J, Summers MF (2016). Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein. J Mol Biol  428, 1637-55.   https://doi.org/10.1016/j.jmb.2016.03.005|4. Waheed AA, MacDonald S, Khan M, Mounts M, Swiderski M, Xu Y, Ye Y, Freed EO (2016). The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species. Sci Rep  6, 24934.   https://doi.org/10.1038/srep24934",https://intramural.nih.gov/search/searchview.taf?ipid=99285
509,BC011721-02,"October 01, 2016 -  September 30, 2017",Envelope Glycoprotein Incorporation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Summers (University of Maryland, Baltimore County)|Simon  Cocklin (Drexel University)|Eric  Barklis (University of Oregon)",Sherimay  Ablan (Retroviral Replication Laboratory)|Abdul Latheef Abdul Waheed (Retroviral Replication Laboratory)|Rachel  van Duyne (Retroviral Replication Laboratory)|Mariia  Novikova; PhD (Retroviral Replication Laboratory)|Melissa Victoria Fernandez; PhD (Retroviral Replication Laboratory)|Phuong Nhat Pham (Retroviral Replication Laboratory),NULL,"1. Alfadhli A, Mack A, Ritchie C, Cylinder I, Harper L, Tedbury PR, Freed EO, Barklis E (2016). Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities. J Virol  90, 5657-5664.   https://doi.org/10.1128/JVI.00509-16|2. Tedbury PR, Novikova M, Ablan SD, Freed EO (2016). Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation. Proc Natl Acad Sci U S A  113, E182-90.   https://doi.org/10.1073/pnas.1516618113",https://intramural.nih.gov/search/searchview.taf?ipid=99287
510,BC011722-02,"October 01, 2016 -  September 30, 2017",Genomic characterization and development of therapies for Rhabdomyosarcoma,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99286
511,BC011725-02,"October 01, 2016 -  September 30, 2017",Metabolic basis of chronic graft-versus-host disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Don Eugene Farthing|Evelyn Frieda Kandov,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Daniel  Crooks (Urologic Oncology Branch)|Carole  Sourbier (Urologic Oncology Branch)|Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99289
512,BC011726-02,"October 01, 2016 -  September 30, 2017",Phenotypic variability within isogenic population of lymphocytes,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,Oleg  Krichevsky (Ben Gurion University)|Lia  Palomba (Memorial Sloan Kettering)|Paul  Franois (McGill University),NULL,NULL,"1. Argyropoulos KV, Vogel R, Ziegler C, Altan-Bonnet G, Velardi E, Calafiore M, Dogan A, Arcila M, Patel M, Knapp K, Mallek C, Hunter ZR, Treon SP, van den Brink MR, Palomba ML (2016). Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling. Leukemia  30, 1116-25.   https://doi.org/10.1038/leu.2016.8|2. Vogel RM, Erez A, Altan-Bonnet G (2016). Dichotomy of cellular inhibition by small-molecule inhibitors revealed by single-cell analysis. Nat Commun  7, 12428.   https://doi.org/10.1038/ncomms12428",https://intramural.nih.gov/search/searchview.taf?ipid=99290
513,BC011727-02,"October 01, 2016 -  September 30, 2017",In vivo cell kinetics and imaging of chronic graft-versus-host-disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Don Eugene Farthing|Evelyn Frieda Kandov,NULL,"Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Murali  Krishna; PhD (Radiation Biology Branch)|Keita  Saito (Radiation Biology Branch)","Andrea Christine Bohrer (NIAID) |Michael  Eckhaus; DVM (OD) |Martin J Lizak; PhD (NINDS) |Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99291
514,BC011728-02,"October 01, 2016 -  September 30, 2017",Cell-cell communications create robust collective immunological responses,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Andrew Leonard Belmonte|Ratnadeep  Mukherjee; PhD|Deepti  Agnihotri|Kevin Anton Spiekermann,Oleg  Krichevsky (Ben Gurion University)|Laurent  Lauvau (Albert Einstein College of Medicine),NULL,"Ronald N Germain; MD, PhD (NIAID)","1. Malandro N, Budhu S, Kuhn NF, Liu C, Murphy JT, Cortez C, Zhong H, Yang X, Rizzuto G, Altan-Bonnet G, Merghoub T, Wolchok JD (2016). Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion. Immunity  44, 179-193.   https://doi.org/10.1016/j.immuni.2015.12.018|2. Oyler-Yaniv A, Oyler-Yaniv J, Whitlock BM, Liu Z, Germain RN, Huse M, Altan-Bonnet G, Krichevsky O (2017). A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System. Immunity  46, 609-620.   https://doi.org/10.1016/j.immuni.2017.03.011|3. Oyler-Yaniv J, Oyler-Yaniv A, Shakiba M, Min NK, Chen YH, Cheng SY, Krichevsky O, Altan-Bonnet N, Altan-Bonnet G (2017). Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation. Mol Cell  66, 635-647.e7.   https://doi.org/10.1016/j.molcel.2017.05.011",https://intramural.nih.gov/search/searchview.taf?ipid=99292
515,BC011730-02,"October 01, 2016 -  September 30, 2017",Studies on drug resistance in HIV-related Kaposis sarcoma,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Robert W Robey,NULL,Fatima Ghazanfar Ali-Rahmani (Multidrug Resistence Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99294
516,BC011732-02,"October 01, 2016 -  September 30, 2017",Discovery of combination therapy for KRAS mutant cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shinjen  Lin,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99296
517,BC011733-02,"October 01, 2016 -  September 30, 2017",Mechanism of anchorage independent growth driven by the KRAS oncogene,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD|Junqiu  Yue; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99297
518,BC011734-02,"October 01, 2016 -  September 30, 2017",Genomic dissection of tumor heterogeneity and progression,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiyan  Lei|Carly Meyer Sayers|Xiyuan  Zhang|Brigitte  Widemann; MD,NULL,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99298
519,BC011736-02,"October 01, 2016 -  September 30, 2017",Preclinical Development of Therapeutics in Murine Models of Lung Cancer,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Bonita Anne Sears|Rajaa  Elmeskini|Michelle Leann Gumprecht|Anthony Joseph Iacovelli|Alan Edward Kulaga|Zoe W Ohler|Show all 10,NULL,Deborah B Householder (Basic Research Laboratory)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Hisataka  Kobayashi (Molecular Imaging Program),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99300
520,BC011737-02,"October 01, 2016 -  September 30, 2017",Therapeutic evaluation in ovarian and breast cancer GEMGDA models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Bonita Anne Sears|Zoe W Ohler|Melanie  Gordon|Ludmila  Szabova; MS, PhD|Wendi Raye Custer Lawrence|Catherine I Drennan|Show all 8",NULL,Deborah B Householder (Basic Research Laboratory)|Xiuyun  Lu (Basic Research Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Laura  Schmidt (Urologic Oncology Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99301
521,BC011738-02,"October 01, 2016 -  September 30, 2017",Preclinical GEM and GDA Models of Primary and Metastatic Melanoma,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Bonita Anne Sears|Rajaa  Elmeskini|Michelle Leann Gumprecht|Anthony Joseph Iacovelli|Alan Edward Kulaga|Zoe W Ohler|Show all 10,NULL,Deborah B Householder (Basic Research Laboratory)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|William Douglas Figg Ii (Genitourinary Malignancies Branch)|Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|Peter L Choyke; MD (Molecular Imaging Program)|Carol J Thiele (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99302
522,BC011739-02,"October 01, 2016 -  September 30, 2017",Development and Preclinical Application of Pancreatic Adenocarcinoma Models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Theresa Mae Guerin|Catherine I Drennan|Jerome  Schlomer|Wendi Raye Custer Lawrence|Bonita Anne Sears,"Guillermina Gigi  Lozano (MD Anderson)|Frank  McCormick (UCSF School of Medicine)|Leaf  Huang (University of North Carolina)|David  Frost (AbbVie)|Peppi  Prasit (Inception 2, Inc.)|Ruihong  Chen (K-Gen, Inc.)",Udo  Rudloff (Thoracic & Oncologic Surgery Branch)|Ira H Pastan; MD (Molecular Biology Section)|Christine Campo Alewine (Laboratory of Molecular Biology)|James Halpern Doroshow (Office of the Director)|Bradley D St Croix (Mouse Cancer Genetics Program)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99303
523,BC011740-02,"October 01, 2016 -  September 30, 2017",Inhibitors of Viral Membrane Fusion,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Amanda Lee Whiting|Merissa Lynnea Baxter,NULL,Eric  Batchelor; PhD (Laboratory of Pathology),Peter  Jahrling (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99304
524,BC011741-02,"October 01, 2016 -  September 30, 2017",Targeting Metabolic Pathways in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mamatha  Garige|Leonard  Neckers; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99305
525,BC011742-02,"October 01, 2016 -  September 30, 2017",Natural History Study of the Complications Associated with Allogeneic HCT,Juan Carlos Gea-Banacloche; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Daniel H Fowler|Steven  Pavletic; MD, MS|Dennis D Hickstein",NULL,Nirali Niranjan Shah (Pediatric Oncology Branch)|Terry J Fry (Pediatric Oncology Branch),Steven M Holland; MD (NIAID) |Michail S Lionakis (NIAID) |Theresa Donohue Jerussi (CC) |Mark  Parta (NIAID) |Elizabeth M Kang; MD (NIAID) |Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99306
526,BC011743-02,"October 01, 2016 -  September 30, 2017",NIH Chronic GVHD Study Group,"Steven  Pavletic; MD, MS|IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,Paul  Martin|Daniel  Weisdorf (University of Minnesota)|J Doug  Rizzo (Medical College of Wisconsin)|Mary  Horawitz (Medical College of Wisconsin)|Georgia  Vogelsang (Johns Hopkins University)|Stephanie  Lee (University of Washington-Fred Hutchinson CRC)|Show all 12,"Daoud M Meerzaman (Cancer Informatics Branch)|Sandra  Mitchell (Outcomes Research Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)","Jacqueline W Mays; DDS, PhD (NIDCR) |Ann M Cohen-Berger; MD (CC) |Edward W Cowen (NIAMS) |Galen O Joe (CC) |Manuel B Datiles; MD (NEI) |Rachel Jessica Bishop; MD (NEI)","1. Bilic E, Delimar V, Desnica L, Pulanic D, Bilic E, Bakovic M, Curtis LM, Seiwerth RS, Stipetic MM, Ceovic R, Pulanic TK, Aleric I, Milos O, Vrhovac R, Nemet D, Pavletic SZ (2016). High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD. Bone Marrow Transplant  51, 1513-1517.   https://doi.org/10.1038/bmt.2016.158|2. Curtis LM, Pavletic SZ (2016). IL-2, the next best thing in chronic GVHD therapy? Blood  128, 13-5.   https://doi.org/10.1182/blood-2016-05-711796|3. Katić M, Pirsl F, Steinberg SM, Dobbin M, Curtis LM, Pulanić D, Desnica L, Titarenko I, Pavletic SZ (2016). Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease. Croat Med J  57, 276-86.   https://doi.org/10.3325/cmj.2016.57.276|4. Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, Pusic I, Flowers ME, Arora M, Pavletic SZ, Lee SJ (2016). Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease. Blood  127, 160-6.   https://doi.org/10.1182/blood-2015-08-662874|5. Pirsl F, Curtis LM, Steinberg SM, Tella SH, Katić M, Dobbin M, Hsu J, Hakim FT, Mays JW, Im AP, Pulanić D, Mitchell SA, Baruffaldi J, Masuch L, Halverson DC, Gress RE, Barsony J, Pavletic SZ (2016). Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant  22, 1517-1524.   https://doi.org/10.1016/j.bbmt.2016.04.012|6. Prenc E, Pulanic D, Pucic-Bakovic M, Pezer M, Desnica L, Vrhovac R, Nemet D, Pavletic SZ (2016). Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation. Biochim Biophys Acta  1860, 1615-22.   https://doi.org/10.1016/j.bbagen.2016.02.015|7. Pusic I, Rettig MP, DiPersio JF, Bauer S, McFarland K, Gale RP, Pavletic SZ (2016). Phase-1/-2 study of pomalidomide in chronic GvHD. Bone Marrow Transplant  51, 612-4.   https://doi.org/10.1038/bmt.2015.298|8. Vukić T, Robinson Smith S, Ljubas Kelečić D, Desnica L, Prenc E, Pulanić D, Vrhovac R, Nemet D, Pavletic SZ (2016). Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters. Croat Med J  57, 266-75.   https://doi.org/10.3325/cmj.2016.57.266",https://intramural.nih.gov/search/searchview.taf?ipid=99308
527,BC011744-01,"October 01, 2016 -  September 30, 2017",Kinase complexes in human diseases,Ping  Zhang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Baohua  Cao; PhD|Sathish Narashimiha Yadav Kadapalakere|Juliana Andrea Martinez Fiesco; PhD,Sanford  Simon (Rockefeller University)|Susan S Taylor,Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102937
528,BC011745-01,"October 01, 2016 -  September 30, 2017",Development of biologic based therapies for rhabdomyosarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,NULL,"1. Heske CM, Yeung C, Mendoza A, Baumgart JT, Edessa LD, Wan X, Helman LJ (2016). The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. Transl Oncol  9, 540-547.   https://doi.org/10.1016/j.tranon.2016.09.002",https://intramural.nih.gov/search/searchview.taf?ipid=102936
529,BC011746-01,"October 01, 2016 -  September 30, 2017",Development Therapeutics Branch Clinical Trials,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Anish  Thomas; MD|James Halpern Doroshow|Jane Beth Trepel,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102976
530,BC011754-01,"October 01, 2016 -  September 30, 2017","Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1","Karlyne M Reilly; BS, PhD",Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Robert  Tuskan|John Frederick Shern,NULL,John A Beutler (Molecular Targets Laboratory)|Margaret  Cam; PhD (Office of the Director)|Fathi  Elloumi (Developmental Therapeutics Branch),Kapil  Bharti; PhD (NEI),"1. Reilly K, Kim A, Blakely J, Ferner R, Gutmann D, Legius E, Miettinen M, Randall R, Ratner N, Jumbe N, Bakker A, Viskochil D, Widemann B, Stewart D (2017) Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. J National Cancer Institute, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=102940
531,BC011755-01,"October 01, 2016 -  September 30, 2017",Neuro-immune crosstalk within intestinal microenvironment,Chuan  Wu|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Zuojia  Chen; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102941
532,BC011756-01,"October 01, 2016 -  September 30, 2017",The Intersection between Cell-Intrinsic Innate Immunity and Metabolic Sensing,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Guoli  Shi|Kazi Mohammad Mostafizur Rahman,Sergi  Padilla-Parra (University of Oxford)|Bruce  Torbett (The Scripps Research Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102939
533,BC011757-01,"October 01, 2016 -  September 30, 2017","Biogenesis, Function and Turnover of Noncoding RNAs","Sandra Lynn Wolin; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Kevin James Hughes|Cedric  Belair; PhD|Xinguo  Chen; PhD|Soyeong  Sim|Marco Elio Boccitto; PhD,"Paul  Bieniasz (Rockefeller University)|Andrew  Goodman (Yale School of Medicine)|Martin  Kriegel (Yale School of Medicine)|Eric  Meffre; MD (Dept of Immunobiology, Yale University)|S  Shuman (Sloan-Kettering Institute)|Sanford  Simon (Rockefeller University)|Show all 7",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102938
534,BC011758-01,"October 01, 2016 -  September 30, 2017",Computationally Modeling Tumor Dynamics,Orit  Lavi; PhD,Michael Marc Gottesman; MD,"Multidrug Resistence Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102943
535,BC011759-01,"October 01, 2016 -  September 30, 2017",Interrogating the molecular underpinnings of metastatic colonization,Jonathan Matthew Hernandez|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Surajit  Sinha; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102942
536,BC011760-01,"October 01, 2016 -  September 30, 2017",Understand glioma biology,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Yang  Liu|Yanxin  Lu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102944
537,BC011761-01,"October 01, 2016 -  September 30, 2017",Develop novel therapeutic strategy for brain tumor,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Yang  Liu|Yanxin  Lu|Jing  Wu; MD, PhD",NULL,NULL,NULL,"1. Lu Y, Kwintkiewicz J, Liu Y, Tech K, Frady LN, Su YT, Bautista W, Moon SI, MacDonald J, Ewend MG, Gilbert MR, Yang C, Wu J (2017). Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair. Cancer Res  77, 1709-1718.   https://doi.org/10.1158/0008-5472.CAN-16-2773",https://intramural.nih.gov/search/searchview.taf?ipid=102945
538,BC011762-01,"October 01, 2016 -  September 30, 2017",Screening to identify protectors and mitigators of Radiation GI Syndrome,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Ayla Oksuz White|Bradley T Scroggins|Seok Joo  Kwon; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102946
539,BC011763-01,"October 01, 2016 -  September 30, 2017",Signaling pathways regulating stem cell fate decisions,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Maria Del Pilar Pedro; PhD,NULL,Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102950
540,BC011764-01,"October 01, 2016 -  September 30, 2017",G-protein-coupled receptor signaling in cancer development and treatment,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",James Joseph Hoy,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102951
541,BC011765-01,"October 01, 2016 -  September 30, 2017",Transcriptional regulation of inflammatory and autoimmune responses,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yuanyuan  Gao; PhD,NULL,Yan  Wang (Immune Targeting Section),Yasmine  Belkaid; PhD (NIAID) |Dorian  McGavern (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102952
542,BC011766-01,"October 01, 2016 -  September 30, 2017",Regulation of RNA biogenesis and function by RNA modifications,Pedro Jorge De Oliveira Rodrigues Batista; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Xu  Feng; PhD|Christina Marie Fitzsimmons; PhD|Alexandra Collins Schmiechen,NULL,Quinton Alexander Brail (Office Of Workforce Planning & Development),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102949
543,BC011767-01,"October 01, 2016 -  September 30, 2017",Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1,Chengkai  Dai|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Zijian  Tang|Kun-Han  Chuang|Kuo-Hui  Su|Meng  Xu,NULL,NULL,NULL,"1. Dai C (2017) The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis. Philosophical Transactions of The Royal Society B, in press.|2. Su KH, Dai C (2017). mTORC1 senses stresses: Coupling stress to proteostasis. Bioessays  39.   https://doi.org/10.1002/bies.201600268",https://intramural.nih.gov/search/searchview.taf?ipid=102947
544,BC011768-01,"October 01, 2016 -  September 30, 2017",Natural History and Specimen Banking for Patients with CNS Tumors,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Alvina A Acquaye|Elizabeth  Vera,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102948
545,BC011770-01,"October 01, 2016 -  September 30, 2017",Evolution of prostate cancer genome,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,Margaret  Cam; PhD (Office of the Director)|Justin Britt Lack (Office of the Director),NULL,"1. Lack J, Gillard M, Cam M, Paner GP, VanderWeele DJ (2017). Circulating tumor cells capture disease evolution in advanced prostate cancer. J Transl Med  15, 44.   https://doi.org/10.1186/s12967-017-1138-3",https://intramural.nih.gov/search/searchview.taf?ipid=102955
546,BC011771-01,"October 01, 2016 -  September 30, 2017",Development of therapy for aggressive variant prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Kathleen  Kelly; PhD,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102953
547,BC011772-01,"October 01, 2016 -  September 30, 2017",The role of Galpha13 signaling in suppression of lymphoma,Jagan Reddy Muppidi|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Huifang  Li|Raud  Razzaghi|Hang T Nguyen|Anne Robins Albright|Louis  Staudt; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102954
548,BC011773-01,"October 01, 2016 -  September 30, 2017",Hypoxia signaling in cancer development,"Zhengping  Zhuang; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Qi  Zhang; MD|Herui  Wang; PhD|Chun Zhang  Yang; PhD,NULL,NULL,"Emily Y Chew; MD (NEI) |John D Heiss; MD (NINDS) |Karel  Pacak; MD, PhD (NICHD)","1. Därr R, Nambuba J, Del Rivero J, Janssen I, Merino M, Todorovic M, Balint B, Jochmanova I, Prchal JT, Lechan RM, Tischler AS, Popovic V, Miljic D, Adams KT, Prall FR, Ling A, Golomb MR, Ferguson M, Nilubol N, Chen CC, Chew E, Taïeb D, Stratakis CA, Fojo T, Yang C, et al. [3 more authors] (2016). Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome. Endocr Relat Cancer  23, 899-908.   https://doi.org/10.1530/ERC-16-0231|2. Feldman MJ, Sizdahkhani S, Edwards NA, Merrill MJ, Ray-Chaudhury A, Zhuang Z, Lonser RR, Oldfield EH, Chittiboina P (2016). Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling. Sci Rep  6, 35486.   https://doi.org/10.1038/srep35486|3. Gao P, Yang C, Nesvick CL, Feldman MJ, Sizdahkhani S, Liu H, Chu H, Yang F, Tang L, Tian J, Zhao S, Li G, Heiss JD, Liu Y, Zhuang Z, Xu G (2016). Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling. Oncotarget  7, 15200-14.   https://doi.org/10.18632/oncotarget.7710|4. Hao S, Hong CS, Feng J, Yang C, Chittiboina P, Zhang J, Zhuang Z (2016). Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome. J Neurosurg  124, 1562-7.   https://doi.org/10.3171/2015.4.JNS15191|5. Nesvick CL, Zhang C, Edwards NA, Montgomery BK, Lee M, Yang C, Wang H, Zhu D, Heiss JD, Merrill MJ, Ray-Chaudhury A, Zhuang Z (2016). ZEB1 expression is increased in IDH1-mutant lower-grade gliomas. J Neurooncol  130, 111-122.   https://doi.org/10.1007/s11060-016-2240-8|6. Zhang C, Yang C, Feldman MJ, Wang H, Pang Y, Maggio DM, Zhu D, Nesvick CL, Dmitriev P, Bullova P, Chittiboina P, Brady RO, Pacak K, Zhuang Z (2017) Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha. Oncotarget, in press (e-pub ahead of print)  https://doi.org/10.18632/oncotarget.18125|7. Zhuang Z, Yang C, Ryska A, Ji Y, Hou Y, Graybill SD, Bullova P, Lubensky IA, Klöppel G, Pacak K (2016). HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma. Endocr Relat Cancer  23, L13-6.   https://doi.org/10.1530/ERC-16-0148",https://intramural.nih.gov/search/searchview.taf?ipid=102956
549,BC011774-01,"October 01, 2016 -  September 30, 2017",Development and translation of novel therapies for pediatric sarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Anna Elizabeth Gibson,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),"1. Heske CM, Mendoza A, Edessa LD, Baumgart JT, Lee S, Trepel J, Proia DA, Neckers L, Helman LJ (2016). STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma. Oncotarget  7, 65540-65552.   https://doi.org/10.18632/oncotarget.11869",https://intramural.nih.gov/search/searchview.taf?ipid=102957
550,BC011775-01,"October 01, 2016 -  September 30, 2017",Immune cell control of ovarian cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Daniel Saul Green|Michelle K Ozaki|Anna Rose Duemler|Jung-Min  Lee,NULL,NULL,Kathryn C Zoon; PhD (NIAID),"1. Green DS, Nunes AT, Annunziata CM, Zoon KC (2016). Monocyte and interferon based therapy for the treatment of ovarian cancer. Cytokine Growth Factor Rev  29, 109-15.   https://doi.org/10.1016/j.cytogfr.2016.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=102961
551,BC011777-01,"October 01, 2016 -  September 30, 2017",Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Don Eugene Farthing|Evelyn Frieda Kandov,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Keita  Saito (Radiation Biology Branch),"Martin J Lizak; PhD (NINDS) |Hellmut  Merkle; MS, PHD (NINDS)","1. Buxbaum NP, Farthing DE, Maglakelidze N, Lizak M, Merkle H, Carpenter AC, Oliver BU, Kapoor V, Castro E, Swan GA, Dos Santos LM, Bouladoux NJ, Bare CV, Flomerfelt FA, Eckhaus MA, Telford WG, Belkaid Y, Bosselut RJ, Gress RE (2017). In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease. JCI Insight  2.   https://doi.org/10.1172/jci.insight.92851|2. Farthing DE, Buxbaum NP, Lucas PJ, Maglakelidze N, Oliver B, Wang J, Hu K, Castro E, Bare CV, Gress RE (2017). Comparing DNA enrichment of proliferating cells following administration of different stable isotopes of heavy water. Sci Rep  7, 4043.   https://doi.org/10.1038/s41598-017-04404-2",https://intramural.nih.gov/search/searchview.taf?ipid=102958
552,BC011778-01,"October 01, 2016 -  September 30, 2017",Quantitative Single-Cell Assessment of Lentivirus Susceptibility Determinants,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Saliha  Majdoul,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102959
553,BC011779-01,"October 01, 2016 -  September 30, 2017",Antiviral Mechanism of IFITM Proteins during HIV and Other Retrovirus Infections,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Guoli  Shi|Kazi Mohammad Mostafizur Rahman|Alvin Quang-Viet Cao|Alan  Rein; PhD,Chen  Liang (McGill University)|Olivier  Schwartz (Institut Pasteur)|Jacob  Yount (The Ohio State University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102960
554,BC011780-01,"October 01, 2016 -  September 30, 2017",Clinical development of mechanism-based lymphoma therapies,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Weihong  Xu|Roland  Schmitz|Ryan Matthew Young|Da Wei  Huang|Yandan  Yang; PhD|Show all 8,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Roschewski M, Staudt LM, Wilson WH (2016). Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma. Blood  127, 3127-32.   https://doi.org/10.1182/blood-2016-03-635219",https://intramural.nih.gov/search/searchview.taf?ipid=102962
555,BC011781-01,"October 01, 2016 -  September 30, 2017",Dynamics of hematopoietic differentiation,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Amir  Erez; PhD|Ratnadeep  Mukherjee; PhD,Frdric  Geissman (Memorial Sloan Kettering)|Pankaj  Mehta (Boston University),Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102964
556,BC011782-01,"October 01, 2016 -  September 30, 2017",Mechanisms of pathogenesis in patient derived organoid models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin|Keith Henry Jansson|Supreet  Agarwal|Michael Louis Beshiri; PhD|Kerry Alexandra McGowen|Caitlin Marie Tice|Show all 9,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Pan H, Jansson K, Beshiri M, Yin J, Fang L, Agarwal S, Nguyen H, Corey E, Zhang Y, Liu J, Fan H, Lin H, Siebenlist K (2017) Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=102963
557,BC011784-01,"October 01, 2016 -  September 30, 2017",Bioinformatics:  Characterizing Brain Tumor Date,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Aiguo  Li|Orieta  Celiku,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102965
558,BC011785-01,"October 01, 2016 -  September 30, 2017",Better understanding and handling of tautomerism,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Devendra Kumar  Dhaked|Hitesh Jayantilal Patel; PhD,Steve  Heller (NIST)|Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH),NULL,NULL,"1. Guasch L, Yapamudiyansel W, Peach ML, Kelley JA, Barchi JJ, Nicklaus MC (2016). Experimental and Chemoinformatics Study of Tautomerism in a Database of Commercially Available Screening Samples. J Chem Inf Model  56, 2149-2161.   https://doi.org/10.1021/acs.jcim.6b00338",https://intramural.nih.gov/search/searchview.taf?ipid=102966
559,BC011786-01,"October 01, 2016 -  September 30, 2017",A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Yvonne  Wall|Rebecca Christine Dolan,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Jane Beth Trepel (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102967
560,BC011787-01,"October 01, 2016 -  September 30, 2017",Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer,Haobin  Chen|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Lisa  Gesumaria|Christopher S Tao,Phillip  Liu (Incyte)|John  Poirier (MSKCC)|Charles  Rudin (MSKCC)|Nenghui  Wang (Ningbo Wenda Pharma),Dinah  Singer; PhD (Experimental Immunology Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102968
561,BC011789-01,"October 01, 2016 -  September 30, 2017",Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma  pheochromocytoa,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Jaydira  del Rivero; MD (Pediatric Oncology Branch),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102969
562,BC011790-01,"October 01, 2016 -  September 30, 2017",Metabolic imaging of the effects of brain radiotherapy,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Hari Mony Nath,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102970
563,CP000101-13,"October 01, 2016 -  September 30, 2017",Human Studies of Diet and Nutrition,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99353
564,CP000112-13,"October 01, 2016 -  September 30, 2017",Nutrition Intervention Trials,"Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman|Gwen  Murphy,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Alisa  Goldstein; PhD (Clinical Genetics Branch)|Kai  Yu (Biostatistics Branch)|Paula L Hyland (Genetic Epidemiology Branch),NULL,"1. Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR (2017). Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort. Cancer Sci  108, 1667-1672.   https://doi.org/10.1111/cas.13292|2. Ren J, Murphy G, Fan J, Dawsey SM, Taylor PR, Selhub J, Qiao Y, Abnet CC (2016). Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China. Sci Rep  6, 35281.   https://doi.org/10.1038/srep35281",https://intramural.nih.gov/search/searchview.taf?ipid=99352
565,CP000176-13,"October 01, 2016 -  September 30, 2017",Biologic Specimen Bank for Early Lung Cancer Markers,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|George M Weinstock|Jie  He (CICAMS)|Bert R Vogelstein,"Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Guoqin  Yu (Genetic Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99354
566,CP000185-13,"October 01, 2016 -  September 30, 2017",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Ning  Lu (Cancer Institute, Chinese Academy of Medical Sciences)|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|Show all 11",NULL,NULL,"1. Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M, Delavari A, Amani M, Feyz-Sani A, Poustchi H, Pourshams A, Sadjadi AM, Khoshnia M, Qaravi S, Abnet CC, Dawsey S, Brennan P, Kamangar F, Boffetta P, Sadjadi A, Malekzadeh R (2017). Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia. BMJ Open  7, e013548.   https://doi.org/10.1136/bmjopen-2016-013548|2. Choi K, Sabado M, El-Toukhy S, Vogtmann E, Freedman ND, Hatsukami D (2017). Tobacco Product Use Patterns, and Nicotine and Tobacco-Specific Nitrosamine Exposure: NHANES 1999-2012. Cancer Epidemiol Biomarkers Prev  26, 1525-1530.   https://doi.org/10.1158/1055-9965.EPI-17-0338|3. Etemadi A, Khademi H, Kamangar F, Freedman ND, Abnet CC, Brennan P, Malekzadeh R, Golestan Cohort Study Team (2017). Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a Cohort Study of 50 000 individuals from Iran. Tob Control  26, 674-682.   https://doi.org/10.1136/tobaccocontrol-2016-053245|4. Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R (2017). Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study. Am J Epidemiol  185, 697-711.   https://doi.org/10.1093/aje/kww139|5. Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R (2017). Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran. Am J Prev Med  52, 237-248.   https://doi.org/10.1016/j.amepre.2016.10.041|6. Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G (2017). White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health  17, 133.   https://doi.org/10.1186/s12889-016-3999-4|7. Loftfield E, Freedman ND, Dodd KW, Vogtmann E, Xiao Q, Sinha R, Graubard BI (2016). Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors. J Nutr  146, 1762-8.   https://doi.org/10.3945/jn.116.233940|8. McCormack VA, Menya D, Munishi MO, Dzamalala C, Gasmelseed N, Leon Roux M, Assefa M, Osano O, Watts M, Mwasamwaja AO, Mmbaga BT, Murphy G, Abnet CC, Dawsey SM, Schüz J (2017). Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors. Int J Cancer  140, 259-271.   https://doi.org/10.1002/ijc.30292|9. Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC (2017). Oral bisphosphonates and colorectal cancer. Sci Rep  7, 44177.   https://doi.org/10.1038/srep44177|10. Vogtmann E, Etemadi A, Kamangar F, Islami F, Roshandel G, Poustchi H, Pourshams A, Khoshnia M, Gharravi A, Brennan PJ, Boffetta P, Dawsey SM, Malekzadeh R, Abnet CC (2017). Oral health and mortality in the Golestan Cohort Study. Int J Epidemiol  46, 2028-2035.   https://doi.org/10.1093/ije/dyx056",https://intramural.nih.gov/search/searchview.taf?ipid=99355
567,CP004410-41,"October 01, 2016 -  September 30, 2017",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Human Genetics Program, NCI",June  Peters,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,Kenneth H Kraemer; MD (Dermatology Branch),"Jeffery P Struewing; MS, MD (NHGRI)","1. Baker MJ, Goldstein AM, Gordon PL, Harbaugh KS, Mackley HB, Glantz MJ, Drabick JJ (2016). An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies. J Med Genet  53, 721-727.   https://doi.org/10.1136/jmedgenet-2015-103446|2. Castillo JJ, Garcia-Sanz R, Hatjiharissi E, Kyle RA, Leleu X, McMaster M, Merlini G, Minnema MC, Morra E, Owen RG, Poulain S, Stone MJ, Tam C, Varettoni M, Dimopoulos MA, Treon SP, Kastritis E (2016). Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia. Br J Haematol  175, 77-86.   https://doi.org/10.1111/bjh.14196|3. de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M, Gapstur SM, Gaudet MM, Freedman ND, Landi MT, Lemonnier N, Hainaut P, Savage SA, Achatz MI (2017). Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. Hum Mutat  38, 1723-1730.   https://doi.org/10.1002/humu.23320|4. Goldin LR, McMaster ML, Rotunno M, Herman SE, Jones K, Zhu B, Boland J, Burdett L, Hicks B, Ravichandran S, Luke BT, Yeager M, Fontaine L, Goldstein AM, Chanock SJ, Tucker MA, Wiestner A, Marti G, Caporaso NE (2016). Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility. Blood  128, 2261-2263.   https://doi.org/10.1182/blood-2016-02-697771|5. Shi J, Zhou W, Zhu B, Hyland PL, Bennett H, Xiao Y, Zhang X, Burke LS, Song L, Hsu CH, Yan C, Chen Q, Meerzaman D, Dagnall CL, Burdette L, Hicks B, Freedman ND, Chanock SJ, Yeager M, Tucker MA, Goldstein AM, Yang XR (2016). Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma. J Invest Dermatol  136, 2436-2443.   https://doi.org/10.1016/j.jid.2016.07.023|6. Yang XR, Rotunno M, Xiao Y, Ingvar C, Helgadottir H, Pastorino L, van Doorn R, Bennett H, Graham C, Sampson JN, Malasky M, Vogt A, Zhu B, Bianchi-Scarra G, Bruno W, Queirolo P, Fornarini G, Hansson J, Tuominen R, Burdett L, Hicks B, Hutchinson A, Jones K, Yeager M, Chanock SJ, et al. [7 more authors] (2016). Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. Hum Genet  135, 1241-1249.   https://doi.org/10.1007/s00439-016-1715-1",https://intramural.nih.gov/search/searchview.taf?ipid=99327
568,CP005782-23,"October 01, 2016 -  September 30, 2017",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch),Barbara  Rehermann; MD (NIDDK) |Raymond  Donnelly (OD),"1. Kuniholm MH, Strickler HD, Anastos K, Prokunina-Olsson L, Aouizerat BE, O'Brien TR (2017). Relationship of Genotype for HLA B*57 and IFNL4 With Disease Progression in Female HIV Controllers. Clin Infect Dis  65, 1243-1244.   https://doi.org/10.1093/cid/cix481|2. O'Brien TR, Feld JJ, Kottilil S, Pfeiffer RM (2016). No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL. Hepatology  63, 28-30.   https://doi.org/10.1002/hep.28292|3. O'Brien TR, Kottilil S, Feld JJ, Morgan TR, Pfeiffer RM (2017). Race or genetic makeup for hepatitis C virus treatment decisions? Hepatology  65, 2124-2125.   https://doi.org/10.1002/hep.29057",https://intramural.nih.gov/search/searchview.taf?ipid=99326
569,CP005803-23,"October 01, 2016 -  September 30, 2017",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD|Dilys  Parry; PhD,"Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)",NULL,"1. Gu F, Xu S, Devesa SS, Zhang F, Klerman EB, Graubard BI, Caporaso NE (2017). Longitude Position in a Time Zone and Cancer Risk in the United States. Cancer Epidemiol Biomarkers Prev  26, 1306-1311.   https://doi.org/10.1158/1055-9965.EPI-16-1029|2. Guo C, Sung H, Zheng S, Guida J, Li E, Li J, Hu N, Deng J, Figueroa JD, Sherman ME, Gierach GL, Lu N, Yang XR (2017). Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors. Breast Cancer Res  19, 61.   https://doi.org/10.1186/s13058-017-0850-5|3. Li M, Tse LA, Chan WC, Kwok CH, Leung SL, Wu C, Yu WC, Lee PM, Tsang KH, Law SH, Vermeulen R, Gu F, Caporaso NE, Yu IT, Wang F, Yang XR (2017). Nighttime eating and breast cancer among Chinese women in Hong Kong. Breast Cancer Res  19, 31.   https://doi.org/10.1186/s13058-017-0821-x|4. Yu G, Phillips S, Gail MH, Goedert JJ, Humphrys MS, Ravel J, Ren Y, Caporaso NE (2017). The effect of cigarette smoking on the oral and nasal microbiota. Microbiome  5, 3.   https://doi.org/10.1186/s40168-016-0226-6",https://intramural.nih.gov/search/searchview.taf?ipid=99325
570,CP005804-23,"October 01, 2016 -  September 30, 2017",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Infection & Immunoepidemiology Branch)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, Jones K, Zhou W, Bouk AJ, Boland J, Hicks B, Risch A, Bennett H, Luke BT, Song L, Duan J, Liu P, Kohno T, Chen Q, Meerzaman D, Marconett C, et al. [9 more authors] (2016). Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. PLoS Med  13, e1002162.   https://doi.org/10.1371/journal.pmed.1002162|2. Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, Caporaso NE, Goedert JJ, Ravel J, Landi MT (2016). Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol  17, 163.   https://doi.org/10.1186/s13059-016-1021-1",https://intramural.nih.gov/search/searchview.taf?ipid=99324
571,CP010119-22,"October 01, 2016 -  September 30, 2017",Studies of Occupational Cancer (Pesticides),"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Gabriella  Andreotti|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD",Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Jane  Hoppin (North Carolina State University),NULL,NULL,"1. Andreotti G, Freedman ND, Silverman DT, Lerro CC, Koutros S, Hartge P, Alavanja MC, Sandler DP, Freeman LB (2017). Tobacco Use and Cancer Risk in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev  26, 769-778.   https://doi.org/10.1158/1055-9965.EPI-16-0748|2. Carnes MU, Hoppin JA, Metwali N, Wyss AB, Hankinson JL, O'Connell EL, Richards M, Long S, Freeman LE, Sandler DP, Henneberger PK, Barker-Cummings C, Umbach DM, Thorne PS, London SJ (2017). House Dust Endotoxin Levels Are Associated with Adult Asthma in a U.S. Farming Population. Ann Am Thorac Soc  14, 324-331.   https://doi.org/10.1513/AnnalsATS.201611-861OC|3. Christensen CH, Barry KH, Andreotti G, Alavanja MC, Cook MB, Kelly SP, Burdett LA, Yeager M, Beane Freeman LE, Berndt SI, Koutros S (2016). Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study. Front Oncol  6, 237.   https://doi.org/10.3389/fonc.2016.00237|4. House JS, Wyss AB, Hoppin JA, Richards M, Long S, Umbach DM, Henneberger PK, Beane Freeman LE, Sandler DP, Long O'Connell E, Barker-Cummings C, London SJ (2017). Early-life farm exposures and adult asthma and atopy in the Agricultural Lung Health Study. J Allergy Clin Immunol  140, 249-256.e14.   https://doi.org/10.1016/j.jaci.2016.09.036|5. Lerro CC, Beane Freeman LE, Portengen L, Kang D, Lee K, Blair A, Lynch CF, Bakke B, De Roos AJ, Vermeulen RC (2017). A longitudinal study of atrazine and 2,4-D exposure and oxidative stress markers among iowa corn farmers. Environ Mol Mutagen  58, 30-38.   https://doi.org/10.1002/em.22069|6. Meyer A, Sandler DP, Beane Freeman LE, Hofmann JN, Parks CG (2017). Pesticide Exposure and Risk of Rheumatoid Arthritis among Licensed Male Pesticide Applicators in the Agricultural Health Study. Environ Health Perspect  125, 077010.   https://doi.org/10.1289/EHP1013|7. Rusiecki JA, Beane Freeman LE, Bonner MR, Alexander M, Chen L, Andreotti G, Barry KH, Moore LE, Byun HM, Kamel F, Alavanja M, Hoppin JA, Baccarelli A (2017). High pesticide exposure events and DNA methylation among pesticide applicators in the agricultural health study. Environ Mol Mutagen  58, 19-29.   https://doi.org/10.1002/em.22067|8. Wyss AB, House JS, Hoppin JA, Richards M, Hankinson JL, Long S, Henneberger PK, Beane Freeman LE, Sandler DP, O'Connell EL, Cummings CB, Umbach DM, London SJ (2018). Raw milk consumption and other early-life farm exposures and adult pulmonary function in the Agricultural Lung Health Study. Thorax  73, 279-282.   https://doi.org/10.1136/thoraxjnl-2017-210031",https://intramural.nih.gov/search/searchview.taf?ipid=99319
572,CP010120-22,"October 01, 2016 -  September 30, 2017",Studies of Occupational Cancer,"Laura Elizabeth Beane Freeman|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Lee Elizabeth Moore; PhD, MD|Show all 10",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Office of the Director)|Montserrat  Garcia-Closas; MD, PhD (Office of the Director)","Dale  Sandler; PhD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Dai Y, Niu Y, Duan H, Bassig BA, Ye M, Zhang X, Meng T, Bin P, Jia X, Shen M, Zhang R, Hu W, Yang X, Vermeulen R, Silverman D, Rothman N, Lan Q, Yu S, Zheng Y (2016). Effects of occupational exposure to carbon black on peripheral white blood cell counts and lymphocyte subsets. Environ Mol Mutagen  57, 615-622.   https://doi.org/10.1002/em.22036|2. Silverman DT (2017). Diesel exhaust causes lung cancer: now what? Occup Environ Med  74, 233-234.   https://doi.org/10.1136/oemed-2016-104197|3. Silverman DT, Attfield MD, Blair AE, Lubin JH, Stewart PA, Vermeulen R (2016). Re: ""The hidden impact of a healthy-worker effect on the results of the Diesel Exhaust in Miners Study"". Eur J Epidemiol  31, 805-6.   https://doi.org/10.1007/s10654-016-0188-9|4. Wong JYY, Bassig BA, Seow WJ, Hu W, Ji BT, Blair A, Silverman DT, Lan Q (2017). Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial. Occup Environ Med  74, 440-448.   https://doi.org/10.1136/oemed-2016-104168",https://intramural.nih.gov/search/searchview.taf?ipid=99321
573,CP010121-22,"October 01, 2016 -  September 30, 2017",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Mark  Purdue|Laura Elizabeth Beane Freeman","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13",NULL,NULL,"1. GBD 2015 Healthcare Access and Quality Collaborators. Electronic address: cjlm@uw.edu, GBD 2015 Healthcare Access and Quality Collaborators (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet  390, 231-266.   https://doi.org/10.1016/S0140-6736(17)30818-8|2. Lu SS, Grigoryan H, Edmands WM, Hu W, Iavarone AT, Hubbard A, Rothman N, Vermeulen R, Lan Q, Rappaport SM (2017). Profiling the Serum Albumin Cys34 Adductome of Solid Fuel Users in Xuanwei and Fuyuan, China. Environ Sci Technol  51, 46-57.   https://doi.org/10.1021/acs.est.6b03955|3. Seow WJ, Lan Q (2016). Domestic incense use and lung cancer in Asia: a review. Rev Environ Health  31, 155-8.   https://doi.org/10.1515/reveh-2015-0060|4. Seow WJ, Matsuo K, Hsiung CA, Shiraishi K, Song M, Kim HN, Wong MP, Hong YC, Hosgood HD, Wang Z, Chang IS, Wang JC, Chatterjee N, Tucker M, Wei H, Mitsudomi T, Zheng W, Kim JH, Zhou B, Caporaso NE, Albanes D, Shin MH, Chung LP, An SJ, Wang P, et al. [161 more authors] (2017). Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Hum Mol Genet  26, 454-465.   https://doi.org/10.1093/hmg/ddw414|5. Wang Z, Seow WJ, Shiraishi K, Hsiung CA, Matsuo K, Liu J, Chen K, Yamji T, Yang Y, Chang IS, Wu C, Hong YC, Burdett L, Wyatt K, Chung CC, Li SA, Yeager M, Hutchinson A, Hu W, Caporaso N, Landi MT, Chatterjee N, Song M, Fraumeni JF, Kohno T, et al. [125 more authors] (2016). Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Hum Mol Genet  25, 620-9.   https://doi.org/10.1093/hmg/ddv494|6. Wong JY, Bassig BA, Vermeulen R, Hu W, Ning B, Seow WJ, Ji BT, Downward GS, Katki HA, Barone-Adesi F, Rothman N, Chapman RS, Lan Q (2017). Sleep Duration across the Adult Lifecourse and Risk of Lung Cancer Mortality: A Cohort Study in Xuanwei, China. Cancer Prev Res (Phila)  10, 327-336.   https://doi.org/10.1158/1940-6207.CAPR-16-0295",https://intramural.nih.gov/search/searchview.taf?ipid=99322
574,CP010122-22,"October 01, 2016 -  September 30, 2017",Occupational Exposure Assessment,Qing  Lan|IRP Faculty Profile  | |Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Mark  Purdue|Sarah J Locke|Debra  Silverman; ScD, ScM|Show all 9",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99320
575,CP010123-22,"October 01, 2016 -  September 30, 2017",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Melissa Charmaine Friesen|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt",NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Wong JYY, Bassig BA, Seow WJ, Hu W, Ji BT, Blair A, Silverman DT, Lan Q (2017). Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial. Occup Environ Med  74, 440-448.   https://doi.org/10.1136/oemed-2016-104168",https://intramural.nih.gov/search/searchview.taf?ipid=99323
576,CP010124-22,"October 01, 2016 -  September 30, 2017",Human papillomavirus (HPV) infection and cervical and anal cancers,Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Julia  Gage|Clara  Bodelon,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Joshua Neil Sampson (Biostatistics Branch)|Vikrant Vasant Sahasrabuddhe (Breast and Gynecologic Cancer Research Group)|Hannah  Yang (Office of the Director)|Douglas  Lowy; MD (Office Of The Director),NULL,"1. Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N (2016). Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer  139, 2001-11.   https://doi.org/10.1002/ijc.30243|2. Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada''s Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph''s Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children''s Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis (2017). Integrated genomic and molecular characterization of cervical cancer. Nature  543, 378-384.   https://doi.org/10.1038/nature21386|3. Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N (2017). Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer  141, 701-710.   https://doi.org/10.1002/ijc.30781|4. Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N (2017). Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol  130, 1218-1225.   https://doi.org/10.1097/AOG.0000000000002330|5. Mayeaux EJ, Novetsky AP, Chelmow D, Garcia F, Choma K, Liu AH, Papasozomenos T, Einstein MH, Massad LS, Wentzensen N, Waxman AG, Conageski C, Khan MJ, Huh WK (2017). ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States. J Low Genit Tract Dis  21, 242-248.   https://doi.org/10.1097/LGT.0000000000000342|6. Schiffman M (2017). Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice. Prev Med  98, 3-4.   https://doi.org/10.1016/j.ypmed.2016.12.028|7. Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS (2017). Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines. J Low Genit Tract Dis  21, 87-90.   https://doi.org/10.1097/LGT.0000000000000300|8. Wentzensen N, Arbyn M (2017). HPV-based cervical cancer screening- facts, fiction, and misperceptions. Prev Med  98, 33-35.   https://doi.org/10.1016/j.ypmed.2016.12.040|9. Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, Farley C, Monsonego J, Franceschi S (2017). Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. Int J Cancer  140, 2192-2200.   https://doi.org/10.1002/ijc.30579|10. Wentzensen N, Litwin T (2018). Accuracy of visual cervical screening: verification bias revisited. BJOG  125, 554.   https://doi.org/10.1111/1471-0528.14797|11. Wentzensen N, Schiffman M, Palmer T, Arbyn M (2016). Triage of HPV positive women in cervical cancer screening. J Clin Virol  76 Suppl 1, S49-S55.   https://doi.org/10.1016/j.jcv.2015.11.015",https://intramural.nih.gov/search/searchview.taf?ipid=99315
577,CP010125-22,"October 01, 2016 -  September 30, 2017",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Rena Rae Jones|Joanne S Colt|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Lee Elizabeth Moore; PhD, MD|Show all 9","James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John W Brock (CDC)|Alexander  Parker (Mayo Clinic, Rochestor, NM)|Show all 28",Jay  Lubin; PhD (Biostatistics Branch)|Maki  Inoue Choi (Hormonal and Reproductive Epidemiology Branch),Lawrence Stuart Engel; PhD (NIEHS),"1. Jones RR, Weyer PJ, DellaValle CT, Robien K, Cantor KP, Krasner S, Beane Freeman LE, Ward MH (2017). Ingested Nitrate, Disinfection By-products, and Kidney Cancer Risk in Older Women. Epidemiology  28, 703-711.   https://doi.org/10.1097/EDE.0000000000000647",https://intramural.nih.gov/search/searchview.taf?ipid=99328
578,CP010126-22,"October 01, 2016 -  September 30, 2017",Hormone-Related Cancers,"Louise  Brinton; PhD| | |Michael Blaise Cook|IRP Faculty Profile  | |Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Gretchen L Gierach|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI","Roni T Falk|Hannah  Yang|Stephen J Chanock; MD, PhD",David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Abubakar M, Orr N, Daley F, Coulson P, Ali HR, Blows F, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RA, Seynaeve C, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, et al. [16 more authors] (2016). Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups. Breast Cancer Res  18, 104.   https://doi.org/10.1186/s13058-016-0765-6|2. Bodelon C, Oh H, Chatterjee N, Garcia-Closas M, Palakal M, Sherman ME, Pfeiffer RM, Geller B, Vacek P, Weaver DL, Chicoine R, Papathomas D, Xiang J, Patel DA, Khodr ZG, Linville L, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AMV, He C, Chanock SJ, Gierach GL, et al. [1 more author] (2017). Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int J Cancer  140, 825-832.   https://doi.org/10.1002/ijc.30512|3. Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA (2017). Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst  109, 1-10.   https://doi.org/10.1093/jnci/djw251|4. Brinton L, Figueroa J, Adjei E, Ansong D, Biritwum R, Edusei L, Nyarko KM, Wiafe S, Yarney J, Addai BW, Awuah B, Clegg-Lamptey JN, Ghana Breast Health Study team (2017). Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa. Breast Cancer Res Treat  162, 105-114.   https://doi.org/10.1007/s10549-016-4088-1|5. Brinton LA, Awuah B, Nat Clegg-Lamptey J, Wiafe-Addai B, Ansong D, Nyarko KM, Wiafe S, Yarney J, Biritwum R, Brotzman M, Adjei AA, Adjei E, Aitpillah F, Edusei L, Dedey F, Nyante SJ, Oppong J, Osei-Bonsu E, Titiloye N, Vanderpuye V, Brew Abaidoo E, Arhin B, Boakye I, Frempong M, Ohene Oti N, et al. [2 more authors] (2017). Design considerations for identifying breast cancer risk factors in a population-based study in Africa. Int J Cancer  140, 2667-2677.   https://doi.org/10.1002/ijc.30688|6. Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, Wildiers H, Andrulis IL, Arndt V, Beckmann MW, Benitez J, Blomqvist C, Bojesen SE, Brauch H, Brennan P, Brenner H, Chenevix-Trench G, Choi JY, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Eriksson M, kConFab, et al. [51 more authors] (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res  19, 119.   https://doi.org/10.1186/s13058-017-0909-3|7. Cannioto RA, Trabert B, Poole EM, Schildkraut JM (2017). Ovarian cancer epidemiology in the era of collaborative team science. Cancer Causes Control  28, 487-495.   https://doi.org/10.1007/s10552-017-0862-6|8. Coburn SB, Bray F, Sherman ME, Trabert B (2017). International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer  140, 2451-2460.   https://doi.org/10.1002/ijc.30676|9. Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Ovarian Cancer Association Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Couch FJ, Offit K, Chenevix-Trench G, Monteiro AN, Antoniou A, Freedman M, Coetzee GA, Pharoah PD, Noushmehr H, Gayther SA, Ovarian Cancer Association Consortium The Consortium of Investigators of Modifiers of BRCA1/2 (2015). Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Hum Mol Genet  24, 3595-607.   https://doi.org/10.1093/hmg/ddv101|10. Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Barile M, Barkardottir RB, Barrowdale D, Beckmann L, Beckmann MW, Benitez J, Blank SV, Blomqvist C, et al. [224 more authors] (2016). Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun  7, 11375.   https://doi.org/10.1038/ncomms11375|11. Cuellar-Partida G, Lu Y, Dixon SC, Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, et al. [83 more authors] (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet  135, 741-56.   https://doi.org/10.1007/s00439-016-1663-9|12. Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, Soucy P, Michailidou K, Ghoussaini M, Fues Wahl H, Bolla MK, Wang Q, Dennis J, Alonso MR, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Benitez J, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Broeks A, Brüning T, et al. [89 more authors] (2016). Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Sci Rep  6, 32512.   https://doi.org/10.1038/srep32512|13. Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, AOCS Group & Australian Cancer Study (Ovarian Cancer), Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Rudolph A, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Ovarian Cancer Association Consortium, et al. [88 more authors] (2016). Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol  45, 884-95.   https://doi.org/10.1093/ije/dyw158|14. Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kjær SK, Høgdall E, Berchuck A, Cramer DW, Terry KL, Poole EM, Bandera EV, Paddock LE, et al. [10 more authors] (2017). Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer  116, 1223-1228.   https://doi.org/10.1038/bjc.2017.68|15. Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E, Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Hills M, Jarosz M, Drury S, Canisius S, Bolla MK, Dennis J, EMBRACE, GEMO Study Collaborators, HEBON, kConFab Investigators, et al. [223 more authors] (2016). Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet  48, 374-86.   https://doi.org/10.1038/ng.3521|16. Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, Aittomäki K, Liu J, Ali HR, Andrulis IL, Beckmann MW, Behrens S, Blows FM, Brenner H, Chang-Claude J, Couch FJ, Czene K, Fasching PA, Figueroa J, Floris G, Glendon G, Guo Q, Hall P, kConFab/AOCS Investigators, et al. [27 more authors] (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget  8, 18381-18398.   https://doi.org/10.18632/oncotarget.15110|17. Felix AS, Lenz P, Pfeiffer RM, Hewitt SM, Morris J, Patel DA, Geller B, Vacek PM, Weaver DL, Chicoine RE, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn SD, Johnson JM, Cora RL, Brinton LA, Sherman ME, Gierach GL (2016). Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis. Breast Cancer Res  18, 88.   https://doi.org/10.1186/s13058-016-0746-9|18. Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, Hartmann LC, Frost MH, Stallings Mann ML, Papathomas D, Gierach GL, Hewitt SM, Duggan MA, Visscher D, Sherman ME (2016). Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study. Breast Cancer Res Treat  159, 163-72.   https://doi.org/10.1007/s10549-016-3908-7|19. Ghazarian AA, Kelly SP, Altekruse SF, Rosenberg PS, McGlynn KA (2017). Future of testicular germ cell tumor incidence in the United States: Forecast through 2026. Cancer  123, 2320-2328.   https://doi.org/10.1002/cncr.30597|20. Gierach GL, Curtis RE, Pfeiffer RM, Mullooly M, Ntowe EA, Hoover RN, Nyante SJ, Feigelson HS, Glass AG, Berrington de Gonzalez A (2017). Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting. JAMA Oncol  3, 186-193.   https://doi.org/10.1001/jamaoncol.2016.3340|21. Gurney J, Richiardi L, McGlynn KA, Signal V, Sarfati D (2017). Analgesia use during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis. Hum Reprod  32, 1118-1129.   https://doi.org/10.1093/humrep/dex047|22. Gurney JK, McGlynn KA, Stanley J, Merriman T, Signal V, Shaw C, Edwards R, Richiardi L, Hutson J, Sarfati D (2017). Risk factors for cryptorchidism. Nat Rev Urol  14, 534-548.   https://doi.org/10.1038/nrurol.2017.90|23. Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt V, Baynes C, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, NBCS Collaborators, Couch FJ, Cox A, kConFab/AOCS Investigators, et al. [69 more authors] (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget  7, 80140-80163.   https://doi.org/10.18632/oncotarget.12818|24. Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, et al. [27 more authors] (2015). Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res  1, 18-32.   https://doi.org/10.1002/cjp2.3|25. Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, Chang-Claude J, Devilee P, Fasching PA, Michailidou K, Bolla MK, Dennis J, Wang Q, Guo Q, Rhenius V, Cornelissen S, Rudolph A, Knight JA, Loehberg CR, Burwinkel B, Marme F, Hopper JL, Southey MC, kConFab Investigators, et al. [32 more authors] (2015). SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. Oncotarget  6, 37979-94.   https://doi.org/10.18632/oncotarget.4991|26. Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, Lu L, Olson SH, Palmer JR, Petruzella S, Pike MC, Rebbeck TR, Ricceri F, Risch HA, Sacerdote C, Setiawan VW, et al. [8 more authors] (2017). Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstet Gynecol  129, 1059-1067.   https://doi.org/10.1097/AOG.0000000000002057|27. Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sánchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjønneland A, Trichopoulou A, Tworoger S, et al. [6 more authors] (2017). Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertil Steril  107, 1012-1022.e2.   https://doi.org/10.1016/j.fertnstert.2017.02.105|28. Killian JK, Dorssers LC, Trabert B, Gillis AJ, Cook MB, Wang Y, Waterfall JJ, Stevenson H, Smith WI, Noyes N, Retnakumar P, Stoop JH, Oosterhuis JW, Meltzer PS, McGlynn KA, Looijenga LH (2016). Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res  26, 1490-1504.   https://doi.org/10.1101/gr.201293.115|29. Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, Barile M, Beckmann MW, Behrens S, Benitez J, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Brauch H, Brennan P, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, Chen ST, Chenevix-Trench G, Cheng CY, NBCS Collaborators, et al. [74 more authors] (2016). rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Sci Rep  6, 36874.   https://doi.org/10.1038/srep36874|30. Lu Y, Cuellar-Partida G, Painter JN, Nyholt DR, Australian Ovarian Cancer Study, International Endogene Consortium (IEC), Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Wicklund KG, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, et al. [86 more authors] (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet  24, 5955-64.   https://doi.org/10.1093/hmg/ddv306|31. MacKay HJ, Levine DA, Bae-Jump VL, Bell DW, McAlpine JN, Santin A, Fleming GF, Mutch DG, Nephew KP, Wentzensen N, Goodfellow PJ, Dorigo O, Nijman HW, Broaddus R, Kohn EC (2017). Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget  8, 84579-84594.   https://doi.org/10.18632/oncotarget.19961|32. Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal L, McCue K, McCart Reed AE, Ghoussaini M, NBCS Collaborators, ABCTB Investigators, ConFab/AOCS Investigators, et al. [334 more authors] (2017). Association analysis identifies 65 new breast cancer risk loci. Nature  551, 92-94.   https://doi.org/10.1038/nature24284|33. Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL (2017). Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients. Breast Cancer Res  19, 8.   https://doi.org/10.1186/s13058-016-0791-4|34. Oh H, Coburn SB, Matthews CE, Falk RT, LeBlanc ES, Wactawski-Wende J, Sampson J, Pfeiffer RM, Brinton LA, Wentzensen N, Anderson GL, Manson JE, Chen C, Zaslavsky O, Xu X, Trabert B (2017). Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Breast Cancer Res  19, 28.   https://doi.org/10.1186/s13058-017-0810-0|35. Ong JS, Cuellar-Partida G, Lu Y, Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, et al. [86 more authors] (2016). Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol  45, 1619-1630.   https://doi.org/10.1093/ije/dyw207|36. Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, AOCS Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, Doherty JA, Chang-Claude J, Moysich K, Odunsi K, Goodman MT, Shvetsov YB, Wilkens LR, Thompson PJ, Dörk T, Bogdanova N, Butzow R, et al. [75 more authors] (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget  7, 72381-72394.   https://doi.org/10.18632/oncotarget.10546|37. Ritz BR, Chatterjee N, Garcia-Closas M, Gauderman WJ, Pierce BL, Kraft P, Tanner CM, Mechanic LE, McAllister K (2017). Lessons Learned From Past Gene-Environment Interaction Successes. Am J Epidemiol  186, 778-786.   https://doi.org/10.1093/aje/kwx230|38. Sak M, Duric N, Littrup P, Bey-Knight L, Ali H, Vallieres P, Sherman ME, Gierach GL (2017). Using Speed of Sound Imaging to Characterize Breast Density. Ultrasound Med Biol  43, 91-103.   https://doi.org/10.1016/j.ultrasmedbio.2016.08.021|39. SAK M, DURIC N, LITTRUP P, Sherman M, Gierach G (2016) Using ultrasound tomography to identify the distributions of density throughout the breast Proc SPIE Int Soc Opt Eng 9790:979019|40. Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, Bauer DC, Dorgan JF, Shu XO, Zheng W, Brinton LA, Gail MH, Ziegler RG, Xu X, Hoover RN, Gierach GL (2017). Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. Cancer Res  77, 918-925.   https://doi.org/10.1158/0008-5472.CAN-16-1717|41. Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Arndt V, Bermisheva M, Bogdanova NV, Bolla MK, Brauch H, Brenner H, Brüning T, Burwinkel B, Chang-Claude J, et al. [59 more authors] (2016). Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. J Clin Oncol  34, 2750-60.   https://doi.org/10.1200/JCO.2016.66.5844|42. Thistle JE, Graubard BI, Braunlin M, Vesper H, Trabert B, Cook MB, McGlynn KA (2017). Marijuana use and serum testosterone concentrations among U.S. males. Andrology  5, 732-738.   https://doi.org/10.1111/andr.12358|43. Wang Z, McGlynn KA, Rajpert-De Meyts E, Bishop DT, Chung CC, Dalgaard MD, Greene MH, Gupta R, Grotmol T, Haugen TB, Karlsson R, Litchfield K, Mitra N, Nielsen K, Pyle LC, Schwartz SM, Thorsson V, Vardhanabhuti S, Wiklund F, Turnbull C, Chanock SJ, Kanetsky PA, Nathanson KL, Testicular Cancer Consortium (2017). Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. Nat Genet  49, 1141-1147.   https://doi.org/10.1038/ng.3879|44. Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, Chang-Claude J, Lindstrom S, Bojesen SE, Ahsan H, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Blomqvist C, Bogdanova NV, Børresen-Dale AL, et al. [93 more authors] (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control  27, 679-93.   https://doi.org/10.1007/s10552-016-0741-6",https://intramural.nih.gov/search/searchview.taf?ipid=99329
579,CP010127-22,"October 01, 2016 -  September 30, 2017",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Loftfield E, Freedman ND, Lai GY, Weinstein SJ, McGlynn KA, Taylor PR, Männistö S, Albanes D, Stolzenberg-Solomon RZ (2016). Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes. Cancer Prev Res (Phila)  9, 866-874.   https://doi.org/10.1158/1940-6207.CAPR-16-0141|2. Loftfield E, O'Brien TR, Pfeiffer RM, Howell CD, Horst R, Prokunina-Olsson L, Weinstein SJ, Albanes D, Morgan TR, Freedman ND (2016). Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLoS One  11, e0166036.   https://doi.org/10.1371/journal.pone.0166036",https://intramural.nih.gov/search/searchview.taf?ipid=99347
580,CP010128-22,"October 01, 2016 -  September 30, 2017",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Vikrant Vasant Sahasrabuddhe| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI

Breast and Gynecologic Cancer Research Group, NCI",Roni T Falk,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  Kruger-Kjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Show all 10,NULL,NULL,"1. Brinton LA (2017). Fertility Status and Cancer. Semin Reprod Med  35, 291-297.   https://doi.org/10.1055/s-0037-1603098|2. Reigstad MM, Storeng R, Myklebust TÅ, Oldereid NB, Omland AK, Robsahm TE, Brinton LA, Vangen S, Furu K, Larsen IK (2017). Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study. Cancer Epidemiol Biomarkers Prev  26, 953-962.   https://doi.org/10.1158/1055-9965.EPI-16-0809|3. Zhou Z, Zeng F, Yuan J, Tang J, Colditz GA, Tworoger SS, Trabert B, Su X (2017). Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis. Cancer Causes Control  28, 415-428.   https://doi.org/10.1007/s10552-017-0873-3",https://intramural.nih.gov/search/searchview.taf?ipid=99330
581,CP010131-22,"October 01, 2016 -  September 30, 2017",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,Choonsik  Lee|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Daryl  Freedman|Alina V Brenner|Show all 7,David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Steven L Simon (Epidemiology and Biostatistics Program)|Andre  Bouville (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington de González A, Ntowe E, Kitahara CM, Gilbert E, Miller DL, Kleinerman RA, Linet MS (2016). Long-term Mortality in 43 763 U.S. Radiologists Compared with 64 990 U.S. Psychiatrists. Radiology  281, 847-857.   https://doi.org/10.1148/radiol.2016152472|2. Chernyavskiy P, Edmondson EF, Weil MM, Little MP (2017). High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice. Br J Cancer  117, 41-50.   https://doi.org/10.1038/bjc.2017.141|3. Freedman DM, Wu J, Chen H, Kuncl RW, Enewold LR, Engels EA, Freedman ND, Pfeiffer RM (2016). Associations between cancer and Alzheimer's disease in a U.S. Medicare population. Cancer Med  5, 2965-2976.   https://doi.org/10.1002/cam4.850|4. Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, et al. [3 more authors] (2017). Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects. Radiat Res  187, 186-195.   https://doi.org/10.1667/RR14453.1|5. Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, et al. [2 more authors] (2016). Increased pancreatic cancer risk following radiotherapy for testicular cancer. Br J Cancer  115, 901-8.   https://doi.org/10.1038/bjc.2016.272|6. Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN (2016). Therapeutic radiation and the potential risk of second malignancies. Cancer  122, 1809-21.   https://doi.org/10.1002/cncr.29841|7. Linet MS, Kitahara CM, Ntowe E, Kleinerman RA, Gilbert ES, Naito N, Lipner RS, Miller DL, Berrington de Gonzalez A, Multi-Specialty Occupational Health Group (2017). Mortality in U.S. Physicians Likely to Perform Fluoroscopy-guided Interventional Procedures Compared with Psychiatrists, 1979 to 2008. Radiology  284, 482-494.   https://doi.org/10.1148/radiol.2017161306|8. Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ (2017). National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant  23, 367-378.   https://doi.org/10.1016/j.bbmt.2016.09.005|9. Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, et al. [28 more authors] (2017). Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx058",https://intramural.nih.gov/search/searchview.taf?ipid=99331
582,CP010132-22,"October 01, 2016 -  September 30, 2017",Studies of Populations Exposed to Environmental Sources of Radiation,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Maureen Cusack Hatch; MD|Daryl  Freedman|Alice  Sigurdson; PhD,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Bazyka D, Finch SC, Ilienko IM, Lyaskivska O, Dyagil I, Trotsiuk N, Gudzenko N, Chumak VV, Walsh KM, Wiemels J, Little MP, Zablotska LB (2017). Buccal mucosa micronuclei counts in relation to exposure to low dose-rate radiation from the Chornobyl nuclear accident and other medical and occupational radiation exposures. Environ Health  16, 70.   https://doi.org/10.1186/s12940-017-0273-x|2. Cahoon EK, Nadyrov EA, Polyanskaya ON, Yauseyenka VV, Veyalkin IV, Yeudachkova TI, Maskvicheva TI, Minenko VF, Liu W, Drozdovitch V, Mabuchi K, Little MP, Zablotska LB, McConnell RJ, Hatch M, Peters KO, Rozhko AV, Brenner AV (2017). Risk of Thyroid Nodules in Residents of Belarus Exposed to Chernobyl Fallout as Children and Adolescents. J Clin Endocrinol Metab  102, 2207-2217.   https://doi.org/10.1210/jc.2016-3842|3. Chernyavskiy P, Kendall GM, Wakeford R, Little MP (2016). Spatial prediction of naturally occurring gamma radiation in Great Britain. J Environ Radioact  164, 300-311.   https://doi.org/10.1016/j.jenvrad.2016.07.029|4. Drozdovitch V (2016) CONSTRUCTION OF COHORT OF PERSONS EXPOSED IN UTERO IN BELARUS FOLLOWING THE CHERNOBYL ACCIDENT Medical and Biological Problems of Life Activity (in Russian with English abstract) 15:113-123|5. KENDALL G, Little M, WAKEFORD R, BUNCH K, MILES J, VINCENT T, MEARA J, MURPHY M (2016) A brief review of case-control studies of natural background radiation and childhood cancer in Great Britain Radiation Environment and Medicine 5:27-30|6. Ostroumova E, Hatch M, Brenner A, Nadyrov E, Veyalkin I, Polyanskaya O, Yauseyenka V, Polyakov S, Levin L, Zablotska L, Rozhko A, Mabuchi K (2016). Non-thyroid cancer incidence in Belarusian residents exposed to Chernobyl fallout in childhood and adolescence: Standardized Incidence Ratio analysis, 1997-2011. Environ Res  147, 44-9.   https://doi.org/10.1016/j.envres.2016.01.025|7. Villoing D, McMillan D, Kim KP, Il Park, Lee AK, Choi HD, Lee C (2017). KOREAN PEDIATRIC AND ADULT HEAD COMPUTATIONAL PHANTOMS AND APPLICATION TO PHOTON SPECIFIC ABSORBED FRACTIONS CALCULATIONS. Radiat Prot Dosimetry  176, 294-301.   https://doi.org/10.1093/rpd/ncx009",https://intramural.nih.gov/search/searchview.taf?ipid=99316
583,CP010133-22,"October 01, 2016 -  September 30, 2017",Studies of Populations Exposed to Occupational Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Alice  Sigurdson; PhD|Alina V Brenner|Ethel S Gilbert,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Journy NMY, Bernier MO, Doody MM, Alexander BH, Linet MS, Kitahara CM (2017). Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women. Thyroid  27, 1001-1010.   https://doi.org/10.1089/thy.2017.0063|2. Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM, Jones ME, Adami HO, Agnoli C, Baglietto L, Bernstein L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Butler L, Chen Y, Doody MM, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, et al. [28 more authors] (2017). The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium. Cancer Epidemiol Biomarkers Prev  26, 1360-1369.   https://doi.org/10.1158/1055-9965.EPI-17-0246|3. Preston DL, Kitahara CM, Freedman DM, Sigurdson AJ, Simon SL, Little MP, Cahoon EK, Rajaraman P, Miller JS, Alexander BH, Doody MM, Linet MS (2016). Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008. Br J Cancer  115, 1105-1112.   https://doi.org/10.1038/bjc.2016.292|4. Zamoiski RD, Cahoon EK, Freedman DM, Linet MS, Kitahara CM (2017). Prospective Study of Ultraviolet Radiation Exposure and Thyroid Cancer Risk in the United States. Cancer Epidemiol Biomarkers Prev  26, 684-691.   https://doi.org/10.1158/1055-9965.EPI-16-0739|5. Zamoiski RD, Freedman DM, Linet MS, Kitahara CM, Liu W, Cahoon EK (2016). Prospective study of ultraviolet radiation exposure and risk of breast cancer in the United States. Environ Res  151, 419-427.   https://doi.org/10.1016/j.envres.2016.08.013",https://intramural.nih.gov/search/searchview.taf?ipid=99332
584,CP010134-22,"October 01, 2016 -  September 30, 2017",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner,"Dale  Preston (Hirosoft)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Kyoji  Furukawa; PhD|Kotaro  Ozasa (Radiation Effects Research Foundation)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Nori  Nakamwa (Radiation Effects Research Foundation)|Show all 9",NULL,NULL,"1. Cahoon EK, Preston DL, Pierce DA, Grant E, Brenner AV, Mabuchi K, Utada M, Ozasa K (2017). Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009. Radiat Res  187, 538-548.   https://doi.org/10.1667/RR14583.1",https://intramural.nih.gov/search/searchview.taf?ipid=99357
585,CP010135-22,"October 01, 2016 -  September 30, 2017",Studies of Non-Ionizing Radiation-Related Cancer,Elizabeth  Cahoon|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Alice  Sigurdson; PhD|Rochelle E Curtis,Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Howard  Fine (NYU Langone Medical Center)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Show all 13,Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Preetha  Rajaraman (Center For Global Health)|Gila I Neta (Office of the Director)|Susan Shaw Devesa (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99333
586,CP010136-22,"October 01, 2016 -  September 30, 2017",Cancer Risk in Human Populations,"Sonja  Berndt|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Joanne S Colt|Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH",NULL,Mark  Schiffman; MD (Clinical Genetics Branch),NULL,"1. Colt JS, Hofmann JN, Schwartz K, Chow WH, Graubard BI, Davis F, Ruterbusch J, Berndt S, Purdue MP (2017). Antihypertensive medication use and risk of renal cell carcinoma. Cancer Causes Control  28, 289-297.   https://doi.org/10.1007/s10552-017-0857-3|2. Hashim D, Sartori S, Brennan P, Curado MP, Wünsch-Filho V, Divaris K, Olshan AF, Zevallos JP, Winn DM, Franceschi S, Castellsagué X, Lissowska J, Rudnai P, Matsuo K, Morgenstern H, Chen C, Vaughan TL, Hofmann JN, D'Souza G, Haddad RI, Wu H, Lee YC, Hashibe M, Vecchia CL, Boffetta P (2016). The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann Oncol  27, 1619-25.   https://doi.org/10.1093/annonc/mdw224|3. Hofmann JN, Mailankody S, Korde N, Wang Y, Tageja N, Costello R, Zingone A, Hultcrantz M, Pollak MN, Purdue MP, Landgren O (2017). Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease. Obesity (Silver Spring)  25, 1317-1320.   https://doi.org/10.1002/oby.21894|4. Liao LM, Hofmann JN, Cho E, Pollak MN, Chow WH, Purdue MP (2017). Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Cancer Causes Control  28, 801-807.   https://doi.org/10.1007/s10552-017-0901-3|5. Mafolasire A, Yao X, Nawaf C, Suarez-Sarmiento A, Chow WH, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B (2016). Racial disparities in renal cell carcinoma: a single-payer healthcare experience. Cancer Med  5, 2101-8.   https://doi.org/10.1002/cam4.755|6. Purdue MP, Stewart PA, Friesen MC, Colt JS, Locke SJ, Hein MJ, Waters MA, Graubard BI, Davis F, Ruterbusch J, Schwartz K, Chow WH, Rothman N, Hofmann JN (2017). Occupational exposure to chlorinated solvents and kidney cancer: a case-control study. Occup Environ Med  74, 268-274.   https://doi.org/10.1136/oemed-2016-103849|7. Zhang Y, Hofmann JN, Purdue MP, Lin S, Biswas S (2017). Logistic Bayesian LASSO for genetic association analysis of data from complex sampling designs. J Hum Genet  62, 819-829.   https://doi.org/10.1038/jhg.2017.43",https://intramural.nih.gov/search/searchview.taf?ipid=99334
587,CP010142-19,"October 01, 2016 -  September 30, 2017",Genetic Modifiers of Cancer Risk,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Jennifer T Loud| | |Lisa  Mirabello|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI

Office of the Director, NCI",Anand  Pathak|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Phuong L Mai,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99335
588,CP010144-19,"October 01, 2016 -  September 30, 2017",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Maria Isabel A S Waddington Achatz|IRP Faculty Profile  | |Blanche P Alter|IRP Faculty Profile  | |Shahinaz M Gadalla|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Renee C Bremer|Hormuzdiar Aspandiar Katki; MS|Jennifer T Loud|Mary Louise McMaster; MD|Stephen J Chanock; MD, PhD|Show all 12",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|M.  Elghetany (University of Texas)|Show all 50,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Margaret Anne Tucker (Human Genetics Program)|Gordon B Willis (Tobacco Control Research Branch)|Izumi  Horikawa (Laboratory of Human Carcinogenesis)",Pamela  Stratton; MD (NINDS),"1. Alter BP (2017). Inherited bone marrow failure syndromes: considerations pre- and posttransplant. Blood  130, 2257-2264.   https://doi.org/10.1182/blood-2017-05-781799|2. Alter BP (2017). Inherited bone marrow failure syndromes: considerations pre- and posttransplant. Hematology Am Soc Hematol Educ Program  2017, 88-95.   https://doi.org/10.1182/asheducation-2017.1.88|3. Alter BP, Rosenberg PS (2016). In reference to Natural history and management of fanconi anemia patients with head and neck cancer: A 10-year follow-up. Laryngoscope  126, E229.   https://doi.org/10.1002/lary.25874|4. Dietz AC, Duncan CN, Alter BP, Bresters D, Cowan MJ, Notarangelo L, Rosenberg PS, Shenoy S, Skinner R, Walters MC, Wagner J, Baker KS, Pulsipher MA (2017). The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. Biol Blood Marrow Transplant  23, 24-29.   https://doi.org/10.1016/j.bbmt.2016.10.004|5. Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J, Boulad F, Dalle JH, Bonfim C, de la Fuente J, Duncan CN, Baker KS, Pulsipher MA, Lipton JM, Wagner JE, Alter BP (2017). Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant  23, 726-735.   https://doi.org/10.1016/j.bbmt.2017.01.075|6. Dietz AC, Savage SA, Vlachos A, Mehta PA, Bresters D, Tolar J, Bonfim C, Dalle JH, de la Fuente J, Skinner R, Boulad F, Duncan CN, Baker KS, Pulsipher MA, Lipton JM, Wagner JE, Alter BP (2017). Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT. Biol Blood Marrow Transplant  23, 1422-1428.   https://doi.org/10.1016/j.bbmt.2017.05.022|7. Doulatov S, Vo LT, Macari ER, Wahlster L, Kinney MA, Taylor AM, Barragan J, Gupta M, McGrath K, Lee HY, Humphries JM, DeVine A, Narla A, Alter BP, Beggs AH, Agarwal S, Ebert BL, Gazda HT, Lodish HF, Sieff CA, Schlaeger TM, Zon LI, Daley GQ (2017). Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci Transl Med  9.   https://doi.org/10.1126/scitranslmed.aah5645|8. Gadalla SM, Hilbert JE, Martens WB, Givens S, Moxley RT, Greene MH (2017). Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy. Eur J Neurol  24, 713-718.   https://doi.org/10.1111/ene.13276|9. Giri N, Stratton P, Savage SA, Alter BP (2017). Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort. Blood  130, 1674-1676.   https://doi.org/10.1182/blood-2017-08-802991|10. Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, Barrowdale D, Benitez J, Berthet P, Blok MJ, Bobolis K, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, EMBRACE, GEMO Study Collaborators, HEBON, KConFab Investigators, et al. [143 more authors] (2017). Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Res Treat  161, 117-134.   https://doi.org/10.1007/s10549-016-4018-2|11. Khan NE, Bauer AJ, Doros L, Schultz KA, Decastro RM, Harney LA, Kase RG, Carr AG, Harris AK, Williams GM, Dehner LP, Messinger YH, Stewart DR (2017). Macrocephaly associated with the DICER1 syndrome. Genet Med  19, 244-248.   https://doi.org/10.1038/gim.2016.83|12. Khan NE, Bauer AJ, Schultz KAP, Doros L, Decastro RM, Ling A, Lodish MB, Harney LA, Kase RG, Carr AG, Rossi CT, Field A, Harris AK, Williams GM, Dehner LP, Messinger YH, Hill DA, Stewart DR (2017). Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study. J Clin Endocrinol Metab  102, 1614-1622.   https://doi.org/10.1210/jc.2016-2954|13. Khan NE, Rosenberg PS, Alter BP (2016). Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia. Biol Blood Marrow Transplant  22, 1888-1892.   https://doi.org/10.1016/j.bbmt.2016.06.018|14. Kim A, Stewart DR, Reilly KM, Viskochil D, Miettinen MM, Widemann BC (2017). Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. Sarcoma  2017, 7429697.   https://doi.org/10.1155/2017/7429697|15. Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, Southey M, John EM, Conner TA, Goldgar DE, Buys SS, Janavicius R, Steele L, Ding YC, Neuhausen SL, Hansen TVO, EMBRACE, GEMO Study Collaborators, HEBON, KConFab Investigators, et al. [152 more authors] (2017). Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. J Clin Oncol  35, 2240-2250.   https://doi.org/10.1200/JCO.2016.69.4935|16. Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, et al. [6 more authors] (2017). Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. Cancer Res  77, 1250-1260.   https://doi.org/10.1158/0008-5472.CAN-16-2179|17. Loud JT, Bremer RC, Mai PL, Peters JA, Giri N, Stewart DR, Greene MH, Alter BP, Savage SA (2016). Research participant interest in primary, secondary, and incidental genomic findings. Genet Med  18, 1218-1225.   https://doi.org/10.1038/gim.2016.36|18. Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA (2016). Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer  122, 3673-3681.   https://doi.org/10.1002/cncr.30248|19. Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L (2017). Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol  145, 122-129.   https://doi.org/10.1016/j.ygyno.2017.02.008|20. McReynolds LJ, Savage SA (2017). Pediatric leukemia susceptibility disorders: manifestations and management. Hematology Am Soc Hematol Educ Program  2017, 242-250.   https://doi.org/10.1182/asheducation-2017.1.242|21. Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A (2017). Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol  67, 1-10.   https://doi.org/10.1016/j.humpath.2017.05.010|22. Pemov A, Li H, Patidar R, Hansen NF, Sindiri S, Hartley SW, Wei JS, Elkahloun A, Chandrasekharappa SC, NISC Comparative Sequencing Program, Boland JF, Bass S, NCI DCEG Cancer Genomics Research Laboratory, Mullikin JC, Khan J, Widemann BC, Wallace MR, Stewart DR (2017). The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene  36, 3168-3177.   https://doi.org/10.1038/onc.2016.464|23. Peng G, Bojadzieva J, Ballinger ML, Li J, Blackford AL, Mai PL, Savage SA, Thomas DM, Strong LC, Wang W (2017). Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO. Cancer Epidemiol Biomarkers Prev  26, 837-844.   https://doi.org/10.1158/1055-9965.EPI-16-0695|24. Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC, Lee JM, Coetzee S, Beesley J, McGuffog L, Soucy P, Dicks E, Lee A, Barrowdale D, Lecarpentier J, Leslie G, Aalfs CM, Aben KKH, Adams M, AOCS study group, EMBRACE Study, GEMO Study Collaborators, HEBON Study, KConFab Investigators, OPAL study group, et al. [389 more authors] (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet  49, 680-691.   https://doi.org/10.1038/ng.3826|25. Reilly KM, Kim A, Blakely J, Ferner RE, Gutmann DH, Legius E, Miettinen MM, Randall RL, Ratner N, Jumbé NL, Bakker A, Viskochil D, Widemann BC, Stewart DR (2017). Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx124|26. Savage SA, Dufour C (2017). Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia. Semin Hematol  54, 105-114.   https://doi.org/10.1053/j.seminhematol.2017.04.004|27. Schultz KAP, Harris AK, Finch M, Dehner LP, Brown JB, Gershenson DM, Young RH, Field A, Yu W, Turner J, Cost NG, Schneider DT, Stewart DR, Frazier AL, Messinger Y, Hill DA (2017). DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Gynecol Oncol  147, 521-527.   https://doi.org/10.1016/j.ygyno.2017.09.034|28. Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD, Diller LR, Brugières L, Druker H, Schneider KA, McGee RB, Foulkes WD (2017). PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res  23, e76-e82.   https://doi.org/10.1158/1078-0432.CCR-17-0629|29. Shankar RK, Giri N, Lodish MB, Sinaii N, Reynolds JC, Savage SA, Stratakis CA, Alter BP (2017). Bone mineral density in patients with inherited bone marrow failure syndromes. Pediatr Res  82, 458-464.   https://doi.org/10.1038/pr.2017.117|30. Stewart DR, Givens SS, Harris AK, Williams GM, Messinger YH, Schultz KA, Hill DA (2016). Comment on: DICER1-Negative Pleuropulmonary Blastoma in a Patient With Selective IgA Deficiency. Pediatr Blood Cancer  63, 1869-70.   https://doi.org/10.1002/pbc.26075|31. Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, Caligo MA, Campbell I, Chan SB, Claes KB, Cohn DE, Cook J, Daly MB, Damiola F, Davidson R, Pauw Ad, et al. [121 more authors] (2016). Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS One  11, e0158801.   https://doi.org/10.1371/journal.pone.0158801|32. Villacis RA, Basso TR, Canto LM, Nóbrega AF, Achatz MI, Rogatto SR (2017). Germline large genomic alterations on 7q in patients with multiple primary cancers. Sci Rep  7, 41677.   https://doi.org/10.1038/srep41677|33. Walsh MF, Chang VY, Kohlmann WK, Scott HS, Cunniff C, Bourdeaut F, Molenaar JJ, Porter CC, Sandlund JT, Plon SE, Wang LL, Savage SA (2017). Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders. Clin Cancer Res  23, e23-e31.   https://doi.org/10.1158/1078-0432.CCR-17-0465|34. Wang PY, Li J, Walcott FL, Kang JG, Starost MF, Talagala SL, Zhuang J, Park JH, Huffstutler RD, Bryla CM, Mai PL, Pollak M, Annunziata CM, Savage SA, Fojo AT, Hwang PM (2017). Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. J Clin Invest  127, 132-136.   https://doi.org/10.1172/JCI88668|35. Wegman-Ostrosky T, Savage SA (2017). The genomics of inherited bone marrow failure: from mechanism to the clinic. Br J Haematol  177, 526-542.   https://doi.org/10.1111/bjh.14535",https://intramural.nih.gov/search/searchview.taf?ipid=99336
589,CP010145-18,"October 01, 2016 -  September 30, 2017",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Jennifer T Loud| |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI

Breast and Gynecologic Cancer Research Group, NCI",June  Peters,David  Alberts (University of Arizona Cancer Center)|Steven  Skates (Massachusetts General Hospital)|Marion  Piedmonte (GOG Statistical and Data Center)|Martee  Hensley (Memorial Sloan-Kettering Cancer Center)|Austin  Miller (GOG Statistical and Data Center)|Karen  Lu (MD Anderson Cancer Center)|Show all 15,Margaret Anne Tucker (Human Genetics Program)|Lori M Minasian (Office of the Director)|Richard P Moser (Science Of Research & Technology Branch),Gustavo Javier Rodriguez (OD),"1. Loud JT, Murphy J (2017). Cancer Screening and Early Detection in the 21st Century. Semin Oncol Nurs  33, 121-128.   https://doi.org/10.1016/j.soncn.2017.02.002|2. Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM (2016). Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence. Cancer Prev Res (Phila)  9, 713-20.   https://doi.org/10.1158/1940-6207.CAPR-15-0384|3. Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, Rodriguez G, Schorge JO, Sherman M, Daly MB, Rutherford T, Brewster WR, O'Malley DM, Partridge E, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek S, Davidson SA, Edwards R, Elg SA, Wakeley K, Phillips KA, Armstrong D, et al. [12 more authors] (2017). Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res  23, 3628-3637.   https://doi.org/10.1158/1078-0432.CCR-15-2750",https://intramural.nih.gov/search/searchview.taf?ipid=99337
590,CP010150-18,"October 01, 2016 -  September 30, 2017","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, McGlynn KA, Adami HO, Berrington de González A, Beane Freeman LE, Bernstein L, Buring JE, Freedman ND, Gao YT, Giles GG, Gunter MJ, Jenab M, Liao LM, Milne RL, Robien K, Sandler DP, Schairer C, Sesso HD, Shu XO, Weiderpass E, et al. [5 more authors] (2017). Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev  26, 597-606.   https://doi.org/10.1158/1055-9965.EPI-16-0796|2. Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, DʼSouza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS (2017). Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr  75, 382-390.   https://doi.org/10.1097/QAI.0000000000001394|3. Engels EA (2017). Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do. Am J Transplant  17, 1967-1969.   https://doi.org/10.1111/ajt.14140|4. Engels EA, Parsons R, Besson C, Morton LM, Enewold L, Ricker W, Yanik EL, Arem H, Austin AA, Pfeiffer RM (2016). Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims (""MedWAS""). Cancer Epidemiol Biomarkers Prev  25, 1105-13.   https://doi.org/10.1158/1055-9965.EPI-16-0212|5. Engels EA, Parsons R, Besson C, Morton LM, Yanik EL, Arem H, Pfeiffer RM (2017). RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx026|6. Engels EA, Rabkin CS, Goedert JJ (2017). Invited Commentary: A Landmark Study Launched in a Public Health Maelstrom. Am J Epidemiol  185, 1157-1160.   https://doi.org/10.1093/aje/kwx079|7. Ferreira MP, Coghill AE, Chaves CB, Bergmann A, Thuler LC, Soares EA, Pfeiffer RM, Engels EA, Soares MA (2017). Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer. AIDS  31, 523-531.   https://doi.org/10.1097/QAD.0000000000001367|8. Goedert JJ (2017). The microbiota and HIV: shedding light on dark matters. AIDS  31, 863-865.   https://doi.org/10.1097/QAD.0000000000001410|9. Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA (2017). Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV  4, e495-e504.   https://doi.org/10.1016/S2352-3018(17)30125-X|10. Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA (2016). Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiol Biomarkers Prev  25, 174-9.   https://doi.org/10.1158/1055-9965.EPI-15-0921|11. Karami S, Yanik EL, Moore LE, Pfeiffer RM, Copeland G, Gonsalves L, Hernandez BY, Lynch CF, Pawlish K, Engels EA (2016). Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States. Am J Transplant  16, 3479-3489.   https://doi.org/10.1111/ajt.13862|12. Kitahara CM, Yanik EL, Ladenson PW, Hernandez BY, Lynch CF, Pawlish KS, Engels EA (2017). Risk of Thyroid Cancer Among Solid Organ Transplant Recipients. Am J Transplant  17, 2911-2921.   https://doi.org/10.1111/ajt.14310|13. Mahale P, Engels EA, Li R, Torres HA, Hwang LY, Brown EL, Kramer JR (2018). The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut  67, 553-561.   https://doi.org/10.1136/gutjnl-2017-313983|14. Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, Engels EA (2017). Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study. Cancer  123, 1202-1211.   https://doi.org/10.1002/cncr.30559|15. Mahale P, Yanik EL, Engels EA (2016). Herpes Zoster and Risk of Cancer in the Elderly U.S. Population. Cancer Epidemiol Biomarkers Prev  25, 28-35.   https://doi.org/10.1158/1055-9965.EPI-15-1033|16. Rabkin CS, Goedert JJ (2017). Chronic Hepatitis and Non-Hodgkin Lymphoma Among People With HIV: Implications for Screening, Treatment, and Prevention. Ann Intern Med  166, 69-70.   https://doi.org/10.7326/M16-2340|17. Robbins H, Engels E, ROBERTS J, ARRON S (2016) After A Transplant: New Dangers Skin Cancer Foundation Journal na:36-38|18. Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA (2017). Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer. Cancer Epidemiol Biomarkers Prev  26, 862-868.   https://doi.org/10.1158/1055-9965.EPI-16-0647|19. Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (2017). HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis  64, 468-475.   https://doi.org/10.1093/cid/ciw764|20. Shiels MS, Chernyavskiy P, Anderson WF, Best AF, Haozous EA, Hartge P, Rosenberg PS, Thomas D, Freedman ND, Berrington de Gonzalez A (2017). Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet  389, 1043-1054.   https://doi.org/10.1016/S0140-6736(17)30187-3|21. Shiels MS, Engels EA (2017). Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS  12, 6-11.   https://doi.org/10.1097/COH.0000000000000327|22. Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M (2017). Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States. PLoS One  12, e0182359.   https://doi.org/10.1371/journal.pone.0182359|23. Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM (2017). Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy. JAMA Oncol  3, 974-978.   https://doi.org/10.1001/jamaoncol.2017.0115|24. Yanik EL, Nogueira LM, Koch L, Copeland G, Lynch CF, Pawlish KS, Finch JL, Kahn AR, Hernandez BY, Segev DL, Pfeiffer RM, Snyder JJ, Kasiske BL, Engels EA (2016). Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries. Am J Transplant  16, 2986-2993.   https://doi.org/10.1111/ajt.13818|25. Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA (2017). Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiol Biomarkers Prev  26, 998-1007.   https://doi.org/10.1158/1055-9965.EPI-17-0003",https://intramural.nih.gov/search/searchview.taf?ipid=99338
591,CP010152-18,"October 01, 2016 -  September 30, 2017",PLCO Trial Etiologic and Early Marker Study,"Sonja  Berndt|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Wen-Yi  Huang|Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Christine Dorothy Berg (Office of the Director),NULL,"1. Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Gallinger S, Giovannucci EL, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jeon J, CCFR and GECCO, et al. [23 more authors] (2016). Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet  12, e1006296.   https://doi.org/10.1371/journal.pgen.1006296|2. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, PRACTICAL consortium, et al. [103 more authors] (2016). Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat Commun  7, 10979.   https://doi.org/10.1038/ncomms10979|3. Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, Rohland N, Reich D, Tandon A, Pasaniuc B, Allen A, Quinque D, Mallick S, Notani D, Rosenfeld MG, Jayani RS, et al. [39 more authors] (2016). Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv431|4. Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, et al. [4 more authors] (2017). Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun  8, 14248.   https://doi.org/10.1038/ncomms14248|5. Huang WY, Kemp TJ, Pfeiffer RM, Pinto LA, Hildesheim A, Purdue MP (2017). Impact of freeze-thaw cycles on circulating inflammation marker measurements. Cytokine  95, 113-117.   https://doi.org/10.1016/j.cyto.2017.02.016|6. Kelly SP, Graubard BI, Andreotti G, Younes N, Cleary SD, Cook MB (2017). Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw225|7. Kocarnik JM, Chan AT, Slattery ML, Potter JD, Meyerhardt J, Phipps A, Nan H, Harrison T, Rohan TE, Qi L, Hou L, Caan B, Kroenke CH, Strickler H, Hayes RB, Schoen RE, Chong DQ, White E, Berndt SI, Peters U, Newcomb PA (2016). Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer  139, 1065-72.   https://doi.org/10.1002/ijc.30163|8. Kunzmann AT, Coleman HG, Huang WY, Cantwell MM, Kitahara CM, Berndt SI (2016). Fruit and vegetable intakes and risk of colorectal cancer and incident and recurrent adenomas in the PLCO cancer screening trial. Int J Cancer  138, 1851-61.   https://doi.org/10.1002/ijc.29922|9. Lindström S, Finucane H, Bulik-Sullivan B, Schumacher FR, Amos CI, Hung RJ, Rand K, Gruber SB, Conti D, Permuth JB, Lin HY, Goode EL, Sellers TA, Amundadottir LT, Stolzenberg-Solomon R, Klein A, Petersen G, Risch H, Wolpin B, Hsu L, Huyghe JR, Chang-Claude J, Chan A, Berndt S, Eeles R, PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO, et al. [6 more authors] (2017). Quantifying the Genetic Correlation between Multiple Cancer Types. Cancer Epidemiol Biomarkers Prev  26, 1427-1435.   https://doi.org/10.1158/1055-9965.EPI-17-0211|10. Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N (2017). Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Int J Cancer  140, 600-610.   https://doi.org/10.1002/ijc.30478|11. Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, et al. [30 more authors] (2017). Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. PLoS One  12, e0187741.   https://doi.org/10.1371/journal.pone.0187741|12. Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, Chamosa S, Clendenen TV, Dossus L, Fortner R, Gapstur SM, Gaudet MM, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, et al. [29 more authors] (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol  34, 2888-98.   https://doi.org/10.1200/JCO.2016.66.8178|13. Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB (2017). Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts. Cancer Prev Res (Phila)  10, 410-420.   https://doi.org/10.1158/1940-6207.CAPR-17-0033",https://intramural.nih.gov/search/searchview.taf?ipid=99339
592,CP010158-17,"October 01, 2016 -  September 30, 2017",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",NULL,NULL,"1. Lin J, Gill A, Zahm SH, Carter CA, Shriver CD, Nations JA, Anderson WF, McGlynn KA, Zhu K (2017). Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system. Int J Cancer  141, 254-263.   https://doi.org/10.1002/ijc.30724|2. Lin J, McGlynn KA, Carter CA, Nations JA, Anderson WF, Shriver CD, Zhu K (2016). The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System. Cancer Epidemiol Biomarkers Prev  25, 1564-1571.   https://doi.org/10.1158/1055-9965.EPI-16-0316|3. Major JM, Penberthy L, McGlynn KA (2016). Data systems and record linkage: considerations for pharmacoepidemiologic studies examining cancer risk. Ann Epidemiol  26, 746-748.   https://doi.org/10.1016/j.annepidem.2016.08.015|4. Manjelievskaia J, Brown D, McGlynn KA, Anderson W, Shriver CD, Zhu K (2017). Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer. JAMA Surg  152, 452-459.   https://doi.org/10.1001/jamasurg.2016.5050|5. Rivera DR, McGlynn KA, Freedman AN (2016). Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomes. Ann Epidemiol  26, 741-745.   https://doi.org/10.1016/j.annepidem.2016.10.001|6. Yang B, Petrick JL, Abnet CC, Graubard BI, Murphy G, Weinstein SJ, Männistö S, Albanes D, McGlynn KA (2017). Tooth loss and liver cancer incidence in a Finnish cohort. Cancer Causes Control  28, 899-904.   https://doi.org/10.1007/s10552-017-0906-y|7. Yang B, Shebl FM, Sternberg LR, Warner AC, Kleiner DE, Edelman DC, Gomez A, Dagnall CL, Hicks BD, Altekruse SF, Hernandez BY, Lynch CF, Meltzer PS, McGlynn KA (2016). Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States. PLoS One  11, e0166828.   https://doi.org/10.1371/journal.pone.0166828",https://intramural.nih.gov/search/searchview.taf?ipid=99340
593,CP010167-17,"October 01, 2016 -  September 30, 2017",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,Chester  Douglass (Harvard School of Dentistry)|Patricia  Hartge; ScD (NCI),Sharon Ann Savage (Clinical Genetics Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99341
594,CP010168-17,"October 01, 2016 -  September 30, 2017",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 11",NULL,NULL,"1. Houghton LC, Ganmaa D, Rosenberg PS, Davaalkham D, Stanczyk FZ, Hoover RN, Troisi R (2016). Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk. Int J Environ Res Public Health  13.   https://doi.org/10.3390/ijerph13111066|2. Marchand NE, Davaasambuu G, McElrath TF, Davaasambuu E, Baatar T, Troisi R (2016). Prevalence of pregnancy hypertensive disorders in Mongolia. Pregnancy Hypertens  6, 413-417.   https://doi.org/10.1016/j.preghy.2016.10.001",https://intramural.nih.gov/search/searchview.taf?ipid=99342
595,CP010169-16,"October 01, 2016 -  September 30, 2017","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Louise  Brinton; PhD|Mitchell Henry Gail; PhD, MD|Hormuzdiar Aspandiar Katki; MS","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Stephanie Joan Weinstein (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Colli LM, Machiela MJ, Zhang H, Myers TA, Jessop L, Delattre O, Yu K, Chanock SJ (2017). Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management. Cancer Res  77, 3666-3671.   https://doi.org/10.1158/0008-5472.CAN-16-3338|2. Flegal KM, Graubard BI, Yi SW (2017). Comparative effects of the restriction method in two large observational studies of body mass index and mortality among adults. Eur J Clin Invest  47, 415-421.   https://doi.org/10.1111/eci.12756|3. Machiela MJ, Chanock SJ (2017). The ageing genome, clonal mosaicism and chronic disease. Curr Opin Genet Dev  42, 8-13.   https://doi.org/10.1016/j.gde.2016.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=99345
596,CP010170-17,"October 01, 2016 -  September 30, 2017",Multidisciplinary Studies of Hematopoietic Malignancies,Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI","Joanne S Colt|Aaron E Blair; PhD, MPH|Mary Helen Ward; MS, PhD","Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)",Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99343
597,CP010176-17,"October 01, 2016 -  September 30, 2017",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Office of the Director)|Denise  Whitby (Office Of The Director)",NULL,"1. Agerbaek MØ, Pereira MA, Clausen TM, Pehrson C, Oo HZ, Spliid C, Rich JR, Fung V, Nkrumah F, Neequaye J, Biggar RJ, Reynolds SJ, Tosato G, Pullarkat ST, Ayers LW, Theander TG, Daugaard M, Bhatia K, Nielsen MA, Mbulaiteye SM, Salanti A (2017). Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration. Int J Cancer  140, 1597-1608.   https://doi.org/10.1002/ijc.30575|2. Begré L, Rohner E, Mbulaiteye SM, Egger M, Bohlius J (2016). Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. Int J Cancer  139, 776-83.   https://doi.org/10.1002/ijc.30129|3. Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, et al. [4 more authors] (2017). Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr  75, 568-576.   https://doi.org/10.1097/QAI.0000000000001450|4. Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, DʼSouza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS (2017). Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr  75, 382-390.   https://doi.org/10.1097/QAI.0000000000001394|5. Maziarz M, KINYERA T, OTIM I, KAGWA P, NABALENDE H, LEGASON I, OGWANG M, KIRIMUNDA S, Emmanuel B, REYNOLDS S, KERCHAN P, JOLOBA M, Bergen A, Bhatia K, TALISUNA A, BIGGAR R, Goedert J, Pfeiffer R, Mbulaiteye S (2017) Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda. Malaria journal 16:124|6. Mbulaiteye SM, Anderson WF (2018). Age-related heterogeneity of Burkitt lymphoma. Br J Haematol  180, 153-155.   https://doi.org/10.1111/bjh.14288|7. Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA (2017). Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States. Cancer  123, 4663-4671.   https://doi.org/10.1002/cncr.30923|8. Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni AK, Engels EA, Morton LM (2017). Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. Cancer Res  77, 4196-4203.   https://doi.org/10.1158/0008-5472.CAN-16-3291",https://intramural.nih.gov/search/searchview.taf?ipid=99344
598,CP010180-16,"October 01, 2016 -  September 30, 2017",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,NULL,NULL,"1. Zhou CK, Young D, Yeboah ED, Coburn SB, Tettey Y, Biritwum RB, Adjei AA, Tay E, Niwa S, Truelove A, Welsh J, Mensah JE, Hoover RN, Sesterhenn IA, Hsing AW, Srivastava S, Cook MB (2017). TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences. Am J Epidemiol  186, 1352-1361.   https://doi.org/10.1093/aje/kwx235",https://intramural.nih.gov/search/searchview.taf?ipid=99358
599,CP010181-15,"October 01, 2016 -  September 30, 2017",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  | |Paul Stuart Albert|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",NULL,"Gang  Zheng (National Heart Lung and Blood Institute)|Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Show all 13","Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Edward L Korn (Biostatistics Branch)",NULL,"1. Best A, WOLFSON D (2017) Nested case-control study designs for left-truncated survival data Canadian Journal of Statistics 45:4-28|2. Flegal KM, Graubard BI, Yi SW (2017). Comparative effects of the restriction method in two large observational studies of body mass index and mortality among adults. Eur J Clin Invest  47, 415-421.   https://doi.org/10.1111/eci.12756|3. Forrest MP, Zhang H, Moy W, McGowan H, Leites C, Dionisio LE, Xu Z, Shi J, Sanders AR, Greenleaf WJ, Cowan CA, Pang ZP, Gejman PV, Penzes P, Duan J (2017). Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci. Cell Stem Cell  21, 305-318.e8.   https://doi.org/10.1016/j.stem.2017.07.008|4. Hyun N, Cheung L, PAN Q, Schiffman M, Katki H (2017). FLEXIBLE RISK PREDICTION MODELS FOR LEFT OR INTERVAL-CENSORED DATA FROM ELECTRONIC HEALTH RECORDS. Annals of Applied Statistics  11, 1063-1084.|5. Kant AK, Graubard BI (2017). A prospective study of water intake and subsequent risk of all-cause mortality in a national cohort. Am J Clin Nutr  105, 212-220.   https://doi.org/10.3945/ajcn.116.143826|6. Landgren O, Graubard BI, Kumar S, Kyle RA, Katzmann JA, Murata K, Costello R, Dispenzieri A, Caporaso N, Mailankody S, Korde N, Hultcrantz M, Therneau TM, Larson DR, Cerhan JR, Rajkumar SV (2017). Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey. Blood Cancer J  7, e618.   https://doi.org/10.1038/bcj.2017.97|7. Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindström S, et al. [20 more authors] (2016). Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. JAMA Oncol  2, 1295-1302.   https://doi.org/10.1001/jamaoncol.2016.1025|8. Tomassi D, Forzani L, Bura E, Pfeiffer R (2017). Sufficient dimension reduction for censored predictors. Biometrics  73, 220-231.   https://doi.org/10.1111/biom.12556",https://intramural.nih.gov/search/searchview.taf?ipid=99318
600,CP010182-15,"October 01, 2016 -  September 30, 2017",Epidemiologic Field Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Le L, Schairer C, Hablas A, Meza J, Watanabe-Galloway S, Ramadan M, Merajver SD, Seifeldin IA, Soliman AS (2017). Reliability of medical records in diagnosing inflammatory breast cancer in Egypt. BMC Res Notes  10, 126.   https://doi.org/10.1186/s13104-017-2433-z",https://intramural.nih.gov/search/searchview.taf?ipid=99348
601,CP010183-15,"October 01, 2016 -  September 30, 2017",Descriptive Studies and Record Linkage,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |William Frederick Anderson,NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD",Susan Shaw Devesa (NCI)|Ismail  Jatoi (US Army)|Ahmedin  Jemal (American Cancer Society)|Niels  Kroman (Danish Breast Cancer Group)|Timothy R Rebbeck|Rebecca B Siegel|Show all 9,"Louise  Brinton; PhD (Office of the Director)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",Sean Fitzgerald Altekruse (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99317
602,CP010184-15,"October 01, 2016 -  September 30, 2017",Consultation and Collaboration,Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Hormuzdiar Aspandiar Katki; MS|Joshua Neil Sampson|Jianxin  Shi|Show all 7",Eleuterio  Bravo-Otero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Show all 78,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Wen-Yi  Huang (Occupational and Environmental Epidemiology Branch)",Harvey J Alter; MD (CC) |Joni L Rutter (OD) |Dale  Sandler; PhD (NIEHS) |Clarice  Weinberg; PhD (NIEHS),"1. Flegal KM, Graubard BI, Yi SW (2017). Comparative effects of the restriction method in two large observational studies of body mass index and mortality among adults. Eur J Clin Invest  47, 415-421.   https://doi.org/10.1111/eci.12756",https://intramural.nih.gov/search/searchview.taf?ipid=99350
603,CP010185-15,"October 01, 2016 -  September 30, 2017",Biodefense Project,Choonsik  Lee|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Steven L Simon|Amy  de Gonzalez,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",Andre  Bouville (Epidemiology and Biostatistics Program),NULL,"1. Simon SL, Bouville A (2016). LONG-TERM BIODOSIMETRY REDUX. Radiat Prot Dosimetry  172, 244-247.   https://doi.org/10.1093/rpd/ncw156",https://intramural.nih.gov/search/searchview.taf?ipid=99349
604,CP010187-13,"October 01, 2016 -  September 30, 2017",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,"1. Figueroa JD, Koutros S, Colt JS, Kogevinas M, Garcia-Closas M, Real FX, Friesen MC, Baris D, Stewart P, Schwenn M, Johnson A, Karagas MR, Armenti KR, Moore LE, Schned A, Lenz P, Prokunina-Olsson L, Banday AR, Paquin A, Ylaya K, Chung JY, Hewitt SM, Nickerson ML, Tardón A, Serra C, et al. [9 more authors] (2015). Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. J Natl Cancer Inst  107.   https://doi.org/10.1093/jnci/djv223|2. Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Furberg H, Matullo G, Golka K, Gago-Dominguez M, Taylor JA, Fletcher T, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, et al. [102 more authors] (2016). Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet  25, 1203-14.   https://doi.org/10.1093/hmg/ddv492",https://intramural.nih.gov/search/searchview.taf?ipid=99356
605,CP010188-13,"October 01, 2016 -  September 30, 2017",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI",Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington)|Stephanie Ann Kovalchik|Ju-Hyun  Park,"Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,"1. Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK (2016). Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. JAMA  315, 2300-11.   https://doi.org/10.1001/jama.2016.6255",https://intramural.nih.gov/search/searchview.taf?ipid=99351
606,CP010190-12,"October 01, 2016 -  September 30, 2017",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Shahinaz M Gadalla|IRP Faculty Profile  |Payal Premchand Khincha| | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Lisa  Mirabello|Lisa James McReynolds|Neelam K Giri; MD|Blanche P Alter,"Immaculata  DeVivo (Harvard Medical School)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Davide  Ruggero (University of California San Francisco)|Catherine  Keegan (University of Michigan)|Show all 10",NULL,NULL,"1. Gadalla SM, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Katki HA, Lee SJ, Savage SA (2016). Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia. Biol Blood Marrow Transplant  22, 2276-2282.   https://doi.org/10.1016/j.bbmt.2016.09.012|2. Khincha PP, Bertuch AA, Agarwal S, Townsley DM, Young NS, Keel S, Shimamura A, Boulad F, Simoneau T, Justino H, Kuo C, Artandi S, McCaslin C, Cox DW, Chaffee S, Collins BF, Giri N, Alter BP, Raghu G, Savage SA (2017). Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders. Eur Respir J  49.   https://doi.org/10.1183/13993003.01640-2016|3. Wang Y, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Lee SJ, Savage SA, Gadalla SM (2017). Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia. Biol Blood Marrow Transplant  23, 1054-1058.   https://doi.org/10.1016/j.bbmt.2017.03.032",https://intramural.nih.gov/search/searchview.taf?ipid=99359
607,CP010193-11,"October 01, 2016 -  September 30, 2017",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",NULL,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|H  Bueno-de-Mesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Show all 17",Geoffrey Scott Tobias (Office of the Director)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99360
608,CP010195-11,"October 01, 2016 -  September 30, 2017","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Philip  Taylor; MD, ScD|Michael Blaise Cook",David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Argirion I, Weinstein SJ, Männistö S, Albanes D, Mondul AM (2017). Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer. Cancer Epidemiol Biomarkers Prev  26, 1519-1524.   https://doi.org/10.1158/1055-9965.EPI-17-0293|2. Guertin KA, Li XS, Graubard BI, Albanes D, Weinstein SJ, Goedert JJ, Wang Z, Hazen SL, Sinha R (2017). Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev  26, 945-952.   https://doi.org/10.1158/1055-9965.EPI-16-0948|3. Huang J, Mondul AM, Weinstein SJ, Karoly ED, Sampson JN, Albanes D (2017). Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor. Oncotarget  8, 45190-45199.   https://doi.org/10.18632/oncotarget.16775|4. Huang J, Mondul AM, Weinstein SJ, Koutros S, Derkach A, Karoly E, Sampson JN, Moore SC, Berndt SI, Albanes D (2016). Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer  115, 1087-1095.   https://doi.org/10.1038/bjc.2016.305|5. Midttun Ø, Theofylaktopoulou D, McCann A, Fanidi A, Muller DC, Meyer K, Ulvik A, Zheng W, Shu XO, Xiang YB, Prentice R, Thomson CA, Pettinger M, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, et al. [29 more authors] (2017). Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations. Am J Clin Nutr  105, 1314-1326.   https://doi.org/10.3945/ajcn.116.151241|6. Miranti EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, Männistö S, Taylor PR, Freedman ND, Albanes D, Abnet CC, Murphy G (2017). Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer. Int J Cancer  141, 1120-1129.   https://doi.org/10.1002/ijc.30809|7. Mondul AM, Moore SC, Weinstein SJ, Evans AM, Karoly ED, Männistö S, Sampson JN, Albanes D (2016). Serum Metabolomic Response to Long-Term Supplementation with all-rac-α-Tocopheryl Acetate in a Randomized Controlled Trial. J Nutr Metab  2016, 6158436.   https://doi.org/10.1155/2016/6158436|8. Murphy G, Abnet CC, Choo-Wosoba H, Vogtmann E, Weinstein SJ, Taylor PR, Männistö S, Albanes D, Dawsey SM, Rehfeld JF, Freedman ND (2017). Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers. Int J Epidemiol  46, 914-923.   https://doi.org/10.1093/ije/dyx030|9. Nelson SM, Panagiotou OA, Anic GM, Mondul AM, Männistö S, Weinstein SJ, Albanes D (2016). Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Int J Epidemiol  45, 1458-1468.   https://doi.org/10.1093/ije/dyw148|10. Nogueira LM, Newton CC, Pollak M, Silverman DT, Albanes D, Männistö S, Weinstein SJ, Jacobs EJ, Stolzenberg-Solomon RZ (2017). Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking? Cancer Epidemiol Biomarkers Prev  26, 914-922.   https://doi.org/10.1158/1055-9965.EPI-16-0891|11. Playdon MC, Moore SC, Derkach A, Reedy J, Subar AF, Sampson JN, Albanes D, Gu F, Kontto J, Lassale C, Liao LM, Männistö S, Mondul AM, Weinstein SJ, Irwin ML, Mayne ST, Stolzenberg-Solomon R (2017). Identifying biomarkers of dietary patterns by using metabolomics. Am J Clin Nutr  105, 450-465.   https://doi.org/10.3945/ajcn.116.144501",https://intramural.nih.gov/search/searchview.taf?ipid=99361
609,CP010196-11,"October 01, 2016 -  September 30, 2017",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Rachael Zoe Solomon|Neal David Freedman|Steven  Moore|Christian Cormac Abnet; PhD, MPH",NULL,Louise  Brinton; PhD (Office of the Director),NULL,"1. Arem H, Pfeiffer RM, Moore SC, Brinton LA, Matthews CE (2016). Body mass index, physical activity, and television time in relation to mortality risk among endometrial cancer survivors in the NIH-AARP Diet and Health Study cohort. Cancer Causes Control  27, 1403-1409.   https://doi.org/10.1007/s10552-016-0813-7|2. Etemadi A, Sinha R, Ward MH, Graubard BI, Inoue-Choi M, Dawsey SM, Abnet CC (2017). Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study. BMJ  357, j1957.   https://doi.org/10.1136/bmj.j1957|3. Gordon-Dseagu VLZ, Thompson FE, Subar AF, Ruder EH, Thiébaut ACM, Potischman N, Stolzenberg-Solomon R (2017). A Cohort Study of Adolescent and Midlife Diet and Pancreatic Cancer Risk in the NIH-AARP Diet and Health Study. Am J Epidemiol  186, 305-317.   https://doi.org/10.1093/aje/kwx036|4. Inoue-Choi M, Freedman ND (2017). When to Adjust for Potentially Confounding Variables-Reply. JAMA Intern Med  177, 892.   https://doi.org/10.1001/jamainternmed.2017.1086|5. Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND (2017). Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med  177, 87-95.   https://doi.org/10.1001/jamainternmed.2016.7511|6. Lee JT, Lai GY, Liao LM, Subar AF, Bertazzi PA, Pesatori AC, Freedman ND, Landi MT, Lam TK (2017). Nut Consumption and Lung Cancer Risk: Results from Two Large Observational Studies. Cancer Epidemiol Biomarkers Prev  26, 826-836.   https://doi.org/10.1158/1055-9965.EPI-16-0806|7. Mamluk L, O'Doherty MG, Orfanos P, Saitakis G, Woodside JV, Liao LM, Sinha R, Boffetta P, Trichopoulou A, Kee F (2017). Fruit and vegetable intake and risk of incident of type 2 diabetes: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES). Eur J Clin Nutr  71, 83-91.   https://doi.org/10.1038/ejcn.2016.143|8. Nash SH, Liao LM, Harris TB, Freedman ND (2017). Cigarette Smoking and Mortality in Adults Aged 70 Years and Older: Results From the NIH-AARP Cohort. Am J Prev Med  52, 276-283.   https://doi.org/10.1016/j.amepre.2016.09.036|9. Sun L, Subar AF, Bosire C, Dawsey SM, Kahle LL, Zimmerman TP, Abnet CC, Heller R, Graubard BI, Cook MB, Petrick JL (2017). Dietary Flavonoid Intake Reduces the Risk of Head and Neck but Not Esophageal or Gastric Cancer in US Men and Women. J Nutr  147, 1729-1738.   https://doi.org/10.3945/jn.117.251579|10. Xiao Q, Arem H, Pfeiffer R, Matthews C (2017). Prediagnosis Sleep Duration, Napping, and Mortality Among Colorectal Cancer Survivors in a Large US Cohort. Sleep  40.   https://doi.org/10.1093/sleep/zsx010|11. Xiao Q, Berrigan D, Keadle SK, Matthews CE (2017). Neighborhood Socioeconomic Deprivation and Weight Change in a Large U.S. Cohort. Am J Prev Med  52, e173-e181.   https://doi.org/10.1016/j.amepre.2017.01.036|12. Xiao Q, Berrigan D, Matthews CE (2017). A prospective investigation of neighborhood socioeconomic deprivation and self-rated health in a large US cohort. Health Place  44, 70-76.   https://doi.org/10.1016/j.healthplace.2017.01.003|13. Yang B, Petrick JL, Kelly SP, Graubard BI, Freedman ND, McGlynn KA (2017). Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort. Int J Cancer  141, 271-278.   https://doi.org/10.1002/ijc.30737|14. Yu D, Takata Y, Smith-Warner SA, Blot W, Sawada N, White E, Freedman N, Robien K, Giovannucci E, Zhang X, Park Y, Gao YT, Chlebowski RT, Langhammer A, Yang G, Severi G, Manjer J, Khaw KT, Weiderpass E, Liao LM, Caporaso N, Krokstad S, Hveem K, Sinha R, Ziegler R, et al. [5 more authors] (2017). Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies. Cancer Epidemiol Biomarkers Prev  26, 1060-1070.   https://doi.org/10.1158/1055-9965.EPI-16-0863",https://intramural.nih.gov/search/searchview.taf?ipid=99367
610,CP010197-11,"October 01, 2016 -  September 30, 2017","Physical Activity, Energy Balance, and Cancer",Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Alessa HB, Chomistek AK, Hankinson SE, Barnett JB, Rood J, Matthews CE, Rimm EB, Willett WC, Hu FB, Tobias DK (2017). Objective Measures of Physical Activity and Cardiometabolic and Endocrine Biomarkers. Med Sci Sports Exerc  49, 1817-1825.   https://doi.org/10.1249/MSS.0000000000001287|2. Keadle SK, Conroy DE, Buman MP, Dunstan DW, Matthews CE (2017). Targeting Reductions in Sitting Time to Increase Physical Activity and Improve Health. Med Sci Sports Exerc  49, 1572-1582.   https://doi.org/10.1249/MSS.0000000000001257|3. Matthews CE, Keadle SK, Troiano RP, Kahle L, Koster A, Brychta R, Van Domelen D, Caserotti P, Chen KY, Harris TB, Berrigan D (2016). Accelerometer-measured dose-response for physical activity, sedentary time, and mortality in US adults. Am J Clin Nutr  104, 1424-1432.   https://doi.org/10.3945/ajcn.116.135129|4. Menni C, Migaud M, Kastenmüller G, Pallister T, Zierer J, Peters A, Mohney RP, Spector TD, Bagnardi V, Gieger C, Moore SC, Valdes AM (2017). Metabolomic Profiling of Long-Term Weight Change: Role of Oxidative Stress and Urate Levels in Weight Gain. Obesity (Silver Spring)  25, 1618-1624.   https://doi.org/10.1002/oby.21922|5. Murphy RA, Moore SC, Playdon M, Meirelles O, Newman AB, Milijkovic I, Kritchevsky SB, Schwartz A, Goodpaster BH, Sampson J, Cawthon P, Simonsick EM, Gerszten RE, Clish CB, Harris TB, Health ABC Study (2017). Metabolites Associated With Lean Mass and Adiposity in Older Black Men. J Gerontol A Biol Sci Med Sci  72, 1352-1359.   https://doi.org/10.1093/gerona/glw245|6. Pfister T, Matthews CE, Wang Q, Kopciuk KA, Courneya K, Friedenreich C (2017). Comparison of two accelerometers for measuring physical activity and sedentary behaviour. BMJ Open Sport Exerc Med  3, e000227.   https://doi.org/10.1136/bmjsem-2017-000227|7. Shiroma EJ, Schepps MA, Harezlak J, Chen KY, Matthews CE, Koster A, Caserotti P, Glynn NW, Harris TB (2016). Daily physical activity patterns from hip- and wrist-worn accelerometers. Physiol Meas  37, 1852-1861.   https://doi.org/10.1088/0967-3334/37/10/1852|8. Welk GJ, Beyler NK, Kim Y, Matthews CE (2017). Calibration of Self-Report Measures of Physical Activity and Sedentary Behavior. Med Sci Sports Exerc  49, 1473-1481.   https://doi.org/10.1249/MSS.0000000000001237|9. Xiao Q, Derkach A, Moore S, ZHENG W, SHU X, Gu F, Caporaso N, Sampson J, Matthews C (2017) Habitual Sleep and human plasma metabolomics Metabolomics 13:63|10. Yu D, Moore SC, Matthews CE, Xiang YB, Zhang X, Gao YT, Zheng W, Shu XO (2016). Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults. Metabolomics  12.   https://doi.org/10.1007/s11306-015-0890-8",https://intramural.nih.gov/search/searchview.taf?ipid=99362
611,CP010198-11,"October 01, 2016 -  September 30, 2017",Lower Gastrointestinal Cancer Studies,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy,NULL,NULL,NULL,"1. Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R (2016). Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev  25, 1483-1490.   https://doi.org/10.1158/1055-9965.EPI-16-0409|2. Vogtmann E, Chen J, Amir A, Shi J, Abnet CC, Nelson H, Knight R, Chia N, Sinha R (2017). Comparison of Collection Methods for Fecal Samples in Microbiome Studies. Am J Epidemiol  185, 115-123.   https://doi.org/10.1093/aje/kww177|3. Vogtmann E, Chen J, Kibriya MG, Chen Y, Islam T, Eunes M, Ahmed A, Naher J, Rahman A, Amir A, Shi J, Abnet CC, Nelson H, Knight R, Chia N, Ahsan H, Sinha R (2017). Comparison of Fecal Collection Methods for Microbiota Studies in Bangladesh. Appl Environ Microbiol  83.   https://doi.org/10.1128/AEM.00361-17",https://intramural.nih.gov/search/searchview.taf?ipid=99363
612,CP010199-11,"October 01, 2016 -  September 30, 2017",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Charles E Matthews,NULL,Amy F Subar (Risk Factor Assessment Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Assessment Branch)|Douglas N Midthune (Biometry Research Group)|Richard P Troiano (Risk Factor Assessment Branch),NULL,"1. Chomistek AK, Yuan C, Matthews CE, Troiano RP, Bowles HR, Rood J, Barnett JB, Willett WC, Rimm EB, Bassett DR (2017). Physical Activity Assessment with the ActiGraph GT3X and Doubly Labeled Water. Med Sci Sports Exerc  49, 1935-1944.   https://doi.org/10.1249/MSS.0000000000001299",https://intramural.nih.gov/search/searchview.taf?ipid=99364
613,CP010200-10,"October 01, 2016 -  September 30, 2017",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",Mark  Purdue,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99366
614,CP010201-08,"October 01, 2016 -  September 30, 2017",Laboratory of Translational Genomics,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Ricks-Santi L, McDonald JT, Gold B, Dean M, Thompson N, Abbas M, Wilson B, Kanaan Y, Naab TJ, Dunston G (2017). Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. Ethn Dis  27, 169-178.   https://doi.org/10.18865/ed.27.2.169|2. Samimi G, Bernardini MQ, Brody LC, Caga-Anan CF, Campbell IG, Chenevix-Trench G, Couch FJ, Dean M, de Hullu JA, Domchek SM, Drapkin R, Spencer Feigelson H, Friedlander M, Gaudet MM, Harmsen MG, Hurley K, James PA, Kwon JS, Lacbawan F, Lheureux S, Mai PL, Mechanic LE, Minasian LM, Myers ER, Robson ME, et al. [8 more authors] (2017). Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. J Clin Oncol  35, 2329-2337.   https://doi.org/10.1200/JCO.2016.70.3439",https://intramural.nih.gov/search/searchview.taf?ipid=99371
615,CP010202-09,"October 01, 2016 -  September 30, 2017","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99314
616,CP010206-08,"October 01, 2016 -  September 30, 2017","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Nicolas Albert Hermann Wentzensen|Julia  Gage|Lisa  Mirabello,Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Walter  Kinney (Kaiser Permanente Northern California)|Tina  Raine-Bennett (Kaiser Permanente Northern California)|Cosette  Wheeler (University of New Mexico)|Show all 11,Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Meredith  Yeager (Office of the Director)|Douglas  Lowy; MD (Office Of The Director),NULL,"1. Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2016). Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol  128, 1248-1257.   https://doi.org/10.1097/AOG.0000000000001721|2. Schiffman M (2017). Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice. Prev Med  98, 3-4.   https://doi.org/10.1016/j.ypmed.2016.12.028|3. Schiffman M, Wentzensen N (2016). A Suggested Approach to Simplify and Improve Cervical Screening in the United States. J Low Genit Tract Dis  20, 1-7.   https://doi.org/10.1097/LGT.0000000000000170|4. Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N (2017). Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. Int J Cancer  140, 718-725.   https://doi.org/10.1002/ijc.30456|5. Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE (2016). The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer  122, 3682-3686.   https://doi.org/10.1002/cncr.30277",https://intramural.nih.gov/search/searchview.taf?ipid=99372
617,CP010207-08,"October 01, 2016 -  September 30, 2017",PLCO EEMS and Extended Follow Up,"Neal David Freedman|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Philip  Prorok (Office of the Director)|Paul F Pinsky (Early Detection Research Group),NULL,"1. Pinsky PF, Yu K, Black A, Huang WY, Prorok PC (2016). Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort. Cancer Epidemiol  45, 26-31.   https://doi.org/10.1016/j.canep.2016.09.003|2. Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC (2016). Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. Gynecol Oncol  143, 270-275.   https://doi.org/10.1016/j.ygyno.2016.08.334|3. Zhu CS, Huang WY, Pinsky PF, Berg CD, Sherman M, Yu KJ, Carrick DM, Black A, Hoover R, Lenz P, Williams C, Hawkins L, Chaloux M, Yurgalevitch S, Mathew S, Miller A, Olivo V, Khan A, Pretzel SM, Multerer D, Beckmann P, Broski KG, Freedman ND (2016). The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. Cancer Epidemiol Biomarkers Prev  25, 1635-1642.   https://doi.org/10.1158/1055-9965.EPI-16-0506",https://intramural.nih.gov/search/searchview.taf?ipid=99373
618,CP010209-08,"October 01, 2016 -  September 30, 2017",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Beachler DC, Waterboer T, Pierce Campbell ChM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR (2016). HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Res  2, 141-144.   https://doi.org/10.1016/j.pvr.2016.07.003|2. Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T (2017). Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx005|3. Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL (2017). Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Cancer  123, 4382-4390.   https://doi.org/10.1002/cncr.30966",https://intramural.nih.gov/search/searchview.taf?ipid=99375
619,CP010210-08,"October 01, 2016 -  September 30, 2017","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99376
620,CP010211-08,"October 01, 2016 -  September 30, 2017",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Kelly Jen-Yi Yu,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Cancer Inflammation Program)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)",NULL,"1. Bei JX, Su WH, Ng CC, Yu K, Chin YM, Lou PJ, Hsu WL, McKay JD, Chen CJ, Chang YS, Chen LZ, Chen MY, Cui Q, Feng FT, Feng QS, Guo YM, Jia WH, Khoo AS, Liu WS, Mo HY, Pua KC, Teo SH, Tse KP, Xia YF, Zhang H, International Nasopharyngeal Carcinoma (NPC) Genetics Working Group, et al. [4 more authors] (2016). A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. Cancer Epidemiol Biomarkers Prev  25, 188-192.   https://doi.org/10.1158/1055-9965.EPI-15-0144|2. Chang ET, Liu Z, Hildesheim A, Liu Q, Cai Y, Zhang Z, Chen G, Xie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Lin L, Ernberg I, Vaughan TL, Adami HO, Huang G, Zeng Y, Zeng YX, Ye W (2017). Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China. Am J Epidemiol  185, 1272-1280.   https://doi.org/10.1093/aje/kwx018|3. Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clin Cancer Res  22, 3451-7.   https://doi.org/10.1158/1078-0432.CCR-15-2299|4. Correia S, Palser A, Elgueta Karstegl C, Middeldorp JM, Ramayanti O, Cohen JI, Hildesheim A, Fellner MD, Wiels J, White RE, Kellam P, Farrell PJ (2017). Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA. J Virol  91.   https://doi.org/10.1128/JVI.00375-17|5. Lo YL, Pan WH, Hsu WL, Chien YC, Chen JY, Hsu MM, Lou PJ, Chen IH, Hildesheim A, Chen CJ (2016). Partial Least Square Discriminant Analysis Discovered a Dietary Pattern Inversely Associated with Nasopharyngeal Carcinoma Risk. PLoS One  11, e0155892.   https://doi.org/10.1371/journal.pone.0155892",https://intramural.nih.gov/search/searchview.taf?ipid=99377
621,CP010212-08,"October 01, 2016 -  September 30, 2017",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Derks S, Liao X, Chiaravalli AM, Xu X, Camargo MC, Solcia E, Sessa F, Fleitas T, Freeman GJ, Rodig SJ, Rabkin CS, Bass AJ (2016). Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers. Oncotarget  7, 32925-32.   https://doi.org/10.18632/oncotarget.9076|2. Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC (2017). Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol  400, 277-304.   https://doi.org/10.1007/978-3-319-50520-6_12|3. Goedert JJ, Hosgood HD, Biggar RJ, Strickler HD, Rabkin CS (2016). Screening for Cancer in Persons Living with HIV Infection. Trends Cancer  2, 416-428.   https://doi.org/10.1016/j.trecan.2016.06.007|4. Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS (2017). Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays. Helicobacter  22.   https://doi.org/10.1111/hel.12393|5. Miller HK, Santo L, Camargo MC, Winkler CA, Goedert JJ, Kersh GJ, Rabkin CS (2017). Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma. Blood  129, 3262-3264.   https://doi.org/10.1182/blood-2016-12-756569|6. Rabkin CS, Goedert JJ (2017). Chronic Hepatitis and Non-Hodgkin Lymphoma Among People With HIV: Implications for Screening, Treatment, and Prevention. Ann Intern Med  166, 69-70.   https://doi.org/10.7326/M16-2340",https://intramural.nih.gov/search/searchview.taf?ipid=99378
622,CP010213-08,"October 01, 2016 -  September 30, 2017",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Yu K (2017). Head and Neck Cancer Incidence Trends in Taiwan,  1980  2014. International Journal of Head and Neck Science  1, 180-189.",https://intramural.nih.gov/search/searchview.taf?ipid=99379
623,CP010214-08,"October 01, 2016 -  September 30, 2017",Microbes and Human Malignancies,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Roberto  Flores (Nutritional Science Research Group)|Rashmi P Sinha; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99380
624,CP010215-08,"October 01, 2016 -  September 30, 2017",Human microbiome and cancer,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99381
625,CP010216-08,"October 01, 2016 -  September 30, 2017",Immune responses to HPV infection and HPV vaccination,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99382
626,CP010217-07,"October 01, 2016 -  September 30, 2017",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Anil Kumar Chaturvedi,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),NULL,NULL,"1. Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N (2016). Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis. J Infect Dis  213, 1444-54.   https://doi.org/10.1093/infdis/jiv753|2. Beachler DC, Lang Kuhs KA, Struijk L, Schussler J, Herrero R, Porras C, Hildesheim A, Cortes B, Sampson J, Quint W, Gonzalez P, Kreimer AR (2017). The Natural History of Oral Human Papillomavirus in Young Costa Rican Women. Sex Transm Dis  44, 442-449.   https://doi.org/10.1097/OLQ.0000000000000625|3. Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS (2017). Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecol Oncol  144, 391-395.   https://doi.org/10.1016/j.ygyno.2016.11.031|4. Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WAJ, Porras C, Quint W, Rodriguez AC, Schiffman M, Schussler J, Skinner SR, Teixeira JC, Wheeler CM, Herrero R, Hildesheim A, Lehtinen M, Costa Rica Vaccine Trial and the PATRICIA study groups (2017). Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw300",https://intramural.nih.gov/search/searchview.taf?ipid=99383
627,CP010218-07,"October 01, 2016 -  September 30, 2017",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen MC, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J (2017). Association of Aflatoxin and Gallbladder Cancer. Gastroenterology  153, 488-494.e1.   https://doi.org/10.1053/j.gastro.2017.04.005|2. Koshiol J, Wozniak A, Cook P, Adaniel C, Acevedo J, Azócar L, Hsing AW, Roa JC, Pasetti MF, Miquel JF, Levine MM, Ferreccio C, Gallbladder Cancer Chile Working Group (2016). Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis. Cancer Med  5, 3310-3235.   https://doi.org/10.1002/cam4.915|3. Van Dyke AL, Kemp TJ, Corbel AF, Zhu B, Gao YT, Wang BS, Rashid A, Shen MC, Hildesheim A, Hsing AW, Pinto LA, Koshiol J (2016). Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation. Ann Epidemiol  26, 704-709.   https://doi.org/10.1016/j.annepidem.2016.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=99384
628,CP010219-07,"October 01, 2016 -  September 30, 2017",Studies of other risk factors for radiosensitive tumors,Amy  de Gonzalez|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99385
629,CP010220-07,"October 01, 2016 -  September 30, 2017",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA (2018). Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut  67, 418-529.   https://doi.org/10.1136/gutjnl-2016-312223|2. Cook MB, Drahos J, Wood S, Enewold L, Parsons R, Freedman ND, Taylor PR, Ricker W, Abnet CC (2016). Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus. Br J Cancer  115, 1383-1390.   https://doi.org/10.1038/bjc.2016.344|3. Drahos J, Ricker W, Pfeiffer RM, Cook MB (2017). Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data. Cancer  123, 657-665.   https://doi.org/10.1002/cncr.30365|4. Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP (2016). Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol  14, 1412-1419.e3.   https://doi.org/10.1016/j.cgh.2016.05.032|5. Petrick JL, Kelly SP, Liao LM, Freedman ND, Graubard BI, Cook MB (2017). Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies. Br J Cancer  116, 951-959.   https://doi.org/10.1038/bjc.2017.29|6. Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA (2016). Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol  111, 1528-1535.   https://doi.org/10.1038/ajg.2016.348",https://intramural.nih.gov/search/searchview.taf?ipid=99386
630,CP010221-07,"October 01, 2016 -  September 30, 2017",Etiologic Studies of Prostate Cancer,"Demetrius  Albanes; MD|IRP Faculty Profile  | |Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Office of the Director, NCI",Mark  Purdue|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99387
631,CP010222-07,"October 01, 2016 -  September 30, 2017",Studies of Populations Exposed to Diagnostic Medical Radiation,Cari Meinhold Kitahara|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Kiyohiko  Mabuchi; MD, DPhil|Martha S Linet; PhD|Show all 9",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Steven L Simon (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Chang LA, Simon SL, Jorgensen TJ, Schauer DA, Lee C (2017). Dose coefficients for ICRP reference pediatric phantoms exposed to idealised external gamma fields. J Radiol Prot  37, 127-146.   https://doi.org/10.1088/1361-6498/aa559e|2. Harbron RW, Chapple CL, O'Sullivan JJ, Best KE, Berrington de González A, Pearce MS (2017). Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children. Heart  103, 341-346.   https://doi.org/10.1136/heartjnl-2016-309773|3. Journy NM, Lee C, Harbron RW, McHugh K, Pearce MS, Berrington de González A (2017). Projected cancer risks potentially related to past, current, and future practices in paediatric CT in the United Kingdom, 1990-2020. Br J Cancer  116, 109-116.   https://doi.org/10.1038/bjc.2016.351|4. Journy NM, McHugh K, Harbron RW, Pearce MS, Berrington De Gonzalez A (2016). Medical conditions associated with the use of CT in children and young adults, Great Britain, 1995-2008. Br J Radiol  89, 20160532.   https://doi.org/10.1259/bjr.20160532|5. Little MP (2016). Radiation and circulatory disease. Mutat Res  770, 299-318.   https://doi.org/10.1016/j.mrrev.2016.07.008",https://intramural.nih.gov/search/searchview.taf?ipid=99388
632,CP010224-06,"October 01, 2016 -  September 30, 2017",Esophageal cancer genetic project,Alisa  Goldstein; PhD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|LiDong  Wang (Zhengzhou Medical University)|DongXin  Lin (CICAMS)|Wei  Zheng (Vanderbilt University)|XiaoOu  Shu (Vanderbilt University)|JianMin  Yuan (University of Pittsburgh)","Nan  Hu (Hormonal and Reproductive Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Sanford Martin Dawsey; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Paula L Hyland (Genetic Epidemiology Branch)",NULL,"1. Sahasrabudhe R, Lott P, Bohorquez M, Toal T, Estrada AP, Suarez JJ, Brea-Fernández A, Cameselle-Teijeiro J, Pinto C, Ramos I, Mantilla A, Prieto R, Corvalan A, Norero E, Alvarez C, Tapia T, Carvallo P, Gonzalez LM, Cock-Rada A, Solano A, Neffa F, Della Valle A, Yau C, Soares G, Borowsky A, Latin American Gastric Cancer Genetics Collaborative Group, et al. [10 more authors] (2017). Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer. Gastroenterology  152, 983-986.e6.   https://doi.org/10.1053/j.gastro.2016.12.010|2. Song X, Li WQ, Hu N, Zhao XK, Wang Z, Hyland PL, Jiang T, Kong GQ, Su H, Wang C, Wang L, Sun L, Fan ZM, Meng H, Zhang TJ, Ji LF, Hu SJ, Han WL, Wu MJ, Zheng PY, Lv S, Li XM, Zhou FY, Burdett L, Ding T, et al. [12 more authors] (2017). GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer. Sci Rep  7, 4642.   https://doi.org/10.1038/s41598-017-04822-2",https://intramural.nih.gov/search/searchview.taf?ipid=99390
633,CP010225-06,"October 01, 2016 -  September 30, 2017",Barretts esophagus early detection project,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Nan  Hu|Sanford Martin Dawsey; MD|Christian Cormac Abnet; PhD, MPH",Ming  Zhou (SAIC)|Patrick  Young (WRNMMC),Paula L Hyland (Genetic Epidemiology Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99391
634,CP010227-03,"October 01, 2016 -  September 30, 2017",Laboratory of Genetic Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Chris  Amos (Dartmouth University)|Smita  Bhatia (University of Alabama School of Medicine)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|James  Cerhan (Mayo Clinic)|Fergus  Couch; PhD (Dept of Laboratory Medicine & Pathology, Mayo Clinic)|Olivier  Delattre (Institut Curie, Paris, France)|Show all 20","Leandro Machado Colli (Laboratory Of Genetic Susceptibility)|Lea  Jessop (Laboratory Of Genetic Susceptibility)|Roelof  Koster (Laboratory Of Genetic Susceptibility)|Mitchell John Machiela; PhD (Laboratory Of Genetic Susceptibility)|Timothy A Myers (Laboratory Of Genetic Susceptibility)|Mary  Carrington; MS, PhD (Cancer Inflammation Program)",NULL,"1. Bigot P, Colli LM, Machiela MJ, Jessop L, Myers TA, Carrouget J, Wagner S, Roberson D, Eymerit C, Henrion D, Chanock SJ (2016). Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41. Nat Commun  7, 12098.   https://doi.org/10.1038/ncomms12098|2. Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il'yasova D, Kinnersley B, Ostrom QT, Labreche K, Chen Y, Armstrong G, Liu Y, Eckel-Passow JE, Decker PA, Labussière M, Idbaih A, Hoang-Xuan K, Di Stefano AL, Mokhtari K, Delattre JY, Broderick P, Galan P, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, GliomaScan Consortium, et al. [38 more authors] (2017). Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet  49, 789-794.   https://doi.org/10.1038/ng.3823",https://intramural.nih.gov/search/searchview.taf?ipid=99393
635,CP010228-02,"October 01, 2016 -  September 30, 2017",Human Papillomavirus (HPV) Genomics Project,Mark  Schiffman; MD|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Yanzi  Xiao,NULL,Meredith  Yeager (Office of the Director)|Joseph  Boland (Office of the Director)|Kai  Yu (Biostatistics Branch)|Bin  Zhu (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99394
636,SC000550-37,"October 01, 2016 -  September 30, 2017",Lymphoma Disease Discovery and Definition,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Stefania  Pittaluga|Caoimhe Mary Egan; MD|Hao-Wei  Wang|Mark  Raffeld; MD|Svetlana Dmitriyevna Pack; PhD,"Wing  Chan (Pathology, University of Nebraska)|Elias  Campo (University of Barcelona)|Steven  Swerdlow (University of Pittsburgh Med Center)|Reiner  Siebert (University of Kiel)|Lisa  Rimsza (University of Arizona Cancer Center)|Falko  Fend|Show all 7","Louis  Staudt; MD (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|George W Wright (Computational & Systems Biology Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Brett FM, Flavin R, Chen D, Loftus T, Looby S, McCarthy A, de Gascun C, Jaffe ES, Nor N, Javadpour M, McCabe D (2017). EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline. Hum Pathol (N Y)  10, 64-68.   https://doi.org/10.1016/j.ehpc.2017.06.007|2. Dunleavy K, Pittaluga S, Shovlin M, Roschewski M, Lai C, Steinberg SM, Jaffe ES, Wilson WH (2016). Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma. Haematologica  101, e27-9.   https://doi.org/10.3324/haematol.2015.131151|3. Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, Staudt LM, Gascoyne RD, Scott DW, Rimsza LM (2016). Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Leuk Lymphoma  57, 717-20.   https://doi.org/10.3109/10428194.2015.1072767|4. King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL (2016). Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements. Am J Surg Pathol  40, 36-43.   https://doi.org/10.1097/PAS.0000000000000500|5. Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balagué O, Mozos A, Cabeçadas J, van der Walt J, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldívar JE, Clot G, Bárcena C, Pérez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, et al. [3 more authors] (2016). Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. Blood  128, 1101-11.   https://doi.org/10.1182/blood-2016-03-703819|6. Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares P, Rauert-Wunderlich H, Royo C, Clot G, Pinyol M, Boyle M, Chan FC, Braziel RM, Chan WC, Weisenburger DD, Cook JR, Greiner TC, Fu K, Ott G, Delabie J, Smeland EB, Holte H, Jaffe ES, Steidl C, Lymphoma/Leukemia Molecular Profiling Project, et al. [6 more authors] (2017). New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. J Clin Oncol  35, 1668-1677.   https://doi.org/10.1200/JCO.2016.70.7901",https://intramural.nih.gov/search/searchview.taf?ipid=99405
637,SC000892-34,"October 01, 2016 -  September 30, 2017",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Danielle Laurene Brooks|Imran  Khan; PhD|Brunilde M Gril,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Khan I, Steeg P (2017) Metastasis Suppressors: Functional Pathways. Laboratory Investigation, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99407
638,SC003669-28,"October 01, 2016 -  September 30, 2017",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,Maria Irene Morasso; PhD (NIAMS) |Ulrich K Siebenlist; PhD (NIAID) |Keisuke  Nagao (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99408
639,SC004002-48,"October 01, 2016 -  September 30, 2017",IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD|Juergen R Mueller; PhD|Masao  Nakagawa|Yuquan  Lin|Yong  Zhang|Mei  Zhang; MD, PhD|Show all 8",Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen),NULL,NULL,"1. Ju W, Zhang M, Wilson KM, Petrus MN, Bamford RN, Zhang X, Guha R, Ferrer M, Thomas CJ, Waldmann TA (2016). Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma. Proc Natl Acad Sci U S A  113, 1624-9.   https://doi.org/10.1073/pnas.1524668113|2. Mocsár G, Volkó J, Rönnlund D, Widengren J, Nagy P, Szöllősi J, Tóth K, Goldman CK, Damjanovich S, Waldmann TA, Bodnár A, Vámosi G (2016). MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T Cells. Biophys J  111, 100-12.   https://doi.org/10.1016/j.bpj.2016.05.044|3. Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY (2017). Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol  92, 892-901.   https://doi.org/10.1002/ajh.24794|4. Waldmann TA (2017). JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics. Mol Cell Endocrinol  451, 66-70.   https://doi.org/10.1016/j.mce.2017.02.019|5. Yeh CH, Bai XT, Moles R, Ratner L, Waldmann TA, Watanabe T, Nicot C (2016). Erratum to: 'Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia'. Mol Cancer  15, 20.   https://doi.org/10.1186/s12943-016-0504-8|6. Yeh CH, Bai XT, Moles R, Ratner L, Waldmann TA, Watanabe T, Toshiki W, Nicot C (2016). Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia. Mol Cancer  15, 15.   https://doi.org/10.1186/s12943-016-0500-z",https://intramural.nih.gov/search/searchview.taf?ipid=99409
640,SC004020-40,"October 01, 2016 -  September 30, 2017","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Masaki  Terabe|Yongjun  Sui|Zheng  Xia|Charles D Pendleton|Laurel  Lagenaur; PhD|Lauren V Wood; MD|Show all 16,"David  Carbone (Vanderbilt University)|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Wayne M. Yokoyama; MD (Rheumatology Division, Washington University)|Show all 39","Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Dennis M Klinman; MD, PhD (Cancer Inflammation Program)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Raj K Puri (OD) |Warren J Leonard; MD (NHLBI)","1. Berzofsky JA, Terabe M, Trepel JB, Pastan I, Stroncek DF, Morris JC, Wood LV (2018). Cancer vaccine strategies: translation from mice to human clinical trials. Cancer Immunol Immunother  67, 1863-1869.   https://doi.org/10.1007/s00262-017-2084-x|2. Leshem Y, O'Brien J, Liu X, Bera TK, Terabe M, Berzofsky JA, Bossenmaier B, Niederfellner G, Tai CH, Reiter Y, Pastan I (2017). Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity. Cancer Immunol Res  5, 685-694.   https://doi.org/10.1158/2326-6066.CIR-16-0330|3. Parchment RE, Voth AR, Doroshow JH, Berzofsky JA (2016). Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations. Semin Oncol  43, 501-13.   https://doi.org/10.1053/j.seminoncol.2016.06.008|4. Solaymani-Mohammadi S, Lakhdari O, Minev I, Shenouda S, Frey BF, Billeskov R, Singer SM, Berzofsky JA, Eckmann L, Kagnoff MF (2016). Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules. J Leukoc Biol  99, 475-82.   https://doi.org/10.1189/jlb.4A0115-003RR|5. Sui Y, Lee EM, Wang Y, Hogg A, Frey B, Venzon D, Pal R, Berzofsky JA (2016). Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum. J Acquir Immune Defic Syndr  71, 353-8.   https://doi.org/10.1097/QAI.0000000000000890|6. Terabe M, Robertson FC, Clark K, De Ravin E, Bloom A, Venzon DJ, Kato S, Mirza A, Berzofsky JA (2017). Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. Oncoimmunology  6, e1308616.   https://doi.org/10.1080/2162402X.2017.1308616",https://intramural.nih.gov/search/searchview.taf?ipid=99410
641,SC006321-38,"October 01, 2016 -  September 30, 2017",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Janet W Gamson|Anastasia L Sowers|Rajani  Choudhuri|Askale Y Mathias|Sarwat  Naz; PhD|Show all 9,NULL,Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) |Clint Tanner Allen (NIDCD)","1. Naz S, Krishna M, Mitchell J (2017) Application of functional molecular imaging in radiation oncology, in Cancer Drug Discovery, Development: Increasing the Therapeutic ratio of Radiotherapy. , pp. 103-134.|2. Eytan D, Snow G, Carlson S, Saleh A, Schiltz S, Derakhshan A, Cheng H, Mohan S, Cornelius S, Coupar J, Sowers A, Hernandez L, Mitchell J, Annunziata C, Chen Z, Van Waes C (2016) SMAC mimetic birinapant plus radiation eradicates human head and neck cancers with genomic amplifications of cell death genes FADD and BIRC2. Cancer Res, in press.|3. Stone HB, Bernhard EJ, Coleman CN, Deye J, Capala J, Mitchell JB, Brown JM (2016). Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations. Transl Oncol  9, 46-56.   https://doi.org/10.1016/j.tranon.2016.01.002|4. Takakusagi Y, Kishimoto S, Matsumoto S, Saito K, Hart C, Mitchell J, Krishna M (2017) Radiotherapy synergizes with the hypoxia-activated prodrug evofosfamide; In vitro and in vivo studies. Antioxid Redox Signal, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99411
642,SC006330-37,"October 01, 2016 -  September 30, 2017",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Holly  Ning|Barbara Chin Arora|Jason Yulin Cheng; PhD|Ying  Zhuge|Peter  Guion|Mary Kathleen Hawes,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99400
643,SC006353-35,"October 01, 2016 -  September 30, 2017",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Diane E Milenic|Rachel Gail Barkley,Andrew  Scott (Ludwig Institute for Cancer Research)|Marty  Pomper (Johns Hopkins),NULL,NULL,"1. Burvenich IJ, Farrugia W, Lee FT, Catimel B, Liu Z, Makris D, Cao D, O'Keefe GJ, Brechbiel MW, King D, Spirkoska V, Allan LC, Ramsland PA, Scott AM (2016). Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor. MAbs  8, 775-86.   https://doi.org/10.1080/19420862.2016.1156285|2. Burvenich IJ, Lee FT, O'Keefe GJ, Makris D, Cao D, Gong S, Rigopoulos A, Allan LC, Brechbiel MW, Liu Z, Ramsland PA, Scott AM (2016). Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers. EJNMMI Res  6, 26.   https://doi.org/10.1186/s13550-016-0180-0|3. Guérard F, Beyler M, Lee YS, Tripier R, Gestin JF, Brechbiel MW (2017). Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications. Dalton Trans  46, 4749-4758.   https://doi.org/10.1039/c6dt04625h|4. Guérard F, Lee YS, Baidoo K, Gestin JF, Brechbiel MW (2016). Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts. Chemistry  22, 12332-9.   https://doi.org/10.1002/chem.201600922|5. Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG (2016). (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy. J Nucl Med  57, 1569-1575.   https://doi.org/10.2967/jnumed.116.174300|6. Milenic DE, Baidoo KE, Kim YS, Barkley R, Brechbiel MW (2017). Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease. Dalton Trans  46, 14591-14601.   https://doi.org/10.1039/c7dt01819c|7. Milenic DE, Baidoo KE, Kim YS, Barkley R, Brechbiel MW (2017). Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab. Transl Oncol  10, 535-545.   https://doi.org/10.1016/j.tranon.2017.04.004|8. Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW (2016). Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model. PLoS One  11, e0159904.   https://doi.org/10.1371/journal.pone.0159904",https://intramural.nih.gov/search/searchview.taf?ipid=99412
644,SC006387-30,"October 01, 2016 -  September 30, 2017",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Rajani  Choudhuri|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),Tracey Ann Rouault; MD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99413
645,SC006538-24,"October 01, 2016 -  September 30, 2017",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Andrea Borghese Apolo|Show all 7","Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Brent R Copp; PhD (Chemistry, University of Auckland)|Michael  Gutschow (University of Bonn)","Phoebe Ao-Xue Huang (Office Of The Clinical Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)",Nigel H Greig; PhD (NIA),"1. Ambrożak A, Steinebach C, Gardner ER, Beedie SL, Schnakenburg G, Figg WD, Gütschow M (2016). Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids. ChemMedChem  11, 2621-2629.   https://doi.org/10.1002/cmdc.201600496|2. Beedie SL, Mahony C, Walker HM, Chau CH, Figg WD, Vargesson N (2016). Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model. Sci Rep  6, 30038.   https://doi.org/10.1038/srep30038|3. Beedie SL, Rore HM, Barnett S, Chau CH, Luo W, Greig NH, Figg WD, Vargesson N (2016). In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems. Oncotarget  7, 33237-45.   https://doi.org/10.18632/oncotarget.8909",https://intramural.nih.gov/search/searchview.taf?ipid=99414
646,SC006663-28,"October 01, 2016 -  September 30, 2017",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Sheila Ann Prindiville (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99415
647,SC006737-26,"October 01, 2016 -  September 30, 2017",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Victoria Y Wang|David A Davis; MD|Hiroaki  Mitsuya,NULL,"George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (HIV Drug Resistance Program)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)",Paul T Wingfield; PhD (NIAMS),"1. Gonçalves PH, Uldrick TS, Yarchoan R (2017). HIV-associated Kaposi sarcoma and related diseases. AIDS  31, 1903-1916.   https://doi.org/10.1097/QAD.0000000000001567",https://intramural.nih.gov/search/searchview.taf?ipid=99416
648,SC006738-26,"October 01, 2016 -  September 30, 2017",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Yuki  Takamatsu; MD|Manabu  Aoki; PhD|Hiromi  Aoki|Haydar  Bulut; PhD|Nicole  Delino|Show all 7,"Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Irene  Weber (Department of Biology, Georgia State University)|Anderson  Karen (Yale University School of Medicine)|Show all 9",NULL,Paul T Wingfield; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99401
649,SC006741-25,"October 01, 2016 -  September 30, 2017",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH (2017). Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. Cancer Cell  31, 833-843.e5.   https://doi.org/10.1016/j.ccell.2017.04.012|2. Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M (2017). PD-1 Blockade in Mediastinal Gray-Zone Lymphoma. N Engl J Med  377, 89-91.   https://doi.org/10.1056/NEJMc1704767",https://intramural.nih.gov/search/searchview.taf?ipid=99402
650,SC006891-29,"October 01, 2016 -  September 30, 2017",Clinical Studies in Pediatric Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Crystal L. Mackall; MD|Brigitte  Widemann; MD,Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Fernanda  Arnaldez (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ (2016). Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol  2, 922-8.   https://doi.org/10.1001/jamaoncol.2016.0256|2. Grohar PJ, Glod J, Peer CJ, Sissung TM, Arnaldez FI, Long L, Figg WD, Whitcomb P, Helman LJ, Widemann BC (2017). A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript. Cancer Chemother Pharmacol  80, 645-652.   https://doi.org/10.1007/s00280-017-3382-x|3. Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, Maher ER, Nichols KE, Plon SE, Porter CC, Rednam S, Schultz KAP, States LJ, Tomlinson GE, Zelley K, Druley TE (2017). Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma. Clin Cancer Res  23, e115-e122.   https://doi.org/10.1158/1078-0432.CCR-17-0710|4. Osgood CL, Maloney N, Kidd CG, Kitchen-Goosen S, Segars L, Gebregiorgis M, Woldemichael GM, He M, Sankar S, Lessnick SL, Kang M, Smith M, Turner L, Madaj ZB, Winn ME, Núñez LE, González-Sabín J, Helman LJ, Morís F, Grohar PJ (2016). Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor. Clin Cancer Res  22, 4105-18.   https://doi.org/10.1158/1078-0432.CCR-15-2624",https://intramural.nih.gov/search/searchview.taf?ipid=99417
651,SC006892-29,"October 01, 2016 -  September 30, 2017",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Choh L Yeung,Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Fernanda  Arnaldez (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Natasha  Caplen (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD) |Karel  Pacak; MD, PhD (NICHD)","1. Hyun O J, Luber BS, Leal JP, Wang H, Bolejack V, Schuetze SM, Schwartz LH, Helman LJ, Reinke D, Baker LH, Wahl RL (2016). Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor. J Nucl Med  57, 735-40.   https://doi.org/10.2967/jnumed.115.162412|2. Weldon CB, Madenci AL, Boikos SA, Janeway KA, George S, von Mehren M, Pappo AS, Schiffman JD, Wright J, Trent JC, Pacak K, Stratakis CA, Helman LJ, La Quaglia MP (2017). Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. J Clin Oncol  35, 523-528.   https://doi.org/10.1200/JCO.2016.68.6733",https://intramural.nih.gov/search/searchview.taf?ipid=99418
652,SC007263-25,"October 01, 2016 -  September 30, 2017",Activating Cell Death Pathways in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Donna M Voeller|Yoshimi Endo Greer|Samuel Fredrick Gilbert; MPH|Christina M Annunziata|Patricia  Steeg; PhD|Alexandra Dos Santos Zimmer,Sandra M Swain; MD|David  Tice (MedImmune),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Anand S Merchant (Office of the Director)|Margaret  Cam; PhD (Office of the Director)|Luca  Gattinoni (Experimental Transplantation and Immunology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)",Markus  Hafner (NIAMS) |Madhu A Lal (NCATS),"1. Endo Greer Y, Lipkowitz S (2016). ONC201: Stressing tumors to death. Sci Signal  9, fs1.   https://doi.org/10.1126/scisignal.aad7955",https://intramural.nih.gov/search/searchview.taf?ipid=99419
653,SC007281-24,"October 01, 2016 -  September 30, 2017",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Center For Cancer Training)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. de Oliveira GA, Cheng RYS, Ridnour LA, Basudhar D, Somasundaram V, McVicar DW, Monteiro HP, Wink DA (2017). Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers. Antioxid Redox Signal  26, 1059-1077.   https://doi.org/10.1089/ars.2016.6850|2. Kovacevic Z, Sahni S, Lok H, Davies MJ, Wink DA, Richardson DR (2017). Regulation and control of nitric oxide (NO) in macrophages: Protecting the ""professional killer cell"" from its own cytotoxic arsenal via MRP1 and GSTP1. Biochim Biophys Acta Gen Subj  1861, 995-999.   https://doi.org/10.1016/j.bbagen.2017.02.021",https://intramural.nih.gov/search/searchview.taf?ipid=99420
654,SC009144-33,"October 01, 2016 -  September 30, 2017",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Suzanne Laurie Sanford|Zuqin  Nie; PhD|Lipeng  Wu|Emil Francis Michelotti; PhD,Juhong  Liu (FDA)|Leonie  Quinn (University of Melbourne),"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99421
655,SC009172-29,"October 01, 2016 -  September 30, 2017",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes|Sukhbir  Kaur|Elizabeth Chase Lessey-Morillon; PhD|Anthony Lee Schwartz; PhD|Rajdeep  Banerjee|Pulak Ranjan Nath|Show all 8,Jeff  Isenberg (University of Pittsburgh)|Katherine  Cook (Georgetown University Medical Center)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine),"David Anderson Wink (Cancer Inflammation Program)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Susan H Garfield (Laboratory of Cancer Biology and Genetics)",Abdel G Elkahloun; PhD (NHGRI) |Chengyu  Liu; PhD (NHLBI) |Satya P Singh; PhD (NIAID),"1. Roberts D, Isenberg J, SotoPantoja D (2017) CD47, in Encyclopedia of Signaling Molecules, in press.|2. Roberts D, Kaur S, SotoPantoja D (2017) Thrombospondin-1, in Encyclopedia of Signaling Molecules, in press.|3. Cook KL, Soto-Pantoja DR, Clarke PA, Cruz MI, Zwart A, Wärri A, Hilakivi-Clarke L, Roberts DD, Clarke R (2016). Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer. Cancer Res  76, 5657-5670.   https://doi.org/10.1158/0008-5472.CAN-15-2616|4. Kaur S, Roberts DD (2016). Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling. Int J Biochem Cell Biol  81, 184-194.   https://doi.org/10.1016/j.biocel.2016.05.005|5. Roberts DD, Kaur S, Isenberg JS (2017). Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer. Antioxid Redox Signal  27, 874-911.   https://doi.org/10.1089/ars.2017.7140|6. Soto-Pantoja DR, Sipes JM, Martin-Manso G, Westwood B, Morris NL, Ghosh A, Emenaker NJ, Roberts DD (2016). Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min/+) model of colon cancer. Oncogenesis  5, e230.   https://doi.org/10.1038/oncsis.2016.37",https://intramural.nih.gov/search/searchview.taf?ipid=99397
656,SC009173-29,"October 01, 2016 -  September 30, 2017",Host Colonization and Vascular Dissemination of Candida albicans,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes,NULL,NULL,Michail S Lionakis (NIAID),"1. Navarathna DH, Pathirana RU, Lionakis MS, Nickerson KW, Roberts DD (2016). Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis. PLoS One  11, e0164449.   https://doi.org/10.1371/journal.pone.0164449",https://intramural.nih.gov/search/searchview.taf?ipid=99398
657,SC009174-29,"October 01, 2016 -  September 30, 2017",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes|Sukhbir  Kaur|Anthony Lee Schwartz; PhD,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)|Douglas  Thomas (University of Illinois at Chicago)|Katherine  Cook (Georgetown University Medical Center)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine),David Anderson Wink (Cancer Inflammation Program),NULL,"1. Roberts D, Isenberg J, SotoPantoja D (2017) CD47, in Encyclopedia of Signaling Molecules, in press.|2. Roberts D, Kaur S, SotoPantoja D (2017) Thrombospondin-1, in Encyclopedia of Signaling Molecules, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99396
658,SC009179-29,"October 01, 2016 -  September 30, 2017","The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. Chowdhury A, Brinson R, Wei B, Stetler-Stevenson WG (2017). Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein. Biochemistry  56, 6423-6433.   https://doi.org/10.1021/acs.biochem.7b00700",https://intramural.nih.gov/search/searchview.taf?ipid=99422
659,SC009389-24,"October 01, 2016 -  September 30, 2017",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99423
660,SC010051-22,"October 01, 2016 -  September 30, 2017",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99424
661,SC010074-22,"October 01, 2016 -  September 30, 2017",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Wanping  Xu|Kristin  Eckfeld|Abbey Dyanne Zuehlke|Michael Anthony Moses|Megan Leighann Tigue|Ibrahim Abdoalatif Alsomairy|Show all 7,"YunJin  Jung (Pusan National University)|Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Show all 12",NULL,NULL,"1. Calderwood SK, Neckers L (2016). Hsp90 in Cancer: Transcriptional Roles in the Nucleus. Adv Cancer Res  129, 89-106.   https://doi.org/10.1016/bs.acr.2015.08.002|2. Yim KH, Prince TL, Qu S, Bai F, Jennings PA, Onuchic JN, Theodorakis EA, Neckers L (2016). Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β. Proc Natl Acad Sci U S A  113, E4801-9.   https://doi.org/10.1073/pnas.1606655113|3. Zuehlke AD, Neckers L (2016). Clients Place Unique Functional Constraints on Hsp90. Trends Biochem Sci  41, 562-564.   https://doi.org/10.1016/j.tibs.2016.05.011",https://intramural.nih.gov/search/searchview.taf?ipid=99425
662,SC010093-21,"October 01, 2016 -  September 30, 2017",Epigenetic Therapy for Thoracic Malignanceis,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Julie A Hong|Mary R Zhang|Colleen Donahue Bond,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99404
663,SC010098-15,"October 01, 2016 -  September 30, 2017",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",NULL,Phil  Kantoff (DFCI)|Joseph  KIm (Yale),"William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter A Pinto; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)",NULL,"1. Karzai FH, Madan RA, Dahut WL (2016). Metabolic syndrome in prostate cancer: impact on risk and outcomes. Future Oncol  12, 1947-55.   https://doi.org/10.2217/fon-2016-0061|2. Madan R, Gulley J, Dahut W (2016) Radium-223 in prostate cancer: emitting the right signals. Lancet Oncol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99443
664,SC010288-20,"October 01, 2016 -  September 30, 2017",Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ronald E Gress; MD|Steven  Pavletic; MD, MS|Frances  Hakim; PhD","Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Robert  Korngold (Cancer Center, Hackensack University)|David  Vesole (Georgetown University)|Scott  Rowley (Hackensack University)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99427
665,SC010354-18,"October 01, 2016 -  September 30, 2017",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Eva  Dombi|Nalini M Jayaprakash|Robert F Murphy|Andrea Michelle Gross; MD|Christine Sarah Higham|Ira Lignugaris Kraft|Show all 13,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|AeRang  Kim (Children's National Medical Center)|Srivandana  Akshintala","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Alice Pinting Chen (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director)","Karel  Pacak; MD, PhD (NICHD)","1. Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA (2016). Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. J Clin Oncol  34, 3031-8.   https://doi.org/10.1200/JCO.2015.65.5381|2. Shah NN, Merchant MS, Cole DE, Jayaprakash N, Bernstein D, Delbrook C, Richards K, Widemann BC, Wayne AS (2016). Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. Pediatr Blood Cancer  63, 997-1005.   https://doi.org/10.1002/pbc.25937|3. Widemann BC (2016). Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion. Pediatr Blood Cancer  63, 366.   https://doi.org/10.1002/pbc.25798",https://intramural.nih.gov/search/searchview.taf?ipid=99428
666,SC010355-18,"October 01, 2016 -  September 30, 2017",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Hidetaka  Ohnuki|Michael Joseph Diprima|Shinichiro  Hasegawa; MD, PhD|Lisa Beth Ritchey|Taekyu  Ha",Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Amparo  Acher-Palmer (University of Frankfurt)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory),Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI),"1. Espígol-Frigolé G, Planas-Rigol E, Ohnuki H, Salvucci O, Kwak H, Ravichandran S, Luke B, Cid MC, Tosato G (2016). Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling. Sci Signal  9, ra28.   https://doi.org/10.1126/scisignal.aad2357|2. Ohnuki H, Tosato G (2017). Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling. Methods Mol Biol  1493, 345-361.   https://doi.org/10.1007/978-1-4939-6448-2_25",https://intramural.nih.gov/search/searchview.taf?ipid=99429
667,SC010356-18,"October 01, 2016 -  September 30, 2017",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Hidetaka  Ohnuki|Michael Joseph Diprima,Frederick  Wang (Harvard Univ)|Stefan  Rose-John (Univ. of Kiel),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch),Manfred  Boehm; MD (NHLBI),"1. Chen II, Caprioli A, Ohnuki H, Kwak H, Porcher C, Tosato G (2016). EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta. Sci Rep  6, 27195.   https://doi.org/10.1038/srep27195|2. Hu D, Wang V, Yang M, Abdullah S, Davis DA, Uldrick TS, Polizzotto MN, Veeranna RP, Pittaluga S, Tosato G, Yarchoan R (2016). Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. J Virol  90, 368-78.   https://doi.org/10.1128/JVI.01192-15|3. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R (2016). Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin Infect Dis  62, 730-738.   https://doi.org/10.1093/cid/civ996|4. Sanchez-Martin D, Uldrick TS, Kwak H, Ohnuki H, Polizzotto MN, Annunziata CM, Raffeld M, Wyvill KM, Aleman K, Wang V, Marshall VA, Whitby D, Yarchoan R, Tosato G (2017). Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx016",https://intramural.nih.gov/search/searchview.taf?ipid=99430
668,SC010357-18,"October 01, 2016 -  September 30, 2017",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Shuo  Gu,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)|Chuxia  Deng; PhD (NIDDK)|John  Doorbar (National Institute for Medical Research)|Show all 7",Michael John Kruhlak; PhD (Experimental Immunology Branch)|Xinhua  Ji; PhD (Biomolecular Structure Section),Jun  Zhu; PhD (NHLBI),"1. Ajiro M, Jia R, Yang Y, Zhu J, Zheng ZM (2016). A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Nucleic Acids Res  44, 1854-70.   https://doi.org/10.1093/nar/gkv1500|2. Ajiro M, Tang S, Doorbar J, Zheng ZM (2016). Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements. J Virol  90, 9138-52.   https://doi.org/10.1128/JVI.00965-16|3. Ma Y, Liu P, Majerciak V, Zhu J, Zheng ZM (2016). CLIP-seq to Identify KSHV ORF57-Binding RNA in Host B Cells. Curr Protoc Microbiol  41, 1E.11.1-1E.11.18.   https://doi.org/10.1002/cpmc.3|4. Majerciak V, Zheng ZM (2016). Alternative RNA splicing of KSHV ORF57 produces two different RNA isoforms. Virology  488, 81-7.   https://doi.org/10.1016/j.virol.2015.10.031|5. Ni T, Majerciak V, Zheng ZM, Zhu J (2016). PA-seq for Global Identification of RNA Polyadenylation Sites of Kaposi's Sarcoma-Associated Herpesvirus Transcripts. Curr Protoc Microbiol  41, 14E.7.1-14E.7.18.   https://doi.org/10.1002/cpmc.1|6. Sharma NR, Wang X, Majerciak V, Ajiro M, Kruhlak M, Meyers C, Zheng ZM (2016). Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2. J Biol Chem  291, 2302-9.   https://doi.org/10.1074/jbc.C115.695049|7. Wang X, Liu H, Wang HK, Meyers C, Chow L, Zheng ZM (2016). HPV18 DNA replication inactivates the early promoter P55 activity and prevents viral E6 expression. Virol Sin  31, 437-440.   https://doi.org/10.1007/s12250-016-3887-1|8. Wang X, Zheng ZM (2016). Construction of a Transcription Map for Papillomaviruses using RACE, RNase Protection, and Primer Extension Assays. Curr Protoc Microbiol  40, 14B.6.1-29.   https://doi.org/10.1002/9780471729259.mc14b06s40",https://intramural.nih.gov/search/searchview.taf?ipid=99431
669,SC010366-17,"October 01, 2016 -  September 30, 2017",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Peter  Ambros (Children’s Cancer Research Institute)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Janet  Shipley (The Institute of Cancer Research)|Show all 7","Carol J Thiele (Pediatric Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,"1. Ignatius MS, Hayes MN, Lobbardi R, Chen EY, McCarthy KM, Sreenivas P, Motala Z, Durbin AD, Molodtsov A, Reeder S, Jin A, Sindiri S, Beleyea BC, Bhere D, Alexander MS, Shah K, Keller C, Linardic CM, Nielsen PG, Malkin D, Khan J, Langenau DM (2017). The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma. Cell Rep  19, 2304-2318.   https://doi.org/10.1016/j.celrep.2017.05.061|2. Tenente IM, Hayes MN, Ignatius MS, McCarthy K, Yohe M, Sindiri S, Gryder B, Oliveira ML, Ramakrishnan A, Tang Q, Chen EY, Petur Nielsen G, Khan J, Langenau DM (2017). Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma. Elife  6.   https://doi.org/10.7554/eLife.19214",https://intramural.nih.gov/search/searchview.taf?ipid=99432
670,SC010372-17,"October 01, 2016 -  September 30, 2017",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99433
671,SC010373-17,"October 01, 2016 -  September 30, 2017",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99434
672,SC010375-17,"October 01, 2016 -  September 30, 2017",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Anne G M Gegonne Bosselut (Molecular Regulation Section)|Dan  Cheng (Molecular Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99435
673,SC010376-17,"October 01, 2016 -  September 30, 2017","TNF Signaling, Cell Death and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Jin Young  Baik|Delong  Jiao; PhD,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)",NULL,Richard James Youle; PhD (NINDS) |Chengyu  Liu; PhD (NHLBI),"1. Xu Q, Jitkaew S, Choksi S, Kadigamuwa C, Qu J, Choe M, Jang J, Liu Z, Liu Z (2017) Cytoplasmic nuclear receptor RAR? controls RIP1 initiated cell death when cIAP activity is inhibited. Nature Communication, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99436
674,SC010378-17,"October 01, 2016 -  September 30, 2017",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Zhenhua  Zhang|Yang-Jo  Chung|Masahiro  Onozawa|Subhadip  Kundu|Mianmian  Yin|Joseph  Dufraine; PhD|Show all 8,"Trang  Hoang (U. Montreal)|Adolfo  Ferrando (Genetics, Columbia U.)",Crystal L. Mackall; MD (Pediatric Oncology Branch)|David  Levens; PhD (Laboratory of Pathology),NULL,"1. Goldberg L, Gough SM, Lee F, Dang C, Walker RL, Zhu YJ, Bilke S, Pineda M, Onozawa M, Jo Chung Y, Meltzer PS, Aplan PD (2017). Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance. Genes Chromosomes Cancer  56, 472-483.   https://doi.org/10.1002/gcc.22451|2. Hourigan CS, Aplan PD (2016). Accurate Medicine: Indirect Targeting of NPM1-Mutated AML. Cancer Discov  6, 1087-1089.   https://doi.org/10.1158/2159-8290.CD-16-0917|3. Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CK, Ness SA, Rusch M, Li Y, Onozawa M, Martinez C, Wood BL, Asselin BL, Chen IM, Roberts KG, Baruchel A, Soulier J, Dombret H, Zhang J, Larson RS, Raetz EA, Carroll WL, Winick NJ, Aplan PD, Loh ML, et al. [6 more authors] (2016). MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study. Leukemia  30, 1909-12.   https://doi.org/10.1038/leu.2016.60|4. Zhou W, Chung YJ, Parrilla Castellar ER, Zheng Y, Chung HJ, Bandle R, Liu J, Tessarollo L, Batchelor E, Aplan PD, Levens D (2016). Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels. Am J Pathol  186, 701-15.   https://doi.org/10.1016/j.ajpath.2015.10.028",https://intramural.nih.gov/search/searchview.taf?ipid=99437
675,SC010379-17,"October 01, 2016 -  September 30, 2017",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Zhenhua  Zhang|Masahiro  Onozawa|Mianmian  Yin,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,"1. Canela A, Maman Y, Jung S, Wong N, Callen E, Day A, Kieffer-Kwon KR, Pekowska A, Zhang H, Rao SSP, Huang SC, Mckinnon PJ, Aplan PD, Pommier Y, Aiden EL, Casellas R, Nussenzweig A (2017). Genome Organization Drives Chromosome Fragility. Cell  170, 507-521.e18.   https://doi.org/10.1016/j.cell.2017.06.034|2. Onozawa M, Aplan PD (2016). Templated Sequence Insertion Polymorphisms in the Human Genome. Front Chem  4, 43.   https://doi.org/10.3389/fchem.2016.00043",https://intramural.nih.gov/search/searchview.taf?ipid=99438
676,SC010384-17,"October 01, 2016 -  September 30, 2017",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,David  Russell (University of Washington)|Punam  Malik,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99439
677,BC010906-10,"October 01, 2016 -  September 30, 2017",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Sigrid Priscilla Dubois|Michael N Petrus|Liyanage P Perera; PhD|Arlethia J Spencer|Bonita R Bryant|Kevin Charles Conlon|Show all 8,"Nicole  Urquhart (Dept of, University of the West Indies)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)|Jeffrey  Miller (University of Minnesota)","Hoyoung  Maeng; MD (Vaccine Branch)|Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98938
678,BC009255-43,"October 01, 2016 -  September 30, 2017",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger|Donald G Plugge|Assiatu Jalloh Crossman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98646
679,BC010469-15,"October 01, 2016 -  September 30, 2017",Molecular Targets Laboratory,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",Tanya R Johnson|Anthony  Wamiru|Jennifer A Wilson|Curtis  Henrich|Girma M Woldemichael|Emad  Darvishi|Show all 9,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Patrick  Cummings (Masters Program development, Johns Hopkins University)|Ihsan  Calis (Natural product diversity librarires, Hacteppe University)|Johnny  Easmon (HDAC Inhibitors, University of Innsbruck)|Yutaka  Takebe (National Institute of Infectious Diseases)|Show all 9",Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|William Marston Linehan; MD (Urologic Oncology Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Jonathan S Wiest; PhD (Center For Cancer Training),Michael P Bray (NIAID),"1. Caropreso V, Darvishi E, Turbyville TJ, Ratnayake R, Grohar PJ, McMahon JB, Woldemichael GM (2016). Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells. J Biol Chem  291, 10058-66.   https://doi.org/10.1074/jbc.M115.701375",https://intramural.nih.gov/search/searchview.taf?ipid=98767
680,BC010517-15,"October 01, 2016 -  September 30, 2017",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Hitesh Jayantilal Patel; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 11,NULL,"Christopher P Austin; AB, MD (NCATS) |Evan  Bolton; PhD (NLM) |Igor V Filippov (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98770
681,BC010548-15,"October 01, 2016 -  September 30, 2017",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Cody John Peer|Julie Katherine Barnes|Keith Thomas Schmidt|Oliver Morgan Hall,NULL,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)",NULL,"1. Goey AK, Figg WD (2016). UGT genotyping in belinostat dosing. Pharmacol Res  105, 22-7.   https://doi.org/10.1016/j.phrs.2016.01.002|2. Peer CJ, Lee JM, Roth J, Rodgers L, Nguyen J, Annunziata CM, Minasian L, Kohn EC, Figg WD (2017). Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women's cancers. Cancer Chemother Pharmacol  80, 165-175.   https://doi.org/10.1007/s00280-017-3346-1",https://intramural.nih.gov/search/searchview.taf?ipid=98851
682,BC010639-14,"October 01, 2016 -  September 30, 2017",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|John Stephen Schneekloth|Jordan Leslie Meier; PhD|Jeffrey  Gildersleeve,Iwona Elzbieta Weidlich|Julieta  Comin (University of Buenos Aires),"Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|David D Roberts; PhD (Laboratory of Pathology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)","Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98780
683,BC010685-13,"October 01, 2016 -  September 30, 2017",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Willie J Young,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NHLBI)","1. Kleiner DE (2017). Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am  46, 273-296.   https://doi.org/10.1016/j.gtc.2017.01.004|2. Kleiner DE (2017). On beyond staging and grading: Liver biopsy evaluation in a posttreatment world. Hepatology  65, 1432-1434.   https://doi.org/10.1002/hep.29111|3. Kleiner DE (2017). The Role of the Hepatopathologist in the Assessment of Drug-induced Liver Injury. Clin Liver Dis (Hoboken)  9, 34-37.   https://doi.org/10.1002/cld.612",https://intramural.nih.gov/search/searchview.taf?ipid=98795
684,BC010687-13,"October 01, 2016 -  September 30, 2017",Histology Core Laboratory,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Tashanda Renee Ashford|Terrica Shuntay Johnson|Mohammad Javed Mahboob|Michael Kanwolo Newford|Claire D Roque|Silke  Williams|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98797
685,BC010858-11,"October 01, 2016 -  September 30, 2017",CCR Confocal Microscopy Core,Susan H Garfield,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Langston  Lim,NULL,Sukhbir  Kaur (Laboratory of Pathology),Kevin G Chen; MD (NINDS),"1. Kaur S, Elkahloun AG, Singh SP, Chen QR, Meerzaman DM, Song T, Manu N, Wu W, Mannan P, Garfield SH, Roberts DD (2016). A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer. Oncotarget  7, 10133-52.   https://doi.org/10.18632/oncotarget.7100",https://intramural.nih.gov/search/searchview.taf?ipid=98856
686,BC010903-10,"October 01, 2016 -  September 30, 2017",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Holly Marie Morris|Robert H Koogle,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98929
687,BC010905-10,"October 01, 2016 -  September 30, 2017",Surgery Branch Cell Prep Core,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI","Nicholas Phillip Restifo; MD|Paul  Robbins|Udai S Kammula|James Chung-Yin Yang; MD, PhD|Richard  Sherry; MD|Donald E White|Show all 15",NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch)|Robert Taylor Ripley; MD (Thoracic & Oncologic Surgery Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,"1. Assadipour Y, Zacharakis N, Crystal JS, Prickett TD, Gartner JJ, Somerville RPT, Xu H, Black MA, Jia L, Chinnasamy H, Kriley I, Lu L, Wunderlich JR, Zheng Z, Lu YC, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2017). Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer. Clin Cancer Res  23, 4347-4353.   https://doi.org/10.1158/1078-0432.CCR-16-1423|2. Deniger DC, Kwong ML, Pasetto A, Dudley ME, Wunderlich JR, Langhan MM, Lee CR, Rosenberg SA (2017). A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma. Clin Cancer Res  23, 351-362.   https://doi.org/10.1158/1078-0432.CCR-16-0906",https://intramural.nih.gov/search/searchview.taf?ipid=98944
688,BC010915-10,"October 01, 2016 -  September 30, 2017",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Dinah  Singer; PhD|Vanja  Lazarevic|Damian  Kovalovsky; PhD|Jung-Hyun  Park|Richard J Hodes; MD,NULL,"Zhi Ming  Zheng; MD, PhD (Rna Biology Laboratory)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Mark  Udey; MD (Office Of The Clinical Director)|Joseph M Ziegelbauer (HIV and AIDS Malignancy Branch)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Jeffrey Burnett Kopp; MD (NIDDK) |Myung Hee  Park; PhD (NIDCR) |Hira  Nakhasi (OD)","1. Pongas G, Kim M, Min D, House C, Jordan E, Caplen N, Chakka S, Ohiri J, Kruhlak MJ, Annunziata C (2017) BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1) Oncotarget 8:51402-15|2. Strickfaden H, McDonald D, Kruhlak MJ, Haince JF, Th'ng JP, Rouleau M, Ishibashi T, Corry GN, Ausio J, Underhill DA, Poirier GG, Hendzel MJ (2016). Poly(ADP-ribosyl)ation-dependent Transient Chromatin Decondensation and Histone Displacement following Laser Microirradiation. J Biol Chem  291, 1789-802.   https://doi.org/10.1074/jbc.M115.694992",https://intramural.nih.gov/search/searchview.taf?ipid=98958
689,BC010934-10,"October 01, 2016 -  September 30, 2017",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Xiao Y Yan|Jeremy J Rose|Shayla M Duncan|Eileen Ying Zhi|Adam  Tyrlik|Sean Campbell Dougherty|Show all 12,"Jian  Campian (Washington University)|Stuart  Grossman (Neuro-Oncology, Johns Hopkins Oncology Center)",NULL,"David F Stroncek; MD (CC) |Ping  Jin (CC) |Edward W Cowen (NIAMS) |Matthew M Hsieh (NHLBI) |Jacqueline W Mays; DDS, PhD (NIDCR) |John F Tisdale; MD (NHLBI)","1. Campian J, Piotrowski A, Ye X, Hakim F, Rose J, Yan X, Lu Y, Gress R, Grossman S (2017) Serial changes in lymphocyte subsets in patients with newly diagnosed high grade gliomas treated with standard radiation and temozolomide. Journal of Neuro-Oncology, in press.|2. Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB, Martin PJ, Paczesny S, Vogelsang G, Pavletic S, Ritz J, Schultz KR, Blazar BR (2017). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant  23, 211-234.   https://doi.org/10.1016/j.bbmt.2016.09.023",https://intramural.nih.gov/search/searchview.taf?ipid=98895
690,BC010936-10,"October 01, 2016 -  September 30, 2017",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Sophia Nadine Brown|Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Masaki  Terabe|Monica  Vaccari|Yongjun  Sui|Show all 12,Kent  Weinhold (DUMC)|Cliburn  Chan (Duke University)|Marcin  Moniuszko|Jason  Warfal (FDA),Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)|Charles  Vinson; PhD (Nucleic Acids Section)|Cynthia  Masison (Office of the Director)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Lois Jean Patterson (OD) |Myong-Hee  Sung (NIA),"1. de Castro-Amarante MF, Pise-Masison CA, McKinnon K, Washington Parks R, Galli V, Omsland M, Andresen V, Massoud R, Brunetto G, Caruso B, Venzon D, Jacobson S, Franchini G (2015). Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans. J Virol  90, 2195-207.   https://doi.org/10.1128/JVI.02735-15|2. Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, Rosner A, Demberg T, Watson DC, Karpova TS, Freeman GJ, DeKruyff RH, Pavlakis GN, Terabe M, Robert-Guroff M, Berzofsky JA, Jones JC (2017). Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep  7, 1878.   https://doi.org/10.1038/s41598-017-01731-2|3. Shaw JM, Miller-Novak LK, Mohanram V, McKinnon K, Demberg T, Vargas-Inchaustegui DA, Venzon D, Robert-Guroff M (2017). Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia. J Virol  91.   https://doi.org/10.1128/JVI.01727-16",https://intramural.nih.gov/search/searchview.taf?ipid=98971
691,BC010937-10,"October 01, 2016 -  September 30, 2017",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Charli Lynn Dominguez|Kristen Koenig McCampbell|Jeffrey  Schlom; PhD|James W Hodge; PhD,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Marc  Ferrer-Alegre (NCATS),"1. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017) A novel bifunctional anti-PD-L1TGF-B Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology, in press.|2. David JM, Dominguez C, Hamilton DH, Palena C (2016). The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines (Basel)  4.   https://doi.org/10.3390/vaccines4030022|3. David JM, Hamilton DH, Palena C (2016). MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition. Oncoimmunology  5, e1117738.   https://doi.org/10.1080/2162402X.2015.1117738|4. Dominguez C, Tsang KY, Palena C (2016). Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death Dis  7, e2380.   https://doi.org/10.1038/cddis.2016.297|5. Fernando RI, Hamilton DH, Dominguez C, David JM, McCampbell KK, Palena C (2016). IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib. Oncotarget  7, 42031-42044.   https://doi.org/10.18632/oncotarget.9662|6. Hamilton DH, Griner LM, Keller JM, Hu X, Southall N, Marugan J, David JM, Ferrer M, Palena C (2016). Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer. Clin Cancer Res  22, 6204-6216.   https://doi.org/10.1158/1078-0432.CCR-15-3059|7. Hamilton DH, Roselli M, Ferroni P, Costarelli L, Cavaliere F, Taffuri M, Palena C, Guadagni F (2016). Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer. Endocr Relat Cancer  23, 783-796.   https://doi.org/10.1530/ERC-16-0037",https://intramural.nih.gov/search/searchview.taf?ipid=98982
692,BC010947-10,"October 01, 2016 -  September 30, 2017",Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Adam G Sowalsky|David James Vanderweele,NULL,Electron  Kebebew; MD (Endocrine Oncology Branch)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology)|Kandice Danielle Tanner; PhD (Laboratory of Cell Biology)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|Sadhana  Jackson (Neuro-Oncology Branch),NULL,"1. Staunton JR, Vieira W, Fung KL, Lake R, Devine A, Tanner K (2016). Mechanical properties of the tumor stromal microenvironment probed in vitro and ex vivo by in situ-calibrated optical trap-based active microrheology. Cell Mol Bioeng  9, 398-417.   https://doi.org/10.1007/s12195-016-0460-9|2. Zhang L, Boufraqech M, Lake R, Kebebew E (2016). Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer. Oncotarget  7, 16517-28.   https://doi.org/10.18632/oncotarget.7760",https://intramural.nih.gov/search/searchview.taf?ipid=98941
693,BC010948-10,"October 01, 2016 -  September 30, 2017",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Yili  Li|Shahram S Farid|Arnold L Mixon|Todd  Prickett|Jared Joseph Gartner|Li  Jia|Show all 8,Benoit  Van den Eynde (Ludwig Institute for Cancer Research)|Yardena  Samuel (Weizmann Institute of Science)|Cyrille  Cohen|David  Haussler (Howard Hughes Medical Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98899
694,BC010953-10,"October 01, 2016 -  September 30, 2017",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jennifer B Dwyer|Shelley B Hoover|John  Hickerson|Munish  Puri|Jing  Huang|Ji  Luo|Show all 9,brandon  gallas (Food and Drug Administration)|Charles Harrison Castle Halsey (LABORATORY CANCER BIOLOGY & GENETICS),"Bih-Rong  Wei (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Natasha  Caplen (Cancer Genetics Branch)",NULL,"1. Venugopalan A, Lee MJ, Niu G, Medina-Echeverz J, Tomita Y, Lizak MJ, Cultraro CM, Simpson RM, Chen X, Trepel JB, Guha U (2016). EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models. Oncotarget  7, 54137-54156.   https://doi.org/10.18632/oncotarget.11021",https://intramural.nih.gov/search/searchview.taf?ipid=98912
695,BC010965-10,"October 01, 2016 -  September 30, 2017",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98930
696,BC010978-10,"October 01, 2016 -  September 30, 2017",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Ying  Zhang|Ramiro  Iglesias-Bartolome; PhD",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine)|Eilon  Sherman,"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)","Paul E Love; MD, PhD (NICHD) |Keir Cajal Neuman; BA, PhD (NHLBI)","1. Barr VA, Sherman E, Yi J, Akpan I, Rouquette-Jazdanian AK, Samelson LE (2016). Development of nanoscale structure in LAT-based signaling complexes. J Cell Sci  129, 4548-4562.   https://doi.org/10.1242/jcs.194886|2. Sherman E, Barr VA, Merrill RK, Regan CK, Sommers CL, Samelson LE (2016). Hierarchical nanostructure and synergy of multimolecular signalling complexes. Nat Commun  7, 12161.   https://doi.org/10.1038/ncomms12161|3. Yi J, Manna A, Barr VA, Hong J, Neuman KC, Samelson LE (2016). madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell  27, 3591-3600.   https://doi.org/10.1091/mbc.E16-05-0330",https://intramural.nih.gov/search/searchview.taf?ipid=98868
697,BC010981-10,"October 01, 2016 -  September 30, 2017",Biomarker Investigations for Clinical Trials,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Javed  Khan; MD,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Jung-Min  Lee (Womens Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98876
698,BC010989-10,"October 01, 2016 -  September 30, 2017",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Hui  Xu|Mary Alexandra Black|Harshini  Chinnasamy|Nikolaos  Zacharakis; PhD|James Chung-Yin Yang; MD, PhD|Nicholas Phillip Restifo; MD",Dirk  Jager (University Medical Center Heidelberg)|Gary T Lee|Marc  Better (KITE Pharma),Ira H Pastan; MD (Molecular Biology Section)|James N Kochenderfer (Experimental Transplantation and Immunology Branch),Joseph  Shiloach; PhD (NIDDK) |Harry Lewis Malech; MD (NIAID),"1. Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, Ferrone CR, Ferrone S (2016). Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv435",https://intramural.nih.gov/search/searchview.taf?ipid=98886
699,BC010991-10,"October 01, 2016 -  September 30, 2017",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98874
700,BC011016-10,"October 01, 2016 -  September 30, 2017",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS|Janet R Fields,"Jozsef  Tozser|Robert  Ulrich (Molecular Immunology, USAMRIID)|Vaclav  Veverka (Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i.)",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Rna Biology Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|John Stephen Schneekloth (Chemical Biology Laboratory)|Ding Jun Jin (Rna Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98931
701,BC011021-09,"October 01, 2016 -  September 30, 2017",Basic Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98636
702,BC011029-10,"October 01, 2016 -  September 30, 2017",Preclinical development and clinical monitoring of adoptive immune therapy,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Vicki  Fellowes|Xiao Y Yan|Jeremy J Rose|Shayla M Duncan|Eileen Ying Zhi|Adam  Tyrlik|Show all 10,NULL,Ronit  Jolles Mazor; MSc (Molecular Biology Section)|Ira H Pastan; MD (Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98896
703,BC011030-10,"October 01, 2016 -  September 30, 2017",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Paul  Robbins,NULL,NULL,Michael  Norcross (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98983
704,BC011040-10,"October 01, 2016 -  September 30, 2017",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",David  Petersen|Marbin A Pineda|Yonghong  Wang|Sven  Bilke|Jonathan Keith Killian|Jennifer  Walling|Show all 14,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Frederic Glenn Barr (Laboratory of Pathology)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98884
705,BC011041-10,"October 01, 2016 -  September 30, 2017",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",David  Petersen|Marbin A Pineda|Yonghong  Wang|Sven  Bilke|Jonathan Keith Killian,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Brid Mairead Ryan (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98885
706,BC011042-10,"October 01, 2016 -  September 30, 2017",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Hye-Jung  Chung|Russell William Bandle|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98959
707,BC011044-10,"October 01, 2016 -  September 30, 2017",Tissue Processing-Sequencing Facility,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Robert A Worrell|Youfeng  Yang|Julian  Custer,William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman|James  Brugarolas (University of Texas Southwestern Medical Center)|Maria  Czyzyk-Krzeska (University of Cincinnati),"Catherine  Wells (Office Of The Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Ann C.M. Smith; MA, DSc (hon) (NHGRI) |Leslie Glenn Biesecker; MD (NHGRI)","1. Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, et al. [1 more author] (2017). Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget  8, 17628-17642.   https://doi.org/10.18632/oncotarget.12192|2. Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA, Peterson J, Yang Y, Linehan WM (2017). Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer  56, 484-492.   https://doi.org/10.1002/gcc.22452",https://intramural.nih.gov/search/searchview.taf?ipid=98936
708,BC011047-10,"October 01, 2016 -  September 30, 2017",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Beverly  Mock; PhD|Stuart H Yuspa; MD|Jing  Huang|Li  Yang; PhD|Kent W Hunter; PhD,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Suman Kumar Vodnala (Surgery Branch)|John Stephen Schneekloth (Chemical Biology Laboratory)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID) |Neal S Young; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98881
709,BC011052-10,"October 01, 2016 -  September 30, 2017",Cytopathology Core,Armando  Filie|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Dana K Erickson|Tangi Y Howard|May Ester Owens|Mark J Roth|Mark  Raffeld; MD|Stephen M Hewitt; MD, PhD|Show all 7",NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch),Joanna  Klubo-Gwiezdzinska (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98887
710,BC011075-10,"October 01, 2016 -  September 30, 2017",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98882
711,BC011077-10,"October 01, 2016 -  September 30, 2017",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98883
712,BC011079-10,"October 01, 2016 -  September 30, 2017",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Trinh  Pham|Liqiang  Xi; MD|Thu A Pham|Winnifred Theresa Navarro|Snehalkumar Bhikhubhai Patel|Elaine S Jaffe; MD|Show all 8,"Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Giuseppe  Giaccone; MD|Michael  Tangrea|Philippe  Trougouboff (Emek Medical Center)|Sandeep  Dave (Duke University)","Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Udai S Kammula (Surgery Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)","Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |Adrian U Wiestner; MD, PhD (NHLBI) |William A Gahl; MD, PhD (NHGRI) |Irina  Maric; MD (CC) |Jeffrey  Baron; MD (NICHD)","1. Alberobello AT, Wang Y, Beerkens FJ, Conforti F, McCutcheon JN, Rao G, Raffeld M, Liu J, Rahhal R, Zhang YW, Giaccone G (2016). PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors. J Thorac Oncol  11, 1345-1356.   https://doi.org/10.1016/j.jtho.2016.04.013|2. Carter CA, Rajan A, Keen C, Szabo E, Khozin S, Thomas A, Brzezniak C, Guha U, Doyle LA, Steinberg SM, Xi L, Raffeld M, Tomita Y, Lee MJ, Lee S, Trepel JB, Reckamp KL, Koehler S, Gitlitz B, Salgia R, Gandara D, Vokes E, Giaccone G (2016). Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer. Ann Oncol  27, 693-9.   https://doi.org/10.1093/annonc/mdw008|3. Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA (2017). Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A  114, 3975-3980.   https://doi.org/10.1073/pnas.1700682114|4. Cortese I, Ohayon J, Fenton K, Lee CC, Raffeld M, Cowen EW, DiGiovanna JJ, Bielekova B (2016). Cutaneous adverse events in multiple sclerosis patients treated with daclizumab. Neurology  86, 847-55.   https://doi.org/10.1212/WNL.0000000000002417|5. Duffy AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, Fioravanti S, Walker M, Abdullah S, Raffeld M, Anderson V, Abi-Jaoudeh N, Levy E, Wood BJ, Lee S, Tomita Y, Trepel JB, Steinberg SM, Revenko AS, MacLeod AR, Peer CJ, Figg WD, Greten TF (2016). Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer. Int J Cancer  139, 1648-57.   https://doi.org/10.1002/ijc.30199|6. Dumitriu B, Ito S, Feng X, Stephens N, Yunce M, Kajigaya S, Melenhorst JJ, Rios O, Scheinberg P, Chinian F, Keyvanfar K, Battiwalla M, Wu CO, Maric I, Xi L, Raffeld M, Muranski P, Townsley DM, Young NS, Barrett AJ, Scheinberg P (2016). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol  3, e22-9.   https://doi.org/10.1016/S2352-3026(15)00227-6|7. Holkova B, Zingone A, Kmieciak M, Bose P, Badros AZ, Voorhees PM, Baz R, Korde N, Lin HY, Chen JQ, Herrmann M, Xi L, Raffeld M, Zhao X, Wan W, Tombes MB, Shrader E, Weir-Wiggins C, Sankala H, Hogan KT, Doyle A, Annunziata CM, Wellons M, Roberts JD, Sullivan D, et al. [2 more authors] (2016). A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma. Clin Cancer Res  22, 1067-75.   https://doi.org/10.1158/1078-0432.CCR-15-1076|8. Jee YH, Sadowski SM, Celi FS, Xi L, Raffeld M, Sacks DB, Remaley AT, Wellstein A, Kebebew E, Baron J (2016). Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer. PLoS One  11, e0149383.   https://doi.org/10.1371/journal.pone.0149383|9. Lopez-Chavez A, Thomas A, Evbuomwan MO, Xi L, Chun G, Vidaurre T, Arrieta O, Oblitas G, Oton AB, Calvo AR, Rajan A, Raffeld M, Steinberg SM, Arze-Aimaretti L, Giaccone G (2016). EGFR Mutations in Latinos From the United States and Latin America. J Glob Oncol  2, 259-267.   https://doi.org/10.1200/JGO.2015.002105|10. Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES (2017). EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol  41, 67-74.   https://doi.org/10.1097/PAS.0000000000000735|11. Nicolae A, Xi L, Pham TH, Pham TA, Navarro W, Meeker HG, Pittaluga S, Jaffe ES, Raffeld M (2016). Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia  30, 2245-2247.   https://doi.org/10.1038/leu.2016.178|12. Rosenberg AZ, Armani MD, Fetsch PA, Xi L, Pham TT, Raffeld M, Chen Y, O'Flaherty N, Stussman R, Blackler AR, Du Q, Hanson JC, Roth MJ, Filie AC, Roh MH, Emmert-Buck MR, Hipp JD, Tangrea MA (2016). High-Throughput Microdissection for Next-Generation Sequencing. PLoS One  11, e0151775.   https://doi.org/10.1371/journal.pone.0151775|13. Rothermel LD, Sabesan AC, Stephens DJ, Chandran SS, Paria BC, Srivastava AK, Somerville R, Wunderlich JR, Lee CC, Xi L, Pham TH, Raffeld M, Jailwala P, Kasoji M, Kammula US (2016). Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clin Cancer Res  22, 2237-49.   https://doi.org/10.1158/1078-0432.CCR-15-2294|14. Sharma K, Janik JE, O'Mahony D, Stewart D, Pittaluga S, Stetler-Stevenson M, Jaffe ES, Raffeld M, Fleisher TA, Lee CC, Steinberg SM, Waldmann TA, Morris JC (2017). Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma. Clin Cancer Res  23, 35-42.   https://doi.org/10.1158/1078-0432.CCR-16-1022|15. Wang K, Goodman KN, Li DY, Raffeld M, Chavez M, Cohen JI (2016). A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. J Virol  90, 562-74.   https://doi.org/10.1128/JVI.01845-15|16. Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES (2016). Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol  55, 108-116.   https://doi.org/10.1016/j.humpath.2016.04.019|17. Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I (2017). Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica  102, 364-372.   https://doi.org/10.3324/haematol.2015.138081",https://intramural.nih.gov/search/searchview.taf?ipid=98988
713,BC011093-10,"October 01, 2016 -  September 30, 2017",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Linda Shonk Weaver|Catharine S Mccoy|Constance M Yuan|Dalia Abdel-Raouf Salem,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)",NULL,"1. Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH (2017). Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. Cancer Cell  31, 833-843.e5.   https://doi.org/10.1016/j.ccell.2017.04.012",https://intramural.nih.gov/search/searchview.taf?ipid=98927
714,BC011104-10,"October 01, 2016 -  September 30, 2017",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Linda Shonk Weaver|Catharine S Mccoy|Constance M Yuan|Dalia Abdel-Raouf Salem,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Terry J Fry (Pediatric Oncology Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I (2016). Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. Clin Cancer Res  22, 310-8.   https://doi.org/10.1158/1078-0432.CCR-15-1412|2. Skarzynski M, Niemann CU, Lee YS, Martyr S, Maric I, Salem D, Stetler-Stevenson M, Marti GE, Calvo KR, Yuan C, Valdez J, Soto S, Farooqui MZ, Herman SE, Wiestner A (2016). Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy. Clin Cancer Res  22, 86-95.   https://doi.org/10.1158/1078-0432.CCR-15-1304",https://intramural.nih.gov/search/searchview.taf?ipid=98926
715,BC011138-10,"October 01, 2016 -  September 30, 2017",ETIB FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98986
716,BC011139-10,"October 01, 2016 -  September 30, 2017",Application of novel laser technology for flow cytometric analysis,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98987
717,BC011236-09,"October 01, 2016 -  September 30, 2017",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Roberta M Matthai|James Benjamin Mitchell,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99016
718,BC011237-09,"October 01, 2016 -  September 30, 2017",CIP Genetics and Microbiome Core,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Ying  Qi|Vishal Vijayan Thovarai|Wuxing  Yuan|Husen  Zhang|Shurjo  Sen; PhD|Mary  Carrington; MS, PhD|Show all 8",Effie  Petersdorf (Fred Hutchinson)|Robert  Lanford (Texas Biomedical Research Institute),Michael  Dean; PhD (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99017
719,BC011265-08,"October 01, 2016 -  September 30, 2017",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Susan W Reid|Bradley D St Croix,Ted  Dawson (Johns Hopkins University)|Valina  Dawson (Johns Hopkins University)|Phillip  Kaldis (Institute of Molecular and Cell Biology),"Mary Ellen  Palko (Neural Development Section)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|David  Levens; PhD (Laboratory of Pathology)",NULL,"1. Anderson MJ, Southon E, Tessarollo L, Lewandoski M (2016). Fgf3-Fgf4-cis: A new mouse line for studying Fgf functions during mouse development. Genesis  54, 91-8.   https://doi.org/10.1002/dvg.22913|2. Chalamalasetty RB, Ajima R, Garriock RJ, Kennedy MW, Tessarollo L, Yamaguchi TP (2016). A new gain-of-function mouse line to study the role of Wnt3a in development and disease. Genesis  54, 497-502.   https://doi.org/10.1002/dvg.22959|3. Hartford SA, Chittela R, Ding X, Vyas A, Martin B, Burkett S, Haines DC, Southon E, Tessarollo L, Sharan SK (2016). Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2. PLoS Genet  12, e1006236.   https://doi.org/10.1371/journal.pgen.1006236|4. Tobe R, Carlson BA, Huh JH, Castro NP, Xu XM, Tsuji PA, Lee SG, Bang J, Na JW, Kong YY, Beaglehole D, Southon E, Seifried H, Tessarollo L, Salomon DS, Schweizer U, Gladyshev VN, Hatfield DL, Lee BJ (2016). Selenophosphate synthetase 1 is an essential protein with roles in regulation of redox homoeostasis in mammals. Biochem J  473, 2141-54.   https://doi.org/10.1042/BCJ20160393|5. Xiong Y, Neifert S, Karuppagounder SS, Stankowski JN, Lee BD, Grima JC, Chen G, Ko HS, Lee Y, Swing D, Tessarollo L, Dawson TM, Dawson VL (2017). Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology. eNeuro  4.   https://doi.org/10.1523/ENEURO.0004-17.2017|6. Zhao R, Grunke SD, Keralapurath MM, Yetman MJ, Lam A, Lee TC, Sousounis K, Jiang Y, Swing DA, Tessarollo L, Ji D, Jankowsky JL (2016). Impaired Recall of Positional Memory following Chemogenetic Disruption of Place Field Stability. Cell Rep  16, 793-804.   https://doi.org/10.1016/j.celrep.2016.06.032",https://intramural.nih.gov/search/searchview.taf?ipid=99036
720,BC011309-08,"October 01, 2016 -  September 30, 2017",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Paul A Roche; PhD (Experimental Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch)|Chuan  Wu (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99053
721,BC011310-08,"October 01, 2016 -  September 30, 2017",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99054
722,BC011331-08,"October 01, 2016 -  September 30, 2017",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99066
723,BC011380-07,"October 01, 2016 -  September 30, 2017",Multivalent Inhibition of Membrane Receptors,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99083
724,BC011428-06,"October 01, 2016 -  September 30, 2017","CCR, LGI, Flow Cytometry Core Facility",Ferenc  Livak,Andre A Nussenzweig; PhD,"Laboratory Of Genome Integrity, NCI",Subhadra  Banerjee|Caiyi  Li|Karen Marie Wolcott,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99140
725,BC011430-06,"October 01, 2016 -  September 30, 2017",CPTR - Mass Spectrometry Unit,Lisa Marie Jenkins,Suresh V Ambudkar; PhD,"Pigment Cell Biology Section, NCI",NULL,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Ettore  Appella; MD (Chemical Immunology Section)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)",NULL,"1. Chen PW, Jian X, Heissler SM, Le K, Luo R, Jenkins LM, Nagy A, Moss J, Sellers JR, Randazzo PA (2016). The Arf GTPase-activating Protein, ASAP1, Binds Nonmuscle Myosin 2A to Control Remodeling of the Actomyosin Network. J Biol Chem  291, 7517-26.   https://doi.org/10.1074/jbc.M115.701292|2. James TD, Cardozo T, Abell LE, Hsieh ML, Jenkins LM, Jha SS, Hinton DM (2016). Visualizing the phage T4 activated transcription complex of DNA and E. coli RNA polymerase. Nucleic Acids Res  44, 7974-88.   https://doi.org/10.1093/nar/gkw656|3. Kumar JS, Miller Jenkins LM, Gottesman MM, Hall MD (2016). The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging. Mol Imaging  15.   https://doi.org/10.1177/1536012115625225|4. Luo R, Chen PW, Wagenbach M, Jian X, Jenkins L, Wordeman L, Randazzo PA (2016). Direct functional interaction of the kinesin-13 family member kinesin-like protein 2A (Kif2A) and Arf GAP with GTP-binding protein-like, ankyrin repeats and PH domains 1 (AGAP1). J Biol Chem  291, 25761.   https://doi.org/10.1074/jbc.A116.732479",https://intramural.nih.gov/search/searchview.taf?ipid=99122
726,BC011434-06,"October 01, 2016 -  September 30, 2017","Nano-scale proteomic analysis: development, implementation, and applications",Jinqiu  Chen,Peter  Blumberg; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Xiaoling  Luo|Lalage  Wakefield; PhD|Beverly  Mock; PhD|Stuart H Yuspa; MD|Ji  Luo|Kenneth H Kraemer; MD,NULL,"Javed  Khan; MD (Cancer Genetics Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Christina M Annunziata (Womens Malignancies Branch)|Christine Campo Alewine (Laboratory of Molecular Biology)",NULL,"1. Cekan P, Hasegawa K, Pan Y, Tubman E, Odde D, Chen JQ, Herrmann MA, Kumar S, Kalab P (2016). RCC1-dependent activation of Ran accelerates cell cycle and DNA repair, inhibiting DNA damage-induced cell senescence. Mol Biol Cell  27, 1346-57.   https://doi.org/10.1091/mbc.E16-01-0025|2. Flanders KC, Yang YA, Herrmann M, Chen J, Mendoza N, Mirza AM, Wakefield LM (2016). Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium. Oncotarget  7, 38164-38179.   https://doi.org/10.18632/oncotarget.9416|3. Noonan AM, Bunch KP, Chen JQ, Herrmann MA, Lee JM, Kohn EC, O'Sullivan CC, Jordan E, Houston N, Takebe N, Kinders RJ, Cao L, Peer CJ, Figg WD, Annunziata CM (2016). Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. Cancer  122, 588-597.   https://doi.org/10.1002/cncr.29783",https://intramural.nih.gov/search/searchview.taf?ipid=99126
727,BC011475-05,"October 01, 2016 -  September 30, 2017",Genomics and Bioinformatics Group web site development and maintenance,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma,NULL,NULL,NULL,"1. Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, Reinhold W, Sander C, Pommier Y (2016). rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics  32, 1272-4.   https://doi.org/10.1093/bioinformatics/btv701",https://intramural.nih.gov/search/searchview.taf?ipid=99152
728,BC011497-05,"October 01, 2016 -  September 30, 2017",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99150
729,BC011499-05,"October 01, 2016 -  September 30, 2017",DNA methylation data and its web-based tool for the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99149
730,BC011509-05,"October 01, 2016 -  September 30, 2017",Comparison of molecular factors to drug activities,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,Jacques  Robert (DEVELOPMENTAL THERAPEUTICS BRANCH)|Fabricio Garmus Sousa (LABORATORY MOLECULAR PHARMACOLOGY),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|David Jay Goldstein (Office of the Director)",NULL,"1. Nogales V, Reinhold WC, Varma S, Martinez-Cardus A, Moutinho C, Moran S, Heyn H, Sebio A, Barnadas A, Pommier Y, Esteller M (2016). Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs. Oncotarget  7, 3084-97.   https://doi.org/10.18632/oncotarget.6413|2. Reinhold WC, Thomas A, Pommier Y (2017). DNA-Targeted Precision Medicine; Have we Been Caught Sleeping? Trends Cancer  3, 2-6.   https://doi.org/10.1016/j.trecan.2016.11.002|3. Thomas A, Tanaka M, Trepel J, Reinhold WC, Rajapakse VN, Pommier Y (2017). Temozolomide in the Era of Precision Medicine. Cancer Res  77, 823-826.   https://doi.org/10.1158/0008-5472.CAN-16-2983",https://intramural.nih.gov/search/searchview.taf?ipid=99151
731,BC011515-05,"October 01, 2016 -  September 30, 2017",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gary T Pauly,NULL,Eric O Freed; PhD (HIV Drug Resistance Program)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Patricia  Steeg; PhD (Womens Malignancies Branch),NULL,"1. Medina S, Schneider J (2017) Chemical Ligations in the Design of Hydrogel Materials, in Chemoselective and Bioorthogonal Ligation. , pp. 497.|2. Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE (2016). Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget  7, 69804-69815.   https://doi.org/10.18632/oncotarget.12001|3. Smith SJ, Pauly GT, Akram A, Melody K, Ambrose Z, Schneider JP, Hughes SH (2016). Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants. J Acquir Immune Defic Syndr  72, 485-91.   https://doi.org/10.1097/QAI.0000000000001031|4. Smith SJ, Pauly GT, Akram A, Melody K, Rai G, Maloney DJ, Ambrose Z, Thomas CJ, Schneider JT, Hughes SH (2016). Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants. Retrovirology  13, 11.   https://doi.org/10.1186/s12977-016-0244-2",https://intramural.nih.gov/search/searchview.taf?ipid=99160
732,BC011531-05,"October 01, 2016 -  September 30, 2017",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar|Mohammad Rashid Siddiqui,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch),Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99168
733,BC011532-05,"October 01, 2016 -  September 30, 2017",CCR Collaborative Bioinformatics Resource,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,"Karlyne M Reilly; BS, PhD (Pediatric Oncology Branch)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Udai S Kammula (Surgery Branch)|Cheryl Ann Winkler (Basic Research Laboratory)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch)","Isaac Franklin Brownell; MD, PhD (NIAMS)","1. Kennedy MW, Chalamalasetty RB, Thomas S, Garriock RJ, Jailwala P, Yamaguchi TP (2016). Sp5 and Sp8 recruit β-catenin and Tcf1-Lef1 to select enhancers to activate Wnt target gene transcription. Proc Natl Acad Sci U S A  113, 3545-50.   https://doi.org/10.1073/pnas.1519994113",https://intramural.nih.gov/search/searchview.taf?ipid=99178
734,BC011535-04,"October 01, 2016 -  September 30, 2017",SAXS Core,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99216
735,BC011567-04,"October 01, 2016 -  September 30, 2017",HiTIF Microscopy Core Facility,Gianluca  Pegoraro,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Prabhakar R Gudla; PhD|Adrian Alejandro Carcamo|Thomas A Misteli; PhD|Daniel Robert Larson; PhD|Philipp  Oberdoerffer,NULL,Laurent L Ozbun (Hormone Action and Oncogenesis Section)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Carol J Thiele (Pediatric Oncology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Munira A Basrai; PhD (Cancer Genetics Branch),"Mary C Dasso; BA, PhD (NICHD) |Madhu A Lal (NCATS) |Iain  Fraser (NIAID)","1. Pegoraro G, Misteli T (2017) High-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease. Trends in Genetics, in press.|2. Stavreva DA, Varticovski L, Levkova L, George AA, Davis L, Pegoraro G, Blazer V, Iwanowicz L, Hager GL (2016). Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants. Toxicology  368-369, 69-79.   https://doi.org/10.1016/j.tox.2016.08.012|3. Wang Q, Sawyer IA, Sung MH, Sturgill D, Shevtsov SP, Pegoraro G, Hakim O, Baek S, Hager GL, Dundr M (2016). Cajal bodies are linked to genome conformation. Nat Commun  7, 10966.   https://doi.org/10.1038/ncomms10966|4. Zane L, Chapus F, Pegoraro G, Misteli T (2017). HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging. Mol Biol Cell  28, 2290-2302.   https://doi.org/10.1091/mbc.E16-12-0870",https://intramural.nih.gov/search/searchview.taf?ipid=99197
736,BC011569-04,"October 01, 2016 -  September 30, 2017",Cell Production Core Facility,Robert P Somerville,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99195
737,BC011571-04,"October 01, 2016 -  September 30, 2017",Transcription factor mobility,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Gunjan Deepakkumar Mehta; PhD,NULL,NULL,NULL,"1. Paakinaho V, Presman DM, Ball DA, Johnson TA, Schiltz RL, Levitt P, Mazza D, Morisaki T, Karpova TS, Hager GL (2017). Single-molecule analysis of steroid receptor and cofactor action in living cells. Nat Commun  8, 15896.   https://doi.org/10.1038/ncomms15896|2. Presman DM, Ganguly S, Schiltz RL, Johnson TA, Karpova TS, Hager GL (2016). DNA binding triggers tetramerization of the glucocorticoid receptor in live cells. Proc Natl Acad Sci U S A  113, 8236-41.   https://doi.org/10.1073/pnas.1606774113|3. Swinstead EE, Miranda TB, Paakinaho V, Baek S, Goldstein I, Hawkins M, Karpova TS, Ball D, Mazza D, Lavis LD, Grimm JB, Morisaki T, Grøntved L, Presman DM, Hager GL (2016). Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions. Cell  165, 593-605.   https://doi.org/10.1016/j.cell.2016.02.067",https://intramural.nih.gov/search/searchview.taf?ipid=99189
738,BC011574-04,"October 01, 2016 -  September 30, 2017",LRBGE Optical Microscopy Core,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",David Allan Ball|Daniel Robert Larson; PhD|Thomas A Misteli; PhD|Philipp  Oberdoerffer,John S Choy|Jeffrey  Rothstein (Johns Hopkins University School of Medicine),"Munira A Basrai; PhD (Cancer Genetics Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Kyung  Lee; PhD (Chemistry Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)","Marta Liliana Catalfamo; PhD (NIAID) |Edward  Giniger; BS, MS, PHD (NINDS)","1. Kannan R, Song JK, Karpova T, Clarke A, Shivalkar M, Wang B, Kotlyanskaya L, Kuzina I, Gu Q, Giniger E (2017). The Abl pathway bifurcates to balance Enabled and Rac signaling in axon patterning in Drosophila. Development  144, 487-498.   https://doi.org/10.1242/dev.143776|2. Kim J, Sturgill D, Tran AD, Sinclair DA, Oberdoerffer P (2016). Controlled DNA double-strand break induction in mice reveals post-damage transcriptome stability. Nucleic Acids Res  44, e64.   https://doi.org/10.1093/nar/gkv1482|3. Shrestha RL, Ahn GS, Staples MI, Sathyan KM, Karpova TS, Foltz DR, Basrai MA (2017). Mislocalization of centromeric histone H3 variant CENP-A contributes to chromosomal instability (CIN) in human cells. Oncotarget  8, 46781-46800.   https://doi.org/10.18632/oncotarget.18108|4. Vargas-Inchaustegui DA, Demers A, Shaw JM, Kang G, Ball D, Tuero I, Musich T, Mohanram V, Demberg T, Karpova TS, Li Q, Robert-Guroff M (2016). Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol  196, 1700-10.   https://doi.org/10.4049/jimmunol.1502137",https://intramural.nih.gov/search/searchview.taf?ipid=99192
739,BC011596-04,"October 01, 2016 -  September 30, 2017",CCR Dedicated Cores at the ATRF,Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99180
740,BC011622-03,"October 01, 2016 -  September 30, 2017",Development of novel molecular or phenotypic databases,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,"Manel  Esteller (Cancer Epigenetics Laboratory, Spanish National Cancer Center)|Mathew  Garnett (Wellcome Trust Sanger Institute)|Ruedi  Aebersold (Institute for Systems Biology)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99236
741,BC011623-03,"October 01, 2016 -  September 30, 2017",CCR Genomics Core,Elizabeth A Conner,Javed  Khan; MD,"Cancer Genetics Branch, NCI",Steven W Shema|Valery  Bliskovsky; PhD|Qin  Wei,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99234
742,BC011638-03,"October 01, 2016 -  September 30, 2017",Experimental Pathology Laboratory (EPL),"Stephen M Hewitt; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Joon Yong Chung|Kristofferson R Ylaya|Russell William Bandle|Hye-Jung  Chung|Jeffrey C Hanson|Elaine S Jaffe; MD|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99229
743,BC011641-03,"October 01, 2016 -  September 30, 2017",Pre-clinical Translational Research Facility,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Dionne  Davis|Jinkyu  Jung|Jing  Wu; MD, PhD|Yu-Ting  Su|Wei  Zhang|Hua  Song",NULL,Rolanda  Bailey (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99240
744,BC011724-02,"October 01, 2016 -  September 30, 2017",Effects of Cytosine Modifications on Transcription Factor Binding,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Charles  Vinson; PhD (Nucleic Acids Section),NULL,"1. Khund-Sayeed S, He X, Holzberg T, Wang J, Rajagopal D, Upadhyay S, Durell SR, Mukherjee S, Weirauch MT, Rose R, Vinson C (2016). 5-Hydroxymethylcytosine in E-box motifs ACAT|GTG and ACAC|GTG increases DNA-binding of the B-HLH transcription factor TCF4. Integr Biol (Camb)  8, 936-45.   https://doi.org/10.1039/c6ib00079g",https://intramural.nih.gov/search/searchview.taf?ipid=99288
745,BC011731-02,"October 01, 2016 -  September 30, 2017",Tissue Procurement  Processing Facility and Biorepository,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Neil J Hardegen|Mohammad Javed Mahboob|Sarah Paige Young,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99295
746,CO020007-09,"October 01, 2016 -  September 30, 2017",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Kristin L Komschlies McConville; PhD  (NCI Frederick Office Scientific Operations),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99313
747,CP010178-16,"October 01, 2016 -  September 30, 2017",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Michael  Beerman|Laura Ann Burdett|Salma  Chowdhury; MS|Casey  Dagnall|Belynda D Hicks|Show all 11,NULL,Xiang  Deng (Radiation Oncology Branch)|Calvin  Ott (Office Of The Director)|Liqun  Qi (Biorepositories & Biospecimen Research Branch),NULL,"1. Machiela MJ, Chanock SJ (2017). The ageing genome, clonal mosaicism and chronic disease. Curr Opin Genet Dev  42, 8-13.   https://doi.org/10.1016/j.gde.2016.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=99346
748,CP010192-10,"October 01, 2016 -  September 30, 2017","Biorepository Processing, Storage, and Research","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99365
749,CP010203-09,"October 01, 2016 -  September 30, 2017",Applied Molecular Pathology Laboratory,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Human Genetics Program, NCI",NULL,NULL,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Karen E Berliner (Office of the Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99368
750,CP010223-06,"October 01, 2016 -  September 30, 2017",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Louise  Brinton; PhD| | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Regina Gale Ziegler; PhD, MPH",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99389
751,CP010226-04,"October 01, 2016 -  September 30, 2017",Cohort and Biobank Development,"Amy  de Gonzalez|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99392
752,SC006536-24,"October 01, 2016 -  September 30, 2017",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Alesia J Holly|Cody John Peer|Diana  Roame|Trung C Pham|Julie Katherine Barnes|Aaron David Frederick|Show all 7,Richard  Horenstein (University of Maryland)|Michael  Pacanowski (FDA),"Paula A Carter (Office of the Director)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)","Heidi H Kong (NIAMS) |Isaac Franklin Brownell; MD, PhD (NIAMS)","1. Dao K, Chtioui H, Lu Y, Peer CJ, Figg WD, Pruijm M, Buclin T, Kissling S (2017). Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter. Am J Kidney Dis  69, 553-554.   https://doi.org/10.1053/j.ajkd.2016.10.026|2. Dao K, Lu Y, Peer CJ, Figg WD, Stadelmann R, Burnier M, Buclin T, Kissling S (2017). Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure. Cancer Chemother Pharmacol  79, 215-218.   https://doi.org/10.1007/s00280-016-3219-z|3. Ferraz Nogueira Filho MA, Peer CJ, Nguyen J, McCalla A, Helman L, Figg WD (2017). A simple and rapid UHPLC-MS/MS method for the quantitation of the dual aurora kinase A/B inhibitor SCH-1473759 in murine plasma. J Pharm Biomed Anal  132, 223-226.   https://doi.org/10.1016/j.jpba.2016.10.003|4. Goey AK, Sissung TM, Peer CJ, Trepel JB, Lee MJ, Tomita Y, Ehrlich S, Bryla C, Balasubramaniam S, Piekarz R, Steinberg SM, Bates SE, Figg WD (2016). Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer. J Clin Pharmacol  56, 461-73.   https://doi.org/10.1002/jcph.625|5. Lee JM, Cimino-Mathews A, Peer CJ, Zimmer A, Lipkowitz S, Annunziata CM, Cao L, Harrell MI, Swisher EM, Houston N, Botesteanu DA, Taube JM, Thompson E, Ogurtsova A, Xu H, Nguyen J, Ho TW, Figg WD, Kohn EC (2017). Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study. J Clin Oncol  35, 2193-2202.   https://doi.org/10.1200/JCO.2016.72.1340|6. Madan RA, Karzai FH, Ning YM, Adesunloye BA, Huang X, Harold N, Couvillon A, Chun G, Cordes L, Sissung T, Beedie SL, Dawson NA, Theoret MR, McLeod DG, Rosner I, Trepel JB, Lee MJ, Tomita Y, Lee S, Chen C, Steinberg SM, Arlen PM, Gulley JL, Figg WD, Dahut WL (2016). Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer. BJU Int  118, 590-7.   https://doi.org/10.1111/bju.13412|7. Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, Burton D, Gil LA, Figg WD, Maric I, Calvo KR, Yuan C, Stetler-Stevenson M, Korde N, Landgren O (2017). Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone. Leuk Lymphoma  58, 639-645.   https://doi.org/10.1080/10428194.2016.1214953|8. Peer C, Ronner P, Rodgers L, McCully C, Warren K, Figg W (2016) Quantitation of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration following Intranasal or Intravenous Delivery Separations (formerly Chromatography) 3:4|9. Uldrick TS, Gonçalves PH, Wyvill KM, Peer CJ, Bernstein W, Aleman K, Polizzotto MN, Venzon D, Steinberg SM, Marshall V, Whitby D, Little RF, Wright JJ, Rudek MA, Figg WD, Yarchoan R (2017). A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma. Oncologist  22, 505-e49.   https://doi.org/10.1634/theoncologist.2016-0486",https://intramural.nih.gov/search/searchview.taf?ipid=99441
753,SC006537-24,"October 01, 2016 -  September 30, 2017",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Cody John Peer|Tristan  Sissung|Jonathan Dale Strope|Julie Katherine Barnes|Keith Thomas Schmidt|Oliver Morgan Hall|Show all 7,Michael  Pacanowski (FDA)|C  Landgren (Memorial Sloan Kettering Cancer Center)|Richard  Horenstein (University of Maryland),Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Heidi H Kong (NIAMS) |Edward W Cowen (NIAMS),"1. Backman JD, O'Connell JR, Tanner K, Peer CJ, Figg WD, Spencer SD, Mitchell BD, Shuldiner AR, Yerges-Armstrong LM, Horenstein RB, Lewis JP (2017). Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response. Pharmacogenet Genomics  27, 159-163.   https://doi.org/10.1097/FPC.0000000000000272|2. Lee JM, Peer CJ, Yu M, Amable L, Gordon N, Annunziata CM, Houston N, Goey AK, Sissung TM, Parker B, Minasian L, Chiou VL, Murphy RF, Widemann BC, Figg WD, Kohn EC (2017). Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer. Clin Cancer Res  23, 1397-1406.   https://doi.org/10.1158/1078-0432.CCR-16-1546|3. Nicoli ER, Al Eisa N, Cluzeau CV, Wassif CA, Gray J, Burkert KR, Smith DA, Morris L, Cologna SM, Peer CJ, Sissung TM, Uscatu CD, Figg WD, Pavan WJ, Vite CH, Porter FD, Platt FM (2016). Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease. PLoS One  11, e0152007.   https://doi.org/10.1371/journal.pone.0152007|4. O'Sullivan CC, Lindenberg M, Bryla C, Patronas N, Peer CJ, Amiri-Kordestani L, Davarpanah N, Gonzalez EM, Burotto M, Choyke P, Steinberg SM, Liewehr DJ, Figg WD, Fojo T, Balasubramaniam S, Bates SE (2016). ANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessment. Breast Cancer Res Treat  160, 51-59.   https://doi.org/10.1007/s10549-016-3972-z|5. Peer C, Ronner P, Rodgers L, McCully C, Warren K, Figg W (2016) Quantitation of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration following Intranasal or Intravenous Delivery Separations (formerly Chromatography) 3:4|6. Peer CJ, Goey AK, Sissung TM, Erlich S, Lee MJ, Tomita Y, Trepel JB, Piekarz R, Balasubramaniam S, Bates SE, Figg WD (2016). UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation. J Clin Pharmacol  56, 450-60.   https://doi.org/10.1002/jcph.627|7. Strauss J, Figg WD (2016). Using Epigenetic Therapy to Overcome Chemotherapy Resistance. Anticancer Res  36, 1-4.",https://intramural.nih.gov/search/searchview.taf?ipid=99442
754,SC006743-24,"October 01, 2016 -  September 30, 2017",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Min Jung Lee|Sunmin T Lee|Akira  Yuno|Ayzhan J Murphy,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Marc  Cox (University of Texas at El Paso)|Shiv  Srivastava (Urology, CPDR, USUHS)|Christophe  Nicot (-, University of Kansas Medical Center)|Luke  Whitesell (Pediatrics, University of Arizona)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)","Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99440
755,SC009372-26,"October 01, 2016 -  September 30, 2017",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Linda Shonk Weaver|Catharine S Mccoy|Constance M Yuan|Dalia Abdel-Raouf Salem|Bradley Austin Lezak,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Terry J Fry (Pediatric Oncology Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Wong DH, Jones J, Sun C, Marti GE, Farooqui MZ, Wiestner A (2016). Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study. Clin Cancer Res  22, 1572-82.   https://doi.org/10.1158/1078-0432.CCR-15-1965|2. Salem D, Stetler-Stevenson M, Yuan C, Landgren O (2016). Myeloma minimal residual disease testing in the United States: Evidence of improved standardization. Am J Hematol  91, E502-E503.   https://doi.org/10.1002/ajh.24540",https://intramural.nih.gov/search/searchview.taf?ipid=99403
756,BC010686-13,"October 01, 2016 -  September 30, 2017",Clinical Operations for Laboratory of Pathology,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Neil J Hardegen|Mohammad Javed Mahboob|Kayla A O'Donnell|Silke  Williams|Sarah Paige Young|Michael Kanwolo Newford,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98796
757,BC010882-10,"October 01, 2016 -  September 30, 2017",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",Susan G Mcmullen|Elizabeth A Ness|Lisa R King|Deborah Anne Grady,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98924
758,BC010963-10,"October 01, 2016 -  September 30, 2017",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniele N Avila|Hua  Zhang|Megan Irene Kenyon|Hong  Ye|Lauren R Skeffington|Jennifer Sproul Wilder|Show all 8,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98891
759,BC010987-10,"October 01, 2016 -  September 30, 2017",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98925
760,BC010990-10,"October 01, 2016 -  September 30, 2017",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98875
761,BC011022-09,"October 01, 2016 -  September 30, 2017",Clinical Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98637
762,BC011089-10,"October 01, 2016 -  September 30, 2017",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Cristiane  Leite|Nana  Yaqub-Ogun|Gustavo Emilio Pene La Grave; MD|Jonathan Barrett Bloom|Vikram Kunal Sabarwal|Dantae Lamont Bowie|Show all 15,NULL,James Q Peterson (Office Of The Clinical Director)|Rabindra  Gautam (Office Of The Clinical Director)|Kristin K Shouck (Office Of The Clinical Director)|Madge  Miles (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98962
763,BC011092-10,"October 01, 2016 -  September 30, 2017",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Cristiane  Leite|Nana  Yaqub-Ogun|Gustavo Emilio Pene La Grave; MD|Jonathan Barrett Bloom|Vikram Kunal Sabarwal|Dantae Lamont Bowie|Show all 12,NULL,James Q Peterson (Office Of The Clinical Director)|Donna  Drake (Office Of The Clinical Director)|Rabindra  Gautam (Office Of The Clinical Director)|Kristin K Shouck (Office Of The Clinical Director)|Maria  Merino; PhD (Laboratory of Pathology),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98963
764,BC011242-09,"October 01, 2016 -  September 30, 2017",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 21,Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Crystal L. Mackall; MD (Pediatric Oncology Branch),"Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD) |Karen T Adams (NICHD) |Karun  Sharma (CC) |Andrew J Mannes; MD (CC) |Sheng  Xu (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99033
765,BC011291-08,"October 01, 2016 -  September 30, 2017",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99044
766,BC011317-08,"October 01, 2016 -  September 30, 2017",Dermatology Consultation Service,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Raphaela  Goldbach-Mansky; MD, MHS (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99059
767,BC011517-05,"October 01, 2016 -  September 30, 2017",Pediatric Oncology Branch Behavioral Science Core,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI","Haven  Battles; PhD|Stacia Martin Peron; PhD|Marina  Noronha F Dearruda Colli|Kari Lyn Struemph|Mary Anne Toledo Tamula|Lori  Wiener; PhD, LCSW-C|Show all 11",NULL,"Fernanda  Arnaldez (Developmental Therapeutics Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Margaret Frances Bevans; RN, PhD (CC) |Courtney Dayle Fitzhugh (NHLBI) |John F Tisdale; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99158
768,BC011534-04,"October 01, 2016 -  September 30, 2017",EOB Clinical Core,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99217
769,BC011540-04,"October 01, 2016 -  September 30, 2017",Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99215
770,BC011541-04,"October 01, 2016 -  September 30, 2017",TGIB Surgical Consultative Services,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Paul J Nolen|Colleen Donahue Bond|Claudia Lissette Espinoza|Yvonne  Shutack|Tatiana  Beresnev|Jeremy Lee Davis; MD|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99214
771,BC011543-04,"October 01, 2016 -  September 30, 2017",Medical Oncology Service Clinical Core,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",Janet A Edds|Jeannette Christine Nashed|Kathryn G Trewhitt|Robert Lee Alderman; PA-C|Denise Lynn Winfield|George L Carter|Show all 14,NULL,Heaven Damitrius Russell (Genitourinary Malignancies Branch)|Gloria L Jackson (Experimental Transplantation and Immunology Branch)|Ravi  Madan (Genitourinary Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)|Austin Gerard Duffy (Thoracic & Oncologic Surgery Branch)|Mark Jason Roschewski (Lymphoid Malignancies Branch),Diane  Aker (CC) |Ekene  Monyei (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99212
772,BC011642-03,"October 01, 2016 -  September 30, 2017",Brain Tumor Clinical and Clinical Research Program,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Brett James Theeler|Tracy D Ani|Nancy B Garren|Deric Minwoo Park|Jing  Wu; MD, PhD|Kiera M Caffee|Show all 10",NULL,Christine M Bryla (Office Of The Clinical Director)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch),"John Anthony Butman; MD, PhD (CC) |John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Edjah K Nduom (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99237
773,BC011683-02,"October 01, 2016 -  September 30, 2017",Medical Oncology HIV-AIDS Clinical Research,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",NULL,NULL,Mark Jason Roschewski (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Priscila Hermont Goncalves; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch),Diane  Aker (CC) |Ekene  Monyei (CC) |Deborah A Kolakowski (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99255
774,BC011716-02,"October 01, 2016 -  September 30, 2017",CCR Research Nursing,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",Bazetta A Blacklock-Schuver|Cynthia B Helsabeck|Ashley Elizabeth Carpenter|Guinevere Joy Ng Chun|Suzanne E Fioravanti|Anne D Goodwin|Show all 76,NULL,Brenna  Hansen (Office of the Director)|Bonnie Dolores Yates (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99281
775,BC011729-02,"October 01, 2016 -  September 30, 2017",Chronic graft-versus-host disease in children and young adults,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Steven  Pavletic; MD, MS",NULL,NULL,"Jacqueline W Mays; DDS, PhD (NIDCR) |Maya Beth Lodish (NICHD) |Ninet  Sinaii (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99293
776,BC011792-01,"October 01, 2016 -  September 30, 2017",Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,Frederic Glenn Barr,"Laboratory of Pathology, NCI","Shannon I Skarshaug|Valerie M Zgonc|Ziedulla  Abdullaev|Armando  Filie|Elaine S Jaffe; MD|David Erwin Kleiner; MD, PhD|Show all 9",NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Christopher Joseph Melani (Lymphoid Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|Raul Eduardo Vizcardo Sakoda (Surgery Branch),"Isaac Franklin Brownell; MD, PhD (NIAMS) |Alexander M Gorbach; PhD (NIBIB) |Catherine  Lai (NHLBI) |Constantine Argyrios Stratakis; MD, DSc (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=102971
777,SC006329-37,"October 01, 2016 -  September 30, 2017",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Holly  Ning|Barbara Chin Arora|Jason Yulin Cheng; PhD|Ying  Zhuge|Peter  Guion|Mary Kathleen Hawes|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99399
778,SC007202-34,"October 01, 2016 -  September 30, 2017",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",Kieron Michael Dunleavy,NULL,"David J Venzon; PhD (Biostatistics and Data Management Section)|David J Liewehr (Biostatistics and Data Management Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",Heidi H Kong (NIAMS) |Edward W Cowen (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99395
779,BC010843-11,"October 01, 2016 -  September 30, 2017",Medical Oncology Fellowship Program,Marijo  Bilusic,"James L Gulley; MD, PhD","Genitourinary Malignancies Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98825
780,BC011023-10,"October 01, 2016 -  September 30, 2017",Clinical Fellowship Training Program,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology),NULL,"1. Hankins RA, Walton-Diaz A, Truong H, Shih J, Bratslavsky G, Pinto PA, Marston Linehan W, Metwalli AR (2016). Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney. Int Urol Nephrol  48, 1817-1821.   https://doi.org/10.1007/s11255-016-1392-y",https://intramural.nih.gov/search/searchview.taf?ipid=98984
781,BC011241-09,"October 01, 2016 -  September 30, 2017",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Stefania  Pittaluga|Nancy Ellen Diener|Alison Rozmus Huppmann; MD|Thomas A Summers; MD|Hao-Wei  Wang|Show all 11,Donald  Karcher (George Washington University Medical Center)|Michael  Borowitz (Johns Hopkins Medical School),NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G (2016). The genetic landscape of dural marginal zone lymphomas. Oncotarget  7, 43052-43061.   https://doi.org/10.18632/oncotarget.9678|2. Laurent C, Fabiani B, Do C, Tchernonog E, Cartron G, Gravelle P, Amara N, Malot S, Palisoc MM, Copie-Bergman C, Glehen AT, Copin MC, Brousset P, Pittaluga S, Jaffe ES, Coppo P (2016). Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients. Haematologica  101, 976-84.   https://doi.org/10.3324/haematol.2016.141978",https://intramural.nih.gov/search/searchview.taf?ipid=99011
782,BC011384-07,"October 01, 2016 -  September 30, 2017",Anatomic Pathology Residency Program,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Michael  Allgaeuer|Selena Tomeka Brantley|Kelly Maureen Brenan-Rothschild|Sun A  Kim|Drew Wyatt Pratt|Christopher J Trindade|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99087
783,BC011516-05,"October 01, 2016 -  September 30, 2017",Pediatric Oncology Branch Clinical Care and Education,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI","Alissa Caitlin Baker|Lingling  Chen|Sherri L Depollar|Joanne A Derdak|Mark Eric Kohler|Bonnie Wing Yin Lau; MD, PhD|Show all 25",NULL,NULL,NULL,"1. Glod J, Rahme GJ, Kaur H, H Raabe E, Hwang EI, Israel MA (2016). Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities. J Pediatr Hematol Oncol  38, 249-60.   https://doi.org/10.1097/MPH.0000000000000551",https://intramural.nih.gov/search/searchview.taf?ipid=99157
784,BC011542-04,"October 01, 2016 -  September 30, 2017",TGIB Surgical Oncology Fellowship Program,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Claudia Lissette Espinoza|Stacey Lynn Doran; MD|Christine Mari Kariya; MD|Winifred Margaret Lo; MD|Parisa None Malekzadeh; MD|Show all 20,NULL,Gabriel David Ivey (Surgery Branch)|Mohammad Shamsuddin Jafferji; MD (Surgery Branch)|Amy  Copeland (Surgery Branch)|Mackenzie Leigh Shindorf (Surgery Branch),NULL,"1. Eil R, Clever D, Klebanoff C, Sukumar M, Pan J, Palmer D, Yamamoto T, Patel S, Guittard G, Yu Z, Vodnala S, Okkenhaug K, Schrump D, Linehan W, Rosenberg S, Roychoudhuri R, Restifo N (2016) Ionic immune suppression within the tumor microenvironment limits T cell effector function. Nature, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=99213
785,BC011653-03,"October 01, 2016 -  September 30, 2017",Clinical Support,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99241
786,BC011656-03,"October 01, 2016 -  September 30, 2017",EOB Clinical and Research Fellowship Training Program,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99224
787,SC000853-64,"October 01, 2016 -  September 30, 2017",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|Mark  Raffeld; MD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99406
788,BC010856-11,"October 01, 2016 -  September 30, 2017",Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,Mary C Custer,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98855
789,BC010931-10,"October 01, 2016 -  September 30, 2017",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jennifer B Dwyer|Shelley B Hoover|John  Hickerson|Munish  Puri|Tyler John Peat|Michael Anthony Richardson; DVM|Show all 13,"Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Matti  Kiupel; PhD|John M Cullen; VMD, PhD|Margaret  Miller (Purdue)","Bih-Rong  Wei (Office Of The Director)|Amy Claire McCalla-Martin (Pediatric Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jonathan S Wiest; PhD (Center For Cancer Training)|Natasha  Caplen (Cancer Genetics Branch)|Scott K Durum; PhD (Cancer Inflammation Program)",NULL,"1. LeBlanc AK, Mazcko C, Brown DE, Koehler JW, Miller AD, Miller CR, Bentley RT, Packer RA, Breen M, Boudreau CE, Levine JM, Simpson RM, Halsey C, Kisseberth W, Rossmeisl JH, Dickinson PJ, Fan TM, Corps K, Aldape K, Puduvalli V, Pluhar GE, Gilbert MR (2016). Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients. Neuro Oncol  18, 1209-18.   https://doi.org/10.1093/neuonc/now051|2. Martin PL, Yin JJ, Seng V, Casey O, Corey E, Morrissey C, Simpson RM, Kelly K (2017). Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer. Oncogene  36, 525-533.   https://doi.org/10.1038/onc.2016.223",https://intramural.nih.gov/search/searchview.taf?ipid=98911
790,BC011689-02,"October 01, 2016 -  September 30, 2017",Comparative Oncology Trials Consortium,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",NULL,"Lisa  Barber (Veterinary Medicine, Tufts University)|Antonella  Borgatti (University of Minnesota)|E  Ehrhart (Colorado State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Carolyn  Henry (Veterinary Medicine, University of Missouri)|Michael  Kent (UC Davis)|Show all 39",James Halpern Doroshow (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99260
791,BC011735-02,"October 01, 2016 -  September 30, 2017",Development of Novel Preclinical Animal Models - CAPR Infrastructure,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Bonita Anne Sears|Rajaa  Elmeskini|Zoe W Ohler|Melanie  Gordon|Jerome  Schlomer|Ludmila  Szabova; MS, PhD|Show all 10","Guillermina Gigi  Lozano (MD Anderson)|Michael  Oberst (MedImmune, Inc.)",N Keith Collins (Basic Research Laboratory)|Debra J Gilbert (Basic Research Laboratory)|Xiuyun  Lu (Basic Research Laboratory)|Theresa N O'Sullivan (Basic Research Laboratory)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Udo  Rudloff (Thoracic & Oncologic Surgery Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99299
792,BC011235-09,"October 01, 2016 -  September 30, 2017",Support of NCI CCR Clinical Research and Bioinformatics,Jason Edward Levine,Thomas A Misteli; PhD,"Office of the Director, NCI",Ming  Ji|Ravi Sankar Srinivas Dinavahi|Christian Jose Mambrin|Richard J Moon|Rohit  Paul|James  Waters,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Pamela  Wolters (Pediatric Oncology Branch)|Stacia Martin Peron; PhD (Pediatric Oncology Branch),Heidi H Kong (NIAMS) |Jon W McKeeby (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99023
793,BC011445-06,"October 01, 2016 -  September 30, 2017",Mathematical Modeling of cell colony growth and DNA Replication.,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir|Kandice Danielle Tanner; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99116
794,BC011703-02,"October 01, 2016 -  September 30, 2017","Integrated analyses of genetics, epigenetics, and gene expression",Maxwell P Lee; PhD,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Howard H Yang|Huaitian  Liu|Lalage  Wakefield; PhD|Kent W Hunter; PhD|Jeffrey E Green; MD|Beverly  Mock; PhD|Show all 11,Kathleen  Arcaro (University of Massachusetts)|Hai  Hu (Windber Research Institute)|Sulma Ibrahim Mohammed,"Dinah  Singer; PhD (Experimental Immunology Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Masaki  Terabe (Vaccine Branch)|Philip  Taylor; MD, ScD (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99271
795,CO020005-09,"October 01, 2016 -  September 30, 2017",National Cancer Informatics Program (NCIP),Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Anthony Robert Kerlavage|Warren Alden Kibbe,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99312
796,CP010205-09,"October 01, 2016 -  September 30, 2017",Scientific Computing,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Alyssa Marie Voss|Geoffrey Scott Tobias,NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Amanda  Black (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99370
797,BC011234-09,"October 01, 2016 -  September 30, 2017",CCR New Space Activation,Darren W Henderson,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99006
798,CO020002-09,"October 01, 2016 -  September 30, 2017",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99310
799,BC011133-09,"October 01, 2016 -  September 30, 2017",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",NULL,NULL,Viola D Black (Center For Cancer Training)|Terry  Moody; PhD (Center For Cancer Training)|Mary L Velthuis (Center For Cancer Training)|Keyonna  Earle (Center For Cancer Training)|Ravi  Dhar; PhD (Center For Cancer Training),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98638
800,BC011285-08,"October 01, 2016 -  September 30, 2017",CCR Education and Outreach,Melissa A Bronez,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99041
801,BC011365-05,"October 01, 2016 -  September 30, 2017","Cancer, Genetics, and Signaling Training Program",Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98635
802,CP010204-09,"October 01, 2016 -  September 30, 2017","Communications, Education and Outreach","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Alyssa Marie Voss|Catherine B McClave|Wendy  Schneider-Levinson|Jennifer K Loukissas|Victoria Anne McCallum|Jackie Ann Lavigne,NULL,Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99369
803,CP010208-08,"October 01, 2016 -  September 30, 2017",Special Studies Institutional Review Board Support,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine G Schairer|Catherine B McClave,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99374
804,BC010857-11,"October 01, 2016 -  September 30, 2017",Science and Technology Resources,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Mariam Q Malik|Margaret  Cam; PhD|Peter C Fitzgerald|Carl E Mcintosh,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=98857
805,CO020001-09,"October 01, 2016 -  September 30, 2017",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Karen M Maurey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=99309
